Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABAT GABAT ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674565-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.3;liver: 136.5;pancreas: 54.2" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 234.8;Proximal tubular cells: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria No No 1500000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favorable (5.36e-5)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favorable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 2.1 12.6 26.1 2.7 39.3 1.7 3.2 19.9 43.3 2.2 5.2 10.9 0.1 17.5 2.1 5.0 3.0 2.8 2.7 6.2 20.4 30.9 53.3 136.5 2.8 2.8 24.5 26.1 5.3 54.2 4.0 22.1 2.3 14.3 9.9 4.2 2.6 2.6 2.5 1.4 2.1 8.4 2.1 14.1 2.5 3.9 6.3 11.8 1.0 12.7 0.4 3.3 6.4 1.1 2.2 1.9 8.8 5.8 1.6 2.5 1.8 0.2 0.0 12.1 6.9 1.9 0.7 0.5 1.4 0.8 0.7 0.2 4.5 0.3 1.4 0.5 0.8 0.4 3.1 0.8 2.8 0.9 0.8 0.6 2.0 0.0 45.3 3.1 0.4 3.1 2.5 1.3 1.2 0.5 0.3 0.2 3.9 0.3 1.0 0.2 29.1 0.7 0.2 1.0 8.5 0.1 3.5 25.6 0.6 0.4 7.2 1.9 5.8 0.7 0.4 0.0 2.5 15.9 1.2 0.2 0.2 2.0 0.9 0.0 1.1 0.1 0.3 0.3 2.1 1.4 1.1 3.1 4.1 2.5 3.6 1.1 0.8 1.7 1.7 1.9 2.2 1.1 1.8 8.8 1.6 5.8 0.3 1.6 1.8 26.1 39.3 19.9 35.1 20.4 30.9 24.5 26.1 14.3 11.8 0.0 5.8 12.2 3.3 1.3 16.6 8.9 15.3 2.7 7.9 1.8 3.9 1.2 19.9 1.2 8.3 1.4 10.3 0.0 5.5 1.2 2.1 9.6 1.1 234.8 4.3 33.4 15.0 5.5 9.1 6.0 3.4 5.4 1.7 0.0 4.9 48.7 6.3 6.5 4.2 72.0 6.0 0.0 2.5 1.5 0.9 0.5 1.1 7.2 6.8 4.2 ABCC2 "CMOAT, cMRP, DJS, MRP2" ENSG00000023839 "ATP binding cassette subfamily C member 2" Q92887 10 99782732-99852192 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 28.4;kidney: 25.6;liver: 74.3" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 52.9" "Cancer enhanced" "Detected in many" "liver cancer: 24.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.1" "Group enriched" "Detected in some" 5 "A549: 60.2;Hep G2: 60.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA071145 Enhanced NA NA "HPA071145: " "unprognostic (1.49e-3)" "unprognostic (5.92e-2)" "unprognostic (1.59e-1)" "unprognostic (3.67e-1)" "unprognostic (1.93e-2)" "unprognostic (2.33e-1)" "unprognostic (2.51e-1)" "unprognostic (7.15e-3)" "unprognostic (5.68e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (1.40e-3)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.95e-1)" "unprognostic (1.26e-2)" 0.8 0.3 0.1 0.1 0.1 0.1 1.1 0.3 0.1 0.2 13.4 0.1 0.1 16.1 0.3 0.5 0.2 0.4 13.7 0.2 0.1 0.1 25.6 74.3 0.3 0.1 0.1 0.1 0.2 0.6 0.0 0.1 1.2 0.1 0.3 0.0 0.1 0.3 0.1 0.6 0.6 28.4 0.1 0.2 0.8 0.4 0.4 0.1 0.1 0.3 0.4 0.1 0.7 0.3 0.3 0.7 4.1 0.2 0.1 0.5 0.0 0.0 60.2 0.9 3.0 4.6 3.5 1.0 0.1 0.3 0.1 0.2 12.9 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.2 60.0 0.1 0.0 0.2 0.6 4.1 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.1 11.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.9 7.4 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.2 0.0 0.0 4.9 1.0 0.3 4.1 0.2 0.3 0.3 0.0 0.4 0.2 0.3 0.1 0.3 0.3 0.3 0.1 1.3 0.1 0.1 0.7 0.5 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.2 0.4 2.5 4.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.1 52.9 0.2 0.0 0.0 0.6 1.3 0.2 0.3 0.0 5.0 0.0 0.0 0.2 0.1 0.0 0.0 9.1 1.4 0.0 0.4 0.7 0.3 0.0 1.4 0.0 0.0 0.0 AC012531.3 ENSG00000273049 12 53985845-54034888 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 8.6;kidney: 24.3;skeletal muscle: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.5" "Lineage enriched" "Detected in single" 26 "T-cells: 2.5" "Cell line enhanced" "Detected in some" "AN3-CA: 13.6;fHDF/TERT166: 3.2;HDLM-2: 5.0" NA NA 8.6 0.9 0.1 0.1 0.2 0.0 1.2 0.1 0.1 1.0 0.4 0.0 0.0 0.2 2.0 4.5 0.8 2.8 0.0 0.4 0.1 0.1 24.3 0.3 0.3 1.2 0.1 0.0 3.2 0.5 0.8 0.2 1.1 0.1 0.7 0.0 0.0 0.3 0.0 10.3 0.8 1.2 1.3 0.4 0.3 0.7 1.1 0.0 0.0 0.4 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.6 0.9 0.0 13.6 1.1 0.0 0.0 0.2 0.2 0.7 0.2 0.0 1.2 0.0 0.3 3.2 0.1 1.5 0.0 0.0 0.0 5.0 0.0 0.0 0.3 0.3 0.3 0.0 0.4 0.4 0.0 0.4 0.4 0.0 0.0 0.2 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.7 0.1 0.3 1.3 0.3 2.5 0.1 0.0 0.8 1.9 1.3 0.3 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC026461.4 ENSG00000275691 16 56676132-56677763 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "blood: 1.1;intestine: 2.7;kidney: 1.0;thyroid gland: 2.7" "Group enriched" "Detected in some" 6 "Distal tubular cells: 1.7;Proximal tubular cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;naive CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.03e-1)" "unprognostic (2.92e-2)" "unprognostic (2.63e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 2.7 0.1 0.0 0.3 0.0 0.0 0.6 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.5 0.0 0.3 0.2 0.1 0.0 0.1 1.1 0.0 0.0 0.1 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC117457.1 ENSG00000275163 3 178419123-178843300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 1.4;Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HSkMC: 5.7" NA NA 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.1 2.9 0.0 0.0 0.0 11.8 0.0 12.2 0.3 0.2 0.3 5.2 0.2 1.5 0.0 0.0 0.0 2.6 2.9 0.0 19.9 0.0 11.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC126283.2 ENSG00000285330 4 109713916-109801999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "kidney: 61.8;liver: 135.8" "Group enriched" "Detected in some" 60 "Alveolar cells type 2: 2.9;Club cells: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.6;EFO-21: 5.2;Hep G2: 9.6;RPTEC TERT1: 9.8" "HPA001143, HPA024061, HPA035909" Uncertain NA NA "HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074" 2.4 2.3 0.4 2.0 0.4 0.0 1.6 0.0 1.3 2.6 2.2 0.1 1.3 3.8 2.2 7.6 2.4 1.8 2.5 2.6 0.5 61.8 135.8 4.3 1.5 0.6 0.0 6.6 6.5 0.7 2.0 2.2 1.1 2.0 0.7 4.0 0.5 0.7 1.4 0.0 3.9 0.8 1.4 4.7 1.3 1.8 0.4 0.0 3.0 0.9 0.4 2.6 1.8 0.2 0.8 0.2 0.3 0.2 0.7 1.2 0.0 0.5 0.0 0.3 0.2 0.1 0.0 0.4 1.0 0.0 0.1 0.1 27.6 0.1 5.2 0.2 0.2 0.0 0.1 0.0 0.0 4.2 0.1 0.0 0.4 9.6 3.3 0.3 0.0 3.5 0.0 0.0 0.1 0.5 1.8 0.0 0.3 1.6 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.1 9.8 0.8 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 4.2 0.1 1.2 0.2 0.3 0.0 0.3 0.0 0.4 0.1 0.5 0.3 0.7 0.2 0.7 0.5 0.0 0.2 0.2 0.8 0.5 1.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAD11 FLJ12592 ENSG00000240303 "Acyl-CoA dehydrogenase family member 11" Q709F0 3 132558138-132660723 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 35.0;liver: 42.7" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Intestinal endocrine cells: 4.6;Syncytiotrophoblasts: 8.1" "Cancer enhanced" "Detected in single" "renal cancer: 1.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048317 Enhanced NA NA "HPA048317: AB_2680354" "unprognostic (5.04e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (3.31e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-4)" "unprognostic (1.20e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (5.90e-2)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (1.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.71e-2)" "unprognostic (2.93e-1)" 10.0 7.6 4.9 2.6 9.6 6.3 5.2 5.4 8.0 7.4 9.8 7.2 6.8 11.1 7.2 8.3 3.2 6.4 4.2 8.8 6.6 3.9 35.0 42.7 4.9 3.2 12.9 3.8 7.6 5.9 3.8 13.9 5.9 8.7 4.7 2.7 5.5 4.7 7.4 3.7 6.9 18.8 4.9 12.6 4.5 4.0 5.3 10.2 4.0 5.5 2.3 3.3 5.4 4.7 1.9 2.3 0.2 0.8 2.4 3.7 0.9 4.0 4.0 5.8 8.1 6.2 6.5 7.6 8.7 12.6 4.5 5.8 11.6 1.3 2.8 5.3 3.4 6.6 3.4 3.2 5.7 4.9 4.9 4.1 3.3 3.3 8.5 8.8 2.3 2.3 4.9 3.9 5.9 11.5 9.4 4.2 3.1 1.8 5.4 4.8 5.3 2.3 2.6 3.7 1.9 4.4 2.5 4.7 4.0 7.8 2.2 3.4 5.5 7.5 3.0 18.1 4.4 8.2 2.6 4.0 3.4 1.9 2.5 3.4 5.7 1.8 3.0 4.6 0.9 2.7 0.0 0.7 0.2 1.6 0.8 1.6 1.3 1.4 0.7 0.5 1.9 3.7 1.7 0.0 2.4 0.8 2.3 0.7 0.9 4.9 9.6 5.4 8.0 6.6 3.9 12.9 3.8 8.7 10.2 6.0 2.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.7 0.6 0.5 0.9 0.0 1.0 0.6 0.7 0.2 1.1 3.0 0.6 0.0 4.6 0.0 1.5 0.0 0.6 0.3 0.0 3.6 0.0 1.0 0.3 0.0 0.7 1.1 1.9 0.0 0.4 0.0 0.2 0.3 8.1 0.0 0.8 0.1 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058311 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 28.9;liver: 114.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 481.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041458, HPA063555" Enhanced Supported Mitochondria NA NA 63000 Mitochondria "HPA041458: AB_2677491, HPA063555: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favorable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favorable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 4.6 9.4 6.7 2.4 9.0 1.4 8.3 10.3 8.3 3.9 5.3 5.5 6.4 16.8 4.1 3.3 4.4 4.1 3.1 13.7 8.5 4.8 28.9 114.2 4.3 2.7 5.1 8.2 5.0 5.3 8.0 4.9 1.9 7.5 7.9 5.8 4.9 5.6 6.0 12.7 4.7 5.5 5.2 4.8 2.7 4.8 2.9 5.4 3.6 4.3 7.9 3.9 5.0 4.1 6.3 6.8 13.5 5.0 9.0 11.7 6.0 9.7 7.0 5.2 9.5 7.1 8.9 4.6 6.0 12.2 6.1 6.1 6.1 3.2 10.2 4.2 5.1 3.7 4.1 8.1 4.2 10.1 6.6 8.4 5.3 2.1 35.3 5.0 7.5 5.1 6.5 4.3 3.8 3.5 9.0 5.8 8.6 5.1 7.5 7.5 4.5 7.1 6.2 3.2 5.4 4.4 8.5 10.9 3.2 8.6 10.8 1.0 6.0 9.2 2.8 9.5 5.2 8.4 3.7 6.1 3.3 3.0 7.5 7.3 8.5 9.6 5.4 5.1 7.1 2.5 13.5 5.0 12.3 10.0 5.0 11.7 5.9 9.4 8.6 6.8 6.3 8.9 9.9 3.2 9.0 3.0 4.1 7.6 6.0 6.7 9.0 10.3 8.3 8.5 4.8 5.1 8.2 7.5 5.4 26.8 40.3 7.3 7.2 8.2 17.2 64.9 43.3 17.4 29.6 10.4 9.8 17.9 39.7 6.4 6.0 7.4 6.8 0.0 4.2 2.5 7.5 26.5 3.5 481.6 6.3 20.6 11.6 15.4 11.8 7.8 12.4 7.6 6.8 8.2 13.3 12.2 4.3 5.8 10.3 116.2 7.3 19.4 11.3 9.7 2.5 12.0 25.2 13.8 15.7 10.7 ACMSD ENSG00000153086 "Aminocarboxymuconate semialdehyde decarboxylase" Q8TDX5 2 134838547-134902034 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "kidney: 44.8;liver: 64.1" "Cell type enhanced" "Detected in some" 29 "Cholangiocytes: 58.6;Distal tubular cells: 46.4;Hepatocytes: 104.7;Proximal tubular cells: 312.9" "Group enriched" "Detected in some" 23 "liver cancer: 21.2;renal cancer: 19.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 24.8" "Not detected" "Not detected" "HPA010533, HPA011179" Enhanced NA NA 11000 "HPA010533: AB_1844517, HPA011179: AB_1844516" "unprognostic (1.06e-2)" "unprognostic (5.30e-2)" "unprognostic (1.40e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-1)" "unprognostic (5.35e-4)" "unprognostic (7.60e-2)" "unprognostic (5.17e-2)" "unprognostic (2.44e-3)" "prognostic favorable (2.39e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (2.65e-5)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 2.5 0.0 0.0 0.0 44.8 64.1 0.1 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.4 0.9 0.6 0.2 1.7 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.3 0.6 0.2 1.1 0.1 0.5 0.1 0.5 0.2 24.8 0.3 1.0 0.3 0.1 0.2 0.4 0.7 0.2 0.6 0.8 0.0 0.3 0.2 0.7 0.2 0.1 0.4 0.2 0.3 0.6 0.0 0.6 0.9 0.9 0.5 0.4 1.5 0.9 1.3 0.9 1.1 1.7 0.9 0.4 0.2 0.5 1.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 58.6 0.0 0.0 8.7 0.0 0.0 46.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.7 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 312.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACOT6 C14orf42 ENSG00000205669 "Acyl-CoA thioesterase 6" Q3I5F7 14 73610945-73619888 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.8;liver: 6.1;skeletal muscle: 6.5" "Cell type enhanced" "Detected in some" 21 "Hepatocytes: 2.4;Proximal tubular cells: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "T-47d: 15.3" HPA058258 Uncertain NA NA "HPA058258: AB_2683656" "unprognostic (1.88e-1)" "unprognostic (1.77e-1)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.15e-2)" "unprognostic (6.52e-2)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (2.28e-1)" "unprognostic (5.04e-1)" 2.6 1.0 1.5 0.0 2.0 0.0 0.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.8 0.6 6.8 6.1 0.0 0.0 0.8 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.1 0.0 0.9 1.4 0.0 0.0 0.0 0.1 1.8 0.0 0.6 0.0 1.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 1.0 2.8 0.1 0.0 15.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.1 0.8 1.8 0.1 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.5 5.0 15.3 2.3 3.4 5.0 9.9 12.3 18.5 6.0 5.1 2.8 4.6 5.8 1.8 11.4 6.0 7.5 4.4 10.3 1.5 21.8 4.6 1.3 9.6 22.2 17.5 6.4 0.8 18.0 6.8 7.9 1.2 3.4 5.4 11.6 3.1 4.1 0.4 18.2 4.6 7.8 1.9 15.2 1.6 37.7 8.5 4.6 4.5 6.9 4.7 5.5 6.0 8.8 5.1 9.2 2.9 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 26.8 22.4 2.4 22.9 5.4 0.0 17.3 10.2 12.0 17.0 3.5 0.0 70.1 10.0 10.9 0.2 5.2 47.0 0.0 3.9 9.5 5.9 3.5 21.9 34.1 19.9 0.0 9.8 4.3 8.8 1.3 24.7 11.5 3.3 15.4 19.9 6.6 4.5 35.1 13.4 99.5 0.2 0.0 3.9 0.0 2.7 6.0 67.7 5.7 18.3 10.6 ACSM2A "A-923A4.1, ACSM2, MGC150530" ENSG00000183747 "Acyl-CoA synthetase medium chain family member 2A" Q08AH3 16 20451461-20487667 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 90 "kidney: 63.5;liver: 82.6" "Group enriched" "Detected in some" 13 "Hepatocytes: 567.1;Proximal tubular cells: 367.9" "Group enriched" "Detected in some" 479 "liver cancer: 22.7;renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Hep G2: 6.6" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.17e-4)" "prognostic favorable (1.41e-5)" "unprognostic (5.25e-1)" "unprognostic (2.42e-1)" "unprognostic (9.28e-3)" "unprognostic (1.52e-1)" "unprognostic (5.10e-1)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.0 63.5 82.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 25.5 0.0 0.2 0.0 0.3 35.7 0.0 0.0 7.0 0.0 0.0 26.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 567.1 0.0 0.0 0.0 21.5 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 367.9 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.5 0.0 0.0 ACSM2B "ACSM2, HXMA, HYST1046" ENSG00000066813 "Acyl-CoA synthetase medium chain family member 2B" Q68CK6 16 20536226-20576427 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "kidney: 76.1;liver: 93.4" "Group enriched" "Detected in some" 13 "Hepatocytes: 830.9;Proximal tubular cells: 347.6" "Group enriched" "Detected in some" 450 "liver cancer: 30.9;renal cancer: 17.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 5.5;Hep G2: 10.1" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.34e-2)" "prognostic favorable (3.31e-4)" "unprognostic (7.13e-2)" "unprognostic (2.29e-1)" "unprognostic (6.67e-2)" "unprognostic (1.24e-1)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 76.1 93.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.9 1.0 0.5 0.2 1.2 0.0 1.0 0.0 5.5 1.5 0.0 0.0 1.4 0.9 0.2 0.0 0.0 1.2 0.9 0.1 2.8 0.0 0.9 0.8 0.0 0.0 0.0 1.0 0.7 0.3 1.3 10.1 0.0 1.3 1.4 0.0 0.0 0.0 0.4 0.8 0.6 0.3 0.9 1.2 0.0 0.7 0.6 1.3 1.2 1.7 0.0 0.1 1.2 0.2 0.4 0.2 1.9 1.0 2.7 0.0 1.0 0.2 2.0 0.4 0.0 0.0 1.0 0.0 0.8 0.8 0.5 0.7 0.7 3.5 1.9 0.5 0.5 0.2 0.6 0.0 0.6 0.1 0.8 0.2 0.1 0.6 0.7 1.2 1.0 0.2 0.1 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 41.9 0.0 0.2 0.0 0.3 28.1 0.0 0.0 7.0 0.0 0.0 29.9 0.1 0.7 0.5 0.0 46.7 0.0 0.0 0.0 0.0 0.0 830.9 0.1 0.0 1.7 23.9 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 347.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACY1 ENSG00000243989 "Aminoacylase 1" Q03154 3 51983278-51989202 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "intestine: 53.3;kidney: 91.6;liver: 77.8" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 70.2;Erythroid cells: 23.3;Proximal tubular cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB003695, HPA036174, HPA036175" Enhanced NA NA 28000000 "CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989" "unprognostic (4.28e-2)" "unprognostic (1.89e-1)" "unprognostic (2.10e-1)" "unprognostic (2.48e-3)" "unprognostic (3.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.08e-2)" "unprognostic (2.36e-2)" "unprognostic (2.70e-2)" "prognostic favorable (2.93e-4)" "unprognostic (3.57e-1)" "unprognostic (3.75e-1)" "unprognostic (7.88e-2)" "prognostic favorable (6.77e-4)" 4.4 8.5 2.5 3.9 3.0 1.5 4.4 1.5 3.3 3.2 24.9 4.1 9.8 34.5 1.9 7.9 3.8 3.0 8.4 4.1 2.3 1.8 91.6 77.8 3.5 6.3 2.8 2.9 2.1 9.0 6.2 1.9 4.3 2.9 3.7 6.2 6.6 9.4 9.2 7.6 2.6 53.3 2.1 3.5 3.4 4.9 1.5 1.7 0.6 5.9 6.7 4.1 3.3 2.5 5.0 12.1 3.8 10.0 12.1 6.4 4.5 3.9 8.0 3.9 10.8 9.0 12.1 12.8 4.2 7.9 9.3 5.1 12.4 20.8 2.5 3.5 7.3 3.4 4.9 4.0 25.6 3.7 6.9 5.1 8.9 4.6 38.3 16.6 6.0 5.8 14.0 21.2 8.2 22.1 7.6 3.5 4.4 13.4 7.9 9.1 11.1 0.0 11.0 5.7 25.3 13.6 3.1 3.3 22.5 24.3 15.0 5.5 5.0 5.3 17.5 9.2 1.6 14.1 7.9 1.7 6.7 6.4 8.3 4.9 20.9 4.9 3.8 7.8 12.5 8.0 3.8 10.0 0.2 6.4 9.0 3.6 5.0 2.0 2.8 12.1 4.0 3.3 4.0 0.0 12.1 3.4 1.9 2.7 4.5 2.5 3.0 1.5 3.3 2.3 1.8 2.8 2.9 2.9 1.7 3.0 2.7 0.8 0.8 0.6 0.0 0.1 2.5 2.7 3.4 5.2 0.0 3.3 8.3 12.2 0.2 0.5 70.2 23.3 7.4 3.7 0.8 0.5 6.9 10.9 1.7 0.0 2.4 1.8 2.1 0.4 0.6 2.4 0.0 16.2 9.3 0.8 12.6 21.0 0.0 35.6 0.9 0.0 0.5 0.0 0.2 0.4 3.4 1.5 12.1 0.3 ACY3 "ACY-3, HCBP1, MGC9740" ENSG00000132744 "Aminoacylase 3" Q96HD9 11 67642555-67650659 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 72.2;kidney: 28.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 163.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.1" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;monocytes: 21.1" "Cell line enhanced" "Detected in some" "CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0" "Low region specificity" "Detected in all" "HPA039219, HPA048187" Enhanced NA NA "HPA039219: AB_10671872, HPA048187: AB_2680306" "unprognostic (8.37e-3)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (1.43e-1)" "unprognostic (7.37e-4)" "unprognostic (2.44e-3)" "unprognostic (1.15e-1)" "unprognostic (3.21e-1)" "unprognostic (2.63e-3)" "unprognostic (1.07e-1)" "unprognostic (8.24e-2)" "unprognostic (2.68e-2)" "unprognostic (1.48e-3)" 0.1 0.1 3.4 1.8 5.5 0.6 0.5 0.8 7.8 5.5 13.0 15.3 0.2 38.2 0.3 2.1 0.7 0.4 6.1 0.1 3.1 2.9 28.9 18.3 0.2 3.1 4.6 5.1 0.1 11.2 0.0 0.3 0.1 7.1 0.4 2.2 0.3 1.2 0.2 0.1 0.1 72.2 0.1 5.2 0.9 5.9 0.1 2.8 0.7 0.2 0.0 4.2 0.2 0.2 1.1 5.9 0.0 21.1 2.3 0.9 1.2 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.1 9.5 34.5 0.4 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 1.2 1.5 0.0 9.6 0.0 1.1 0.0 6.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.3 0.0 0.5 0.0 0.1 4.9 0.5 1.0 0.2 0.1 2.6 1.1 0.9 0.6 0.0 2.3 21.1 5.9 0.0 1.2 3.4 5.5 0.8 7.8 3.1 2.9 4.6 5.1 7.1 2.8 0.0 1.7 6.3 0.1 0.0 0.0 0.4 10.2 0.0 1.2 21.0 0.0 0.2 26.6 3.5 0.0 0.0 11.8 0.0 9.0 0.2 0.0 0.6 0.0 17.9 1.7 0.0 1.2 0.0 0.3 0.0 0.0 0.9 5.0 0.0 25.1 0.0 6.8 5.9 0.0 163.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 6.6 0.8 ADGRF1 "GPR110, hGPCR36, PGR19" ENSG00000153292 "Adhesion G protein-coupled receptor F1" Q5T601 6 46997703-47042363 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.4" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038438 Approved "Secreted - unknown location" NA NA "HPA038438: AB_10672645" "unprognostic (4.83e-4)" "unprognostic (1.38e-1)" "unprognostic (1.64e-1)" "unprognostic (6.71e-3)" "unprognostic (1.95e-3)" "unprognostic (3.02e-3)" "unprognostic (7.76e-2)" "unprognostic (2.63e-2)" "unprognostic (2.90e-1)" "unprognostic (4.20e-2)" "unprognostic (3.64e-3)" "unprognostic (1.99e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.41e-2)" "unprognostic (8.39e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 6.5 6.1 0.0 3.7 0.1 1.3 4.2 15.7 0.8 10.0 0.0 0.0 0.0 27.4 0.1 5.4 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.6 0.0 7.5 0.2 0.0 3.2 1.9 0.1 0.1 5.5 2.1 0.1 0.1 1.5 1.3 0.0 0.0 11.3 5.6 12.3 16.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.7 0.0 0.0 8.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 13.0 0.0 0.0 0.0 18.3 45.7 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.9 0.0 12.6 0.0 0.0 0.4 15.3 26.8 25.0 102.9 0.0 0.0 19.9 25.6 0.0 0.0 0.0 0.0 16.7 0.0 0.0 30.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 59.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.4 305.8 AGMAT FLJ23384 ENSG00000116771 Agmatinase Q9BSE5 1 15572353-15585110 "Enzymes, Predicted intracellular proteins" "Putrescine biosynthesis, Spermidine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3;kidney: 54.7;liver: 66.1" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 278.6" "Group enriched" "Detected in all" 5 "colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.6;T-cells: 10.5" "Cell line enhanced" "Detected in many" "CACO-2: 19.0;Hep G2: 46.0;RPMI-8226: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA026443, HPA028321" Enhanced NA NA 250000 "HPA026443: AB_1844644, HPA028321: AB_10600779" "unprognostic (2.27e-2)" "unprognostic (3.45e-1)" "unprognostic (1.79e-3)" "unprognostic (3.60e-2)" "unprognostic (8.72e-2)" "unprognostic (6.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.37e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.13e-4)" "unprognostic (4.43e-3)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-2)" 0.7 0.8 0.7 2.8 0.5 0.1 0.4 0.2 1.0 0.2 14.9 0.3 0.0 7.1 0.3 1.2 0.5 0.2 3.6 0.3 0.6 0.8 54.7 66.1 0.2 1.3 0.7 0.3 0.2 1.1 1.3 0.4 0.2 0.6 0.3 2.8 0.1 9.6 0.0 12.3 0.2 21.3 0.1 0.3 1.0 0.5 0.5 0.1 1.0 0.3 1.7 1.5 0.4 0.2 4.6 0.4 1.4 0.3 0.4 10.5 2.8 4.0 3.2 0.2 0.1 0.0 0.4 0.1 0.7 0.7 0.4 0.2 19.0 2.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 3.9 0.0 2.5 2.7 46.0 0.5 2.0 0.0 0.5 0.2 1.3 0.0 0.3 0.4 0.0 0.0 5.4 1.0 4.3 0.0 1.9 4.3 3.2 1.8 0.0 0.0 11.4 0.1 1.0 0.7 0.6 5.5 0.2 0.6 0.2 0.7 3.8 0.5 0.1 0.1 1.0 0.0 0.1 3.0 2.6 0.2 0.0 0.0 0.9 0.3 0.2 2.4 0.3 3.1 4.6 5.7 3.0 0.2 3.2 10.5 5.9 1.4 0.4 0.2 0.4 7.1 2.8 0.7 0.5 0.2 1.0 0.6 0.8 0.7 0.3 0.6 0.1 0.0 0.0 3.2 1.5 0.2 1.2 0.4 5.1 1.4 0.0 3.5 0.0 0.7 26.6 0.8 6.9 0.1 12.9 0.0 0.8 0.7 0.7 0.9 0.0 38.9 0.9 3.2 1.2 1.8 2.2 3.6 0.3 0.4 1.7 1.0 6.7 0.8 2.0 3.5 0.0 278.6 1.7 0.0 0.4 1.6 2.9 0.5 0.7 5.0 13.8 2.6 AGXT2 AGT2 ENSG00000113492 "Alanine--glyoxylate aminotransferase 2" Q9BYV1 5 34998101-35048135 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "kidney: 63.2;liver: 63.3" "Group enriched" "Detected in some" 5 "Hepatocytes: 87.7;Proximal tubular cells: 319.5" "Group enriched" "Detected in some" 112 "liver cancer: 9.2;renal cancer: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "T-47d: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037382 Enhanced NA NA 7300 "HPA037382: AB_10670851" "unprognostic (2.61e-1)" "unprognostic (1.40e-2)" "prognostic favorable (7.47e-4)" "unprognostic (8.24e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 63.2 63.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.7 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.0 0.0 0.0 1.8 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 319.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AIF1L "C9orf58, FLJ12783, IBA2" ENSG00000126878 "Allograft inflammatory factor 1 like" Q9BQI0 9 131096476-131123152 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 128.9;lymphoid tissue: 92.1" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 338.5;Distal tubular cells: 245.4;Extravillous trophoblasts: 271.1;Proximal tubular cells: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.8" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.8" "Cell line enhanced" "Detected in many" "AF22: 35.3;MCF7: 23.2;NTERA-2: 26.5;RPTEC TERT1: 76.2;SuSa: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020522, HPA056852" Enhanced NA NA "HPA020522: AB_2670463, HPA056852: AB_2683256" "unprognostic (2.59e-2)" "unprognostic (1.83e-3)" "unprognostic (2.55e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-2)" "unprognostic (2.01e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.77e-1)" "unprognostic (4.39e-1)" "unprognostic (2.81e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.54e-6)" "unprognostic (2.48e-2)" "unprognostic (2.37e-1)" "unprognostic (1.38e-2)" "unprognostic (6.20e-2)" 20.5 3.1 31.4 3.3 35.4 2.2 17.4 7.7 24.9 7.6 3.6 42.9 42.1 1.9 5.5 6.1 28.2 6.3 5.1 10.4 36.9 22.4 128.9 1.9 7.0 2.0 45.3 12.4 2.9 3.4 13.2 5.5 12.4 27.3 3.4 4.0 5.9 15.2 39.4 7.4 7.4 2.6 6.1 59.9 92.1 2.8 4.2 25.4 0.0 45.0 7.7 5.2 5.8 6.9 0.1 0.0 0.0 0.0 1.8 0.4 0.2 0.1 0.5 35.3 6.1 0.0 0.0 14.7 0.0 0.0 0.0 0.0 6.3 2.7 0.0 16.0 0.0 0.7 3.3 5.2 0.3 0.2 0.0 6.8 3.5 1.8 12.5 0.0 0.0 1.8 0.3 1.6 0.1 0.1 0.1 1.6 9.6 2.3 0.0 0.0 23.2 2.1 0.4 26.5 2.1 2.4 0.0 0.4 9.7 76.2 2.0 13.4 2.2 1.8 15.0 4.9 21.9 14.2 0.2 0.2 0.9 2.6 0.1 7.2 0.1 0.1 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 31.4 35.4 7.7 24.9 36.9 22.4 45.3 12.4 27.3 25.4 0.0 0.0 0.0 1.8 3.7 0.0 3.9 0.0 0.0 2.3 338.5 0.0 2.9 245.4 1.6 1.1 17.3 0.0 0.0 0.7 271.1 15.3 4.2 0.0 0.0 6.2 0.0 3.5 17.8 0.3 1.7 34.8 0.8 64.1 0.0 1.9 14.5 4.7 0.0 55.5 142.6 0.0 0.0 4.1 0.3 2.3 2.0 17.6 0.0 1.1 1.4 AIFM1 "AIF, CMTX4, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130129362-130165887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 66.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 148.9;Proximal tubular cells: 209.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 160000 Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 9.9 28.9 7.1 11.3 8.6 5.3 7.1 7.5 8.9 10.4 14.2 8.4 10.0 19.6 9.9 11.7 8.6 13.0 11.4 34.2 7.2 7.0 66.8 50.5 5.8 9.8 8.2 7.1 7.3 14.6 16.8 7.7 6.1 8.8 6.9 14.2 12.3 13.1 9.4 35.7 5.8 23.2 8.9 6.4 8.7 14.9 14.9 7.2 19.5 7.9 16.1 9.7 8.4 6.0 10.8 22.0 9.8 18.3 15.8 12.8 8.0 16.8 31.2 12.8 32.0 14.6 10.4 16.9 10.7 9.3 16.5 13.3 22.1 12.5 36.4 37.3 9.8 19.6 16.3 39.4 13.9 17.6 13.9 24.0 23.1 23.5 30.0 18.6 20.2 24.3 12.9 13.7 17.5 15.0 9.2 13.9 27.5 19.8 16.9 11.6 40.6 20.5 31.7 9.2 34.0 24.2 18.6 14.3 42.1 37.3 17.1 16.5 9.6 12.5 28.9 27.8 15.2 14.9 18.3 10.1 7.9 7.6 21.4 20.3 9.0 14.6 17.0 10.1 33.9 11.8 2.9 14.8 9.8 9.1 18.3 9.6 10.8 9.7 11.2 22.0 8.1 9.6 9.7 2.1 15.8 15.5 10.6 12.8 8.0 7.1 8.6 7.5 8.9 7.2 7.0 8.2 7.1 8.8 7.2 14.9 15.3 20.1 8.0 7.7 17.8 148.9 20.4 21.4 15.9 38.4 21.6 48.7 77.9 21.8 1.3 10.2 33.3 0.0 18.1 22.0 13.9 6.9 10.4 83.4 33.5 14.3 9.2 14.7 15.5 3.9 16.1 14.0 10.1 17.2 17.6 12.2 17.3 17.3 16.3 209.8 36.6 6.5 9.0 3.9 32.1 5.9 33.2 13.1 32.6 8.9 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.7;liver: 50.7" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 223.0;Proximal tubular cells: 422.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;myeloid DC: 5.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "Hep G2: 59.4" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 18000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavorable (4.36e-4)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 12.4 1.6 11.7 3.7 11.2 2.7 13.4 12.0 9.9 4.0 9.5 4.0 4.7 2.7 3.9 4.4 12.3 4.2 8.6 26.0 9.3 7.1 89.7 50.7 1.6 1.4 6.3 9.1 5.8 1.8 8.2 2.6 4.5 7.2 8.9 7.7 4.4 9.4 7.3 2.2 14.0 3.5 13.6 8.1 1.2 7.8 6.0 5.0 0.4 1.9 5.7 3.2 12.4 7.4 0.5 5.3 1.6 6.1 0.6 0.5 1.4 20.6 1.4 1.6 7.0 15.6 14.9 3.5 3.5 4.4 7.6 21.2 31.0 2.5 11.1 9.2 5.4 9.5 13.4 5.5 26.1 30.6 9.3 6.3 10.8 7.0 59.4 0.7 8.3 1.3 8.2 14.7 7.4 21.9 12.6 0.2 3.5 13.4 0.2 11.6 8.8 0.3 0.3 7.2 0.3 12.4 0.0 12.1 2.0 11.2 0.9 6.1 4.5 6.2 0.4 4.9 8.0 8.7 3.7 1.2 12.7 10.9 0.9 5.9 11.7 5.2 0.6 20.5 3.1 0.7 1.6 6.1 0.0 0.2 1.4 0.4 0.5 0.2 0.5 5.3 0.4 0.2 0.2 1.0 0.6 0.2 0.8 0.1 1.4 11.7 11.2 12.0 9.9 9.3 7.1 6.3 9.1 7.2 5.0 0.0 0.3 4.9 19.8 44.2 14.7 91.5 61.1 5.3 6.8 29.6 2.0 1.2 48.0 16.1 1.6 17.5 13.5 0.0 11.0 13.9 10.3 33.2 0.0 223.0 3.3 15.9 5.2 5.5 5.6 4.2 3.7 2.7 23.6 7.2 6.7 27.4 22.8 3.5 8.9 422.4 6.2 6.5 27.4 2.1 5.1 65.0 4.1 1.0 22.9 16.6 AL355315.1 ENSG00000249967 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.2;liver: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Lineage enhanced" "Detected in single" "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;EFO-21: 3.4;GAMG: 2.8;HBEC3-KT: 2.6;hTERT-RPE1: 5.1" HPA076857 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA076857: AB_2686817" 2.4 1.1 1.9 0.3 2.3 0.3 1.0 4.6 3.3 1.9 0.9 5.5 0.6 0.3 1.1 2.5 0.8 2.7 2.3 4.9 2.6 1.0 22.2 15.1 0.8 0.3 6.4 3.3 0.8 2.4 5.7 0.9 0.6 4.8 0.8 0.3 2.1 0.8 3.9 2.2 0.9 0.8 0.8 5.5 0.9 0.9 0.9 4.6 0.0 0.8 2.5 0.4 1.0 0.9 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 3.2 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 3.4 0.5 2.8 1.7 0.0 2.6 1.8 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 2.3 4.6 2.3 2.6 1.0 6.4 3.3 4.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH1L1 "10-fTHF, FTHFD" ENSG00000144908 "Aldehyde dehydrogenase 1 family member L1" O75891 3 126103562-126197994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 48.1;liver: 148.7" "Group enriched" "Detected in many" 6 "Hepatocytes: 554.3;Proximal tubular cells: 175.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036900, HPA050139" Enhanced Supported Supported Cytosol No No 640000 Cytosol "HPA036900: AB_10672273, HPA050139: AB_2681031" "unprognostic (5.93e-2)" "unprognostic (1.22e-1)" "unprognostic (9.12e-2)" "unprognostic (2.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (4.73e-2)" "unprognostic (3.05e-3)" "unprognostic (8.40e-2)" "prognostic favorable (2.42e-8)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (7.03e-3)" "unprognostic (7.93e-2)" 28.9 12.1 13.7 1.8 17.1 1.2 6.0 8.6 10.9 7.8 4.9 5.7 2.3 1.1 1.9 2.2 3.6 3.4 1.9 8.1 8.9 5.3 48.1 148.7 1.3 1.2 9.2 10.1 11.3 10.2 1.4 0.9 1.1 10.8 3.3 3.3 5.1 34.1 4.1 30.7 1.5 1.3 2.4 7.7 1.1 1.9 4.9 6.2 0.0 1.7 6.2 2.8 11.0 3.1 0.1 0.8 0.8 0.2 0.2 0.4 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.9 0.7 3.2 0.0 0.6 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 23.9 3.2 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 12.9 0.3 66.0 0.1 0.1 0.3 3.2 0.0 0.2 0.0 0.0 0.1 0.4 1.9 0.0 0.0 13.6 4.2 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.2 0.2 0.2 0.0 0.8 0.1 0.0 13.7 17.1 8.6 10.9 8.9 5.3 9.2 10.1 10.8 6.2 0.0 5.9 4.5 44.7 0.1 0.2 14.9 22.9 10.7 64.8 12.2 0.0 0.0 61.3 2.2 18.0 2.7 2.3 0.0 4.8 0.1 0.8 8.1 25.6 554.3 0.1 0.0 1.2 12.3 15.3 25.4 24.5 2.6 3.3 0.0 9.1 35.7 1.9 0.0 21.2 175.8 1.0 6.5 1.0 1.1 1.2 0.0 0.1 7.0 2.2 48.0 ALDH4A1 "ALDH4, P5CDh" ENSG00000159423 "Aldehyde dehydrogenase 4 family member A1" P30038 1 18871430-18902781 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.7;liver: 92.6" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 313.9;Proximal tubular cells: 167.5" "Cancer enhanced" "Detected in all" "liver cancer: 72.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 34.6;SK-BR-3: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004645, HPA006401, HPA072759" Enhanced Supported Mitochondria NA NA 40000 Mitochondria "CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: " "unprognostic (1.17e-1)" "prognostic favorable (5.06e-4)" "unprognostic (1.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.15e-1)" "unprognostic (7.67e-2)" "unprognostic (1.28e-1)" "unprognostic (6.18e-2)" "unprognostic (1.92e-1)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-3)" "unprognostic (9.41e-3)" "unprognostic (3.83e-1)" "unprognostic (2.69e-3)" "unprognostic (9.34e-2)" 22.9 4.1 14.4 2.0 18.0 4.6 6.6 3.1 16.8 3.8 2.4 8.6 18.9 1.3 2.5 5.2 11.4 2.7 3.0 12.6 8.6 7.1 73.7 92.6 2.4 1.7 15.9 11.2 2.9 2.2 9.4 2.4 8.3 8.5 12.1 1.6 9.7 2.4 12.1 25.6 8.0 1.3 3.3 2.7 2.1 3.4 1.4 6.6 2.8 3.0 8.9 2.9 8.3 3.6 1.5 7.2 2.6 5.6 0.3 1.4 2.2 5.1 8.0 4.1 12.1 17.4 2.6 10.0 4.9 3.0 5.1 4.1 5.8 3.8 3.4 6.6 6.4 2.4 13.8 6.9 14.7 1.9 1.9 6.1 1.9 1.9 34.6 5.5 1.7 6.2 6.7 8.2 2.8 2.8 3.8 5.7 5.8 7.7 2.5 3.4 13.2 1.7 8.3 2.0 10.6 4.1 10.7 3.4 4.0 5.3 13.0 8.1 3.1 8.7 35.8 6.4 6.5 16.3 2.6 4.7 4.4 5.8 5.3 1.7 2.8 6.6 1.0 1.6 13.5 5.8 0.0 4.1 2.6 1.1 5.6 0.9 1.5 0.7 1.4 7.2 1.1 0.3 0.9 0.6 0.3 3.1 2.4 1.0 2.2 14.4 18.0 3.1 16.8 8.6 7.1 15.9 11.2 8.5 6.6 0.0 3.2 7.2 14.0 6.6 3.1 18.5 38.2 1.4 0.0 43.6 9.8 61.1 39.7 5.6 0.4 2.7 0.4 0.0 0.8 7.2 2.3 9.5 4.6 313.9 11.9 19.1 2.4 16.5 14.0 0.4 1.1 1.4 3.3 17.2 2.9 10.8 2.9 1.5 2.5 167.5 4.2 6.5 4.3 2.1 3.6 4.6 72.4 2.2 3.3 9.7 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 453.8;Proximal tubular cells: 730.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria No No 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favorable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favorable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.9 10.2 9.2 3.2 6.1 3.5 6.0 9.1 5.2 5.4 7.2 6.9 2.9 2.7 13.0 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.8 1.3 1.2 15.0 6.6 4.5 11.4 9.2 6.2 12.2 4.0 7.5 2.4 17.8 3.7 2.0 4.5 17.2 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 10.1 29.7 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.2 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 35.7 48.4 23.6 21.0 8.1 17.6 73.0 48.4 25.4 29.6 62.8 3.9 22.5 170.8 8.1 19.8 13.5 22.3 0.0 2.7 12.8 13.1 38.6 7.0 453.8 14.9 11.1 16.3 58.3 22.2 15.8 26.7 9.0 23.6 20.8 37.9 90.4 5.6 10.5 45.3 730.1 15.1 12.9 21.7 10.5 3.9 6.5 25.6 6.9 37.0 15.2 ALDH8A1 ALDH12 ENSG00000118514 "Aldehyde dehydrogenase 8 family member A1" Q9H2A2 6 134917390-134950122 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 26.2;liver: 90.1" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1" "Group enriched" "Detected in some" 7 "liver cancer: 26.3;renal cancer: 17.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026292, HPA055414" Enhanced Approved Nucleoplasm,Centrosome NA NA 24000 Centrosome Nucleoplasm "HPA026292: AB_1844741, HPA055414: AB_2682810" "unprognostic (1.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "unprognostic (1.75e-1)" "unprognostic (2.70e-2)" "unprognostic (6.32e-2)" "unprognostic (4.30e-3)" "unprognostic (1.12e-1)" "unprognostic (3.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (2.36e-2)" "unprognostic (5.86e-5)" 0.3 0.3 0.8 0.3 1.0 0.6 0.3 1.9 0.9 0.3 0.6 0.3 0.3 0.2 0.3 0.6 0.3 0.1 0.3 0.3 1.4 0.6 26.2 90.1 0.3 0.3 1.1 0.4 0.3 0.3 0.2 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.8 0.3 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.3 1.5 1.1 5.9 0.9 2.3 1.3 0.6 0.2 1.1 1.6 0.8 0.5 0.2 1.4 0.4 0.5 0.1 1.0 0.5 0.7 0.4 0.6 0.0 0.4 1.1 1.1 0.1 0.9 1.2 5.6 3.7 3.9 5.3 0.6 1.5 2.0 1.6 1.8 0.4 0.9 1.2 0.4 1.8 5.4 2.2 0.2 0.1 1.8 2.4 0.3 0.4 1.1 0.1 0.5 0.5 6.4 0.8 1.7 0.6 0.3 0.1 1.3 0.5 0.9 0.3 0.4 0.8 3.2 1.3 1.5 5.6 1.7 0.9 0.7 1.4 0.5 5.9 0.9 0.9 1.3 0.3 0.5 1.0 1.2 0.7 0.1 1.5 1.1 0.9 2.4 2.3 0.4 1.1 1.2 0.6 0.8 1.0 1.9 0.9 1.4 0.6 1.1 0.4 0.3 0.3 3.0 1.1 2.2 0.2 0.0 1.8 0.3 2.5 0.0 1.2 29.6 0.0 0.2 16.6 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.4 0.1 0.0 129.5 0.1 3.2 0.0 3.1 1.3 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.0 94.1 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 ALDOB ENSG00000136872 "Aldolase, fructose-bisphosphate B" P05062 9 101420578-101435823 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 804.1;kidney: 253.1;liver: 598.8" "Group enriched" "Detected in many" 9 "Hepatocytes: 2651.5;Proximal tubular cells: 6429.5" "Cancer enriched" "Detected in many" 31 "liver cancer: 1414.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA002198, CAB020827" Enhanced NA NA 930000000 "CAB020827: , HPA002198: AB_1078129" "unprognostic (6.58e-3)" "unprognostic (2.83e-1)" "unprognostic (1.43e-3)" "unprognostic (1.03e-1)" "unprognostic (8.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.44e-3)" "unprognostic (4.34e-2)" "unprognostic (4.57e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (7.48e-2)" "unprognostic (1.66e-2)" "unprognostic (2.02e-1)" "unprognostic (2.58e-1)" "unprognostic (5.19e-2)" "unprognostic (1.96e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.2 0.1 334.5 0.2 0.2 145.9 0.2 0.6 0.1 0.1 5.7 0.1 0.1 0.1 253.1 598.8 0.1 0.1 0.1 0.1 0.1 18.3 0.0 0.4 0.1 0.4 0.1 0.0 0.2 0.2 0.1 0.1 0.1 804.1 0.1 0.1 0.2 1.5 0.3 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.4 0.0 3.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.4 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.2 13.5 0.2 0.4 0.0 0.2 3.1 15.6 0.0 0.0 2.6 13.5 1.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.7 5.4 0.2 0.4 0.2 1.6 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 48.6 0.0 0.0 1.0 0.9 448.4 0.0 0.0 143.1 0.0 0.0 525.6 3.8 0.0 0.0 62.6 46.7 221.2 0.0 0.0 0.0 0.0 2651.5 0.2 3.2 0.0 50.3 57.0 0.0 0.0 0.0 0.0 6.4 2.6 0.4 297.3 28.8 0.0 6429.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 5.0 1.5 0.0 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986178-34008108 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.0;liver: 63.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2" "Cancer enhanced" "Detected in all" "prostate cancer: 34.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 59.8;U-266/84: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 65000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 2.8 8.3 5.2 2.7 8.2 0.9 2.8 4.7 7.8 4.4 14.1 4.3 6.5 6.2 4.0 3.6 8.2 2.3 11.0 3.5 4.5 6.8 68.0 63.6 3.3 2.0 4.5 4.5 2.9 5.1 5.4 4.3 3.2 7.0 13.9 15.5 5.5 25.4 5.4 6.0 2.6 7.4 3.7 3.8 2.9 15.9 2.1 2.1 3.8 3.3 3.4 3.3 5.7 4.5 7.8 10.2 11.2 14.2 9.9 10.0 6.8 4.1 6.6 3.7 4.8 2.6 4.1 6.4 5.5 4.1 2.5 1.9 21.6 5.0 1.3 2.9 7.8 9.7 1.9 0.9 4.0 2.6 4.1 3.5 3.1 4.8 6.2 1.8 1.9 1.0 6.2 2.0 3.3 1.2 3.6 2.8 2.7 1.2 4.9 7.5 3.0 1.6 2.4 3.3 3.0 10.8 1.9 6.3 2.1 11.3 20.7 2.1 2.9 9.1 6.5 5.5 3.2 5.0 1.9 5.2 8.4 1.9 2.1 4.4 59.8 31.1 2.4 2.4 3.9 6.2 0.3 7.1 10.2 10.0 8.8 8.4 7.8 8.7 7.8 10.2 7.0 8.1 6.1 11.2 9.9 14.2 5.3 8.9 6.8 5.2 8.2 4.7 7.8 4.5 6.8 4.5 4.5 7.0 2.1 3.0 2.6 0.0 0.4 0.3 3.3 0.9 7.6 4.0 5.7 1.8 0.0 0.9 5.0 0.7 8.1 0.8 5.0 0.0 3.3 0.9 1.1 0.6 0.0 17.8 0.9 4.8 4.1 1.3 1.2 18.9 0.6 0.8 0.0 1.8 4.5 10.6 2.4 3.5 2.1 33.2 0.8 0.0 0.5 0.7 0.7 0.5 0.2 0.8 4.0 0.3 ANK2 LQT4 ENSG00000145362 "Ankyrin 2" Q01484 4 112818109-113383740 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9" "Cell type enhanced" "Detected in many" 21 "Bipolar cells: 313.8;Cone photoreceptor cells: 451.6;Horizontal cells: 1352.3;Rod photoreceptor cells: 483.8" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 16.5;ASC TERT1: 22.9;RH-30: 31.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893" "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 17.3 8.7 34.0 6.3 42.1 0.8 10.7 43.7 58.5 20.9 9.5 24.5 0.6 4.3 10.5 4.3 8.3 5.8 13.0 56.7 29.4 30.3 59.8 2.0 4.6 5.1 28.7 38.7 19.0 2.4 1.6 8.6 2.0 42.1 5.4 7.2 7.8 2.6 8.7 66.9 3.5 4.7 15.2 19.0 15.1 3.8 5.8 24.2 0.0 5.6 4.4 4.5 4.5 4.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 10.4 4.2 16.5 22.9 0.0 1.1 1.9 0.7 2.1 4.1 0.0 4.3 1.4 3.7 2.5 0.0 7.6 0.4 0.6 1.9 6.3 2.5 0.0 1.7 1.0 1.0 0.7 9.8 1.7 0.9 4.0 2.7 0.0 0.2 0.0 7.0 3.5 0.1 0.2 0.0 5.4 0.0 1.8 0.5 31.5 0.0 0.1 0.0 8.4 15.8 0.1 0.3 5.4 7.4 0.1 0.6 0.0 3.2 1.8 0.2 1.9 4.2 1.2 0.6 12.9 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 42.1 43.7 54.3 29.4 30.3 28.7 38.7 42.1 24.2 0.0 3.8 0.0 0.0 9.3 313.8 152.3 0.0 1.4 2.3 19.2 451.6 0.1 13.3 0.0 92.0 11.6 0.0 0.0 1.5 0.1 44.2 0.4 1.1 0.4 0.8 1352.3 63.4 0.0 0.0 26.4 33.6 1.0 16.9 1.0 0.0 40.0 0.1 0.0 28.3 129.2 483.8 6.5 20.5 1.1 1.5 8.3 0.0 0.0 0.1 0.1 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233665-21253845 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 64.5;kidney: 16.2;liver: 15.0" "Group enriched" "Detected in some" 14 "Enterocytes: 78.6;Hepatocytes: 24.1;Intestinal endocrine cells: 24.1;Mucus-secreting cells: 34.5;Paneth cells: 31.7;Proximal tubular cells: 28.1;Undifferentiated cells: 21.9" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HDLM-2: 5.4;Hep G2: 12.8;OE19: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043523, HPA061125" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043523: AB_10966687, HPA061125: " "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.1 0.1 0.1 4.3 0.2 0.0 0.1 0.9 0.1 0.1 26.9 0.0 0.0 9.3 0.1 1.5 0.1 0.1 9.2 0.1 0.1 0.1 16.2 15.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.5 0.1 64.5 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.6 2.0 0.4 1.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.1 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 3.3 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.5 0.4 0.4 0.3 0.3 0.2 0.5 0.3 0.2 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.6 0.3 0.1 0.1 0.2 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.2 0.6 2.5 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.1 78.6 0.0 1.5 0.0 0.0 0.3 1.1 24.1 0.0 0.0 24.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 34.5 1.2 1.2 31.7 0.0 28.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 21.9 0.3 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784889-89815401 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 195.3;kidney: 78.7;pancreas: 93.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "neutrophil: 59.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 59.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" NA NA 1500000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: AB_2667199" "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 21.3 1.1 0.6 2.9 0.8 9.5 17.0 1.0 1.3 8.2 21.2 0.8 0.5 195.3 1.4 8.4 3.6 1.4 27.7 3.7 0.4 0.3 78.7 37.7 9.7 9.3 0.9 0.9 1.8 93.9 0.0 0.7 14.7 1.3 8.6 4.7 4.0 6.6 1.8 1.6 4.9 155.8 4.3 1.2 7.2 0.8 4.7 0.2 5.6 1.5 4.2 3.8 4.7 3.0 0.0 6.9 59.4 12.8 0.0 0.0 5.5 0.0 5.0 0.0 0.0 61.3 78.5 0.5 78.2 111.8 9.6 8.5 0.5 0.0 0.0 0.9 67.0 0.0 0.0 0.6 0.0 3.8 0.0 0.0 14.7 0.4 11.7 36.1 1.0 71.1 68.7 0.1 30.2 0.0 0.4 87.5 0.0 0.4 0.1 3.7 0.0 0.0 34.7 0.2 0.0 5.3 0.0 0.0 0.8 43.7 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.0 6.8 87.4 42.2 0.0 95.3 0.0 0.0 0.0 0.0 0.1 0.0 2.2 5.7 12.8 10.4 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 59.4 0.0 12.0 0.1 0.0 5.5 0.6 0.8 1.0 1.3 0.4 0.3 0.9 0.9 1.3 0.2 0.0 4.8 8.2 3.1 8.9 0.0 0.8 372.0 2.7 20.5 19.2 0.0 9.7 36.5 10.6 0.1 1.8 993.7 0.0 328.5 12.0 36.3 18.0 24.2 144.7 39.4 0.0 2.9 101.9 51.7 0.0 2.6 46.4 3.3 39.7 10.5 0.0 120.5 201.5 1.4 388.5 0.0 25.8 5.0 0.4 0.1 5.1 5.4 1.0 18.3 1.3 AP000790.4 ENSG00000285010 11 59964033-59970146 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.9;kidney: 1.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "basophil: 5.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.9" "Group enriched" "Detected in some" 5 "HEL: 2.9;K-562: 7.3" "Secreted - unknown location" NA NA 0.0 0.1 0.4 0.2 0.0 0.7 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.5 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 2.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911694-30925516 "Blood group antigen proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" NA NA 250000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favorable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favorable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 68.2 8.0 9.9 8.7 17.1 9.4 51.9 10.7 13.0 46.5 18.1 62.1 7.7 10.8 28.0 20.8 58.8 29.0 36.3 46.7 18.1 15.4 156.5 4.2 103.2 9.1 36.9 17.8 16.4 49.9 12.9 4.0 9.1 63.2 32.4 10.6 8.3 19.8 22.7 35.2 24.8 18.2 41.2 56.4 2.9 18.2 15.0 17.8 1.9 21.3 33.5 12.5 36.0 76.7 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.6 0.4 1.8 0.4 1.2 0.4 0.0 0.0 0.2 0.3 0.0 20.9 1.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 7.0 0.0 0.4 0.1 0.0 3.3 0.0 0.1 0.0 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 5.2 0.1 0.7 0.0 0.2 7.8 1.2 0.6 0.0 3.9 0.1 0.1 0.0 0.0 9.8 0.8 0.3 0.5 0.3 0.0 0.1 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.9 17.1 10.7 13.0 18.1 15.4 36.9 17.8 63.2 17.8 166.7 218.3 2.9 1.1 81.4 1.1 57.7 377.0 6.7 6.8 29.6 7.9 1.9 24.9 35.6 1.9 221.7 4.2 0.0 2.1 3.0 91.5 1.0 1.1 1.3 3.3 0.0 7.0 154.1 1.8 1.6 1.1 9.8 84.4 2.8 18.2 0.3 2.8 19.2 3.2 281.0 0.2 12.9 92.0 0.3 1.3 68.8 6.1 0.0 71.0 1.0 AQP2 ENSG00000167580 "Aquaporin 2" P41181 12 49950741-49958881 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2" "Cell type enriched" "Detected in some" 444 "Collecting duct cells: 3930.9" "Group enriched" "Detected in some" 6 "renal cancer: 1.7;stomach cancer: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "intermediate monocyte: 1.4;non-classical monocyte: 1.3" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.5;EFO-21: 6.9;HEL: 2.0;HMC-1: 4.2;OE19: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA046834 Enhanced NA NA "HPA046834: AB_2679830" "unprognostic (2.10e-1)" "unprognostic (3.77e-2)" "unprognostic (6.96e-3)" "unprognostic (4.48e-3)" "unprognostic (3.60e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (7.38e-3)" "unprognostic (5.92e-2)" "unprognostic (4.60e-2)" "unprognostic (2.01e-2)" "unprognostic (1.11e-1)" 0.1 1.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 178.6 0.0 0.1 3.3 0.1 0.1 0.0 0.6 0.1 0.1 96.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.2 108.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 7.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3930.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 4.5;Collecting duct cells: 5.2" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in many" HPA015278 Enhanced NA NA "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.3 2.0 0.1 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 1.1 1.2 0.0 0.9 0.0 0.0 0.2 0.3 0.0 0.0 0.2 1.4 0.0 0.1 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.1 1.1 0.0 0.2 0.4 0.6 0.0 0.9 0.0 0.6 0.4 5.1 1.0 1.0 0.1 0.5 0.9 0.0 0.5 2.1 0.7 0.0 0.7 0.3 0.0 0.1 0.0 0.6 0.9 0.0 0.5 0.2 0.2 0.0 0.2 0.2 0.4 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.7 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475114-86002670 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 62.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5" "Group enriched" "Detected in many" 4 "B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favorable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 21.3 1.9 5.3 16.4 7.9 10.7 17.6 1.8 9.4 5.8 6.2 8.4 2.4 4.8 9.2 7.3 7.7 3.9 7.1 16.8 6.3 7.3 62.5 6.0 9.9 23.8 11.0 3.3 4.1 21.5 6.9 8.2 13.9 9.0 6.7 4.3 8.7 9.0 5.8 7.6 6.2 8.7 13.2 19.8 33.6 15.9 2.8 6.7 2.1 17.8 6.5 24.2 13.0 5.2 23.1 6.5 2.8 8.0 0.0 0.0 1.4 0.9 1.9 1.4 0.0 36.4 22.1 1.5 6.9 9.2 1.7 2.7 0.0 0.0 0.9 2.4 15.4 2.1 0.0 0.0 2.9 3.6 0.0 0.3 1.1 0.2 0.0 21.3 0.1 0.0 16.1 0.3 3.3 1.5 7.8 39.2 0.0 2.0 0.1 14.9 0.0 0.0 0.0 0.1 0.4 3.6 0.1 7.3 3.6 22.0 0.0 0.7 0.7 0.7 1.1 2.4 1.6 0.1 0.0 27.6 19.7 0.4 1.4 0.1 0.1 0.0 1.2 3.3 0.7 6.4 0.0 8.0 0.0 0.0 1.5 0.0 23.1 0.0 0.0 1.9 18.4 0.0 0.0 2.8 0.0 1.1 6.5 0.0 1.4 5.3 7.9 1.8 9.4 6.3 7.3 11.0 3.3 9.0 6.7 53.6 24.5 105.7 2.4 7.2 3.7 22.1 43.3 25.4 10.3 43.6 5.9 36.9 192.3 7.0 17.7 4.9 0.0 0.0 10.3 22.3 17.9 2.2 1.1 6.6 10.1 104.9 2.4 5.5 24.7 6.8 15.5 12.9 18.6 0.0 2.5 40.3 7.3 2.9 11.7 165.1 6.2 6.5 14.0 5.2 4.1 5.5 194.7 0.9 3.0 1.7 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 46.8;Muller glia cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.4;LHCN-M2: 35.3;TIME: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 3.4 17.7 3.0 2.7 1.4 0.0 7.7 2.3 2.3 9.7 6.7 1.1 8.6 2.3 11.9 9.7 7.1 7.5 12.0 1.5 1.4 1.9 43.0 5.5 5.5 0.3 1.7 3.2 14.5 19.2 0.2 7.0 1.1 2.5 5.1 2.8 4.3 20.0 9.5 0.9 11.1 3.9 2.7 3.3 2.0 14.8 2.0 1.0 4.1 10.5 6.0 6.0 3.4 6.2 0.0 0.0 0.0 0.0 0.6 1.2 0.1 11.1 7.9 0.0 1.0 1.0 1.4 0.0 4.1 8.2 5.2 5.2 2.3 4.8 0.0 8.8 1.4 11.9 3.8 0.5 6.6 7.9 0.1 1.1 0.2 1.2 10.1 8.3 0.0 0.0 1.3 2.7 8.1 38.4 9.8 17.0 0.2 0.0 0.0 35.3 1.0 0.0 0.0 0.1 2.9 3.2 0.0 2.1 1.3 14.2 6.8 0.7 1.5 2.0 0.3 0.2 0.0 1.7 0.0 22.6 2.6 3.5 0.2 3.8 0.4 0.0 0.0 3.9 0.5 1.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.1 3.0 1.4 2.3 2.3 1.4 1.9 1.7 3.2 2.5 1.0 26.8 13.1 0.0 12.3 22.9 0.7 1.8 28.1 46.8 12.5 29.6 0.0 0.1 13.3 12.3 2.9 8.5 3.0 0.0 9.6 0.2 1.3 9.3 1.1 6.7 0.3 12.7 10.9 1.8 0.3 1.7 9.5 1.3 1.7 1.0 9.6 36.2 17.9 5.7 5.3 18.3 1.0 6.5 3.8 0.7 0.4 22.3 0.1 0.0 6.9 14.9 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 1.7;Proximal tubular cells: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.4 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ASPA "ACY2, ASP" ENSG00000108381 Aspartoacylase P45381 17 3472374-3503419 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3;kidney: 33.2" "Group enriched" "Detected in many" 4 "Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3" "Cancer enhanced" "Detected in some" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022142, HPA022145" Enhanced Approved Cytosol NA NA Cytosol "HPA022142: AB_1845102, HPA022145: AB_1845103" "unprognostic (4.42e-2)" "unprognostic (4.79e-2)" "unprognostic (2.02e-2)" "unprognostic (2.79e-3)" "unprognostic (4.36e-2)" "unprognostic (5.01e-1)" "unprognostic (1.08e-3)" "unprognostic (3.57e-1)" "unprognostic (4.17e-1)" "unprognostic (3.43e-1)" "unprognostic (5.27e-2)" "unprognostic (6.27e-2)" "unprognostic (1.25e-1)" "unprognostic (7.07e-4)" "unprognostic (2.77e-1)" "unprognostic (4.68e-1)" "unprognostic (1.49e-1)" 10.9 4.1 14.5 1.8 37.6 1.7 3.3 3.0 19.4 6.2 3.6 35.2 3.1 9.7 4.1 5.5 4.5 5.0 3.3 2.2 21.9 11.0 33.2 12.6 3.2 1.3 50.2 11.3 2.9 1.0 0.9 0.9 3.1 18.9 4.0 4.6 2.6 1.9 4.8 9.3 4.6 13.3 2.9 22.4 4.6 3.9 5.6 51.3 0.0 1.8 1.1 0.8 4.5 3.5 1.7 1.2 3.6 0.7 1.6 1.3 0.2 0.4 0.2 0.9 0.7 8.3 6.5 0.5 0.4 0.3 0.3 0.3 5.5 0.3 1.1 0.3 1.0 0.5 0.5 0.5 0.3 0.4 2.9 0.3 0.5 0.9 0.4 0.9 0.7 0.8 11.7 0.6 0.7 0.2 0.4 0.1 0.7 0.6 2.0 0.4 0.4 0.4 1.0 0.8 0.4 0.5 0.4 0.5 0.9 0.4 1.7 0.7 0.5 1.6 0.6 1.3 0.8 0.6 0.3 0.6 1.0 0.7 0.7 0.4 1.2 0.6 0.7 0.4 0.6 0.8 3.4 0.7 0.8 1.2 0.6 1.0 1.1 1.0 0.9 0.5 1.7 1.2 1.3 3.6 1.6 0.7 1.2 0.5 0.2 14.5 37.6 3.0 19.4 21.9 11.0 50.2 11.3 18.9 51.3 8.9 1.0 0.0 1.2 4.6 0.4 0.8 5.1 0.0 1.2 24.4 0.0 0.0 6.6 0.0 2.8 0.5 1.0 0.0 0.2 0.1 7.4 0.3 0.0 10.2 0.2 7.9 2.4 4.9 1.5 0.5 46.1 0.8 43.9 0.0 0.1 3.4 0.0 0.0 45.3 65.3 0.5 0.0 4.2 4.8 0.6 1.5 0.1 0.0 1.2 1.7 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Group enriched" "Detected in some" 8 "Hepatocytes: 137.5;Proximal tubular cells: 442.0" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042631, HPA042654" Approved Approved Nucleoplasm,Cytosol Yes NA 51000 Nucleoplasm Cytosol "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.6 0.0 0.6 3.8 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 1.6 0.0 1.6 15.9 0.1 0.0 0.5 0.3 0.3 0.3 1.1 0.0 0.2 1.8 9.5 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 2.0 0.2 2.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 0.0 0.0 0.9 0.0 0.0 22.8 0.3 2.5 0.0 0.0 8.7 3.9 0.0 38.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 6.8 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 442.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol No No 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.7 1.1 1.3 2.2 8.9 22.7 4.3 14.0 87.4 2.8 8.5 5.0 3.3 0.0 9.5 28.9 0.8 82.8 5.8 0.5 1.9 2.0 2.6 0.0 1.8 12.8 31.0 1.7 0.1 15.0 80.5 4.5 8.1 0.0 0.1 37.6 0.4 52.2 2.8 58.1 0.6 24.5 1.8 60.2 2.6 0.1 1.5 134.1 7.6 5.8 33.8 0.5 50.0 52.7 3.9 5.4 36.2 100.4 0.0 1.1 7.0 0.2 1.2 8.7 8.3 2.9 22.0 13.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 23.8 25.8 33.7 45.3 62.6 0.0 5.0 94.3 20.1 50.0 45.4 0.0 159.6 112.7 79.7 0.8 23.2 457.5 0.0 98.3 5.0 15.7 85.0 5.7 809.9 12.7 0.0 11.5 35.0 18.0 2.7 28.7 2.6 3.3 2.8 129.1 4.8 73.5 143.8 117.4 889.6 0.3 0.0 10.8 1.1 2.0 15.3 120.5 12.5 77.1 385.2 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 239.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 1634.8;Proximal tubular cells: 927.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced NA NA 4100000 "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favorable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 3.9 26.3 48.7 8.6 45.1 1.3 14.9 39.4 92.1 8.7 43.8 34.5 11.3 61.3 19.8 11.2 28.7 9.4 50.1 36.0 86.3 68.2 239.7 30.6 16.9 1.9 82.3 52.6 11.5 33.0 130.6 16.7 8.3 111.5 9.8 34.8 15.5 55.7 15.4 55.1 11.2 51.2 17.8 64.0 9.6 69.5 8.4 25.9 0.9 60.1 23.7 13.9 12.3 9.0 1.4 8.4 10.5 3.0 5.6 9.1 1.4 12.3 30.2 9.8 7.5 2.3 0.4 3.4 6.1 5.0 6.4 6.7 36.8 25.0 0.0 23.1 4.8 7.2 14.6 5.4 11.6 6.6 0.1 2.4 0.7 22.8 17.1 3.7 0.5 1.1 1.3 2.9 4.7 6.1 11.2 5.8 0.9 0.1 0.1 7.3 4.7 1.0 1.9 3.9 127.3 6.5 0.1 11.9 2.1 68.9 15.4 7.8 57.2 36.1 36.4 1.6 12.5 7.5 1.2 12.3 4.9 13.2 8.3 21.8 0.7 0.9 0.2 5.9 1.8 6.6 10.5 1.0 0.1 2.9 3.0 1.5 1.4 3.4 1.1 8.4 0.2 1.0 1.1 0.3 5.6 0.9 0.4 9.1 1.4 48.7 45.1 39.4 92.1 86.3 68.2 82.3 52.6 111.5 25.9 223.4 199.8 17.7 144.1 46.6 22.3 136.8 749.1 187.4 257.0 1634.8 13.7 3.9 782.5 509.0 2.8 15.2 580.2 0.0 519.8 7.5 62.9 68.0 22.0 232.9 298.5 548.2 154.6 46.6 63.5 4.1 83.1 111.4 234.5 43.3 240.2 24.3 309.0 614.7 140.0 927.9 48.2 6.5 23.6 8.6 62.0 27.7 8.2 25.4 319.0 251.2 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 3.1 1.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 3.0 0.1 0.0 0.0 0.0 35.9 1.2 2.0 0.1 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.4 1.2 15.7 2.0 11.7 26.6 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 4.2 0.0 0.0 1.1 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154228 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 56.8" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 177.4" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles NA NA Vesicles "HPA055327: AB_2682784, HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 6.6 0.3 0.2 1.3 0.3 0.8 0.3 0.2 0.2 0.2 1.5 0.0 11.9 0.7 0.2 1.0 0.2 0.2 0.1 0.2 0.3 0.3 56.8 0.3 12.2 1.2 0.5 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.8 2.0 5.7 1.1 1.2 0.2 0.9 1.0 0.0 0.3 0.4 0.3 0.2 0.0 1.0 0.4 0.3 0.6 0.3 0.2 2.2 1.7 4.6 1.0 2.0 1.5 0.3 0.5 1.2 0.6 0.7 0.0 0.5 2.3 0.0 0.0 1.0 0.3 0.3 0.4 0.3 0.2 0.0 1.6 2.5 0.7 1.6 0.4 0.4 0.1 0.8 1.7 0.1 0.0 0.7 1.4 0.6 0.1 0.9 0.7 1.9 0.4 0.3 0.4 0.7 0.5 0.9 0.0 0.7 0.2 0.3 0.2 0.2 0.2 0.3 0.0 1.1 3.4 0.3 0.1 0.8 5.6 9.2 1.8 0.1 0.3 0.6 0.8 0.7 0.5 0.4 0.2 0.6 8.6 0.6 0.7 2.6 1.0 0.8 1.1 0.5 0.8 1.2 1.0 0.9 0.5 2.2 1.5 1.3 4.6 2.0 1.0 1.7 0.9 0.3 0.2 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 29.5 0.0 177.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.5 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Group enriched" "Detected in some" 9 "BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.4 0.8 1.7 2.0 13.8 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.8 0.0 12.7 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 31.3 0.0 1.8 0.3 0.0 0.3 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 1.8 0.1 0.8 0.4 0.0 1.4 1.2 0.0 7.9 143.1 41.4 0.0 0.6 0.6 0.0 0.0 0.5 41.7 0.7 0.7 0.0 0.0 10.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.3 0.5 0.0 1.1 0.0 3.4 0.0 0.3 0.4 1.3 0.4 54.2 0.0 0.0 0.6 ATP6V1G3 "ATP6G3, Vma10" ENSG00000151418 "ATPase H+ transporting V1 subunit G3" Q96LB4 1 198523222-198540945 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "ductus deferens: 16.9;kidney: 33.4" "Cell type enriched" "Detected in some" 43 "Distal tubular cells: 376.4" "Cancer enriched" "Detected in single" 140 "renal cancer: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028701 Enhanced NA NA "HPA028701: AB_10611681" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 1.8 1.3 0.4 0.0 0.0 0.0 0.6 6.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.5 0.1 1.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 376.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 139.4;liver: 39.3" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1023.7" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTCEpi: 16.2;RPTEC TERT1: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" NA NA 25000 Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 0.9 0.5 9.2 0.5 7.1 0.5 8.2 3.9 7.5 1.5 0.6 4.9 0.1 0.5 0.6 3.6 5.7 3.8 3.6 0.5 7.9 6.3 139.4 39.3 0.6 0.6 10.9 4.3 0.5 0.8 0.5 8.3 1.3 9.2 0.7 0.5 0.0 2.2 2.0 0.6 16.4 0.5 0.5 7.1 0.5 0.6 0.6 5.8 0.0 8.9 1.6 0.7 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 16.2 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.5 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 7.1 3.9 7.5 7.9 6.3 10.9 4.3 9.2 5.8 0.0 1.1 0.0 5.5 7.2 0.0 0.0 17.8 6.7 2.3 43.6 0.0 0.1 189.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 25.4 0.0 0.0 0.0 0.6 1.2 1.1 0.0 0.0 1.7 0.0 0.0 11.3 0.1 0.0 0.4 1023.7 0.3 0.0 0.4 0.0 0.1 31.2 0.2 0.0 0.0 2.2 BCAM "CD239, LU" ENSG00000187244 "Basal cell adhesion molecule (Lutheran blood group)" P50895 19 44809059-44821421 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 101.8" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 519.9;Cytotrophoblasts: 537.1;Syncytiotrophoblasts: 362.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 493.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 31.4;HaCaT: 64.1;SK-BR-3: 60.2;T-47d: 34.1;U-2 OS: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005654 Enhanced Approved "Nucleoli fibrillar center" NA NA 16000000 "Nucleoli fibrillar center" "HPA005654: AB_2667378" "unprognostic (5.63e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.01e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (2.61e-3)" "unprognostic (1.41e-1)" "prognostic favorable (5.94e-6)" "unprognostic (1.83e-2)" "unprognostic (5.74e-2)" "unprognostic (2.14e-2)" "unprognostic (9.97e-3)" 28.9 7.2 4.9 8.1 5.4 1.4 33.1 3.4 8.7 33.5 8.5 4.4 17.8 5.7 24.8 26.5 15.6 46.3 23.2 23.8 4.5 4.2 101.8 13.2 41.6 5.8 4.4 6.5 30.4 17.8 5.8 9.8 28.7 7.0 42.7 2.4 21.4 17.8 27.3 16.7 12.7 7.4 12.5 3.8 14.2 9.6 13.6 2.6 5.7 93.0 23.7 8.5 14.2 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 9.4 0.2 26.2 0.1 0.1 31.4 2.8 1.3 2.3 1.5 14.1 18.0 0.0 14.5 0.3 0.1 64.1 2.3 16.0 0.7 0.0 1.6 0.0 1.9 19.5 5.3 0.0 3.5 2.6 6.2 0.8 0.9 7.5 1.4 0.0 1.5 0.1 0.3 3.7 0.1 0.2 2.9 2.1 3.3 0.1 3.1 0.7 19.6 4.6 0.0 0.1 11.6 60.2 0.7 3.0 34.1 1.0 3.8 0.6 29.5 0.7 1.3 0.1 0.3 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 5.4 3.4 8.7 4.5 4.2 4.4 6.5 7.0 2.6 6.0 10.5 0.5 101.3 36.1 0.6 9.0 38.2 2.7 18.2 519.9 0.0 537.1 69.6 23.4 0.8 63.2 5.1 0.0 3.5 27.0 13.6 65.7 0.0 27.0 38.8 0.0 50.0 39.9 5.9 0.8 27.3 8.0 15.1 0.0 4.7 26.3 14.4 17.5 14.2 123.1 0.5 155.2 124.6 2.2 14.9 21.5 362.4 0.0 10.5 34.4 BDH2 "DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308" ENSG00000164039 "3-hydroxybutyrate dehydrogenase 2" Q9BUT1 4 103079435-103099883 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 139.1" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 179.1;Proximal tubular cells: 617.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 41.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036028, HPA036029" Enhanced Supported Cytosol NA NA Cytosol "HPA036028: AB_10670674, HPA036029: AB_2674909" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (1.64e-1)" "prognostic favorable (5.21e-4)" "unprognostic (3.92e-1)" "unprognostic (2.28e-1)" "unprognostic (3.82e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.37e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.45e-13)" "unprognostic (2.54e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.75e-4)" "unprognostic (9.69e-3)" 12.4 33.1 22.6 7.7 26.0 2.8 17.6 9.6 18.5 15.7 18.9 14.8 12.3 36.7 11.6 18.8 10.4 16.6 13.5 14.9 26.6 15.4 139.1 39.3 13.8 6.0 38.2 15.6 26.2 8.3 23.5 14.8 8.1 29.0 13.0 11.2 27.0 10.2 15.2 6.9 7.9 34.8 10.2 29.7 6.7 11.8 7.2 32.4 10.4 25.1 12.0 7.6 11.0 11.8 9.5 7.5 1.4 4.1 11.6 18.5 7.5 2.6 4.5 25.9 7.8 27.1 30.1 3.7 6.2 16.0 5.9 10.0 3.6 10.3 10.7 10.9 9.5 2.4 1.2 13.4 10.0 6.8 6.3 8.1 2.0 6.6 11.8 17.4 6.2 3.1 24.0 9.4 10.1 2.3 27.0 19.9 17.7 6.5 3.4 22.7 1.4 27.8 6.1 7.8 2.4 2.1 20.1 25.0 6.3 41.3 5.0 3.5 12.5 11.0 5.8 7.0 11.4 5.2 5.1 12.2 7.0 3.7 4.4 2.4 6.5 6.5 11.0 9.3 7.5 5.8 1.4 4.1 0.2 11.9 1.8 12.8 9.5 12.1 11.3 5.8 9.0 14.2 15.3 0.3 11.6 0.3 7.5 18.5 7.5 22.6 26.0 9.6 18.5 26.6 15.4 38.2 15.6 29.0 32.4 29.8 52.6 3.4 39.4 27.0 1.3 8.5 38.2 22.7 33.0 102.9 0.0 6.7 179.1 38.9 1.1 24.3 37.4 0.0 19.3 13.9 51.4 21.0 18.5 63.8 17.7 3.2 22.0 28.3 13.2 2.1 64.7 10.3 21.9 19.8 19.9 45.8 21.4 14.1 73.2 617.5 2.2 12.9 24.2 0.7 1.7 23.3 2.9 17.3 23.0 33.1 BHMT BHMT1 ENSG00000145692 "Betaine--homocysteine S-methyltransferase" Q93088 5 79111779-79132290 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "kidney: 105.9;liver: 216.2" "Group enriched" "Detected in some" 8 "Hepatocytes: 455.1;Proximal tubular cells: 647.0" "Cancer enhanced" "Detected in some" "liver cancer: 90.6;renal cancer: 50.4" "Region enhanced" "Detected in single" "hippocampal formation: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;NTERA-2: 3.6;SCLC-21H: 2.3" "Not detected" "Not detected" "HPA038285, HPA058310" Enhanced Supported Cytosol No NA 9200000 Cytosol "HPA038285: AB_10675791, HPA058310: AB_2683675" "unprognostic (2.61e-2)" "unprognostic (4.12e-1)" "unprognostic (4.45e-1)" "unprognostic (4.14e-3)" "unprognostic (5.62e-2)" "unprognostic (4.14e-1)" "prognostic favorable (7.32e-4)" "unprognostic (5.33e-2)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (9.66e-4)" "unprognostic (6.42e-2)" "unprognostic (8.26e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.30e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.1 1.5 0.0 105.9 216.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 4.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.4 0.0 1.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.3 0.0 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 2.5 0.0 0.0 15.7 0.0 0.0 66.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 455.1 0.0 0.0 0.0 3.7 9.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 647.0 0.1 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 BHMT2 ENSG00000132840 "Betaine--homocysteine S-methyltransferase 2" Q9H2M3 5 79069717-79089466 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "kidney: 87.9;liver: 122.9" "Cell type enhanced" "Detected in many" 25 "Distal tubular cells: 81.2;Hepatocytes: 181.0;Proximal tubular cells: 412.5" "Group enriched" "Detected in many" 14 "liver cancer: 79.6;renal cancer: 52.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;Hep G2: 38.1;hTEC/SVTERT24-B: 23.4;U-87 MG: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA044573 Enhanced NA NA 1400000 "HPA044573: AB_10795044" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-2)" "unprognostic (3.76e-2)" "unprognostic (4.40e-2)" "unprognostic (2.90e-3)" "unprognostic (1.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.87e-2)" "unprognostic (2.45e-3)" "unprognostic (1.41e-2)" "unprognostic (1.02e-1)" "unprognostic (1.76e-2)" "unprognostic (5.05e-2)" "unprognostic (1.49e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-3)" 9.3 4.4 1.7 0.9 2.0 0.2 8.2 1.1 1.0 1.7 3.4 1.1 2.9 0.6 3.2 10.5 3.5 1.4 2.9 3.3 1.5 1.5 87.9 122.9 0.6 0.4 1.6 1.0 1.9 0.5 0.5 3.2 0.3 3.5 3.0 0.8 8.2 0.8 4.0 2.2 0.4 1.3 10.5 2.2 0.3 2.4 1.4 0.9 0.0 4.6 1.9 0.4 6.4 4.4 0.9 0.5 3.2 0.4 2.4 0.7 0.3 0.0 0.0 0.0 0.0 4.4 3.2 1.5 3.8 9.1 2.1 4.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.1 38.1 3.5 0.2 0.0 3.9 0.0 23.4 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.8 0.2 0.0 2.5 0.4 0.7 0.4 0.3 0.5 0.5 0.6 0.4 0.2 0.9 0.6 0.7 3.2 2.4 0.2 0.5 0.4 0.3 1.7 2.0 1.1 1.0 1.5 1.5 1.6 1.0 3.5 0.9 6.0 0.3 0.5 0.4 0.7 1.5 3.5 0.0 0.0 0.0 43.6 2.0 0.2 81.2 0.1 0.3 1.6 0.0 0.0 0.0 0.3 7.3 0.4 0.0 181.0 0.3 0.0 1.2 3.1 3.3 0.0 25.3 1.1 0.0 0.0 0.0 4.8 0.0 0.0 35.0 412.5 1.1 6.5 1.7 0.5 0.4 0.9 0.2 0.0 0.0 0.9 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58513140-58831437 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 119.8;Collecting duct cells: 82.0;Distal tubular cells: 66.3;Ductal cells: 87.3;Leydig cells: 65.9;Proximal tubular cells: 113.1" "Cancer enhanced" "Detected in all" "renal cancer: 25.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "basophil: 8.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "A549: 19.9;BJ hTERT+: 21.1;CACO-2: 31.3;RPTEC TERT1: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070797 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA070797: " "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 11.8 5.7 1.1 5.7 1.5 0.2 9.4 0.5 2.5 9.8 5.1 1.1 4.8 1.0 7.8 12.3 8.1 7.1 11.6 12.1 1.1 1.4 43.0 2.5 5.8 5.2 0.9 2.2 19.0 24.2 0.8 4.6 3.2 2.1 7.8 3.9 18.7 4.8 4.1 22.4 6.5 2.8 6.0 3.9 2.7 3.2 4.9 0.8 0.8 5.1 7.5 3.2 8.6 10.4 0.1 1.1 8.7 0.3 1.0 0.2 0.1 0.0 19.9 0.3 0.0 6.4 8.3 0.0 13.1 21.1 11.9 14.3 31.3 4.2 0.0 13.8 13.3 3.1 0.2 2.1 2.3 16.7 0.0 2.0 0.0 2.6 0.0 4.1 0.0 0.0 12.9 0.7 9.3 10.1 14.9 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 1.3 0.0 5.0 0.0 49.5 2.4 0.0 2.5 0.0 0.1 1.1 0.8 0.0 0.2 0.0 2.9 2.7 0.5 1.6 0.0 0.0 0.0 8.4 0.0 2.7 8.7 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.2 1.0 0.3 0.9 0.1 0.1 1.1 1.5 0.5 2.5 1.1 1.4 0.9 2.2 2.1 0.8 0.0 0.3 0.5 1.1 6.4 0.1 2.2 119.8 17.4 2.3 82.0 0.0 0.4 66.3 87.3 4.0 0.4 0.0 0.0 3.1 0.2 29.2 2.0 0.0 0.5 2.7 0.0 3.5 5.5 0.6 2.2 65.9 0.5 20.3 1.8 1.0 7.5 22.7 0.0 47.0 113.1 0.2 6.5 13.7 0.0 2.1 4.1 3.4 0.0 0.8 0.1 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 5.1 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.8 0.0 1.1 9.5 0.0 27.4 0.0 0.3 0.0 0.0 7.8 0.3 1.1 0.0 14.8 6.4 0.1 11.7 13.6 2.7 0.7 0.5 2.4 3.5 4.6 17.3 1.2 2.0 5.4 1.4 3.0 12.4 4.5 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.5 19.9 0.8 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BPHL "Bph-rp, MCNAA, VACVase" ENSG00000137274 "Biphenyl hydrolase like" Q86WA6 6 3118374-3153578 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 61.6;liver: 47.9" "Cell type enhanced" "Detected in many" 12 "Proximal tubular cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036752, HPA036753" Enhanced Approved Mitochondria NA NA 13000 Mitochondria "HPA036752: AB_10673662, HPA036753: AB_2675291" "unprognostic (2.93e-1)" "unprognostic (1.29e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-1)" "unprognostic (3.72e-3)" "unprognostic (1.84e-1)" "unprognostic (8.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.97e-4)" "unprognostic (4.59e-2)" "unprognostic (9.46e-3)" "prognostic favorable (5.16e-7)" "unprognostic (1.60e-2)" "unprognostic (1.51e-2)" "unprognostic (6.98e-2)" "unprognostic (5.20e-2)" 12.8 9.8 8.4 5.1 12.1 4.0 8.1 6.0 10.1 6.7 19.4 6.3 4.5 19.8 6.1 17.8 8.8 7.1 8.2 6.8 7.5 9.6 61.6 47.9 3.8 4.9 7.8 5.9 5.1 9.8 4.8 8.4 3.7 10.3 5.9 6.4 6.4 8.4 4.1 12.0 6.4 29.1 7.0 6.9 2.7 6.5 7.0 3.8 4.9 4.6 8.8 5.6 6.2 5.6 15.8 13.1 7.3 11.2 11.1 11.7 6.5 13.9 11.0 18.0 16.0 11.3 10.6 8.6 7.1 12.0 15.9 14.0 13.0 15.0 16.6 14.3 11.7 14.8 13.8 16.2 16.5 37.0 19.7 10.5 8.1 8.3 16.8 3.6 10.0 4.4 8.5 7.6 15.6 23.1 9.8 23.3 13.3 7.2 8.5 24.5 20.5 12.2 6.0 13.4 14.7 24.7 12.8 20.2 16.5 12.8 15.8 17.3 13.6 10.6 5.7 27.5 23.1 17.4 4.9 8.2 19.9 16.5 11.8 13.2 7.1 21.6 13.7 4.3 5.8 22.4 7.3 8.7 0.1 7.7 11.2 9.9 15.8 8.9 7.6 13.1 11.8 8.5 11.7 1.0 11.1 6.3 7.3 4.7 6.5 8.4 12.1 6.0 10.1 7.5 9.6 7.8 5.9 10.3 3.8 6.0 9.4 4.7 8.7 7.9 11.6 3.9 35.7 45.5 14.8 15.7 19.6 23.1 59.7 24.9 0.4 7.1 17.1 0.0 11.8 27.7 12.2 7.5 2.3 62.1 19.8 15.9 15.4 3.7 1.8 0.7 13.8 10.5 30.4 21.6 10.1 11.0 17.9 10.8 13.1 218.9 7.2 6.5 9.5 6.7 21.5 8.2 11.7 5.3 16.3 6.8 BSND "BART, DFNB73" ENSG00000162399 "Barttin CLCNK type accessory beta subunit" Q8WZ55 1 54998193-55011784 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 3.9;kidney: 12.3;salivary gland: 4.2" "Group enriched" "Detected in some" 37 "Collecting duct cells: 8.7;Distal tubular cells: 21.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.5" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Cell line enriched" "Detected in single" 20 "RPMI-8226: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053836, HPA060617" Enhanced NA NA "HPA053836: AB_2682277, HPA060617: AB_2732651" "unprognostic (3.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.97e-3)" "unprognostic (3.35e-1)" "unprognostic (8.97e-3)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.93e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-2)" "unprognostic (1.68e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.9 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.3 0.2 0.5 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.9 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 123.3;liver: 55.9" "Group enriched" "Detected in all" 5 "Cholangiocytes: 165.6;Distal tubular cells: 150.9;Hepatocytes: 260.8;Proximal tubular cells: 596.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA 640000 "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favorable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 6.0 10.2 5.0 4.3 7.6 1.8 7.2 6.7 6.0 5.9 12.0 7.7 7.8 12.2 6.4 7.3 6.8 7.5 10.6 8.5 5.3 5.0 123.3 55.9 8.0 4.6 8.4 5.1 8.5 13.9 5.6 11.6 5.7 7.3 9.7 10.0 8.9 8.3 6.5 14.2 5.2 20.0 6.7 9.3 5.2 8.4 5.1 7.8 8.9 11.3 5.3 5.3 6.9 4.9 10.6 12.4 37.6 11.7 9.3 11.9 7.2 3.8 5.5 12.7 7.8 9.9 11.4 14.8 5.3 8.8 5.4 7.5 2.1 21.6 15.7 35.4 10.2 6.0 9.0 14.6 3.9 7.5 15.8 5.0 8.6 12.8 10.1 11.3 7.2 4.6 10.6 7.5 10.0 7.2 14.6 8.7 10.9 11.3 11.0 5.5 3.0 13.1 10.0 4.6 25.6 8.8 12.5 16.5 24.8 30.9 7.4 6.5 8.3 9.7 12.2 11.7 9.9 27.1 5.7 5.7 5.5 4.4 9.6 2.8 4.9 14.3 15.5 4.2 11.9 9.4 23.7 11.7 27.3 9.0 8.5 9.3 10.6 9.3 10.2 8.9 9.5 11.5 10.1 37.6 9.3 7.4 12.4 11.9 7.2 5.0 7.6 6.7 6.0 5.3 5.0 8.4 5.1 7.3 7.8 59.6 41.2 13.2 10.0 4.8 16.3 31.1 165.6 41.5 40.9 45.4 15.7 42.4 150.9 13.7 7.6 15.8 55.5 23.3 12.2 12.2 12.6 30.6 15.0 260.8 15.3 14.3 21.4 22.7 28.8 4.7 23.9 10.6 8.5 13.6 34.5 17.1 11.1 37.0 21.5 596.3 16.8 6.5 7.2 31.1 12.4 8.7 51.8 10.2 31.6 13.7 C21orf62 "B37, C21orf120, PRED81" ENSG00000205929 "Chromosome 21 open reading frame 62" Q9NYP8 21 32793564-32813743 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 40.8;Distal tubular cells: 19.9" "Cancer enriched" "Detected in some" 6 "glioma: 11.0" "Region enriched" "Detected in many" 4 "pons and medulla: 13.4" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "AF22: 7.2;RPTEC TERT1: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016899 Enhanced "Secreted - unknown location" NA NA "HPA016899: AB_1845704" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (1.23e-1)" "unprognostic (4.37e-3)" "unprognostic (9.56e-2)" "unprognostic (3.05e-3)" "unprognostic (2.95e-2)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" 2.2 0.4 1.6 1.1 2.1 0.3 0.3 0.3 2.4 0.1 0.3 3.9 0.0 0.1 0.2 8.4 0.3 1.2 0.4 0.4 3.0 2.4 18.2 0.3 0.2 0.2 1.5 1.0 16.2 5.6 0.1 38.6 0.1 13.4 4.1 0.1 0.0 0.3 0.3 0.3 0.3 0.6 0.3 1.8 0.2 0.3 0.4 3.1 0.0 0.2 0.0 1.1 0.2 0.3 0.0 0.4 1.1 0.0 0.0 1.7 0.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.4 1.7 0.1 1.6 2.1 0.3 2.4 3.0 2.4 1.5 1.0 13.4 3.1 0.0 0.0 0.5 0.8 0.8 5.1 0.1 40.8 0.0 0.0 5.2 5.9 1.1 19.9 0.0 1.2 0.6 0.0 0.0 0.0 0.4 1.1 0.3 0.0 0.0 0.2 0.0 2.9 2.5 0.6 0.0 3.7 0.0 3.3 0.0 0.0 5.6 0.0 0.0 1.8 2.1 6.2 0.0 0.4 0.9 1.1 0.9 0.2 1.7 0.0 0.3 C5orf67 ENSG00000225940 "Chromosome 5 open reading frame 67" F2Z3F1 5 56511567-56606232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;kidney: 9.3;retina: 16.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in some" 5 "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4" HPA054214 Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054214: " "unprognostic (7.28e-2)" "unprognostic (1.41e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-3)" "unprognostic (6.58e-2)" "unprognostic (7.93e-2)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (3.62e-2)" 0.4 0.0 0.2 0.2 1.2 0.4 1.0 0.2 0.2 0.4 0.8 0.4 0.2 1.5 0.6 17.9 0.4 0.4 0.2 0.2 0.6 0.2 9.3 0.2 0.4 0.6 0.7 0.2 0.2 0.2 0.0 0.2 0.2 6.1 0.2 0.0 16.3 1.1 0.2 0.2 0.8 1.6 0.2 0.2 1.5 0.1 0.2 0.2 0.2 2.1 0.2 0.2 0.2 0.2 0.1 1.5 3.3 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.3 0.0 9.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 3.3 0.0 1.9 1.5 0.4 0.1 0.2 1.2 0.2 0.2 0.6 0.2 0.7 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C9orf66 FLJ31158 ENSG00000183784 "Chromosome 9 open reading frame 66" Q5T8R8 9 212824-215741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 20.9;kidney: 17.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 60.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 20.9" "Group enriched" "Detected in many" 4 "granulocytes: 20.9;monocytes: 6.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;MCF7: 3.7;RT4: 3.6;THP-1: 7.8" HPA035652 Uncertain NA NA "HPA035652: AB_10601151" "unprognostic (1.24e-1)" "unprognostic (7.20e-2)" "unprognostic (7.64e-2)" "unprognostic (1.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (9.48e-2)" "unprognostic (6.65e-3)" "unprognostic (9.92e-2)" "unprognostic (5.66e-2)" "prognostic favorable (1.32e-5)" "unprognostic (2.04e-2)" "unprognostic (1.63e-1)" "unprognostic (2.73e-2)" "unprognostic (3.10e-3)" 0.5 3.1 0.3 0.3 0.9 1.7 0.7 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.5 0.1 0.3 0.3 0.3 0.1 17.8 0.5 0.3 0.3 0.3 0.3 0.5 1.3 1.9 0.3 0.3 0.3 0.7 0.0 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 1.4 0.2 0.7 0.8 0.3 1.3 0.3 0.3 0.4 0.3 2.0 3.0 20.9 6.0 1.6 0.6 0.6 0.1 0.4 0.3 0.4 0.1 0.1 3.6 0.1 0.0 0.2 0.1 0.7 2.1 0.4 1.0 0.3 0.4 0.6 0.1 0.0 0.0 0.3 1.1 0.3 0.5 0.3 0.1 0.9 1.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 1.9 0.8 0.0 3.7 0.2 2.4 0.4 0.1 0.8 0.4 0.3 2.1 0.1 3.6 0.6 0.4 0.0 0.2 0.5 0.3 1.6 7.8 1.1 0.3 0.8 0.5 0.2 0.9 0.4 0.1 0.2 1.3 0.7 7.0 4.9 8.0 0.3 3.3 0.1 1.8 0.6 0.4 3.0 2.0 0.1 0.2 20.9 1.6 6.0 0.7 0.1 0.6 0.3 0.9 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.8 0.0 0.3 2.0 1.5 1.0 0.6 1.1 2.5 1.4 0.0 10.4 13.7 8.5 10.0 1.1 0.0 0.3 0.0 0.0 4.7 1.7 0.7 1.5 0.0 0.4 4.9 0.0 3.4 0.0 3.1 0.0 0.9 3.8 0.0 6.4 2.6 0.8 1.1 0.0 0.4 60.2 3.2 6.5 1.0 2.2 5.5 0.1 3.9 2.1 0.2 1.4 C9orf92 Em:AL513424.1 ENSG00000205549 "Chromosome 9 open reading frame 92" A6NGG3 9 16203935-16276313 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "kidney: 3.3" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 4.3;Glandular cells: 2.1;Proximal tubular cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.7;BJ hTERT+: 4.4;HBF TERT88: 2.6;PC-3: 1.4;SH-SY5Y: 1.3;U-2197: 4.8" NA NA "unprognostic (1.06e-1)" "unprognostic (4.77e-2)" "unprognostic (3.74e-2)" "unprognostic (5.47e-2)" "unprognostic (1.20e-1)" "unprognostic (5.04e-1)" "unprognostic (5.09e-2)" 0.6 0.0 0.3 0.5 0.3 0.0 0.6 0.0 0.5 0.5 0.6 0.5 1.7 1.2 0.0 1.2 1.4 0.0 0.6 0.5 3.3 0.4 0.0 0.1 1.3 1.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.0 0.0 1.7 2.8 0.0 1.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.2 0.6 4.8 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 155.1;Enterocytes: 240.0;Paneth cells: 157.9;Suprabasal keratinocytes: 220.4" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 39.0;ASC TERT1: 41.1;RT4: 41.3;SK-BR-3: 33.1;T-47d: 53.4;U-138 MG: 57.0;U-87 MG: 68.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008773, CAB025181, CAB062549, CAB068179" Enhanced NA NA 29000 "CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394" "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 39.0 0.6 0.1 5.2 41.1 2.1 2.8 2.5 0.4 0.7 0.2 0.1 0.0 9.6 2.3 15.4 0.2 0.0 1.9 1.1 0.0 1.4 0.0 2.6 0.0 0.1 0.0 0.0 15.5 2.1 11.9 3.8 0.0 0.5 0.0 0.0 0.0 0.5 22.4 0.0 0.0 0.6 0.0 6.1 0.0 0.0 0.0 0.0 41.3 0.3 0.0 0.1 33.1 0.0 0.4 53.4 0.0 0.0 57.0 3.0 1.8 0.0 0.0 0.0 0.0 68.4 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 0.0 5.8 1.5 18.6 155.1 0.0 0.6 0.0 2.7 3.4 38.4 0.0 0.4 46.4 14.9 12.0 0.0 240.0 0.0 48.3 1.7 5.1 14.8 1.1 0.0 0.6 0.0 8.1 0.0 0.0 3.0 0.0 2.2 21.9 0.0 92.2 2.5 15.0 157.9 0.0 59.0 0.2 0.0 3.9 0.0 0.0 220.4 1.5 0.0 95.7 16.3 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "brain: 73.8;kidney: 121.9" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 26.2;Cone photoreceptor cells: 86.4;Distal tubular cells: 26.6;Horizontal cells: 93.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 7 "granulocytes: 6.4;monocytes: 2.5" "Cell line enhanced" "Detected in many" "A-431: 39.3;EFO-21: 59.6;NTERA-2: 19.4;SuSa: 25.6" "Region enhanced" "Detected in many" "cerebellum: 483.1" "Group enriched" "Detected in all" 4 "basal ganglia: 88.7;cerebellum: 312.3" "CAB002138, HPA023099, HPA056734" Enhanced Approved Vesicles NA NA Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 1.6 1.2 19.6 1.4 73.8 1.0 1.4 66.0 10.9 3.1 1.3 0.5 0.0 1.0 1.0 2.0 1.7 2.0 0.9 1.0 13.8 15.2 121.9 1.5 2.1 1.0 2.8 6.4 0.9 2.0 1.3 3.2 2.2 12.8 0.9 1.4 0.8 1.3 0.8 1.4 1.7 1.1 1.2 14.7 1.1 1.3 2.1 10.6 0.0 1.4 0.0 1.0 1.0 0.1 0.5 0.6 6.4 2.5 0.0 0.2 1.0 39.3 2.1 8.9 0.6 0.2 1.4 1.2 0.6 4.0 0.3 0.5 0.3 4.7 0.2 59.6 0.0 0.6 13.7 12.8 15.8 2.7 0.1 0.7 1.4 16.5 0.3 1.7 0.2 0.7 0.6 5.1 0.8 7.8 2.1 10.6 0.7 2.7 1.1 10.5 0.2 0.6 0.1 19.4 0.5 8.0 0.3 0.2 0.7 4.7 0.3 1.4 0.9 10.7 0.7 0.1 25.6 0.5 0.5 0.0 1.5 8.4 1.9 3.4 1.0 1.3 0.3 0.2 0.1 0.1 2.6 0.5 1.5 0.2 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.2 6.4 0.0 2.5 0.6 0.0 1.0 19.6 73.8 66.0 10.9 13.8 15.2 2.8 6.4 12.8 10.6 0.0 0.0 0.0 0.0 0.0 20.2 1.6 0.0 0.0 0.0 26.2 86.4 0.0 26.6 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.8 3.4 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 17.8 0.2 0.0 0.0 0.0 12.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 CALCR CTR ENSG00000004948 "Calcitonin receptor" 7 93424487-93574730 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;kidney: 7.5" "Group enriched" "Detected in some" 14 "Early spermatids: 13.2;Late spermatids: 4.4" "Cancer enriched" "Detected in single" 5 "renal cancer: 1.1" "Region enhanced" "Detected in many" "hypothalamus: 10.8" "Cell type enhanced" "Detected in single" "classical monocyte: 1.1" "Lineage enhanced" "Detected in single" "monocytes: 1.1" "Group enriched" "Detected in some" 7 "MCF7: 2.4;RPTEC TERT1: 4.0;SuSa: 7.7;T-47d: 7.7" "Group enriched" "Detected in some" 5 "basal ganglia: 6.7;hypothalamus: 28.7" "Low region specificity" "Detected in all" "HPA028962, HPA061428" Enhanced Supported NA NA "HPA028962: AB_10602339, HPA061428: AB_2732661" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (3.88e-2)" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "unprognostic (3.43e-1)" "unprognostic (7.73e-5)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (8.70e-2)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (2.71e-3)" "unprognostic (1.46e-3)" "unprognostic (1.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.05e-2)" 0.3 0.7 1.4 0.0 2.1 0.0 1.3 0.1 1.5 0.5 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.4 0.4 2.1 10.8 7.5 0.1 0.9 0.0 0.8 0.0 0.7 0.1 0.3 3.2 2.1 5.9 0.1 0.2 0.2 1.4 0.0 3.7 0.1 0.2 0.3 2.5 0.1 0.1 2.3 0.7 0.0 0.1 2.5 0.7 0.1 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 7.7 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 2.1 0.1 1.5 2.1 10.8 0.8 0.0 5.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453387-103458888 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sensory transduction, Taste, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.2;U-266/70: 4.4;U-266/84: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA061816 Enhanced NA NA "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 1.1 0.5 0.3 0.8 0.0 3.4 5.7 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 1.2 2.5 2.4 0.0 0.0 0.4 1.3 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.1 0.2 0.0 2.0 0.2 0.0 1.0 1.6 0.8 1.6 1.3 1.0 0.2 0.4 0.3 0.3 0.4 0.1 0.0 0.5 0.4 0.1 0.1 0.2 0.0 0.2 0.3 0.2 0.0 0.3 0.4 0.1 0.3 0.3 0.4 0.7 0.3 0.9 0.2 0.0 0.0 0.4 0.2 0.2 0.1 0.4 0.5 0.0 0.3 0.2 1.1 0.3 0.5 0.0 0.8 0.4 0.0 0.5 0.4 0.3 4.2 0.3 0.5 0.6 0.3 0.2 1.0 0.1 0.5 0.0 0.0 1.0 0.4 0.3 0.2 0.4 4.4 5.0 0.6 0.5 1.1 0.1 0.6 0.6 0.4 1.0 1.6 0.2 0.5 0.4 1.0 1.6 1.0 0.4 0.9 0.8 1.3 1.4 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC150 FLJ39660 ENSG00000144395 "Coiled-coil domain containing 150" Q8NCX0 2 196639554-196763490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.7;testis: 11.9" "Group enriched" "Detected in many" 4 "Early spermatids: 24.9;Late spermatids: 16.8;Melanocytes: 6.8;Proximal tubular cells: 9.8;Spermatocytes: 26.5;Spermatogonia: 13.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048104 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048104: AB_2680264" "unprognostic (1.92e-1)" "unprognostic (3.75e-1)" "unprognostic (2.95e-1)" "unprognostic (2.58e-4)" "unprognostic (9.88e-2)" "unprognostic (1.42e-3)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (5.91e-4)" "unprognostic (2.01e-2)" "unprognostic (3.16e-2)" "unprognostic (9.17e-3)" "unprognostic (5.66e-4)" "unprognostic (7.29e-2)" "unprognostic (1.99e-2)" "unprognostic (4.35e-2)" "unprognostic (2.69e-5)" 0.5 0.4 1.0 2.9 5.2 1.5 0.5 2.6 3.1 0.4 1.0 2.4 0.0 0.6 0.5 0.6 1.6 0.6 0.6 0.5 1.3 0.5 6.7 3.4 0.5 0.8 3.1 0.3 0.5 0.5 0.5 1.0 0.7 2.9 0.4 0.9 0.1 0.4 0.2 0.6 0.6 0.8 1.2 3.1 0.6 0.6 11.9 3.9 3.9 0.4 2.9 2.1 0.6 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.6 7.2 4.6 0.2 0.4 3.2 1.6 0.8 1.3 3.4 2.4 1.5 1.2 0.9 1.3 1.1 2.1 2.9 1.3 3.3 6.6 4.1 2.5 3.5 3.9 0.0 1.3 1.1 0.0 0.2 1.6 0.9 0.4 0.8 2.5 3.2 3.0 0.9 0.7 1.2 2.1 4.1 0.5 1.7 2.7 1.2 0.9 0.5 0.7 7.9 1.4 1.2 0.7 0.3 4.0 1.1 0.8 1.4 2.5 2.1 2.3 1.4 1.3 1.3 2.1 1.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 5.2 2.6 3.1 1.3 0.5 3.1 0.3 2.9 3.9 3.0 1.7 0.8 1.5 1.3 3.9 1.6 0.0 4.0 0.0 0.0 2.0 1.1 1.7 0.3 24.9 1.1 0.0 0.0 0.3 1.7 2.5 1.4 3.5 3.9 1.0 1.6 0.0 1.3 1.0 16.8 1.4 1.5 6.8 0.0 0.7 1.6 0.4 0.2 1.8 9.8 0.7 0.0 0.9 26.5 13.8 0.9 0.6 0.8 1.1 1.1 CCDC195 ENSG00000283428 "Coiled-coil domain containing 195" A0A1B0GUA6 2 224703764-224716365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 1.0;lymphoid tissue: 2.1;skeletal muscle: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Daudi: 7.0;RPMI-8226: 2.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469301-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 25.8;kidney: 75.8;pancreas: 21.8" "Group enriched" "Detected in some" 5 "Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1" "Cancer enhanced" "Detected in many" "renal cancer: 25.1" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "A549: 9.3;RPTEC TERT1: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.6 0.1 0.6 0.1 0.0 1.6 0.7 0.4 25.8 0.1 15.3 17.7 0.1 0.1 0.2 75.8 17.7 0.1 0.0 0.1 0.0 6.1 21.8 0.0 0.1 0.1 1.5 0.1 0.0 0.0 0.1 0.8 0.1 0.4 0.1 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.1 2.7 1.9 4.5 0.9 3.4 5.0 3.6 0.0 9.3 0.0 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.9 0.9 0.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.3 0.1 0.2 0.1 0.2 0.1 0.0 0.2 27.7 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.7 0.5 0.1 0.1 0.3 0.4 0.3 1.4 0.3 0.2 3.1 0.9 0.6 2.1 0.4 2.6 2.1 4.2 3.0 0.2 2.7 3.5 5.0 4.5 3.4 0.6 1.9 5.0 3.6 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 1.5 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 58.0 18.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 165.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD24 CD24A ENSG00000272398 "CD24 molecule" 6 106969831-106975627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "kidney: 383.7" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 26 "eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0" "Group enriched" "Detected in many" 202 "B-cells: 23.4;granulocytes: 30.4" "Cell line enhanced" "Detected in many" "NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2" "HPA045879, CAB078471" Approved Enhanced Vesicles "Intracellular and membrane" NA NA Vesicles "CAB078471: AB_10983158, HPA045879: AB_2732523" "prognostic unfavorable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 0.5 0.5 12.8 2.4 9.9 17.9 25.5 0.5 2.9 69.5 30.6 0.7 1.6 1.2 34.5 5.9 38.1 6.0 25.1 4.2 22.7 383.7 0.8 0.7 0.9 4.8 7.2 15.6 40.0 0.0 5.7 48.2 13.0 3.2 21.2 0.7 15.9 16.6 0.4 0.5 0.8 2.2 4.9 0.7 16.4 0.5 6.5 0.4 48.8 1.2 11.3 4.0 8.1 23.4 0.0 30.4 0.1 0.0 0.0 0.6 23.4 14.5 0.2 1.9 0.0 0.0 27.5 0.0 0.1 0.1 0.0 0.2 0.1 2.3 7.2 0.0 1.0 48.5 8.2 18.3 0.1 0.0 0.1 0.0 17.9 1.0 0.0 0.3 0.1 0.1 21.1 0.2 1.2 1.1 0.1 0.0 0.5 0.0 0.4 29.4 0.1 0.1 66.4 52.2 5.6 54.8 0.0 0.2 313.7 60.5 41.1 30.3 16.6 91.2 0.0 31.1 42.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.1 31.0 0.3 0.1 0.1 0.1 0.0 30.4 0.0 0.0 0.0 23.4 0.0 0.0 0.0 15.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 145.9 106.6 139.4 57.2 0.0 6.5 1.1 1003.8 691.9 180.9 1235.3 2.0 679.9 1347.9 1087.4 21.0 2.3 819.9 0.0 3019.5 709.4 9.3 444.2 10.4 3.8 61.3 0.0 552.5 53.4 8.9 32.3 9.5 11.8 0.0 55.9 391.5 1.1 1516.5 703.5 2.1 408.2 0.5 6.5 0.4 0.5 4.9 0.0 466.9 12.5 734.9 281.9 CDC20B FLJ37927 ENSG00000164287 "Cell division cycle 20B" Q86Y33 5 55112995-55173175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 33.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.5;T-47d: 3.3;U-87 MG: 1.3" "Region enriched" "Detected in single" 4 "hypothalamus: 0.4" HPA053900 Uncertain NA NA "HPA053900: AB_2682299" "unprognostic (7.39e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-2)" "unprognostic (1.78e-3)" "unprognostic (9.94e-2)" "unprognostic (1.59e-2)" "unprognostic (3.12e-1)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (7.84e-3)" "unprognostic (2.83e-2)" "unprognostic (3.06e-1)" "unprognostic (5.15e-4)" "unprognostic (1.99e-2)" "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.29e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.8 0.1 0.1 5.5 0.1 0.1 0.1 0.1 2.9 0.1 4.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.3 0.0 3.3 0.0 0.4 0.0 0.2 0.8 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.4 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.2 0.1 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918984 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 139.7" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 586.2" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 96 "RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB013526, HPA036260" Enhanced NA NA "CAB013526: , HPA036260: AB_2675027" "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favorable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.3 0.0 3.5 0.1 3.4 0.2 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 586.2 0.0 0.0 63.0 0.1 2.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 105.4 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.4 0.0 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193750-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 73.8" "Cell type enhanced" "Detected in some" 14 "Ductal cells: 30.0;Pancreatic endocrine cells: 38.4;Proximal tubular cells: 100.9;Sertoli cells: 45.3;Smooth muscle cells: 69.4" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "EFO-21: 106.5" "Low region specificity" "Detected in many" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 1200000 "Plasma membrane, Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 6.7 1.9 3.4 2.2 7.5 0.6 3.9 1.1 8.4 7.0 2.1 2.4 1.0 2.1 4.5 8.4 3.8 10.0 13.4 3.0 3.3 4.3 73.8 1.4 6.5 1.1 5.0 4.8 3.5 1.3 2.5 2.1 5.3 5.6 2.4 1.7 20.4 1.4 2.9 1.9 1.8 2.0 4.0 6.3 1.4 1.8 0.9 5.5 0.0 3.5 3.3 1.3 4.4 3.4 0.6 0.5 1.7 0.5 0.7 0.4 0.3 0.0 0.4 13.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 106.5 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.4 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.4 1.3 0.3 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.6 0.3 0.4 1.7 0.7 0.5 0.5 0.3 0.3 3.4 7.5 1.1 6.7 3.3 4.3 5.0 4.8 5.6 5.5 0.0 0.3 0.0 0.0 0.8 7.9 1.7 25.5 0.0 3.4 10.4 0.0 0.0 23.2 30.0 0.2 1.4 0.0 0.0 2.5 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.8 0.0 0.3 38.4 0.0 0.4 100.9 0.7 45.3 69.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 CFI "C3b-INA, FI, IF, KAF" ENSG00000205403 "Complement factor I" P05156 4 109740694-109802179 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 90.7;liver: 198.4" "Cell type enhanced" "Detected in many" 18 "Hepatocytes: 510.3;Muller glia cells: 130.7;Proximal tubular cells: 205.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 29.5;Hep G2: 46.8;HSkMC: 19.5;RPTEC TERT1: 52.4" "HPA001143, CAB016777, HPA024061" Supported "Secreted to blood" NA NA 11000000000 "CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129" "unprognostic (1.04e-1)" "unprognostic (5.79e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.55e-2)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" "unprognostic (3.00e-1)" "unprognostic (2.00e-2)" "unprognostic (5.42e-3)" "unprognostic (1.41e-1)" "unprognostic (3.61e-1)" "unprognostic (8.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.06e-4)" 9.5 13.2 1.5 2.3 1.4 0.0 3.9 0.9 2.5 5.0 4.1 1.1 2.9 4.9 5.0 12.0 4.4 9.7 9.3 6.2 1.6 0.8 90.7 198.4 7.2 3.1 1.8 0.7 10.6 7.6 0.5 3.8 3.2 2.6 3.9 0.7 6.8 3.6 3.6 1.4 0.5 4.6 3.0 3.0 7.8 1.7 3.6 1.6 0.5 5.3 2.3 1.4 3.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 29.5 0.0 9.4 0.1 0.2 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.1 46.8 2.0 0.0 0.0 19.5 0.0 0.0 0.0 1.3 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.4 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.9 2.5 1.6 0.8 1.8 0.7 2.6 1.6 11.9 34.5 6.7 10.2 0.9 2.4 1.9 107.0 2.7 36.4 61.1 2.0 0.1 26.6 36.3 0.2 49.6 1.1 0.0 27.7 0.1 3.8 1.7 3.5 510.3 0.6 1.6 0.0 54.6 14.3 0.2 15.5 1.7 0.0 2.8 0.7 130.7 34.8 2.9 0.0 205.0 5.6 0.0 3.2 0.7 0.5 1.0 0.2 4.4 0.6 10.3 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550727 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 81.1;Hepatocytes: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.4;SuSa: 22.4;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" No No "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102" "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favorable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favorable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favorable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 3.1 8.7 10.8 1.7 9.8 0.6 14.6 3.2 12.2 25.7 2.0 7.3 8.9 1.4 14.9 4.9 7.7 7.0 2.7 13.6 11.2 7.8 54.8 26.2 15.3 1.3 8.3 5.9 8.1 13.6 12.5 2.9 20.8 10.9 27.6 2.3 11.1 32.0 12.7 1.0 7.4 1.7 10.6 5.3 0.8 9.0 5.2 9.7 1.3 15.0 4.2 8.0 10.0 14.6 0.5 0.2 1.1 0.1 0.3 0.2 0.0 0.0 0.7 7.4 0.0 0.0 0.0 0.1 0.1 1.6 0.6 1.4 4.6 0.0 0.0 6.5 0.9 1.1 0.0 3.5 0.0 1.0 0.0 0.5 0.0 0.0 3.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 2.5 29.4 0.3 0.0 0.0 1.1 1.3 0.0 0.1 3.6 2.0 0.3 0.0 3.7 0.1 2.5 0.0 0.1 0.4 0.0 2.8 0.0 22.4 0.3 0.3 18.0 0.0 1.9 0.0 1.0 0.0 0.0 0.0 0.1 3.3 0.0 0.9 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.2 0.1 0.0 10.8 9.8 3.2 12.2 11.2 7.8 8.3 5.9 10.9 9.7 47.6 81.1 0.0 10.9 4.0 0.4 19.4 17.8 2.7 18.2 21.0 0.0 0.8 34.9 6.9 2.5 13.5 0.2 23.3 11.6 0.7 19.3 30.4 1.1 49.7 0.3 0.0 12.6 22.1 1.0 11.5 18.4 2.4 6.8 1.0 3.2 37.1 5.1 0.0 26.2 32.9 1.3 0.0 2.8 0.5 0.4 2.0 1.1 0.5 2.9 7.6 CHDH ENSG00000016391 "Choline dehydrogenase" Q8NE62 3 53812335-53846390 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.6;liver: 24.0" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 53.5;Proximal tubular cells: 81.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 6.4;T-reg: 2.8" "Group enriched" "Detected in many" 15 "granulocytes: 6.4;T-cells: 2.8" "Cell line enhanced" "Detected in some" "CACO-2: 8.0;Hep G2: 24.6;OE19: 17.7;T-47d: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036633, HPA058130" Enhanced NA NA "HPA036633: AB_10670841, HPA058130: AB_2683615" "unprognostic (3.40e-3)" "unprognostic (1.17e-2)" "unprognostic (2.26e-3)" "unprognostic (7.17e-3)" "unprognostic (9.15e-2)" "unprognostic (1.17e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-1)" "unprognostic (4.35e-3)" "unprognostic (4.57e-2)" "unprognostic (5.12e-2)" "prognostic favorable (1.88e-8)" "unprognostic (3.37e-2)" "unprognostic (2.42e-1)" "unprognostic (8.26e-2)" "unprognostic (2.29e-2)" 0.7 2.2 11.6 2.3 9.7 0.9 7.8 12.9 10.2 4.1 8.8 8.2 0.8 8.3 3.2 3.8 1.0 2.8 5.5 3.3 13.8 4.0 36.6 24.0 2.6 1.4 11.9 6.5 1.6 15.5 8.0 5.9 0.8 10.0 5.4 9.4 3.3 13.7 1.5 3.8 1.6 14.0 1.4 6.4 0.7 8.1 4.5 13.0 0.0 4.1 0.1 1.6 0.8 1.0 0.3 0.1 6.4 0.1 0.1 2.8 0.1 0.3 3.3 0.8 0.1 0.0 0.0 3.7 0.2 0.4 0.0 0.0 8.0 0.6 0.3 0.6 0.6 0.1 0.0 5.3 0.0 0.0 0.0 2.8 0.0 1.1 24.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.8 0.5 0.0 4.7 0.0 0.1 5.2 17.7 0.6 0.0 1.4 5.6 3.7 2.9 2.2 2.8 1.3 0.1 0.0 0.7 8.1 0.1 0.0 0.0 0.6 0.1 0.7 0.7 1.0 0.0 0.0 0.0 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.1 2.8 0.1 11.6 9.7 12.9 10.2 13.8 4.0 11.9 6.5 10.0 13.0 3.0 5.0 2.7 6.1 6.0 16.8 7.6 53.5 6.7 10.3 10.4 13.7 2.5 6.6 15.1 21.5 0.7 23.4 0.0 11.9 1.8 2.1 17.6 6.9 38.9 0.3 1.6 46.0 1.3 1.9 28.5 5.5 1.9 3.3 0.0 34.1 13.4 9.1 17.5 14.5 81.4 14.6 0.0 1.9 3.3 1.9 4.5 0.7 1.5 45.1 1.2 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922615-50099235 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.1" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 8 "dendritic cells: 6.6;monocytes: 1.8" "Cell line enhanced" "Detected in many" "CACO-2: 25.4;RH-30: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 4.4 4.1 2.5 2.4 2.9 2.1 3.4 9.4 3.4 2.3 3.1 2.6 4.7 5.0 9.8 26.7 3.7 4.6 7.6 2.2 3.1 2.8 46.1 15.8 4.7 3.0 2.6 2.5 10.8 6.7 2.6 8.3 7.3 5.9 2.7 3.7 7.6 4.0 3.5 5.6 6.2 6.4 3.8 4.3 3.0 4.0 5.9 2.3 1.2 3.6 4.0 2.3 2.4 3.1 0.2 6.6 0.5 1.8 0.3 0.4 0.5 1.8 2.8 2.2 3.3 8.4 5.3 4.7 1.5 0.8 1.0 1.2 25.4 1.7 1.8 0.8 1.7 5.6 1.5 6.8 0.8 1.6 0.7 4.6 1.8 1.4 6.6 4.0 2.3 3.4 3.1 1.1 2.6 3.8 0.8 3.6 2.4 2.7 2.7 2.9 1.8 0.8 0.7 3.2 4.2 1.4 1.1 39.3 2.8 3.8 2.9 3.8 2.7 2.2 2.2 3.1 8.7 1.9 1.1 1.8 1.0 2.1 7.8 0.9 2.3 6.9 4.1 1.7 3.8 5.1 0.1 1.8 0.0 0.2 1.5 0.3 0.2 0.4 0.4 3.8 0.2 0.1 0.1 0.5 0.3 0.3 6.6 0.0 0.5 2.5 2.9 9.4 3.4 3.1 2.8 2.6 2.5 5.9 2.3 8.9 5.9 1.5 1.6 6.4 19.5 1.6 5.1 5.3 0.0 12.2 2.0 5.2 10.0 3.7 1.1 3.8 10.9 0.0 2.9 2.2 5.7 3.1 2.3 21.7 8.9 7.9 0.0 0.6 9.5 0.0 4.9 8.9 3.3 5.4 5.7 2.8 5.8 6.2 12.4 32.4 4.3 0.0 3.3 1.0 0.7 8.3 4.2 0.0 6.4 4.6 CLCNKA hClC-Ka ENSG00000186510 "Chloride voltage-gated channel Ka" P51800 1 16018875-16034050 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.9;parathyroid gland: 15.4" "Cell type enriched" "Detected in some" 4 "Late spermatids: 171.7" "Group enriched" "Detected in some" 7 "renal cancer: 4.4;thyroid cancer: 1.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 13.0" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (4.02e-1)" "unprognostic (2.76e-3)" "unprognostic (8.20e-2)" "unprognostic (6.16e-2)" "unprognostic (1.18e-2)" "unprognostic (6.92e-3)" "unprognostic (3.49e-2)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (8.13e-3)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (4.37e-3)" "unprognostic (1.28e-1)" 0.2 0.7 0.2 0.2 0.2 0.0 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 46.9 0.2 0.2 0.2 0.2 0.2 0.2 1.2 15.4 5.8 0.2 0.2 0.2 0.0 0.2 4.4 0.2 0.2 0.0 0.2 0.2 0.2 0.2 1.6 1.1 0.2 0.2 6.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.4 3.1 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.3 0.0 0.0 0.1 0.6 3.5 0.0 0.0 1.2 24.4 0.0 0.4 21.6 0.1 38.8 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.1 12.7 1.2 0.0 0.0 171.7 0.3 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.7 0.7 0.0 0.6 0.0 0.0 0.1 CLCNKB hClC-Kb ENSG00000184908 "Chloride voltage-gated channel Kb" P51801 1 16043736-16057308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 58.4;salivary gland: 25.7" "Group enriched" "Detected in some" 10 "Collecting duct cells: 22.7;Distal tubular cells: 49.7;Early spermatids: 20.7;Late spermatids: 76.4" "Cancer enriched" "Detected in some" 9 "renal cancer: 24.9" "Region enriched" "Detected in single" 7 "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0;SuSa: 2.1" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (9.05e-4)" "unprognostic (1.72e-1)" "unprognostic (2.41e-2)" "unprognostic (2.68e-3)" "unprognostic (1.44e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-4)" "unprognostic (1.87e-1)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (4.57e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.27e-7)" "unprognostic (2.04e-2)" "unprognostic (4.62e-1)" "unprognostic (1.78e-2)" "unprognostic (5.14e-2)" 0.1 0.5 0.2 0.1 0.2 0.0 0.1 2.8 0.2 0.7 0.1 0.1 2.2 0.0 0.5 0.5 0.1 0.1 0.4 1.2 0.1 0.1 58.4 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.9 0.8 0.4 0.3 0.5 0.0 1.2 25.7 0.7 0.1 0.0 0.2 0.3 0.5 0.1 0.1 0.7 0.1 0.1 11.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 2.2 0.0 5.1 0.7 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 3.1 0.1 0.6 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.1 0.4 0.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.8 0.2 0.1 0.1 0.1 0.1 0.3 0.1 3.0 1.1 0.0 0.0 0.0 0.5 4.3 0.0 1.4 2.3 22.7 0.0 0.3 49.7 0.5 20.7 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 76.4 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.1 0.2 0.0 0.0 0.1 1.4 0.6 0.0 0.5 0.0 0.6 0.0 CLDN10 "CPETRL3, OSP-L" ENSG00000134873 "Claudin 10" P78369 13 95433604-95579759 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0" "Group enriched" "Detected in many" 7 "Cholangiocytes: 247.1;Collecting duct cells: 94.2;Distal tubular cells: 114.4;Ductal cells: 224.8;Exocrine glandular cells: 70.7;Melanocytes: 65.8;Muller glia cells: 75.5;Pancreatic endocrine cells: 89.7;Proximal tubular cells: 232.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 7.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.8" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 19.7;SuSa: 64.9" "Low region specificity" "Detected in all" "CAB012969, HPA042348" Enhanced NA NA "CAB012969: AB_2533386, HPA042348: AB_2677955" "unprognostic (6.45e-2)" "unprognostic (5.72e-2)" "unprognostic (3.35e-1)" "unprognostic (4.60e-2)" "unprognostic (4.73e-2)" "unprognostic (2.46e-3)" "unprognostic (6.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.91e-3)" "unprognostic (2.59e-3)" "unprognostic (7.93e-2)" "prognostic favorable (7.46e-5)" "unprognostic (1.11e-2)" "unprognostic (9.94e-2)" "prognostic favorable (2.13e-4)" "unprognostic (4.75e-3)" 0.8 0.5 28.3 0.5 17.1 1.9 2.6 5.9 17.7 26.0 0.6 4.3 0.0 1.4 8.1 15.4 2.6 16.0 23.1 0.6 18.1 6.2 50.5 1.7 0.8 0.5 10.8 12.0 1.1 97.3 0.8 1.1 0.7 5.7 1.4 0.6 3.4 70.0 0.6 0.5 4.5 0.5 0.7 2.8 0.7 1.0 0.9 6.3 0.0 0.5 2.1 49.4 0.6 0.2 1.2 0.6 7.8 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.0 0.0 0.0 0.0 19.7 0.0 0.1 0.1 0.0 0.0 0.0 64.9 0.2 1.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.6 0.0 0.1 28.3 17.1 5.9 17.7 18.1 6.2 10.8 12.0 5.7 6.3 0.0 0.0 0.5 5.8 0.2 0.1 0.4 247.1 9.4 6.8 94.2 0.0 13.8 114.4 224.8 2.4 2.7 0.0 0.0 70.7 5.3 0.5 10.6 0.0 0.0 1.7 0.0 0.0 1.3 0.0 1.7 0.0 0.1 65.8 2.8 0.0 75.5 89.7 0.0 0.4 232.4 3.9 6.5 1.4 6.7 11.3 0.5 19.3 0.0 0.0 3.0 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 7.4;liver: 25.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 7.6;Distal tubular cells: 16.6;Ductal cells: 10.3;Exocrine glandular cells: 7.3;Hepatocytes: 19.8;Pancreatic endocrine cells: 13.1" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enriched" "Detected in some" 14 "HDLM-2: 70.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles NA NA Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favorable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.3 0.0 7.4 25.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.8 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.4 0.0 0.5 1.4 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.2 2.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.3 1.4 0.0 0.2 0.1 1.9 3.7 0.0 0.3 0.1 0.0 0.7 0.2 2.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 1.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 1.0 0.3 0.0 0.8 7.6 0.0 0.0 1.8 0.0 0.1 16.6 10.3 0.4 0.0 0.0 0.0 7.3 0.9 0.0 0.7 0.0 19.8 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.3 1.0 0.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.7 0.0 0.0 1.4 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412143 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "kidney: 55.9" "Cell type enriched" "Detected in many" 7 "Distal tubular cells: 159.2" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 131 "EFO-21: 101.3;RPTEC TERT1: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.2 0.8 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 0.2 0.2 0.3 0.4 55.9 1.2 0.2 0.7 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.5 0.2 1.8 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 3.4 0.2 0.4 0.3 0.2 0.5 0.4 1.4 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 1.4 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 1.2 0.3 0.2 0.4 0.1 0.0 0.4 0.3 0.2 0.5 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0.0 0.0 4.8 6.3 0.2 0.3 5.1 22.7 1.2 8.7 0.0 0.2 159.2 2.2 0.6 0.0 0.0 0.0 0.3 0.1 0.3 1.2 1.1 1.5 0.1 3.2 0.0 0.0 0.3 0.0 0.0 1.0 5.0 0.0 0.0 0.0 0.4 0.0 0.4 0.6 0.1 0.0 0.0 0.1 0.1 11.0 5.1 0.0 0.0 3.1 CLDN19 ENSG00000164007 "Claudin 19" Q8N6F1 1 42733093-42740254 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0" "Cell type enriched" "Detected in some" 7 "Extravillous trophoblasts: 192.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Group enriched" "Detected in some" 54 "midbrain: 13.8;pons and medulla: 9.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4" "Region enhanced" "Detected in some" "olfactory region: 6.7" "Low region specificity" "Detected in all" NA NA "unprognostic (6.23e-4)" "unprognostic (1.80e-1)" "unprognostic (1.85e-6)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-1)" "unprognostic (9.45e-2)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (7.22e-2)" "unprognostic (8.76e-3)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.29e-3)" 1.0 0.2 0.1 0.1 0.2 0.2 1.6 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.9 0.6 0.3 0.1 0.4 0.2 0.1 22.5 0.2 0.2 0.1 13.8 0.0 0.2 0.2 0.1 0.2 20.9 9.5 0.4 0.1 37.0 1.2 2.7 0.4 0.8 0.3 1.0 6.2 0.1 0.5 0.2 0.0 1.3 0.1 2.6 0.1 0.8 1.0 0.5 0.4 1.4 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.5 0.5 1.4 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 13.8 0.0 9.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 1.2 12.2 0.0 9.1 28.2 0.0 0.0 0.0 0.0 0.0 0.0 192.3 0.2 0.1 0.0 0.0 4.4 0.0 0.0 0.6 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 0.0 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Cell type enhanced" "Detected in some" 21 "Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 81.0" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: AB_2681530" "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favorable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 13.3 67.3 0.0 0.0 1.0 0.0 42.5 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 2.8 0.1 0.9 28.7 2.9 0.0 138.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 CLDN24 CLDN21 ENSG00000185758 "Claudin 24" A6NM45 4 183321764-183322426 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 4.6;salivary gland: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.9;fHDF/TERT166: 3.6;HSkMC: 1.5;SCLC-21H: 1.5;SK-BR-3: 3.1" NA NA "unprognostic (1.49e-1)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.93e-3)" 0.1 0.3 0.0 0.5 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.0 0.1 0.0 0.2 0.0 0.0 4.6 0.4 0.6 0.0 0.0 0.2 0.3 0.5 0.1 0.0 0.1 0.0 2.1 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.3 1.9 0.7 0.0 0.3 0.0 0.4 3.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN8 ENSG00000156284 "Claudin 8" P56748 21 30214006-30216073 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 26.2;kidney: 48.4" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 212.9" "Cancer enhanced" "Detected in many" "prostate cancer: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HaCaT: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA060605 Supported NA NA "HPA060605: AB_2684331" "unprognostic (3.74e-2)" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (1.62e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.6 0.6 0.1 0.6 0.0 26.2 0.7 0.6 2.5 10.0 0.0 6.9 0.0 0.7 14.0 4.2 0.8 0.0 0.7 0.6 0.6 48.4 0.9 1.7 0.0 0.6 0.0 0.6 1.5 0.0 1.3 5.9 0.0 4.6 19.5 0.0 14.2 8.7 0.6 2.2 0.8 0.0 0.6 0.6 0.7 1.0 0.0 0.0 12.2 1.2 1.8 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 0.0 0.0 26.8 4.5 212.9 0.0 0.0 10.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 13.5 0.0 0.0 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 6.6 18.2 CLEC18A MRCL ENSG00000157322 "C-type lectin domain family 18 member A" A5D8T8 16 69950705-69964452 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 19.6" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 57.3" "Cancer enriched" "Detected in single" 7 "renal cancer: 1.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.8;BEWO: 3.6" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (1.68e-1)" "unprognostic (3.06e-2)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (3.14e-2)" "unprognostic (4.62e-2)" "unprognostic (1.36e-1)" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-4)" "unprognostic (6.73e-2)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (9.03e-4)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" 0.1 1.3 0.3 0.0 0.8 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.5 19.6 0.1 0.1 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.5 0.0 1.0 0.7 0.5 3.4 0.1 0.1 0.4 0.0 0.9 0.3 1.6 0.0 0.5 0.1 0.0 0.3 0.3 2.8 0.2 0.0 0.8 3.6 0.0 0.0 0.6 0.2 0.6 0.1 0.5 0.3 0.0 0.5 0.0 0.0 0.4 0.3 0.6 0.9 0.0 0.0 1.5 0.0 0.7 1.8 0.0 1.4 1.4 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.4 0.0 0.0 1.0 1.6 0.1 0.8 0.0 0.1 0.5 0.7 1.6 0.0 0.7 1.9 0.2 0.0 0.7 0.8 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.1 1.2 0.4 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.2 0.2 0.2 1.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.6 0.3 0.1 0.0 0.0 0.9 1.5 0.5 0.0 0.0 57.3 1.1 0.0 0.2 0.5 0.1 0.0 0.2 0.0 1.6 0.1 CLEC18B MRCL2 ENSG00000140839 "C-type lectin domain family 18 member B" Q6UXF7 16 74408270-74421953 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 28.1" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 18.2" "Group enriched" "Detected in some" 12 "glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (5.69e-2)" "unprognostic (1.46e-1)" "unprognostic (5.30e-3)" "unprognostic (9.37e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (7.15e-2)" "unprognostic (7.51e-2)" "unprognostic (4.49e-3)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (9.91e-2)" "unprognostic (3.58e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-2)" "unprognostic (5.87e-2)" "unprognostic (5.43e-2)" "unprognostic (4.27e-2)" 0.1 1.1 1.1 0.3 1.4 0.1 0.1 2.5 1.2 0.1 0.1 0.4 0.1 0.6 1.2 0.1 0.3 0.0 1.0 1.0 28.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.1 2.0 0.1 0.1 6.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 1.6 2.9 1.8 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.2 1.1 0.5 0.5 1.0 0.9 0.0 0.1 0.3 0.2 0.4 0.3 0.1 0.7 0.0 0.3 1.7 0.4 0.1 0.1 0.7 0.0 4.1 7.3 0.0 0.3 0.0 0.0 0.0 1.2 0.3 0.8 0.4 0.0 1.6 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.2 0.9 2.7 1.6 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.4 0.0 0.0 18.2 1.1 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 CLEC18C "MGC34761, MRCL3" ENSG00000157335 "C-type lectin domain family 18 member C" Q8NCF0 16 70173322-70187361 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "kidney: 16.5;testis: 4.6" "Cell type enriched" "Detected in single" 48 "Proximal tubular cells: 18.8" "Cancer enriched" "Detected in single" 9 "renal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;RT4: 1.3;TIME: 3.0" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (3.90e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-4)" "unprognostic (5.55e-2)" "unprognostic (5.72e-3)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (6.98e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 16.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.3 1.3 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 10.9;lymphoid tissue: 10.8" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 11.6;granulocytes: 11.5" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 9.2;U-937: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035671, HPA035672" Uncertain Uncertain Vesicles NA NA Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.4 0.5 0.3 5.7 0.3 0.5 0.7 0.4 0.3 1.9 1.8 0.1 0.1 0.7 0.8 1.7 2.0 0.4 1.4 0.3 0.3 0.3 10.9 1.2 3.2 5.0 0.3 0.1 0.5 0.7 0.0 3.2 1.5 0.5 0.5 0.4 1.6 2.5 0.1 0.3 1.2 2.3 1.7 0.3 6.3 1.6 1.1 0.1 8.4 0.5 1.5 10.8 0.4 0.4 3.4 5.5 1.6 0.4 4.3 3.6 0.5 0.1 0.6 0.5 0.3 0.8 0.2 0.6 0.4 0.0 0.1 0.2 0.0 0.4 0.3 0.1 0.4 0.1 0.4 0.0 0.0 0.1 9.2 0.4 0.4 0.5 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.3 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.2 0.1 1.1 0.1 0.6 0.8 0.1 0.3 0.5 0.3 0.3 0.3 0.0 1.0 0.2 0.3 0.6 0.3 0.5 0.1 0.4 0.5 4.8 0.2 1.0 0.4 0.6 0.7 0.3 0.3 3.4 1.2 0.4 5.5 2.9 0.5 0.5 1.6 4.3 0.2 1.4 3.6 0.5 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.1 0.5 0.1 3.0 4.8 0.8 0.8 0.7 1.1 0.6 0.0 0.0 1.2 0.0 2.0 0.3 11.6 0.0 4.9 0.3 0.0 0.0 0.0 1.6 0.4 0.4 11.5 0.2 0.2 0.0 0.0 0.6 0.3 3.1 0.3 1.3 1.7 0.0 0.0 0.2 0.2 0.0 2.1 0.0 0.8 0.0 0.4 1.1 0.5 0.4 0.1 2.5 0.0 0.6 CLRN2 ENSG00000249581 "Clarin 2" A0PK11 4 17515165-17527104 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 1.2;salivary gland: 1.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042407 Uncertain NA NA "HPA042407: AB_10806237" 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN3 "MGC32871, TMEM12, USH3AL1" ENSG00000180745 "Clarin 3" Q8NCR9 10 127877841-127892947 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 69.3;kidney: 14.7;liver: 25.6" "Group enriched" "Detected in some" 5 "Enterocytes: 118.1;Hepatocytes: 34.8;Intestinal endocrine cells: 39.9;Mucus-secreting cells: 70.4;Paneth cells: 98.2;Proximal tubular cells: 59.1;Undifferentiated cells: 39.3" "Group enriched" "Detected in many" 10 "colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "OE19: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014482 Approved NA NA "HPA014482: AB_2082885" "unprognostic (7.34e-3)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (1.46e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (6.22e-2)" "unprognostic (4.67e-1)" "unprognostic (8.86e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.74e-1)" "unprognostic (2.89e-3)" "unprognostic (3.00e-2)" 0.4 0.2 0.3 3.1 0.2 0.0 0.2 0.2 0.3 0.2 27.5 0.3 0.2 23.7 0.2 1.3 0.2 0.1 9.5 0.2 0.3 0.2 14.7 25.6 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 23.5 0.2 0.2 0.2 0.2 0.1 69.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 1.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.1 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 118.1 0.0 0.5 0.0 0.0 0.0 0.0 34.8 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 0.2 98.2 0.0 59.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 0.0 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell type enriched" "Detected in some" 15 "Proximal tubular cells: 679.1" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" "HPA048543: AB_2680436" "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favorable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.1 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 0.2 10.6 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.7 0.0 2.4 0.7 0.6 0.3 3.5 0.2 0.4 3.5 0.9 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 6.5 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.5 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 26.2 0.0 1.9 46.4 19.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 679.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 CMBL FLJ23617 ENSG00000164237 "Carboxymethylenebutenolidase homolog" Q96DG6 5 10275875-10308026 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 182.4;Enterocytes: 265.0;Hepatocytes: 151.5;Proximal tubular cells: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 27.9;HSkMC: 30.8;K-562: 31.3;PC-3: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036571 Uncertain NA NA 590000 "HPA036571: AB_10670114" "unprognostic (1.81e-2)" "unprognostic (2.55e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.20e-1)" "unprognostic (8.64e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.76e-1)" "unprognostic (4.44e-2)" "unprognostic (1.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-1)" 5.7 13.9 8.1 6.1 7.7 2.0 13.1 4.1 7.8 5.6 38.3 2.9 5.2 47.0 4.3 6.1 3.0 5.1 21.6 11.4 7.8 5.1 81.7 83.7 5.5 2.1 5.8 7.6 10.6 6.5 13.9 6.0 1.3 5.1 8.6 17.8 4.8 3.5 8.4 70.6 1.4 71.4 5.0 7.0 1.4 14.4 3.9 4.1 1.3 7.3 10.5 1.6 6.4 4.8 0.8 0.6 3.0 1.2 0.7 2.1 0.8 3.7 4.3 5.1 12.8 20.5 23.5 27.9 6.3 6.8 2.0 2.9 1.8 19.1 0.1 10.6 4.6 9.4 0.1 12.0 8.1 2.5 0.2 9.0 16.7 20.1 14.3 6.3 0.1 0.1 30.8 5.3 4.2 3.8 7.6 6.1 0.0 31.3 0.2 7.1 0.7 0.1 0.6 7.8 0.0 30.2 3.7 0.0 0.4 18.8 2.4 4.1 6.3 15.1 1.4 0.4 6.4 10.5 0.6 1.8 3.0 4.0 4.8 0.0 0.1 0.0 0.0 5.0 0.0 0.0 2.1 1.2 0.5 1.5 0.5 2.1 0.3 1.7 0.7 0.6 0.8 0.8 1.6 3.0 0.7 0.3 0.5 0.2 0.8 8.1 7.7 4.1 7.8 7.8 5.1 5.8 7.6 5.1 4.1 23.8 12.1 3.2 13.6 3.3 2.0 76.4 50.9 18.7 22.7 22.7 3.9 12.7 182.4 9.2 2.2 11.3 265.0 23.3 13.7 8.1 16.4 25.4 12.7 151.5 10.5 0.0 18.5 12.3 5.4 2.2 44.3 3.5 1.7 0.0 82.6 15.4 13.3 100.8 38.9 326.1 2.8 0.0 8.6 0.7 6.4 3.3 4.1 2.5 128.4 10.7 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164565-227314792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 157.8;Cone photoreceptor cells: 375.0;Muller glia cells: 214.6" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory B-cell: 3.8;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 7 "B-cells: 3.8" "Cell line enhanced" "Detected in some" "HeLa: 15.4;hTERT-RPE1: 13.4;Karpas-707: 9.0;RPTEC TERT1: 10.1;U-266/70: 8.3" "Not detected" "Not detected" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favorable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.7 9.5 0.9 5.4 2.9 0.3 0.9 1.4 2.9 0.7 0.7 1.7 12.0 0.7 1.5 15.3 1.1 1.5 5.3 6.7 1.6 1.2 27.9 0.7 15.0 3.6 2.4 0.0 3.6 4.4 0.2 16.7 0.2 7.5 4.9 1.0 20.9 1.1 11.2 17.8 0.6 5.0 2.9 3.1 6.1 1.5 1.5 3.4 0.0 16.2 9.4 5.8 1.8 1.2 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.2 1.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 1.1 0.0 9.0 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 0.0 2.8 10.1 2.0 0.4 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 8.3 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.9 1.4 2.9 1.6 1.2 2.4 0.0 7.5 3.4 157.8 24.8 4.7 0.0 0.1 58.0 1.7 0.0 0.0 17.0 40.1 375.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.8 0.0 1.7 0.0 0.0 214.6 0.9 0.0 11.3 1.0 11.5 12.9 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 COL4A4 CA44 ENSG00000081052 "Collagen type IV alpha 4 chain" P53420 2 227002711-227164453 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.7" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 68.5;Collecting duct cells: 43.6;Cone photoreceptor cells: 53.0;Muller glia cells: 117.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "memory B-cell: 8.0" "Lineage enriched" "Detected in many" 7 "B-cells: 8.0" "Cell line enhanced" "Detected in some" "HeLa: 23.1;hTERT-RPE1: 19.7;Karpas-707: 6.3;RPTEC TERT1: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (7.31e-2)" "unprognostic (7.56e-2)" "unprognostic (6.65e-2)" "unprognostic (4.88e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (8.50e-3)" "unprognostic (5.14e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "prognostic favorable (2.30e-13)" "unprognostic (1.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.30e-1)" "unprognostic (4.15e-2)" 1.6 8.8 1.2 7.2 2.4 0.2 1.3 1.0 1.8 1.0 1.1 0.7 16.1 1.2 4.8 12.7 2.4 3.0 13.7 11.5 1.4 1.5 28.7 1.9 15.8 13.0 2.4 0.0 3.2 6.6 0.5 15.3 0.7 7.4 7.2 1.2 8.3 1.4 10.9 7.5 0.9 3.3 12.0 4.6 3.7 1.9 1.9 1.5 0.9 12.1 6.6 6.2 3.9 3.7 8.0 0.0 0.1 0.0 1.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.4 0.0 0.5 0.0 1.2 0.0 0.5 0.0 2.2 0.7 0.2 0.0 2.4 0.0 23.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 19.7 0.0 0.7 0.0 6.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.9 10.6 3.9 0.6 0.0 1.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.9 0.0 0.2 4.8 3.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.5 0.0 0.0 8.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 2.4 1.0 1.8 1.4 1.5 2.4 0.0 7.4 1.5 68.5 17.9 2.2 0.4 0.5 29.8 2.6 15.3 0.0 11.4 43.6 53.0 0.0 1.7 0.2 0.7 0.3 0.0 0.0 3.2 0.0 0.7 0.1 0.0 0.5 0.1 0.0 1.2 2.5 0.3 2.1 23.3 0.7 0.0 0.0 0.0 117.3 3.3 0.0 25.5 2.2 7.4 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 45.5" "Cell type enhanced" "Detected in single" 35 "Muller glia cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 140 "Hep G2: 28.9" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" "unprognostic (3.68e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.9" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.3 2.9 2.5 18.4 14.1 16.3 2.5 4.7 8.5 2.1 1.7 1.1 3.1 0.0 9.1 6.5 4.8 0.8 2.5 4.2 2.1 8.1 2.0 5.9 0.3 23.0 8.1 1.9 5.4 9.6 2.7 1.5 9.7 7.6 22.3 8.7 0.4 2.3 5.5 12.1 5.1 3.0 0.1 28.9 4.5 2.6 1.6 0.4 17.8 7.1 1.8 2.2 2.8 1.3 21.2 1.3 9.1 7.6 21.3 2.6 1.2 6.3 2.9 3.3 0.6 0.0 4.9 3.3 10.5 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 6.0 6.4 19.9 13.2 9.2 5.0 9.8 48.4 10.7 6.8 73.3 11.8 18.1 411.1 21.5 2.6 23.7 181.3 0.0 27.8 9.4 16.4 23.5 24.3 272.9 59.4 1.6 8.7 49.1 76.7 2.9 24.2 36.1 35.4 11.8 69.9 93.7 32.1 152.6 22.6 848.9 10.8 19.4 12.3 0.9 0.2 8.2 17.4 15.3 78.8 12.2 CRYZ ENSG00000116791 "Crystallin zeta" Q08257 1 74705482-74733408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.0;liver: 79.8" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 151.8;Distal tubular cells: 192.3;Hepatocytes: 184.9;Proximal tubular cells: 384.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 98.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021921, HPA023290" Approved Supported Cytosol NA NA 7200000 Cytosol "HPA021921: AB_1847262, HPA023290: AB_1847263" "unprognostic (3.64e-2)" "unprognostic (3.38e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.32e-3)" "unprognostic (5.79e-2)" "unprognostic (6.29e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-1)" "unprognostic (6.38e-3)" "unprognostic (2.19e-1)" "unprognostic (1.35e-3)" "unprognostic (3.12e-1)" "unprognostic (7.50e-2)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" 6.0 13.4 7.5 4.6 5.4 0.2 8.8 4.2 5.9 19.8 12.6 3.9 27.1 11.3 11.9 29.1 9.7 11.5 15.7 10.4 6.0 9.0 100.0 79.8 7.1 4.8 6.5 3.5 9.4 26.1 13.2 17.2 3.7 11.1 13.8 4.9 9.4 5.9 21.9 5.6 5.6 19.8 14.1 6.8 5.4 9.5 4.9 5.9 7.1 17.1 7.9 5.8 14.8 15.8 18.2 8.9 4.7 8.6 14.4 21.7 9.0 2.5 24.8 12.8 3.6 14.8 16.2 8.7 8.0 12.7 11.6 13.1 19.4 10.3 13.9 14.1 15.5 20.4 6.9 10.4 10.1 19.0 16.0 4.2 5.8 7.7 38.8 7.8 4.9 11.9 7.5 9.0 18.6 3.4 10.9 9.7 7.7 18.2 5.0 24.2 5.8 8.9 8.3 9.6 20.2 16.2 5.7 12.1 5.1 98.3 7.9 3.5 6.3 1.8 13.5 8.7 15.0 12.1 1.6 4.7 2.8 7.0 8.7 12.0 3.6 6.9 6.8 22.8 1.9 7.9 4.7 5.2 0.9 18.2 7.7 14.7 18.2 17.9 16.7 8.9 13.7 15.7 16.7 0.8 14.4 8.6 7.5 21.7 9.0 7.5 5.4 4.2 5.9 6.0 9.0 6.5 3.5 11.1 5.9 26.8 16.9 14.3 23.5 15.9 2.5 25.7 89.2 16.0 12.5 151.8 2.0 12.7 192.3 42.4 0.3 8.0 12.3 0.0 28.1 14.2 21.7 10.3 13.9 184.9 15.3 0.0 6.4 11.6 12.5 1.1 19.2 10.6 10.1 10.0 13.2 6.8 30.1 9.1 19.4 384.2 2.6 0.0 15.9 1.4 6.8 18.4 6.1 15.2 13.3 12.7 CTXN3 ENSG00000205279 "Cortexin 3" Q4LDR2 5 127649044-127658630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 21.9;kidney: 58.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 121.0" "Cancer enriched" "Detected in single" 8 "renal cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 4.5;NTERA-2: 1.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory region: 50.2" NA NA "unprognostic (7.32e-2)" "unprognostic (9.88e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (6.20e-3)" 0.6 0.6 2.2 0.5 9.4 0.5 0.6 0.2 19.1 0.6 0.6 0.7 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 7.9 4.8 58.1 0.6 0.6 0.6 12.6 4.6 0.5 0.5 0.5 5.9 0.5 21.9 0.9 0.6 0.0 0.7 0.6 9.1 0.5 0.5 0.5 0.5 0.5 0.6 0.6 1.0 0.0 0.5 0.3 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.2 19.1 7.9 4.8 12.6 4.6 21.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 19.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CUBN "gp280, IFCR, MGA1" ENSG00000107611 Cubilin O60494 10 16823964-17129831 "Disease related genes, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 28.9;kidney: 79.7" "Cell type enriched" "Detected in many" 12 "Proximal tubular cells: 301.3" "Cancer enriched" "Detected in some" 15 "renal cancer: 24.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 18.2;ASC TERT1: 4.6;SK-MEL-30: 3.4;WM-115: 6.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004133, HPA043854" Enhanced "Intracellular and membrane" NA NA 240000 "HPA004133: AB_2732398, HPA043854: AB_2732510" "unprognostic (1.75e-1)" "unprognostic (2.35e-1)" "unprognostic (2.12e-3)" "unprognostic (8.61e-4)" "unprognostic (9.54e-2)" "unprognostic (2.78e-2)" "unprognostic (2.88e-2)" "unprognostic (7.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.47e-1)" "prognostic favorable (1.12e-4)" "unprognostic (6.24e-3)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.93e-1)" 0.3 0.3 0.3 0.3 0.6 0.1 0.4 0.4 0.3 0.5 0.3 0.3 0.3 0.0 0.4 11.5 0.3 1.6 0.3 0.3 0.3 0.3 79.7 0.3 0.3 0.4 0.3 0.3 2.0 0.3 0.6 1.7 1.1 0.3 0.6 0.1 0.3 0.3 0.3 0.3 0.3 28.9 0.3 0.3 0.5 0.1 1.2 0.3 0.3 3.1 0.3 0.3 0.3 0.3 0.8 1.2 0.9 0.2 0.6 1.4 0.0 0.0 0.1 1.8 18.2 0.6 4.6 0.1 0.1 0.1 0.1 0.1 2.1 0.0 0.0 0.1 0.9 1.2 0.0 0.0 0.2 0.1 0.4 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.6 0.0 0.6 0.2 0.7 1.8 1.0 0.2 0.3 0.2 0.0 0.3 0.3 0.3 0.0 0.2 0.1 0.4 0.0 0.6 0.0 0.0 0.5 0.0 0.0 3.4 0.1 0.0 0.1 1.8 0.2 0.2 0.3 0.2 0.6 0.1 0.0 0.5 0.1 6.9 0.9 0.2 0.0 0.8 0.0 1.0 0.4 0.4 0.2 0.0 0.8 0.8 1.4 0.6 0.6 0.0 1.2 0.7 0.0 0.3 0.6 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 1.0 0.0 0.4 0.5 0.9 1.1 0.0 2.7 5.7 5.2 2.0 0.0 11.6 0.0 25.3 2.7 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.8 25.4 2.6 0.4 6.8 0.0 0.3 8.7 0.1 0.0 1.1 301.3 3.7 0.0 1.2 0.7 0.2 0.6 0.1 0.5 0.0 0.1 CYFIP2 PIR121 ENSG00000055163 "Cytoplasmic FMR1 interacting protein 2" Q96F07 5 157266079-157395595 "Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;brain: 44.2;kidney: 69.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB055519, HPA068106, HPA071459" Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Plasma membrane, Cytosol" "CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (3.76e-1)" "unprognostic (4.58e-2)" "unprognostic (1.14e-1)" "unprognostic (6.91e-3)" "unprognostic (3.97e-2)" "unprognostic (5.25e-2)" "prognostic favorable (1.18e-4)" "unprognostic (3.81e-2)" "prognostic favorable (3.21e-12)" "unprognostic (2.90e-1)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.49e-2)" 1.9 6.6 28.6 13.4 31.7 22.8 1.7 39.1 44.2 1.8 4.3 7.7 1.6 3.1 3.5 12.3 2.1 4.9 4.7 5.1 28.7 20.4 69.7 8.2 5.9 25.9 16.2 27.2 2.7 3.6 30.6 13.2 4.4 15.8 3.2 5.0 4.7 2.2 3.5 3.1 1.8 6.4 2.9 7.9 15.8 9.5 2.6 8.9 28.5 5.4 0.0 25.7 6.0 1.7 13.7 15.6 30.1 42.8 17.4 32.1 22.9 0.0 8.1 12.5 7.0 0.2 0.3 20.0 1.4 2.5 0.6 1.8 1.5 0.1 52.0 3.6 0.8 1.8 0.1 9.9 6.7 1.5 11.8 15.6 6.6 10.6 6.0 1.0 6.9 18.4 1.4 2.7 2.0 0.1 4.9 2.1 35.9 0.1 20.9 1.7 1.9 49.3 1.3 5.5 0.1 2.1 12.2 0.3 24.8 6.6 7.4 18.1 7.2 0.1 7.1 1.1 12.7 4.8 0.2 2.9 0.4 5.3 1.7 1.3 38.4 9.6 36.6 5.5 8.3 2.9 17.4 4.3 30.1 32.1 20.0 22.9 13.7 23.3 27.7 6.2 13.4 24.7 28.1 14.4 17.4 42.8 15.6 18.4 22.9 28.6 31.7 39.1 38.3 28.7 20.4 16.2 27.2 15.8 8.9 3.0 24.0 31.6 2.0 1.0 56.1 15.1 10.2 6.7 11.4 150.1 15.7 28.2 147.6 8.4 15.2 2.7 5.3 0.0 1.4 38.9 2.1 1.2 2.3 30.8 4.7 85.8 13.8 7.4 5.4 14.9 1.7 6.2 6.8 13.6 5.6 10.9 2.5 9.9 6.3 46.6 33.3 0.0 7.1 2.3 11.5 1.3 17.6 48.4 8.8 1.4 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 CYP27B1 "CYP1, P450c1, PDDR, VDD1" ENSG00000111012 "Cytochrome P450 family 27 subfamily B member 1" O15528 12 57762334-57768986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 45.7" "Group enriched" "Detected in many" 4 "Exocrine glandular cells: 18.7;monocytes: 39.7;Proximal tubular cells: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in many" 6 "RH-30: 34.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.59e-2)" "unprognostic (1.42e-1)" "unprognostic (8.89e-2)" "unprognostic (2.77e-2)" "unprognostic (4.16e-2)" "unprognostic (1.03e-2)" "unprognostic (1.28e-2)" "unprognostic (1.44e-1)" "unprognostic (2.10e-2)" "unprognostic (4.72e-2)" "unprognostic (2.51e-1)" "unprognostic (1.17e-2)" "unprognostic (1.75e-3)" "unprognostic (4.10e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.67e-3)" 0.5 1.1 0.3 1.4 0.3 1.5 0.6 0.3 0.4 0.4 0.3 0.3 0.9 0.3 0.8 1.0 0.6 0.2 0.8 0.3 0.3 0.1 45.7 0.8 0.8 1.4 0.3 0.3 0.3 3.6 0.7 0.6 0.5 0.3 0.5 0.8 1.1 0.7 0.3 0.3 0.8 0.4 0.3 0.3 0.3 0.7 0.5 0.3 1.0 4.4 0.3 0.8 0.6 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.1 1.1 0.2 0.6 1.7 0.0 0.3 1.9 0.0 1.7 0.2 0.9 2.0 0.5 2.5 0.2 0.3 0.2 1.7 0.9 2.9 1.1 0.5 0.8 1.6 0.3 0.0 0.1 2.6 2.6 0.0 1.1 1.1 0.1 0.8 0.0 1.7 1.6 5.4 0.0 0.5 0.5 1.1 1.6 0.4 1.6 1.3 34.0 1.3 0.0 0.9 0.7 0.7 1.3 0.0 0.2 0.1 1.3 1.8 0.0 1.4 2.4 1.3 0.9 2.4 2.2 1.3 0.8 3.3 0.8 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 1.3 1.1 4.6 0.2 0.6 0.0 0.0 2.3 0.0 2.0 0.1 1.7 1.6 0.7 0.5 0.4 0.0 18.7 0.4 0.3 0.9 4.6 0.5 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 39.7 0.5 0.7 7.0 0.0 0.4 25.9 4.9 0.0 1.6 0.2 0.7 2.4 0.1 0.0 0.6 0.4 CYP4A11 "CYP4A2, CYP4AII" ENSG00000187048 "Cytochrome P450 family 4 subfamily A member 11" Q02928 1 46929177-46941484 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 78 "kidney: 36.5;liver: 141.0" "Group enriched" "Detected in some" 6 "Hepatocytes: 433.3;Proximal tubular cells: 109.9" "Cancer enriched" "Detected in some" 5 "liver cancer: 73.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;HL-60: 1.2;RH-30: 1.3;SiHa: 1.6;U-698: 2.3;U-937: 1.6" NA NA "unprognostic (9.05e-2)" "unprognostic (4.98e-2)" "unprognostic (4.43e-2)" "unprognostic (4.11e-1)" "unprognostic (7.81e-5)" "unprognostic (5.10e-3)" "unprognostic (1.16e-2)" "unprognostic (1.83e-2)" "unprognostic (1.92e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (4.59e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-3)" "unprognostic (1.68e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.1 0.1 0.0 36.5 141.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 0.0 0.3 0.4 0.0 0.2 0.1 1.1 0.0 1.4 0.0 0.4 0.0 1.2 0.5 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 1.3 0.6 0.0 0.0 0.0 0.4 1.6 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 1.6 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.2 0.0 0.2 0.8 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 7.0 0.0 0.0 14.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.3 0.0 0.0 0.0 6.2 6.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYS1 ENSG00000205795 "Cystin 1" Q717R9 2 10056780-10080944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 75.1" "Group enriched" "Detected in some" 5 "Cholangiocytes: 17.8;Collecting duct cells: 48.8;Distal tubular cells: 59.7;Muller glia cells: 31.8;Proximal tubular cells: 43.8" "Cancer enhanced" "Detected in many" "renal cancer: 46.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RPTEC TERT1: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.48e-2)" "unprognostic (8.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.00e-2)" "unprognostic (2.80e-1)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (1.94e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-2)" "unprognostic (7.03e-2)" "prognostic favorable (1.27e-5)" "unprognostic (2.19e-3)" "unprognostic (1.47e-1)" "unprognostic (8.93e-2)" "unprognostic (1.20e-2)" 1.4 0.8 3.2 3.2 1.6 0.0 0.9 2.8 2.6 8.1 4.5 2.1 2.7 1.2 5.5 6.6 3.3 3.4 14.9 2.8 2.0 1.9 75.1 0.4 3.1 0.5 1.4 3.1 6.9 17.1 0.2 3.2 0.0 2.4 2.6 0.9 5.9 1.4 3.9 0.5 0.7 1.7 3.1 1.5 1.3 1.9 1.4 0.9 0.1 7.8 2.4 1.0 2.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.2 1.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.9 0.1 0.0 2.7 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.6 2.8 2.6 2.0 1.9 1.4 3.1 2.4 0.9 6.0 0.6 0.0 0.0 0.5 8.9 7.1 17.8 0.0 0.0 48.8 0.0 0.0 59.7 5.8 0.0 0.0 0.0 0.0 1.0 0.3 3.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 31.8 0.5 0.0 4.2 43.8 1.3 0.0 2.3 0.0 1.2 0.1 0.0 0.0 0.0 0.0 DAO DAMOX ENSG00000110887 "D-amino acid oxidase" P14920 12 108858932-108901043 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "brain: 37.0;kidney: 39.0;liver: 64.2" "Group enriched" "Detected in some" 11 "Hepatocytes: 41.2;Proximal tubular cells: 75.6" "Cancer enriched" "Detected in some" 9 "liver cancer: 13.2" "Group enriched" "Detected in many" 5 "cerebellum: 37.0;pons and medulla: 31.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.5;HL-60: 1.8;HMC-1: 1.3;RH-30: 1.2" "Group enriched" "Detected in some" 10 "cerebellum: 74.4;pons and medulla: 21.1" "Group enriched" "Detected in many" 4 "cerebellum: 54.0;midbrain: 31.9;pons and medulla: 55.4;thalamus: 16.3" "HPA038653, HPA038654" Enhanced "Intracellular and membrane" NA NA "HPA038653: AB_10673016, HPA038654: AB_10673285" "unprognostic (1.50e-1)" "unprognostic (5.61e-2)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (2.99e-2)" "unprognostic (2.31e-3)" "unprognostic (8.02e-2)" "unprognostic (2.88e-2)" "unprognostic (9.59e-2)" "unprognostic (9.07e-2)" "unprognostic (7.13e-2)" "prognostic favorable (4.11e-4)" "unprognostic (3.44e-3)" "unprognostic (8.96e-2)" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" 0.3 0.2 0.0 0.2 2.7 0.2 0.2 37.0 0.7 0.2 0.9 11.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.9 39.0 64.2 0.3 0.2 6.4 0.5 0.2 0.3 0.2 0.0 0.2 31.2 0.2 1.1 0.0 0.2 0.2 0.2 0.2 0.2 0.3 35.9 0.2 0.2 0.2 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 37.0 0.5 0.8 0.9 6.4 0.5 31.2 0.4 0.0 0.0 0.9 0.0 0.0 0.5 0.4 0.0 0.0 0.0 1.8 0.0 0.6 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.2 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 75.6 5.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 DCDC2 "DCDC2A, DFNB66, KIAA1154, NPHP19, RU2" ENSG00000146038 "Doublecortin domain containing 2" Q9UHG0 6 24171756-24358052 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Neurogenesis" "Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 37.0;kidney: 46.4;pancreas: 22.7" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 61.1;Ciliated cells: 60.2;Collecting duct cells: 75.0;Distal tubular cells: 48.0;Ductal cells: 106.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 20.2;EFO-21: 14.1;Hep G2: 22.9;RPTEC TERT1: 74.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031582, HPA031583, HPA031584" Enhanced Enhanced "Microtubules,Mitotic spindle,Centriolar satellite,Cytosol" NA NA "Mitotic spindle, Cytosol" "Microtubules, Centriolar satellite" "HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-2)" "unprognostic (1.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (5.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.99e-2)" 0.1 0.9 1.1 0.2 1.5 0.0 3.5 0.3 0.9 1.6 0.3 0.2 1.0 0.3 3.4 37.0 0.2 5.8 7.7 0.2 1.3 1.7 46.4 1.8 3.9 0.0 0.6 0.5 2.1 22.7 7.6 4.3 1.7 1.8 1.5 0.3 2.8 0.9 3.7 0.5 0.2 0.2 0.4 0.5 0.1 1.1 3.7 0.2 0.2 8.4 0.0 0.2 1.0 0.1 1.2 0.5 1.3 0.4 1.0 0.5 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 1.5 0.1 0.0 0.4 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.4 0.3 0.5 0.2 0.2 0.5 0.5 0.3 0.3 1.2 0.4 0.4 1.3 1.0 0.2 0.5 0.2 0.2 1.1 1.5 0.3 0.9 1.3 1.7 0.6 0.5 1.8 0.2 17.9 11.8 0.0 0.6 0.1 0.0 0.3 61.1 60.2 10.3 75.0 0.0 0.3 48.0 106.8 23.9 0.0 0.0 0.0 7.2 0.0 0.3 1.1 0.0 1.0 0.5 0.0 3.5 0.0 0.0 11.0 0.3 0.0 0.0 3.6 3.4 1.9 20.8 2.9 0.4 39.0 0.0 0.0 0.3 7.7 2.2 0.1 0.1 0.0 1.2 0.5 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 36.9;SH-SY5Y: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.3 2.3 6.5 1.2 10.9 9.2 0.8 21.7 13.2 7.7 8.2 26.1 4.9 0.0 9.1 24.6 7.6 5.3 23.5 4.5 9.9 0.0 9.0 0.0 6.2 9.1 3.9 16.7 1.0 7.7 0.4 6.5 4.1 9.8 12.3 0.0 0.0 1.8 19.8 1.5 0.8 0.0 7.8 36.9 6.8 0.0 15.2 0.2 33.0 13.7 18.3 35.6 2.8 16.5 2.6 9.7 8.9 1.2 24.0 6.8 5.5 1.6 15.1 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 32.8 31.3 4.2 4.0 12.2 2.7 11.4 68.8 30.8 13.6 66.3 3.9 1.7 106.1 15.6 17.1 4.5 78.7 0.0 26.7 0.8 23.5 37.8 0.0 94.3 0.9 0.0 32.8 9.2 2.2 18.4 14.7 1.5 11.8 1.0 77.8 59.7 34.2 73.6 70.4 219.6 8.0 12.9 18.9 5.0 5.6 12.5 0.7 3.3 85.4 6.5 DDC AADC ENSG00000132437 "Dopa decarboxylase" P20711 7 50458436-50565457 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 90.1;kidney: 68.1" "Group enriched" "Detected in many" 5 "Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "midbrain: 7.9;pons and medulla: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "midbrain: 90.4;pons and medulla: 40.7" HPA017742 Enhanced Approved "Actin filaments" NA NA 380000 "Actin filaments" "HPA017742: AB_1847832" "unprognostic (1.04e-1)" "unprognostic (3.68e-2)" "unprognostic (2.57e-2)" "unprognostic (3.49e-5)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-1)" "unprognostic (5.15e-2)" "unprognostic (4.69e-2)" "unprognostic (5.44e-2)" "unprognostic (9.36e-3)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-1)" "unprognostic (3.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.16e-1)" 0.3 10.9 0.3 3.0 0.7 0.0 0.3 0.3 0.4 0.3 36.7 0.4 0.3 33.5 0.3 1.8 0.3 0.0 0.7 0.3 0.3 1.3 68.1 11.7 0.7 0.3 7.9 0.3 0.4 9.8 0.0 0.3 0.3 3.4 0.4 8.1 0.4 0.3 0.3 0.3 0.1 90.1 0.3 0.3 0.3 4.3 0.6 0.5 0.3 0.3 0.4 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.4 0.0 0.0 0.0 0.2 0.4 0.0 43.6 45.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.3 0.4 0.3 1.3 7.9 0.3 3.4 0.5 0.0 9.8 0.8 0.0 0.0 81.1 0.4 5.1 0.0 1.2 3.5 39.3 0.0 21.6 0.0 3.6 0.0 72.8 0.0 0.7 0.1 0.0 0.4 0.0 58.7 0.1 3.2 394.4 1.3 1.3 4.3 0.0 0.0 0.0 0.0 30.4 24.1 0.2 26.6 0.0 366.2 456.4 0.0 0.0 3.6 0.4 0.0 0.1 0.0 46.0 0.0 DEFB1 "BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822" ENSG00000164825 "Defensin beta 1" P60022 8 6870575-6878022 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 121.1;pancreas: 219.9;salivary gland: 173.0" "Cell type enriched" "Detected in many" 5 "Distal tubular cells: 11270.5" "Cancer enhanced" "Detected in many" "renal cancer: 522.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 1.4;intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 9 "monocytes: 1.6" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 27.8" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.24e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-3)" "unprognostic (4.41e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (2.77e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (5.94e-4)" "unprognostic (3.24e-1)" "prognostic favorable (1.90e-5)" "unprognostic (9.62e-2)" "unprognostic (2.86e-2)" "unprognostic (2.21e-2)" "unprognostic (1.16e-1)" 1.1 0.0 0.2 0.5 0.3 0.5 10.5 0.6 0.3 38.7 2.3 0.3 1.6 0.6 2.6 3.1 14.9 2.7 6.5 0.7 0.3 0.0 121.1 22.3 0.7 0.2 0.4 0.3 0.8 219.9 0.0 1.6 4.3 0.8 3.8 1.5 0.5 173.0 3.2 0.8 14.6 0.7 0.5 0.7 0.3 4.0 0.7 0.3 0.3 0.8 10.4 8.8 1.8 10.6 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.3 0.0 1.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.1 0.2 0.0 1.3 0.6 27.8 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.3 0.3 0.0 0.4 0.3 0.8 0.3 3.0 5.0 2.9 372.3 80.0 0.3 0.0 2435.7 5.3 4.5 931.7 0.0 6.7 11270.5 1231.2 0.0 0.6 52.3 0.0 250.8 0.3 5.0 291.3 0.0 169.8 3.4 0.0 15.1 4.9 6.0 0.0 16.1 5.3 6.8 26.2 10.3 0.5 226.2 20.7 0.0 94.9 0.6 0.0 4.1 0.0 0.0 470.0 3.1 3.8 11.3 236.2 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933682-48944969 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 32.4;kidney: 18.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.8;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 31 "granulocytes: 5.8;T-cells: 4.8" "Cell line enhanced" "Detected in many" "JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.3 0.5 1.5 0.1 2.1 0.1 0.2 1.8 1.5 0.1 8.2 0.2 0.1 10.6 0.2 0.4 0.8 0.3 0.8 0.1 2.7 2.0 18.0 0.7 1.9 0.2 0.4 0.4 0.5 0.4 0.2 2.1 1.3 0.6 3.5 0.1 1.2 0.8 0.2 0.3 0.2 32.4 0.1 0.9 1.8 0.7 2.8 0.1 0.4 0.1 0.5 0.7 1.1 0.3 0.1 0.0 5.8 0.0 0.0 4.8 0.5 2.8 0.0 0.2 1.4 0.8 0.6 1.1 0.0 0.4 0.5 1.4 2.7 2.2 0.0 0.5 0.0 1.8 0.8 0.9 2.0 0.9 1.0 2.2 3.9 0.9 1.0 0.0 0.0 0.9 0.5 0.2 1.1 0.0 0.7 0.0 6.3 1.2 0.4 0.0 0.6 0.0 0.2 0.6 4.0 1.8 1.4 0.2 1.9 0.3 0.9 4.2 2.3 0.5 0.3 0.9 0.3 1.9 0.1 0.0 0.0 1.7 0.6 0.1 6.4 5.0 1.6 1.3 0.0 0.4 5.8 0.0 0.9 1.6 0.0 0.8 0.0 1.6 0.7 0.0 0.1 4.8 3.1 0.1 0.0 0.0 0.0 1.2 0.5 1.5 2.1 1.8 1.5 2.7 2.0 0.4 0.4 0.6 0.1 3.0 5.4 0.0 2.6 0.7 1.3 0.4 0.0 0.0 4.5 3.5 0.0 0.1 8.3 1.3 0.5 0.6 1.7 0.0 0.3 0.1 0.5 5.2 1.1 0.0 10.9 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.7 1.5 1.2 2.9 0.0 56.2 4.3 0.0 0.1 0.0 0.6 0.1 0.1 0.0 0.6 2.6 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "kidney: 36.1;liver: 50.8;thyroid gland: 67.7" "Cell type enhanced" "Detected in some" 22 "Cholangiocytes: 17.8;Hepatocytes: 52.9;Proximal tubular cells: 83.0" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 26 "Hep G2: 17.0;SK-BR-3: 41.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 36.1 50.8 0.4 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 67.7 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 41.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 13.7 17.8 0.0 0.0 0.0 0.0 0.2 10.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 52.9 0.4 0.0 0.0 0.6 2.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997606-79236038 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 50.2;liver: 81.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.2;Hepatocytes: 84.9;Late spermatids: 27.1;Proximal tubular cells: 59.0" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.7;Hep G2: 11.5;hTEC/SVTERT24-B: 3.6;Karpas-707: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria NA NA 440000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859" "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favorable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favorable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 2.8 2.2 0.8 0.8 1.3 0.0 1.5 0.4 0.6 0.5 0.5 0.7 1.9 0.1 0.9 5.9 0.4 0.4 0.6 1.3 0.8 0.8 50.2 81.8 0.1 0.1 0.8 0.3 1.0 0.5 0.3 2.1 0.0 1.1 0.9 0.1 2.7 0.4 1.1 0.6 0.2 0.3 2.0 1.7 0.0 0.4 1.2 0.2 0.0 1.5 0.8 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 1.4 0.4 0.3 5.7 1.3 2.3 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 11.5 3.2 0.0 0.0 2.7 3.3 3.6 2.6 2.5 0.0 1.3 0.0 3.6 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.3 0.4 0.6 0.8 0.8 0.8 0.3 1.1 0.2 0.0 0.6 1.4 0.4 0.1 1.5 0.8 2.5 2.7 0.0 8.7 2.0 0.2 16.6 0.4 25.2 0.6 0.5 0.0 0.6 0.1 0.8 0.9 0.0 84.9 0.1 0.0 1.2 1.3 2.4 27.1 2.3 0.4 0.0 0.0 1.1 3.5 0.7 0.6 2.5 59.0 4.1 0.0 0.1 3.4 5.2 0.3 0.2 0.5 0.6 0.7 DMRT2 ENSG00000173253 "Doublesex and mab-3 related transcription factor 2" Q9Y5R5 9 1049858-1057552 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 97.8" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;RH-30: 5.3;RPMI-8226: 19.8;SCLC-21H: 3.1;SK-MEL-30: 5.4;THP-1: 3.8;WM-115: 3.8" "Region enhanced" "Detected in some" "cerebral cortex: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA029297 Uncertain NA NA "HPA029297: AB_10600905" "unprognostic (5.67e-2)" "unprognostic (2.20e-3)" "unprognostic (3.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (7.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.43e-3)" "unprognostic (8.93e-2)" "unprognostic (8.62e-2)" "unprognostic (4.93e-2)" "unprognostic (1.27e-3)" 3.8 0.5 1.9 0.5 6.5 0.4 4.5 0.5 4.5 0.5 1.6 11.0 2.6 0.4 0.5 1.3 0.6 0.6 0.4 0.5 3.2 1.3 27.3 0.4 2.4 0.6 7.0 2.5 0.4 0.4 52.9 0.7 0.6 3.6 0.6 1.1 0.0 1.4 1.5 9.0 0.6 0.4 0.5 3.0 0.4 0.4 0.9 6.2 18.4 0.4 6.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 19.8 0.0 0.9 3.1 0.0 0.0 0.0 5.4 0.3 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.5 0.5 4.5 3.2 1.3 7.0 2.5 3.6 6.2 0.0 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 97.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.7 0.3 0.0 2.3 0.0 0.0 1.7 0.0 0.0 4.2 1.5 0.1 0.1 0.0 1.5 0.1 DNMT3L MGC1090 ENSG00000142182 "DNA methyltransferase 3 like" Q9UJW3 21 44246339-44262216 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 7.8;liver: 20.5" "Group enriched" "Detected in some" 4 "Hepatocytes: 17.3;Proximal tubular cells: 13.5" "Cancer enriched" "Detected in some" 90 "testis cancer: 46.3" "Region enriched" "Detected in single" 13 "cerebellum: 2.5" "Group enriched" "Detected in some" 16 "memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 19 "B-cells: 3.2;dendritic cells: 1.1" "Cell line enriched" "Detected in some" 7 "BEWO: 31.2" "HPA055234, HPA066780" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055234: AB_2682750, HPA066780: AB_2685719" "unprognostic (1.05e-4)" "unprognostic (1.91e-1)" "unprognostic (2.73e-9)" "unprognostic (2.77e-1)" "unprognostic (5.28e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 7.8 20.5 0.1 1.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 4.6 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 161.7;kidney: 52.2;pancreas: 100.5" "Cell type enhanced" "Detected in many" 26 "Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 270000 "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.1 0.4 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 53.6 0.1 0.4 16.1 0.2 3.4 0.3 0.1 0.9 0.1 0.1 0.1 52.2 0.1 0.3 0.9 0.1 0.1 0.2 100.5 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.3 0.4 0.1 0.4 161.7 0.1 0.1 0.9 0.2 9.8 0.1 0.2 0.1 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.1 2.8 0.0 0.0 0.0 0.0 5.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 20.3 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.7 2.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.1 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 3.0 2.6 14.9 0.0 0.5 3.3 0.3 0.0 0.0 1.2 22.7 0.0 0.1 48.0 0.3 10.3 0.1 4.2 0.0 171.7 0.3 4.5 0.0 1.1 0.0 0.5 0.0 8.5 1.8 0.0 29.1 268.4 1.7 5.0 1.8 1.9 0.0 43.8 11.5 1144.5 391.6 0.1 6.5 0.3 15.6 2.9 0.3 0.3 0.5 1.2 0.0 DPYS DHPase ENSG00000147647 Dihydropyrimidinase Q14117 8 104330324-104467053 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "kidney: 42.2;liver: 103.6" "Group enriched" "Detected in some" 15 "Hepatocytes: 429.9;Proximal tubular cells: 408.7" "Group enriched" "Detected in some" 21 "liver cancer: 57.6;renal cancer: 11.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 13 "monocytes: 1.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0;U-698: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA024785 Enhanced NA NA 89000 "HPA024785: AB_1847856" "unprognostic (1.54e-3)" "unprognostic (2.33e-1)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-1)" "unprognostic (2.38e-3)" "unprognostic (4.16e-4)" "unprognostic (1.56e-1)" "unprognostic (3.53e-2)" "unprognostic (3.85e-3)" "unprognostic (2.43e-1)" "unprognostic (4.81e-2)" "unprognostic (9.56e-3)" "unprognostic (2.72e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-1)" 2.5 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.2 2.1 0.1 0.0 0.0 0.0 1.6 0.1 0.2 1.3 0.0 0.0 0.1 42.2 103.6 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.1 0.9 0.0 0.2 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.7 0.0 0.0 0.0 1.2 0.0 0.0 2.7 0.0 0.1 0.0 0.2 0.0 1.3 1.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.7 0.0 0.1 0.6 1.3 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.0 1.5 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.4 28.1 0.0 0.0 19.2 0.0 0.0 23.2 0.0 9.9 0.0 0.0 23.3 0.0 0.0 0.6 2.5 0.0 429.9 1.3 0.0 0.0 6.2 6.2 9.7 0.9 0.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 408.7 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 DUSP23 "DUSP25, FLJ20442" ENSG00000158716 "Dual specificity phosphatase 23" Q9BVJ7 1 159780932-159782543 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 88.0" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028211, HPA045792" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028211: AB_2672522, HPA045792: AB_10961133" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-2)" "unprognostic (4.36e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.16e-1)" "unprognostic (4.62e-1)" "unprognostic (3.33e-3)" "unprognostic (4.72e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (8.58e-2)" "unprognostic (2.84e-2)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" 25.0 28.0 7.6 9.3 10.5 11.2 27.3 4.4 9.0 15.5 15.9 5.9 6.6 17.2 12.2 15.0 21.2 10.9 12.6 14.9 7.8 5.2 88.0 80.8 12.1 15.4 8.5 4.6 12.3 21.5 12.5 4.3 7.4 9.6 18.0 9.1 9.5 37.8 10.9 32.8 15.8 16.1 7.7 9.6 8.7 11.0 9.7 7.3 5.7 27.0 17.4 11.4 10.5 19.1 13.6 59.7 49.9 43.2 21.3 24.0 24.0 12.2 13.2 0.1 0.0 12.9 11.1 0.1 5.0 4.1 5.9 4.6 5.4 14.1 0.0 30.0 5.5 1.3 0.5 3.4 4.5 3.2 3.0 1.5 16.9 4.8 0.0 19.3 10.2 13.0 46.8 12.3 3.8 13.9 4.3 22.6 0.0 7.7 6.2 8.3 22.2 1.0 0.4 22.9 22.1 18.9 0.0 0.0 5.8 7.2 2.1 5.8 12.8 9.1 20.0 23.4 2.4 12.9 16.0 16.5 4.9 0.2 0.6 0.0 4.4 10.3 0.1 8.3 8.2 3.7 20.0 43.2 49.9 24.0 33.4 13.3 13.6 18.1 22.5 59.7 9.8 11.0 16.4 43.2 21.3 22.1 13.6 15.7 24.0 7.6 10.5 4.4 9.0 7.8 5.2 8.5 4.6 9.6 7.3 38.7 65.7 25.0 97.5 66.2 8.4 26.4 94.3 38.8 83.0 48.8 5.9 13.5 222.2 148.8 39.6 154.1 106.2 0.0 394.0 20.1 31.9 94.9 53.1 219.9 155.2 1.6 34.0 66.3 86.6 5.5 24.5 94.8 40.5 32.5 101.6 59.7 258.6 101.7 14.9 620.9 7.1 12.9 32.0 3.2 13.0 65.1 4.8 43.7 91.6 102.1 DUSP9 "MKP-4, MKP4" ENSG00000130829 "Dual specificity phosphatase 9" Q99956 X 153642492-153651326 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 23.0;placenta: 63.1" "Group enriched" "Detected in some" 14 "Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Hep G2: 90.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6" HPA003336 Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003336: AB_1078709" "unprognostic (4.64e-2)" "unprognostic (6.48e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.52e-2)" "unprognostic (2.74e-3)" "unprognostic (9.36e-3)" "unprognostic (6.15e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-1)" "unprognostic (1.29e-2)" "unprognostic (1.38e-2)" "unprognostic (2.68e-7)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (5.52e-2)" 0.2 0.1 3.2 0.2 4.4 0.1 0.3 0.2 2.0 0.2 0.1 0.7 0.0 0.2 0.1 0.3 0.3 0.2 0.1 0.2 2.5 0.6 23.0 0.7 0.2 0.2 1.1 0.6 1.9 0.5 0.1 0.0 63.1 0.9 0.2 0.1 0.0 0.8 1.5 0.1 0.2 0.2 0.1 0.5 0.2 0.2 1.1 0.8 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 0.0 4.0 0.0 0.3 1.8 10.1 0.2 0.0 0.2 1.8 0.0 0.7 90.8 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.2 0.2 0.4 3.7 0.0 0.0 0.0 0.0 2.3 0.1 0.3 0.6 0.7 0.3 0.2 0.1 0.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.4 0.2 2.0 2.5 0.6 1.1 0.6 0.9 0.8 0.0 0.0 0.0 0.6 0.6 0.0 1.8 0.0 0.0 0.0 10.4 0.0 876.9 616.8 0.1 0.0 0.0 0.0 0.0 0.0 57.4 0.2 0.3 0.0 0.8 72.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 0.0 0.0 0.0 0.7 8.3 0.0 1451.1 0.0 0.0 0.9 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.0;breast: 83.4;kidney: 75.9" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 333.2;Sertoli cells: 194.1;Smooth muscle cells: 137.2;Syncytiotrophoblasts: 220.7" "Cancer enhanced" "Detected in all" "breast cancer: 100.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.1" "Group enriched" "Detected in many" 5 "granulocytes: 6.1;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 30.4;RPTEC TERT1: 16.4;SK-BR-3: 72.5;T-47d: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" No NA "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: AB_2680716, HPA056959: AB_2683288" "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 16.1 4.0 32.0 2.3 71.3 1.1 83.4 4.1 39.1 37.2 3.9 85.0 0.8 2.7 22.2 16.5 5.1 16.7 6.0 13.5 42.0 24.5 75.9 24.2 4.0 2.3 85.0 25.2 32.1 39.3 4.8 3.5 55.2 43.2 8.0 3.4 12.9 10.1 13.8 13.5 5.9 3.8 10.3 66.0 20.7 3.7 7.3 80.1 0.0 6.8 3.6 1.8 5.0 9.3 0.8 0.7 6.1 0.7 0.3 1.6 0.3 0.0 0.8 1.4 0.3 0.5 0.0 30.4 6.3 0.5 0.5 0.4 0.2 0.1 0.0 0.4 2.7 0.7 0.0 4.5 0.0 0.0 0.1 2.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.3 0.9 0.1 0.1 0.5 0.1 0.0 1.9 0.0 0.0 0.1 1.7 0.1 16.4 0.1 0.0 0.7 2.1 72.5 4.2 10.7 56.7 0.6 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.2 1.9 0.7 0.4 0.7 0.3 1.2 0.8 1.0 1.0 0.3 0.3 1.6 1.6 6.1 0.3 0.2 0.7 0.3 0.3 32.0 71.3 4.1 35.5 42.0 24.5 85.0 25.2 43.2 80.1 0.0 0.0 0.9 2.3 3.2 0.2 5.5 2.5 1.4 1.2 33.2 0.0 88.3 333.2 0.0 5.5 3.6 0.0 0.0 0.0 19.0 12.5 5.1 0.0 67.8 7.6 0.0 0.0 4.9 1.0 4.7 41.1 1.8 8.5 0.0 0.0 41.8 0.0 0.0 53.7 77.7 1.1 194.1 137.2 1.4 9.8 2.8 220.7 0.0 0.1 1.8 EGF ENSG00000138798 "Epidermal growth factor" P01133 4 109912884-110012266 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 38.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;SK-BR-3: 14.9;U-251 MG: 4.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 209000 25000 "unprognostic (2.83e-2)" "unprognostic (1.02e-2)" "unprognostic (8.50e-3)" "unprognostic (1.88e-3)" "unprognostic (4.24e-2)" "unprognostic (1.64e-3)" "unprognostic (5.06e-4)" "unprognostic (8.30e-2)" "unprognostic (2.21e-3)" "unprognostic (4.25e-2)" "unprognostic (1.80e-2)" "unprognostic (2.95e-1)" "unprognostic (7.72e-3)" "unprognostic (4.64e-5)" "unprognostic (2.63e-1)" "unprognostic (9.80e-5)" "unprognostic (3.92e-3)" 0.8 0.1 0.4 0.0 0.4 0.0 5.9 0.1 0.9 0.2 0.2 0.3 0.3 0.0 0.3 2.6 0.9 0.2 0.3 2.3 0.8 0.3 48.4 0.0 0.6 0.0 1.2 0.7 0.0 41.2 0.0 0.4 0.0 1.4 0.6 0.4 3.9 8.4 0.1 19.8 0.5 0.2 1.9 0.6 0.2 0.0 0.2 0.2 0.0 1.2 4.5 0.4 0.4 0.5 0.0 0.4 1.7 0.0 0.0 0.0 2.6 0.2 0.3 2.4 0.1 0.0 0.1 0.0 0.6 1.5 0.8 0.5 0.1 0.1 0.0 8.2 0.8 2.1 0.0 0.3 0.0 0.6 0.1 0.4 0.1 0.9 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.2 0.8 0.1 0.0 0.0 2.9 0.0 0.6 0.2 0.1 0.7 0.7 0.2 0.0 0.0 0.0 14.9 0.5 1.8 3.5 0.0 0.0 1.3 2.0 0.0 4.7 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 2.6 0.4 0.4 0.1 0.9 0.8 0.3 1.2 0.7 1.4 0.2 0.0 0.0 0.0 0.1 0.9 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 2.2 0.0 0.4 0.0 4.9 0.0 0.0 1.5 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 38.3 1.6 0.0 0.0 1.2 1.1 0.0 0.0 0.5 0.3 1.3 0.0 0.0 1.6 0.1 EHHADH ECHD ENSG00000113790 "Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase" Q08426 3 185190624-185281990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 37.1;liver: 91.2" "Group enriched" "Detected in many" 7 "Hepatocytes: 227.5;Proximal tubular cells: 124.0" "Group enriched" "Detected in all" 7 "liver cancer: 42.2;renal cancer: 25.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036401, HPA042021" Enhanced NA NA "HPA036401: AB_10670165, HPA042021: AB_2677801" "unprognostic (1.20e-1)" "unprognostic (5.99e-2)" "unprognostic (2.17e-3)" "unprognostic (2.69e-2)" "unprognostic (6.82e-2)" "unprognostic (1.48e-1)" "unprognostic (4.79e-3)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (3.89e-2)" "unprognostic (3.19e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-5)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.96e-2)" "unprognostic (2.80e-1)" 4.1 1.2 1.2 1.7 1.4 0.1 1.5 0.5 1.2 1.7 6.4 0.8 0.4 5.2 1.0 2.0 2.9 0.8 3.0 3.2 1.2 0.9 37.1 91.2 1.9 1.0 1.7 0.7 0.8 2.5 2.7 0.9 1.3 2.1 1.7 2.6 8.3 2.7 0.4 0.7 1.1 9.9 1.0 1.4 1.7 2.4 0.9 0.9 1.4 2.1 1.7 1.2 1.8 1.0 1.5 6.0 0.2 2.2 2.7 2.7 1.1 8.3 3.5 1.0 0.0 5.3 4.5 1.1 4.0 1.2 2.6 3.0 15.2 5.3 0.0 15.9 4.0 1.0 4.1 0.0 3.3 5.5 11.1 3.7 5.9 0.9 15.4 3.5 0.7 0.1 6.4 4.3 2.7 2.4 3.6 3.8 0.0 3.8 4.3 5.0 4.3 0.1 3.5 2.1 3.0 4.4 0.0 7.1 0.3 11.0 4.7 3.2 4.6 7.8 4.6 7.3 9.1 16.8 6.9 1.8 1.7 2.6 1.3 0.3 1.2 3.8 0.3 0.6 2.6 2.8 0.2 2.2 0.0 1.6 2.1 1.0 1.5 1.1 2.4 6.0 0.2 1.6 2.7 0.1 2.7 2.0 2.4 1.4 1.1 1.2 1.4 0.5 1.2 1.2 0.9 1.7 0.7 2.1 0.9 14.9 7.5 13.7 1.5 1.3 0.2 17.9 25.5 4.0 4.5 19.2 3.9 7.2 16.6 2.0 0.1 2.8 13.8 0.0 5.9 2.1 1.5 1.8 0.0 227.5 3.7 0.0 7.5 12.3 12.4 0.0 0.6 1.3 3.3 15.4 11.6 1.7 3.3 8.6 0.4 124.0 0.9 0.0 2.0 3.9 4.1 0.4 1.1 3.2 10.6 1.6 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Group enriched" "Detected in some" 8 "Collecting duct cells: 52.4;Proximal tubular cells: 31.6" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.8 0.0 0.0 1.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 52.4 0.0 0.0 5.0 0.0 0.8 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 ENAM AIH2 ENSG00000132464 Enamelin Q9NRM1 4 70628744-70686816 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 10.1;heart muscle: 5.0;kidney: 7.9" "Cell type enriched" "Detected in some" 7 "Melanocytes: 32.1" "Cancer enhanced" "Detected in some" "renal cancer: 1.7" "Group enriched" "Detected in some" 18 "memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 20 "B-cells: 1.7;dendritic cells: 2.2" "Group enriched" "Detected in some" 4 "Daudi: 2.4;RPTEC TERT1: 1.5;U-266/70: 2.5;U-266/84: 3.4;U-698: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (1.52e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.02e-2)" "unprognostic (2.78e-2)" "unprognostic (1.02e-1)" "unprognostic (7.94e-3)" "unprognostic (4.73e-2)" "unprognostic (2.06e-1)" "unprognostic (9.06e-4)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.81e-14)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.1 1.5 5.0 0.0 0.0 7.9 0.5 0.0 0.0 0.0 0.0 2.5 0.8 0.5 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 1.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 3.4 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.5 0.0 0.0 3.5 0.0 0.0 3.3 0.7 4.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 32.1 0.0 0.0 0.0 0.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENPEP "CD249, gp160" ENSG00000138792 "Glutamyl aminopeptidase" Q07075 4 110365733-110565285 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 165.1;kidney: 63.8" "Cell type enhanced" "Detected in many" 14 "Proximal tubular cells: 153.4;Sertoli cells: 155.2;Smooth muscle cells: 60.8;Syncytiotrophoblasts: 49.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 41.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HEK 293: 11.4;MOLT-4: 2.7;SuSa: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005128 Enhanced NA NA 37000000 "HPA005128: AB_1844795" "unprognostic (2.73e-3)" "unprognostic (2.84e-3)" "unprognostic (5.16e-3)" "unprognostic (3.48e-1)" "unprognostic (2.90e-1)" "unprognostic (8.74e-2)" "unprognostic (3.34e-2)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.47e-2)" "unprognostic (4.49e-3)" "unprognostic (3.43e-3)" "unprognostic (1.52e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-3)" 5.8 1.0 0.4 0.4 0.6 0.0 2.8 0.3 1.0 1.1 54.4 0.4 0.7 11.1 5.3 2.4 0.8 1.4 1.1 2.3 0.5 0.3 63.8 14.5 2.7 0.5 0.4 0.3 1.0 1.0 33.3 0.8 4.4 0.5 1.4 0.0 0.8 0.6 0.5 2.3 0.4 165.1 3.1 0.5 4.7 0.7 0.4 0.4 1.4 2.4 2.0 0.4 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.0 0.1 0.2 4.2 0.6 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.5 2.7 0.5 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.1 0.2 0.0 2.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 1.0 0.5 0.3 0.4 0.3 0.5 0.4 0.0 1.3 0.0 0.1 1.4 0.0 3.3 0.0 0.0 0.0 10.4 0.0 33.0 14.9 0.0 0.4 1.4 2.6 0.0 0.0 2.7 19.7 0.1 0.0 24.1 2.4 0.0 1.7 1.8 0.3 0.0 0.6 0.6 0.0 0.0 0.8 0.0 0.0 0.8 0.4 153.4 0.0 155.2 60.8 0.0 0.2 0.9 49.0 1.3 1.1 0.1 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;kidney: 30.8" "Group enriched" "Detected in some" 5 "Peritubular cells: 33.2;Proximal tubular cells: 21.8" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 1.9;Karpas-707: 6.4;SH-SY5Y: 7.3;U-266/70: 6.0;U-266/84: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042740, HPA069197" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 68000 "Golgi apparatus" "HPA042740: AB_10793984, HPA069197: " "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.5 0.6 2.0 1.1 8.0 1.1 1.0 1.7 6.7 0.5 1.3 35.2 0.4 2.0 0.5 6.9 1.3 0.5 0.8 0.5 5.4 3.5 30.8 0.4 0.6 1.1 26.1 3.3 13.7 0.3 0.3 4.1 0.4 19.5 2.7 1.3 7.7 0.9 6.9 0.4 0.5 2.5 0.4 28.2 1.2 1.5 2.7 14.0 0.0 0.5 0.0 3.1 0.9 0.7 0.9 0.8 2.2 0.9 1.5 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 1.9 0.0 0.7 0.3 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.4 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.2 7.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.1 0.0 0.1 6.0 3.2 0.1 0.1 0.1 0.0 2.2 0.9 0.6 0.5 0.5 0.6 0.7 0.4 0.3 0.1 0.9 0.4 0.5 1.7 1.5 0.3 0.8 0.5 0.1 2.0 8.0 1.7 6.7 5.4 3.5 26.1 3.3 19.5 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.9 0.8 0.2 0.0 0.0 0.2 0.0 0.2 0.1 5.7 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.7 0.0 1.7 1.8 0.0 0.0 0.0 0.0 33.2 21.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 ENTPD5 "CD39L4, NTPDase-5, PCPH" ENSG00000187097 "Ectonucleoside triphosphate diphosphohydrolase 5" O75356 14 73958010-74019399 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.0;kidney: 43.1;liver: 71.4" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4" "Cancer enhanced" "Detected in all" "prostate cancer: 39.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 15.0;eosinophil: 8.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in all" "RT4: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002927 Enhanced "Secreted to blood" NA NA 5000000 "HPA002927: AB_1078744" "unprognostic (4.19e-1)" "unprognostic (9.63e-3)" "unprognostic (3.11e-2)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" "unprognostic (6.01e-2)" "unprognostic (6.20e-2)" "unprognostic (2.55e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.25e-1)" "unprognostic (5.06e-2)" "unprognostic (1.76e-1)" "unprognostic (6.92e-3)" 3.0 3.6 2.8 9.4 3.8 1.7 3.5 3.0 4.0 2.4 25.8 5.8 3.1 19.3 3.0 2.7 4.5 2.4 6.6 2.6 2.8 2.3 43.1 71.4 2.3 1.3 3.5 2.3 3.3 5.9 1.8 2.7 2.2 5.5 10.2 29.6 3.2 4.7 1.5 3.8 2.7 52.0 3.9 5.5 3.2 11.8 4.5 2.5 2.1 2.7 3.0 3.3 9.5 3.0 1.6 1.6 15.0 2.1 0.6 2.5 1.2 5.4 4.4 5.0 9.3 10.0 9.5 5.8 5.7 4.7 3.8 4.4 3.3 6.6 6.2 2.9 7.8 3.7 6.5 5.0 8.3 4.3 5.2 2.4 4.6 3.2 18.1 9.7 2.7 5.4 7.7 8.4 5.4 11.2 5.4 7.6 10.2 5.1 9.4 5.6 7.7 3.1 3.3 1.5 4.9 9.6 3.5 4.8 3.0 6.7 34.5 3.6 3.7 9.7 7.7 5.5 4.0 11.1 2.5 6.4 7.7 8.0 4.6 4.2 6.1 9.5 5.0 4.9 5.1 6.9 15.0 1.2 8.3 2.5 2.1 1.3 1.3 1.3 1.7 1.6 1.6 2.1 2.1 0.2 0.6 1.3 0.8 1.4 1.2 2.8 3.8 3.0 4.0 2.8 2.3 3.5 2.3 5.5 2.5 14.9 7.9 6.7 4.8 3.3 6.1 4.8 12.7 5.3 10.3 7.0 3.9 6.4 21.6 5.1 13.9 5.4 99.9 0.0 11.3 5.7 4.9 39.5 1.1 120.9 5.5 9.5 15.5 11.6 7.0 8.7 2.6 5.1 5.0 6.4 67.4 4.8 7.4 54.7 5.3 50.1 12.0 12.9 4.1 20.1 18.3 3.0 2.7 4.9 41.0 12.3 ESM1 ENSG00000164283 "Endothelial cell specific molecule 1" Q9NQ30 5 54977864-55022671 "Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.4;thyroid gland: 14.8" "Cell type enhanced" "Detected in some" 21 "Ductal cells: 8.7;Endothelial cells: 4.9;Ito cells: 1.8;Pancreatic endocrine cells: 1.9" "Cancer enriched" "Detected in all" 8 "renal cancer: 65.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.6;memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.7;naive CD8 T-cell: 1.6;NK-cell: 3.7" "Group enriched" "Detected in many" 32 "NK-cells: 3.7;T-cells: 2.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 55.5;TIME: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB047364 Approved "Secreted to blood" NA NA 1540000 400000 "CAB047364: " "unprognostic (4.70e-2)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.63e-3)" "unprognostic (2.31e-3)" "unprognostic (4.68e-2)" "unprognostic (1.55e-1)" "unprognostic (6.85e-3)" "unprognostic (1.59e-2)" "unprognostic (1.05e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.00e-4)" "unprognostic (7.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.94e-1)" 1.5 3.5 0.3 0.4 0.6 0.2 0.6 0.2 0.7 1.5 1.1 0.8 4.2 0.3 3.0 1.1 0.3 0.2 0.9 2.4 0.9 3.7 31.4 2.2 12.9 0.9 0.5 0.3 2.3 1.8 1.7 9.0 0.5 1.3 4.8 0.0 1.5 5.6 3.2 0.7 0.3 2.4 0.4 1.1 4.0 0.5 0.6 0.5 0.6 14.8 0.8 0.4 1.4 1.0 0.0 0.0 0.0 0.0 3.7 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 1.7 0.7 0.1 0.0 0.0 0.0 1.3 1.0 0.4 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 55.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.7 0.9 2.5 7.2 3.8 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 1.6 0.0 2.7 1.7 0.0 0.0 0.0 1.6 0.0 3.7 0.0 0.0 0.0 0.5 0.3 0.6 0.2 0.7 0.9 3.7 0.5 0.3 1.3 0.5 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 4.9 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 ESRRB "DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2" ENSG00000119715 "Estrogen related receptor beta" O95718 14 76310712-76501837 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 14.5;retina: 50.2" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 14.7;Horizontal cells: 52.4;Late spermatids: 27.9;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.8;K-562: 9.7;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA074772 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074772: " "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.92e-5)" "unprognostic (5.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.14e-1)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.46e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-4)" "unprognostic (4.40e-2)" 0.2 0.1 0.3 0.0 1.0 0.0 0.6 0.3 0.6 0.1 0.0 0.8 0.3 0.0 0.1 0.4 0.1 0.1 0.0 7.8 0.3 0.4 14.5 0.1 0.1 0.9 0.5 0.4 0.0 0.2 0.0 0.3 0.1 1.3 0.2 0.0 50.2 0.1 0.4 9.5 0.0 0.1 0.0 0.5 1.2 5.1 2.0 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.5 0.5 0.0 0.1 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.7 0.4 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 1.0 0.1 0.5 4.9 1.4 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.3 0.6 0.3 0.4 0.5 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.0 0.0 0.0 0.0 2.0 0.0 11.6 0.0 14.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.3 40.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152003 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 65.9;liver: 80.5;testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 370.3;Late spermatids: 1080.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5" "Group enriched" "Detected in many" 11 "NK-cells: 1.5;T-cells: 4.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.4;MCF7: 25.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 8 "basal ganglia: 24.7" HPA057167 Enhanced NA NA "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 3.3 2.3 4.0 0.8 4.7 0.9 6.3 0.9 4.0 5.1 1.6 1.9 6.5 0.8 3.1 11.0 8.3 4.9 1.9 2.6 2.6 2.5 65.9 80.5 1.2 2.0 2.7 1.9 13.1 4.3 6.2 8.8 2.3 2.7 3.8 0.9 4.8 7.6 7.8 0.6 5.1 0.8 2.4 1.5 2.4 1.1 45.0 1.9 1.1 4.0 3.9 12.9 3.8 6.2 0.2 0.0 0.2 0.2 1.5 4.8 1.0 5.2 1.8 5.3 10.1 2.0 0.6 5.3 5.4 12.0 7.5 3.3 9.0 2.6 0.2 9.1 1.3 8.8 4.7 9.4 7.6 5.2 0.2 8.4 0.1 1.0 13.8 8.0 0.2 0.3 2.7 26.4 1.6 0.3 3.9 5.4 5.7 0.7 0.2 0.9 25.5 1.5 0.1 11.1 0.2 4.0 0.4 6.3 0.2 6.5 2.0 1.4 7.6 3.4 16.1 2.5 17.6 15.6 0.3 0.3 2.1 11.7 0.4 3.9 0.2 0.1 0.2 0.1 0.2 3.0 0.1 0.2 0.0 4.8 0.0 4.6 0.0 1.3 2.9 0.0 0.2 2.9 3.6 0.2 1.5 0.1 0.0 0.7 1.0 4.0 4.7 0.9 4.0 2.6 2.5 2.7 1.9 2.7 1.9 0.0 0.0 0.5 9.8 3.7 1.8 0.9 5.1 2.7 0.0 3.5 3.9 4.8 33.2 8.0 370.3 1.0 0.0 0.0 5.6 7.9 5.7 10.1 9.2 156.9 0.7 0.0 1.2 1.8 5.1 1080.2 27.0 0.6 10.1 0.0 0.0 2.6 4.6 0.0 39.6 120.8 0.8 0.0 3.8 9.3 5.9 2.0 7.9 0.9 0.0 8.3 FAM151A "C1orf179, MGC27169" ENSG00000162391 "Family with sequence similarity 151 member A" Q8WW52 1 54609182-54623556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 45.8;kidney: 59.3" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 116.1" "Group enriched" "Detected in many" 5 "liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enriched" "Detected in single" 45 "CACO-2: 41.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA016840 Approved NA NA "HPA016840: AB_2669461" "unprognostic (1.89e-1)" "unprognostic (6.90e-3)" "unprognostic (3.73e-2)" "unprognostic (1.97e-6)" "unprognostic (1.71e-2)" "unprognostic (4.84e-3)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.05e-2)" "unprognostic (4.91e-3)" "unprognostic (9.99e-2)" "prognostic favorable (4.09e-5)" "unprognostic (5.85e-2)" "unprognostic (8.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-3)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.6 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 59.3 5.6 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 45.8 0.1 0.1 0.5 0.0 0.3 0.1 0.3 0.1 0.1 0.9 0.1 0.1 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 41.7 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.0 11.6 0.0 4.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.8 0.0 116.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 FAM24B "AC073585.2, MGC45962" ENSG00000213185 "Family with sequence similarity 24 member B" Q8N5W8 10 122849078-122879641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 24.5" "Cell type enriched" "Detected in many" 4 "Distal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "hTERT-HME1: 43.9;LHCN-M2: 55.2;TIME: 17.8" HPA052490 Supported "Intracellular and membrane" NA NA "HPA052490: AB_2681851" "unprognostic (4.03e-2)" "unprognostic (4.27e-2)" "unprognostic (3.13e-3)" "unprognostic (8.40e-5)" "unprognostic (2.55e-2)" "unprognostic (3.31e-2)" "unprognostic (6.42e-7)" "unprognostic (2.99e-1)" "unprognostic (7.06e-3)" "unprognostic (3.00e-1)" "unprognostic (5.89e-2)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" "unprognostic (2.58e-1)" "unprognostic (9.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.81e-3)" 2.2 2.4 6.9 13.5 6.4 3.9 4.0 6.7 7.4 2.3 4.1 5.1 2.2 2.8 3.4 3.8 3.1 3.8 3.7 1.5 5.8 5.9 24.5 1.7 3.7 6.5 6.9 3.4 5.0 12.5 2.6 11.4 1.1 6.6 3.2 5.9 1.9 2.7 2.6 1.7 4.5 4.1 3.0 6.8 4.7 4.4 11.4 5.6 9.8 2.9 2.0 6.3 2.4 2.5 5.9 11.3 3.0 2.2 2.7 5.3 1.9 2.2 3.8 0.7 0.0 0.4 1.1 1.0 3.3 3.3 1.5 1.1 3.8 4.2 0.8 1.1 1.8 0.4 1.1 0.0 1.7 3.9 4.1 1.5 6.3 3.6 2.0 3.4 0.0 3.7 1.3 0.2 3.1 43.9 0.2 3.4 4.7 2.7 1.5 55.2 2.1 3.9 3.6 1.3 2.3 3.9 0.0 5.6 0.8 2.5 1.7 2.5 1.0 1.5 0.7 4.5 2.2 1.2 3.8 17.8 0.3 1.7 1.4 0.3 1.8 2.0 5.2 2.9 6.1 0.0 3.0 2.2 1.4 2.6 1.9 0.9 5.9 5.0 3.4 3.0 3.7 5.3 3.4 1.4 2.7 1.8 11.3 4.9 1.9 6.9 6.4 6.7 7.4 5.8 5.9 6.9 3.4 6.6 5.6 0.0 0.3 6.9 1.3 6.0 3.6 0.2 2.5 0.0 0.0 8.7 0.0 0.1 43.1 3.7 1.6 0.7 1.5 0.0 6.2 0.1 0.8 1.8 9.2 0.5 1.1 1.6 4.6 1.3 3.2 1.6 3.4 1.9 1.7 2.8 2.8 2.3 7.6 3.5 3.9 1.4 4.5 0.0 2.1 9.8 4.9 4.6 0.0 8.6 2.8 1.0 FCAMR "CD351, FCA/MR, FKSG87" ENSG00000162897 "Fc fragment of IgA and IgM receptor" Q8WWV6 1 206957965-206970625 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 26.5" "Cancer enhanced" "Detected in some" "renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;HMC-1: 1.0" HPA056505 Enhanced NA NA 3600000 "HPA056505: AB_2732604" "unprognostic (2.94e-1)" "unprognostic (1.06e-1)" "unprognostic (8.53e-2)" "unprognostic (2.92e-1)" "unprognostic (7.44e-2)" "unprognostic (4.55e-3)" "unprognostic (2.69e-3)" "unprognostic (1.08e-4)" "unprognostic (3.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.08e-1)" "unprognostic (1.26e-1)" 0.1 0.1 0.1 23.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 23.9 7.6 0.1 8.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.1 0.1 0.1 1.0 0.1 0.5 0.6 0.1 0.2 0.1 0.2 0.2 0.1 9.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.9 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.1 0.3 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 FGF1 "AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1" ENSG00000113578 "Fibroblast growth factor 1" P05230 5 142592178-142698070 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 65.0;heart muscle: 35.5;kidney: 41.5" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 49.6;Collecting duct cells: 19.2;Cone photoreceptor cells: 15.7;Muller glia cells: 68.6" "Cancer enriched" "Detected in many" 12 "glioma: 33.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 19.8;BJ hTERT+: 14.8;BJ hTERT+ SV40 Large T+: 16.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.6;HBF TERT88: 29.5;hTEC/SVTERT24-B: 20.6;LHCN-M2: 13.7;U-2 OS: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003265, CAB017519" Enhanced Supported Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "CAB017519: AB_629473, HPA003265: AB_1848522" "unprognostic (1.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (2.55e-2)" "unprognostic (3.52e-1)" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.63e-1)" "unprognostic (1.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.54e-1)" "prognostic favorable (2.59e-5)" "unprognostic (3.72e-4)" "unprognostic (2.49e-1)" "prognostic favorable (3.45e-5)" "unprognostic (3.01e-4)" 7.3 3.5 44.2 2.0 43.1 1.5 9.7 10.5 59.9 1.8 1.7 65.0 0.0 1.6 3.1 8.7 2.3 2.1 2.7 35.5 47.4 33.0 41.5 2.0 2.9 1.4 62.6 13.8 1.5 1.4 3.4 1.6 2.3 36.3 2.2 1.8 0.8 5.8 2.6 2.3 2.0 1.7 2.6 57.7 5.5 1.1 2.2 48.6 0.0 4.9 0.8 2.2 1.7 0.4 1.2 1.0 1.8 0.6 0.1 2.3 0.2 2.4 0.1 0.1 0.7 0.5 1.5 0.8 19.8 14.8 16.3 20.6 0.1 0.1 0.5 1.4 6.8 0.9 0.3 0.0 1.5 29.5 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.2 0.7 0.5 20.6 1.2 4.4 0.0 0.1 0.0 0.7 13.7 0.3 0.0 0.4 0.6 0.0 0.6 0.1 0.7 0.2 0.6 0.1 0.5 1.0 0.0 0.4 0.2 3.9 0.0 0.1 0.4 2.6 14.7 0.3 9.3 0.3 0.1 0.1 3.7 0.1 0.7 0.3 0.3 1.8 2.3 0.1 1.8 0.4 0.8 0.9 0.2 1.2 0.9 1.9 1.7 0.1 0.6 1.0 0.5 0.2 44.2 43.1 10.5 22.6 47.4 33.0 62.6 13.8 36.3 48.6 0.0 0.0 0.0 3.4 0.3 1.6 49.6 0.0 0.0 3.4 19.2 15.7 0.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.4 1.8 1.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 3.3 0.0 0.0 68.6 0.7 0.0 0.4 0.0 9.6 6.5 4.7 0.0 0.1 0.0 0.7 0.0 0.0 0.3 FGF9 ENSG00000102678 "Fibroblast growth factor 9" P31371 13 21671383-21704498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;kidney: 21.7" "Cell type enhanced" "Detected in many" 23 "Distal tubular cells: 33.2;Horizontal cells: 38.1;Muller glia cells: 152.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.0;T-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.4;HEK 293: 2.4;JURKAT: 3.8;RPMI-8226: 3.6;RPTEC TERT1: 5.5;SCLC-21H: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067007 Enhanced Approved "Secreted in other tissues" NA NA "HPA067007: AB_2732755" "unprognostic (6.59e-3)" "unprognostic (9.09e-3)" "unprognostic (2.15e-2)" "unprognostic (9.24e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.42e-4)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (3.86e-1)" "unprognostic (2.38e-3)" "unprognostic (7.93e-2)" "prognostic favorable (1.70e-6)" "unprognostic (5.38e-2)" "unprognostic (1.27e-1)" "unprognostic (3.49e-1)" "unprognostic (6.92e-2)" 3.1 7.3 2.1 1.0 4.4 0.8 0.7 17.7 7.3 3.8 2.1 0.3 0.5 1.8 3.7 0.9 0.9 1.0 1.2 5.5 3.7 2.6 21.7 0.5 2.6 0.6 2.6 2.5 2.3 1.8 0.5 12.0 0.7 12.6 1.1 3.1 2.4 1.2 1.6 1.4 0.5 4.0 4.0 2.5 0.6 2.2 1.5 0.3 0.0 0.6 0.0 0.5 3.0 1.4 1.0 0.0 0.0 0.2 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.4 0.0 1.7 0.9 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 1.1 3.6 5.5 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.7 1.4 1.7 0.0 1.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 2.1 4.4 17.7 7.3 3.7 2.6 2.6 2.5 12.6 0.3 8.9 3.5 0.0 0.2 1.4 13.4 21.0 0.0 0.0 2.3 3.5 0.0 0.0 33.2 0.2 3.4 0.5 3.5 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 38.1 17.9 0.0 0.0 3.0 0.6 0.0 1.7 2.8 0.9 152.2 0.2 0.0 0.0 0.5 4.6 0.0 0.5 1.4 1.9 1.3 0.2 0.0 6.2 0.1 FGFR4 "CD334, JTK2" ENSG00000160867 "Fibroblast growth factor receptor 4" P22455 5 177086886-177098144 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.6;kidney: 37.7;liver: 45.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 50.9;Hepatocytes: 23.7;Proximal tubular cells: 19.5;Sertoli cells: 19.4;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CACO-2: 43.0;Hep G2: 43.0;RH-30: 69.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005196, HPA027273, HPA027369, HPA028251" Approved "Intracellular and membrane" NA NA 4300000 "CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221" "unprognostic (1.96e-1)" "unprognostic (2.10e-2)" "unprognostic (1.12e-1)" "unprognostic (9.06e-3)" "unprognostic (2.87e-1)" "unprognostic (1.95e-2)" "unprognostic (7.85e-3)" "unprognostic (9.19e-2)" "unprognostic (4.25e-1)" "unprognostic (4.46e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.71e-3)" "unprognostic (2.41e-1)" "unprognostic (5.75e-2)" "unprognostic (4.68e-2)" 0.5 5.7 0.7 14.3 0.6 0.1 1.6 2.6 0.5 2.8 10.4 0.9 0.7 13.5 0.9 4.8 1.6 1.7 33.6 0.7 0.8 0.3 37.7 45.3 25.3 2.5 0.7 1.0 13.6 26.0 0.0 0.7 1.3 0.8 4.0 3.7 2.0 1.6 0.3 4.3 0.5 17.3 1.6 0.8 11.2 5.4 2.9 0.4 0.3 0.8 2.3 0.7 1.9 3.6 1.1 0.9 3.0 1.1 0.4 0.4 0.0 0.7 12.1 0.2 2.9 0.0 0.0 5.9 0.0 0.0 0.0 0.0 43.0 1.6 1.3 5.6 0.0 0.6 0.6 2.4 0.4 0.0 0.7 2.8 0.1 0.6 43.0 1.3 0.1 1.0 0.2 0.0 2.1 0.0 0.0 0.0 0.8 4.0 0.1 0.9 9.8 0.0 0.8 7.3 7.6 1.0 1.9 69.1 7.2 5.8 0.1 0.4 0.7 0.4 3.1 1.4 1.6 2.9 0.6 0.2 0.0 5.8 0.0 0.1 0.4 0.4 0.7 0.0 0.2 0.5 1.5 1.1 0.4 0.4 0.3 0.3 1.1 0.4 0.0 0.1 0.6 0.4 0.4 3.0 0.4 0.3 0.9 0.2 0.0 0.7 0.6 2.6 0.5 0.8 0.3 0.7 1.0 0.8 0.4 0.0 0.0 0.8 0.6 0.6 0.4 0.8 50.9 0.0 0.0 3.5 0.0 1.1 3.3 8.4 0.1 0.1 10.6 0.0 4.4 3.2 1.7 0.3 0.0 23.7 0.3 0.0 4.1 2.5 0.8 0.0 0.6 0.0 0.0 1.0 5.2 0.9 3.6 2.9 1.4 19.5 0.1 19.4 0.5 1.6 12.8 0.4 7.3 0.0 33.6 0.6 FIGNL2 ENSG00000261308 "Fidgetin like 2" A6NMB9 12 51817840-51848766 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 16.7" "Cell type enriched" "Detected in single" 13 "Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.7;BEWO: 10.8;NTERA-2: 6.6;SuSa: 12.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.26e-2)" "unprognostic (7.36e-4)" "unprognostic (1.99e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.71e-2)" "unprognostic (4.75e-2)" "unprognostic (6.40e-2)" "unprognostic (9.78e-6)" "unprognostic (7.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.15e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.48e-2)" 1.1 0.0 0.6 0.6 0.7 0.0 1.0 0.0 2.2 1.4 0.1 0.0 0.4 0.0 2.6 0.9 0.0 0.2 0.3 1.5 0.1 16.7 1.4 2.0 0.7 0.2 1.7 0.0 0.0 4.3 0.1 1.9 1.3 0.9 0.0 1.0 1.8 0.5 2.0 0.2 0.4 0.2 0.2 1.0 0.9 1.3 0.0 0.0 0.2 0.5 0.3 0.2 0.8 0.4 0.8 0.2 0.2 0.0 0.5 0.0 0.0 0.1 16.7 0.0 0.2 0.1 10.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.6 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 1.9 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.3 0.3 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: AB_2683016" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 15.6 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.5 3.1 0.0 0.5 0.3 0.0 4.4 0.0 4.6 0.1 0.0 1.0 0.0 0.2 0.1 1.3 0.0 0.0 2.7 29.4 0.0 5.5 0.0 0.0 0.1 0.0 0.1 3.0 0.2 1.9 0.0 5.1 3.4 0.0 0.0 0.1 0.0 9.9 1.9 0.3 3.2 0.0 0.0 4.9 9.2 0.2 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 202.5 116.8 0.0 129.3 7.7 13.3 0.9 17.8 22.7 126.3 21.0 5.9 0.3 11.6 18.8 0.0 1.6 2.0 0.0 13.0 0.0 5.4 11.3 4.7 7.8 0.2 6.4 10.9 1.8 0.0 0.2 3.4 0.9 5.0 2.8 1.0 0.5 9.4 2.9 0.4 41.7 2.9 0.0 0.1 0.0 0.0 14.4 0.0 0.5 1.5 9.0 FMO1 ENSG00000010932 "Flavin containing monooxygenase 1" Q01740 1 171248471-171285978 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 70.4" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 142.2" "Cancer enriched" "Detected in many" 8 "renal cancer: 18.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 36 "naive B-cell: 3.5" "Lineage enriched" "Detected in single" 36 "B-cells: 3.5" "Cell line enriched" "Detected in some" 7 "HSkMC: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA078132 Approved NA NA "HPA078132: " "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (5.87e-2)" "unprognostic (1.34e-1)" "unprognostic (5.32e-3)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-1)" "unprognostic (9.16e-2)" "unprognostic (9.03e-2)" "unprognostic (1.36e-2)" "unprognostic (2.23e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.49e-4)" "unprognostic (1.40e-1)" "unprognostic (3.58e-1)" "unprognostic (1.37e-1)" 3.4 3.6 0.1 0.1 0.3 0.0 5.6 0.1 0.4 5.6 0.8 0.3 0.8 0.0 2.5 3.0 5.0 3.3 1.8 0.9 0.1 0.0 70.4 1.0 0.8 0.1 0.1 0.1 5.9 2.4 0.1 1.1 0.8 0.2 1.1 0.0 4.0 4.2 1.5 0.1 4.0 14.4 1.5 0.1 0.1 0.5 1.6 0.1 1.8 1.7 5.3 10.3 1.4 1.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.4 2.9 0.0 8.7 5.1 0.0 0.0 3.5 0.0 0.2 11.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 10.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 2.5 142.2 0.0 6.5 1.4 0.0 0.0 1.9 0.7 0.0 0.0 0.0 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.9;HSkMC: 9.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA049100: AB_2680629, HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favorable (1.09e-4)" "prognostic favorable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.5 5.0 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 2.6 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.2 0.6 1.3 0.6 0.3 2.2 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.3 1.6 0.4 0.5 2.5 3.5 0.0 0.2 0.0 1.5 1.5 3.0 5.7 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.5 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 0.0 1.6 0.5 3.8 2.5 0.0 3.5 2.5 6.7 0.0 8.7 0.0 2.1 24.9 1.6 4.0 0.9 8.6 0.0 1.2 1.2 3.1 1.1 1.1 19.8 3.2 0.0 1.2 1.8 5.7 0.4 1.4 2.3 5.0 1.8 1.9 1.5 0.9 0.0 0.4 33.2 0.0 0.0 1.2 0.2 0.2 1.4 1.6 0.5 1.4 1.7 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109725 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 37.0;salivary gland: 12.4" "Cell type enriched" "Detected in some" 13 "Distal tubular cells: 23.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 48 "eosinophil: 4.7" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.7" "Group enriched" "Detected in some" 5 "MCF7: 4.0;SuSa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Uncertain Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 37.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.3 0.0 0.0 12.4 3.7 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 FOXI2 FLJ46831 ENSG00000186766 "Forkhead box I2" Q6ZQN5 10 127737235-127741186 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 6.5;pituitary gland: 10.3" "Group enriched" "Detected in some" 6 "Distal tubular cells: 3.3;Urothelial cells: 1.6" "Cancer enriched" "Detected in some" 6 "renal cancer: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NTERA-2: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.12e-3)" "unprognostic (4.71e-4)" "unprognostic (6.78e-3)" "prognostic favorable (4.23e-7)" "unprognostic (6.31e-3)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "unprognostic (1.65e-2)" 0.7 0.0 0.1 3.0 0.1 0.0 0.7 0.1 0.3 5.4 0.4 0.1 3.1 0.1 1.8 2.7 4.7 0.7 0.2 0.5 0.1 0.1 6.5 0.1 0.4 0.9 0.1 0.1 1.2 0.2 0.1 10.3 0.1 0.4 1.2 0.0 0.1 2.3 1.7 0.3 1.4 0.4 0.5 0.1 2.3 0.5 0.3 0.1 0.4 0.1 0.9 0.8 1.6 2.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 FP565260.4 ENSG00000279493 21 5011799-5017145 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "kidney: 3.4;liver: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 6.0;HeLa: 2.6;Hep G2: 2.2;MCF7: 4.3;SiHa: 6.9" NA NA 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 10.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.0 0.0 0.0 6.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 6.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.8 0.0 0.1 0.0 1.1 0.1 1.8 5.5 0.1 0.1 0.0 5.0 0.2 24.6 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.6 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 0.0 19.8 0.0 0.1 0.6 0.1 2.0 7.6 5.3 2.3 1.8 0.0 5.1 5.0 1.7 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.3 0.0 0.0 22.4 0.2 0.0 0.0 0.1 0.4 0.1 1.6 0.0 0.0 0.0 FRG2B ENSG00000225899 "FSHD region gene 2 family member B" Q96QU4 10 133623895-133626795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;kidney: 1.9;pancreas: 1.2" "Cell type enriched" "Detected in single" 33 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enriched" "Detected in single" 22 "HDLM-2: 13.4" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 13.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRG2C ENSG00000172969 "FSHD region gene 2 family member C" A6NGY1 3 75664330-75667220 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "kidney: 3.5;testis: 3.8" "Group enriched" "Detected in some" 150 "Distal tubular cells: 23.2;Early spermatids: 11.8;Late spermatids: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "HDLM-2: 16.8" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" "unprognostic (3.47e-2)" "unprognostic (8.28e-2)" "unprognostic (9.57e-2)" "unprognostic (2.59e-1)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "unprognostic (4.56e-2)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.4 1.4 0.0 0.1 0.1 0.1 0.0 3.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 3.8 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 258.1;pancreas: 68.9;salivary gland: 91.7" "Group enriched" "Detected in many" 5 "Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 14.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 25 "MOLT-4: 141.0;RPTEC TERT1: 323.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA064218, HPA068838" Supported Approved Mitochondria NA NA 26000 Mitochondria "HPA064218: AB_2685214, HPA068838: AB_2686047" "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favorable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 0.3 0.2 0.2 0.2 0.1 0.0 0.7 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.3 2.8 0.3 0.3 54.7 0.2 0.1 0.2 258.1 2.2 0.2 0.6 0.1 0.0 0.4 68.9 0.0 0.3 0.6 0.1 0.3 0.0 0.1 91.7 0.1 0.1 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.0 9.5 0.2 0.3 0.4 0.2 0.6 0.4 3.2 0.0 1.1 8.4 14.1 2.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.2 0.0 0.0 0.0 0.0 141.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 323.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 1.1 0.2 1.8 14.1 0.2 0.4 5.1 4.1 0.0 8.4 0.0 3.2 1.6 2.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.1 0.8 1434.4 0.0 0.0 413.5 0.0 0.1 2501.8 465.3 14.4 1.3 0.0 0.0 8.3 0.1 1.1 0.1 0.0 2.4 2.9 0.0 14.6 5.5 4.3 15.4 8.6 2.6 0.0 14.4 0.0 0.5 33.3 0.0 7.1 3101.2 3.5 6.5 3.9 0.4 0.2 0.6 0.2 0.0 0.0 0.0 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371642-43376335 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "kidney: 119.5" "Cell type enriched" "Detected in some" 120 "Collecting duct cells: 4780.5" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "SuSa: 15.9" "Not detected" "Not detected" HPA058421 Enhanced NA NA "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.4 0.0 2.2 0.0 0.0 0.1 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.6 0.3 119.5 0.0 1.3 0.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 1.0 0.6 0.0 0.0 4.4 1.5 0.6 0.0 0.0 0.0 0.5 0.0 2.4 0.2 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.2 0.1 1.0 0.6 0.3 1.6 0.4 1.0 1.4 6.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4780.5 0.0 0.4 39.7 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.1 0.9 GADD45A "DDIT1, GADD45" ENSG00000116717 "Growth arrest and DNA damage inducible alpha" P24522 1 67685061-67688338 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 86.7;skeletal muscle: 102.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2362.0;Urothelial cells: 1859.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in all" 5 "granulocytes: 24.9;T-cells: 9.3" "Cell line enhanced" "Detected in many" "HHSteC: 60.1;hTERT-HME1: 92.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053420 Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA053420: AB_2682144" "unprognostic (1.36e-2)" "unprognostic (3.29e-2)" "unprognostic (9.58e-2)" "unprognostic (3.76e-3)" "unprognostic (5.81e-2)" "unprognostic (1.36e-2)" "unprognostic (1.57e-3)" "unprognostic (2.80e-3)" "unprognostic (1.42e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-2)" "unprognostic (5.21e-2)" "prognostic favorable (8.06e-6)" "unprognostic (6.11e-2)" "unprognostic (2.89e-1)" "unprognostic (3.43e-3)" "unprognostic (1.93e-1)" 29.6 6.8 10.7 8.2 20.9 46.2 20.9 1.7 15.8 11.7 10.8 5.8 18.8 10.1 23.3 13.8 12.2 8.8 16.7 12.9 18.1 9.8 86.7 66.9 17.1 4.9 11.4 4.1 13.8 8.3 4.1 5.1 10.8 21.2 16.5 9.0 9.4 9.5 15.6 102.1 14.8 20.4 16.1 15.5 7.4 14.1 9.2 7.5 9.2 26.2 10.1 10.9 23.9 11.1 1.1 2.2 24.9 3.2 3.1 9.3 4.8 22.2 1.4 3.8 1.1 6.8 7.1 35.9 39.6 18.5 13.2 14.4 7.8 3.8 9.6 12.1 6.4 33.1 13.4 0.4 33.9 24.9 7.0 3.8 12.0 3.5 7.8 60.1 3.5 1.1 12.0 17.2 16.7 92.9 6.6 9.4 2.3 25.6 17.1 15.5 0.7 1.0 4.2 4.8 2.9 15.7 2.6 29.5 9.8 6.8 16.8 16.4 2.9 8.3 2.3 23.7 13.5 0.4 3.7 9.7 13.8 18.6 14.5 27.7 43.8 8.5 17.5 6.1 1.7 13.4 7.2 3.2 24.9 3.7 1.5 3.0 1.1 2.5 3.0 1.4 0.7 0.7 1.2 4.1 3.1 1.0 2.2 9.3 4.8 10.7 20.9 1.7 15.8 18.1 9.8 11.4 4.1 21.2 7.5 59.6 21.3 30.0 2362.0 763.0 34.8 176.4 48.4 136.5 91.0 97.7 9.8 17.5 200.6 253.6 0.6 85.9 120.7 93.5 224.9 94.3 192.2 631.8 44.9 99.0 16.2 25.4 126.2 49.1 19.7 2.2 35.4 33.2 150.1 467.1 44.4 25.0 252.2 49.1 60.8 290.2 70.0 51.8 190.0 2.7 12.4 341.6 14.8 38.8 37.5 1859.7 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.7 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.3 3.1 0.3 12.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.3 5.3 0.6 0.0 0.1 0.3 0.9 3.3 8.5 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.6 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 0.0 0.0 0.0 0.1 0.3 0.7 0.6 38.2 0.0 0.0 3.5 0.0 0.0 13.3 5.6 0.9 0.1 17.4 0.0 9.7 0.0 0.0 0.2 0.0 1.3 0.1 0.0 10.5 0.0 0.8 0.6 1.4 0.0 0.0 0.0 7.4 29.4 4.6 7.0 2.1 18.9 1.1 0.0 0.0 3.1 7.5 0.3 0.2 0.0 8.0 0.0 GALNT11 GalNAc-T11 ENSG00000178234 "Polypeptide N-acetylgalactosaminyltransferase 11" Q8NCW6 7 152025674-152122347 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Notch signaling pathway" "Glycosyltransferase, Transferase" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 82.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 116.5;Proximal tubular cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039330 Uncertain NA NA "HPA039330: AB_10795249" "unprognostic (6.09e-2)" "unprognostic (1.22e-1)" "unprognostic (4.98e-2)" "unprognostic (3.48e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.76e-1)" "unprognostic (9.10e-3)" "unprognostic (1.56e-3)" "unprognostic (1.38e-1)" "unprognostic (3.65e-1)" "unprognostic (3.82e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.24e-6)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (2.97e-1)" "unprognostic (9.51e-2)" 10.7 9.4 11.1 5.1 18.7 3.8 10.4 20.8 21.8 9.1 7.5 11.4 7.1 5.1 9.6 9.2 9.8 8.3 9.3 9.2 11.4 9.3 82.0 7.1 9.6 4.9 7.0 13.4 10.6 29.7 19.3 10.5 15.9 34.1 12.0 6.5 21.7 7.8 9.8 8.8 8.3 6.9 9.5 6.5 8.5 7.6 7.3 4.4 4.6 12.5 5.6 6.4 9.4 8.1 6.3 8.3 8.2 12.5 15.7 19.3 8.7 10.6 9.6 14.2 15.8 32.9 32.5 14.6 8.5 9.8 7.2 6.8 7.7 11.3 0.0 22.3 13.8 20.1 5.0 6.7 12.1 8.9 8.8 10.0 2.1 8.7 6.7 10.8 9.6 11.4 28.6 15.6 6.0 5.0 12.6 13.0 7.5 10.7 0.1 18.0 9.2 8.2 8.7 11.6 16.8 7.7 0.0 6.2 0.3 23.7 16.5 12.6 16.8 14.2 6.9 11.5 15.8 10.3 8.3 11.7 9.7 3.4 12.2 9.3 3.2 4.0 0.1 20.2 9.4 33.0 5.8 8.3 8.2 19.3 9.4 19.0 6.3 10.7 17.7 8.3 3.8 9.2 14.0 4.4 15.7 12.5 2.5 7.9 8.7 11.1 18.7 20.8 21.8 11.4 9.3 7.0 13.4 34.1 4.4 11.9 18.5 17.9 21.5 9.3 116.5 24.0 10.2 20.1 11.4 33.2 25.5 66.9 51.4 15.4 3.0 20.7 7.7 0.0 16.2 11.7 25.1 24.5 13.9 13.5 21.9 71.5 21.9 25.8 16.5 2.9 18.4 11.5 16.9 15.4 9.0 30.9 11.9 7.0 33.9 163.9 35.9 0.0 21.7 17.7 13.8 10.3 30.3 22.0 8.5 15.4 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell type enhanced" "Detected in some" 18 "Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 9400 "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 11.1 13.1 0.0 0.0 0.0 0.0 0.0 3.7 2.0 2.5 0.3 0.0 0.0 10.4 3.8 0.2 0.0 0.0 0.4 0.5 0.4 0.3 1.3 5.8 0.0 0.0 0.0 8.4 0.0 0.1 2.3 0.0 8.6 0.1 0.0 0.3 0.0 9.3 0.0 5.1 0.0 0.0 6.2 0.0 0.0 7.3 0.0 15.2 22.4 16.6 12.3 8.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.8 0.0 0.2 0.9 2.8 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 0.0 0.0 0.8 3.8 2.5 0.2 0.4 0.0 0.0 1.2 8.7 0.0 0.0 11.6 2.5 5.3 0.6 0.4 0.0 0.3 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 11.1 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 39.7 0.3 6.5 0.8 0.4 3.4 0.6 0.0 0.0 0.0 1.0 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in many" 8 "Hepatocytes: 1105.8;Proximal tubular cells: 2889.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Group enriched" "Detected in some" 4 "RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria Yes NA 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.8 9.0 0.3 0.0 1.5 0.6 4.5 0.1 0.1 0.4 0.0 0.7 0.1 0.0 0.2 5.2 0.7 0.2 0.2 0.0 0.1 0.0 0.1 2.1 0.1 0.2 0.0 0.1 0.6 0.1 3.2 7.9 0.0 0.1 57.1 0.4 0.9 15.0 6.6 1.1 1.8 0.1 0.3 0.6 0.8 5.9 0.0 0.0 0.1 0.0 1.7 35.3 44.6 0.2 0.5 0.1 0.4 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 3.0 0.6 33.0 12.7 48.2 8.6 29.5 191.1 2.7 5.7 68.0 0.0 1.0 250.4 36.2 7.4 7.8 4.2 23.3 255.7 0.9 9.9 3.9 3.5 1105.8 69.7 7.9 0.0 20.9 55.8 11.0 4.0 39.6 21.9 5.4 0.2 18.7 151.7 0.3 3.2 2889.0 4.0 6.5 11.3 22.9 7.4 116.9 1.5 6.9 0.4 15.5 GGACT A2LD1 ENSG00000134864 "Gamma-glutamylamine cyclotransferase" Q9BVM4 13 100530164-100589528 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.0" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "SCLC-21H: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065320 Enhanced NA NA 75000 "HPA065320: AB_2685466" "unprognostic (1.93e-1)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (1.30e-3)" "unprognostic (9.12e-3)" "unprognostic (1.64e-2)" "unprognostic (1.58e-2)" "unprognostic (2.07e-2)" "unprognostic (7.41e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-2)" "unprognostic (2.45e-1)" "unprognostic (1.95e-2)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" 3.6 6.6 3.2 3.4 3.4 0.9 3.4 2.6 4.5 2.0 4.9 3.6 1.7 5.7 4.0 3.4 2.8 2.5 5.5 1.7 2.6 2.2 47.0 10.9 2.4 4.6 3.5 2.1 2.5 9.8 1.8 1.9 2.1 4.4 2.4 3.4 4.1 12.0 14.2 2.7 3.1 6.7 3.4 4.3 6.1 4.4 11.0 3.3 3.7 2.5 5.0 6.4 2.5 2.5 5.2 4.2 1.0 7.5 8.0 8.3 4.2 5.6 0.7 4.6 5.0 3.9 6.1 2.0 3.5 0.9 0.6 1.6 0.0 5.1 0.5 2.0 2.5 0.1 0.3 0.7 1.0 0.2 7.9 3.1 2.3 0.5 0.3 5.6 3.3 7.8 7.2 4.0 0.1 0.3 0.0 2.3 2.6 1.2 0.1 0.9 0.3 0.5 0.4 0.2 10.8 1.5 0.3 1.1 0.6 5.7 0.9 55.0 2.1 1.1 2.5 2.5 4.5 2.4 11.2 2.2 0.0 0.0 1.2 0.9 3.0 1.6 0.2 0.3 2.5 2.5 0.0 5.1 1.0 7.9 7.2 7.3 5.2 6.4 8.3 4.2 5.0 4.0 5.9 0.0 8.0 7.5 3.0 6.5 4.2 3.2 3.4 2.6 4.5 2.6 2.2 3.5 2.1 4.4 3.3 0.0 1.0 10.4 3.4 2.4 1.1 0.8 0.0 0.0 2.3 7.0 13.7 9.8 6.6 8.4 4.1 3.1 5.3 0.0 9.0 10.2 2.8 2.2 5.7 13.2 10.5 1.6 7.5 4.3 7.8 6.7 2.6 3.6 0.0 8.2 4.5 4.8 8.0 2.9 3.5 65.3 2.1 6.5 0.9 18.2 10.5 1.8 3.7 5.0 7.1 1.6 GGH ENSG00000137563 "Gamma-glutamyl hydrolase" Q92820 8 63015079-63039171 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 42.5;liver: 59.5" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 501.9;Early spermatids: 395.4;Syncytiotrophoblasts: 631.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 18.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019296, HPA025226" Approved "Intracellular and membrane" NA NA 1400000000 "CAB019296: , HPA025226: AB_1849645" "unprognostic (9.29e-2)" "unprognostic (1.22e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.99e-7)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (1.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.11e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-2)" "unprognostic (9.62e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" 3.5 3.6 7.4 4.7 8.6 12.3 11.8 15.5 9.9 3.5 17.6 1.5 1.0 3.7 2.6 3.7 11.0 1.6 2.8 5.9 7.9 7.6 42.5 59.5 3.5 5.0 4.7 7.0 1.9 4.2 1.0 1.6 17.7 14.8 1.9 26.4 2.2 6.5 1.8 1.7 11.1 3.6 4.2 7.6 3.7 3.2 14.0 3.8 5.2 1.4 14.5 7.6 3.9 6.6 4.1 18.2 2.1 1.9 2.9 1.4 1.4 20.0 19.3 19.8 3.0 19.5 8.2 14.6 12.4 21.2 19.7 28.5 27.0 35.6 13.7 3.5 15.3 33.2 16.8 19.6 20.7 29.2 27.8 14.8 22.5 10.4 18.2 3.7 10.5 13.5 6.0 5.9 19.8 9.5 12.5 23.7 14.0 12.0 50.3 36.8 11.3 5.1 10.5 9.3 44.9 18.3 15.3 19.3 18.4 15.2 7.0 7.9 13.6 18.0 19.7 18.8 19.1 21.7 11.7 12.5 21.2 23.8 20.3 22.2 23.6 24.0 16.1 32.7 0.0 37.3 0.0 1.9 2.1 1.1 1.1 0.5 4.1 1.3 1.3 0.6 1.9 1.0 1.3 1.8 2.9 1.2 18.2 1.4 1.4 7.4 8.6 15.5 9.9 7.9 7.6 4.7 7.0 14.8 3.8 14.9 8.2 22.6 16.2 26.9 1.7 1.6 17.8 14.7 14.8 21.0 0.0 501.9 31.5 20.1 395.4 8.3 17.2 46.7 6.4 234.3 29.8 8.2 10.4 171.3 65.1 0.0 12.7 15.4 18.7 97.7 5.5 15.0 23.6 54.1 74.6 20.3 6.2 8.6 7.8 214.6 1.1 25.8 10.8 73.7 141.6 37.6 631.0 10.1 104.6 12.5 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles "Intracellular and membrane" NA NA 4600000 Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favorable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.3 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.2 0.2 4.3 0.0 3.8 2.8 1.4 0.2 0.1 35.6 2.9 0.1 8.6 14.0 1.5 0.3 11.9 0.4 0.2 0.6 0.4 0.3 0.1 5.3 2.0 52.5 0.2 0.4 0.3 14.6 1.4 37.9 0.2 0.2 2.2 51.6 48.0 0.6 0.2 0.3 0.1 9.3 0.2 5.5 9.3 11.1 2.2 3.5 2.3 10.8 0.3 15.8 5.9 0.2 7.4 15.0 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 74.5 21.4 3.4 0.1 0.7 0.4 0.4 40.8 2.7 7.9 1.8 0.0 0.9 1.7 54.8 1.1 0.1 80.7 0.0 7.2 0.3 1.3 3.0 5.7 34.1 4.7 0.0 1.2 2.5 3.0 4.1 0.0 2.9 1.7 5.4 2.5 2.0 33.5 23.0 0.4 32.7 0.0 0.0 0.2 0.6 0.7 0.4 0.7 3.2 4.2 0.0 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles NA NA Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.5 0.6 13.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 3.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 GK "GK1, GKD" ENSG00000198814 "Glycerol kinase" P32189 X 30653359-30731456 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 80.4;Macrophages: 98.4;Proximal tubular cells: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 8 "granulocytes: 51.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.5;Hep G2: 27.3" HPA060687 Supported NA NA "HPA060687: AB_2684343" "unprognostic (8.78e-3)" "unprognostic (8.41e-3)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (5.52e-2)" "unprognostic (1.42e-2)" "unprognostic (3.85e-1)" "unprognostic (8.56e-3)" "unprognostic (1.30e-2)" "unprognostic (1.58e-2)" "prognostic favorable (3.24e-9)" "unprognostic (1.59e-1)" "unprognostic (9.35e-2)" "unprognostic (4.57e-3)" "unprognostic (4.11e-3)" 2.8 4.9 2.4 17.0 7.6 1.6 1.8 2.5 4.7 3.0 7.5 2.7 1.5 28.4 2.5 4.0 4.9 2.7 7.9 4.9 4.6 2.6 35.4 40.7 11.7 8.1 3.8 2.5 2.0 1.9 3.2 5.3 2.3 4.1 1.9 3.4 2.9 6.6 0.6 1.4 3.1 37.9 1.9 6.0 6.4 2.0 2.0 2.2 5.4 2.2 3.8 4.5 4.3 1.7 1.7 4.0 51.4 6.6 1.2 3.2 1.6 2.6 2.1 2.7 4.8 1.7 6.6 1.1 6.4 22.5 4.7 5.3 3.4 2.4 7.5 1.0 2.4 4.2 0.1 5.1 2.1 6.2 4.8 5.7 4.4 4.2 27.3 10.8 8.2 9.6 4.0 3.2 14.8 14.0 1.2 3.6 5.9 2.3 10.7 1.2 3.8 6.3 8.8 4.6 2.9 2.4 8.8 4.3 7.7 3.5 8.8 2.9 3.7 5.6 5.7 12.5 2.9 6.5 5.9 1.4 3.4 1.4 0.1 2.9 5.6 6.0 7.3 5.9 5.4 3.4 1.3 6.6 2.2 0.5 2.0 0.4 0.8 0.9 0.6 4.0 1.7 0.5 0.6 51.4 1.2 2.4 1.2 3.2 1.6 2.4 7.6 2.5 4.7 4.6 2.6 3.8 2.5 4.1 2.2 14.9 24.3 9.1 8.9 6.2 4.1 3.9 10.2 56.2 20.5 7.0 15.7 1.0 29.9 19.8 39.8 3.6 80.4 0.0 9.5 1.0 3.8 12.9 13.9 33.1 30.8 4.8 11.6 4.3 33.0 23.1 1.1 98.4 13.5 44.1 11.5 36.9 13.5 17.5 2.1 143.3 17.9 0.0 4.7 9.9 1.5 14.8 0.7 17.3 7.8 22.6 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761750-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.2;kidney: 10.2;liver: 7.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 11.6;Enterocytes: 17.1;Paneth cells: 10.5;Proximal tubular cells: 31.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;Hep G2: 2.2;K-562: 1.9;MCF7: 6.5;SCLC-21H: 1.3;T-47d: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010667 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.2 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.4 14.7 0.2 0.2 10.3 0.4 5.6 0.3 1.6 3.5 0.2 0.2 0.0 10.2 7.8 1.5 0.2 0.2 0.2 0.4 1.1 0.0 0.6 0.2 0.2 0.4 5.7 1.5 0.6 0.2 0.2 0.1 25.2 0.2 0.2 0.2 1.3 0.7 0.2 0.4 1.9 0.2 0.5 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.3 0.4 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 1.6 0.0 0.4 0.0 0.2 0.0 2.5 4.0 0.0 7.0 0.0 0.0 11.6 0.4 0.1 0.0 17.1 0.0 0.8 0.1 0.0 0.5 0.0 6.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.3 1.2 10.5 0.0 31.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.5 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880827-190965552 "Enzymes, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 127.9" "Cell type enhanced" "Detected in all" 6 "Collecting duct cells: 371.6;Proximal tubular cells: 372.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 141.8;RPTEC TERT1: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" No No 25000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 16.5 37.3 37.8 20.4 24.7 10.7 34.3 43.8 47.3 11.9 13.1 5.8 8.9 36.9 14.6 11.9 7.6 11.0 17.7 15.7 23.3 22.8 127.9 5.3 22.6 25.4 20.6 36.8 14.1 17.0 26.4 10.1 14.8 35.1 9.4 13.1 10.8 9.0 13.9 7.4 13.0 40.9 15.5 11.7 19.3 8.7 6.9 12.1 15.0 17.7 8.0 22.9 14.1 16.1 5.2 5.0 6.0 2.1 3.9 9.4 1.5 6.4 7.1 5.0 6.6 15.7 11.0 13.0 19.2 14.6 14.0 16.1 8.7 6.4 13.2 141.8 40.5 7.1 8.4 8.8 7.5 20.6 32.5 5.7 21.9 10.5 10.7 14.4 12.7 10.3 9.9 7.9 11.0 7.5 14.0 18.1 5.5 10.1 26.9 31.1 3.4 8.6 12.3 13.4 3.8 11.7 11.0 12.9 11.4 65.2 11.8 6.9 7.2 26.2 5.8 24.4 18.7 2.3 7.9 12.9 20.3 14.9 10.1 23.2 8.7 19.8 18.1 7.3 10.5 16.1 6.0 1.5 2.5 5.5 2.1 9.4 4.8 6.5 7.0 2.2 5.2 6.8 8.1 3.0 3.9 1.4 5.0 5.6 1.5 37.8 24.7 43.8 47.3 23.3 22.8 20.6 36.8 35.1 12.1 175.7 95.7 52.1 47.3 155.0 91.0 32.2 30.6 16.0 40.9 371.6 198.3 3.3 43.1 22.6 4.4 51.8 120.5 23.3 20.9 10.2 63.7 42.0 35.8 4.9 25.8 25.4 56.7 57.7 27.2 3.6 26.4 55.5 84.4 88.4 25.7 10.0 29.5 31.6 40.7 372.1 117.6 19.4 70.9 10.7 11.0 142.3 3.3 62.3 28.1 52.1 GLTPD2 ENSG00000182327 "Glycolipid transfer protein domain containing 2" A6NH11 17 4788959-4790390 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;kidney: 9.8;liver: 44.4" "Group enriched" "Detected in some" 6 "Hepatocytes: 65.2;Proximal tubular cells: 128.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 25.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 3.2" "Lineage enriched" "Detected in single" 6 "monocytes: 3.2" "Cell line enhanced" "Detected in some" "BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058295, HPA065267" Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA058295: AB_2683671, HPA065267: AB_2685451" "unprognostic (4.00e-1)" "unprognostic (1.93e-1)" "unprognostic (1.95e-3)" "unprognostic (1.70e-1)" "unprognostic (3.03e-2)" "unprognostic (1.79e-4)" "unprognostic (1.40e-1)" "unprognostic (1.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.33e-2)" "unprognostic (5.62e-4)" "unprognostic (7.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.25e-1)" "unprognostic (4.79e-1)" "unprognostic (1.71e-4)" "unprognostic (7.59e-3)" 0.2 0.3 0.5 0.2 0.7 0.8 0.2 0.8 1.8 0.2 8.0 0.3 0.2 8.6 0.3 0.2 0.4 0.3 0.2 0.2 0.5 0.7 9.8 44.4 0.6 0.2 0.5 0.4 0.2 0.5 0.2 0.5 0.2 0.4 0.2 0.0 0.5 0.8 0.2 0.8 1.4 13.0 0.2 0.4 0.8 0.9 0.2 0.2 0.4 0.2 1.6 0.3 0.4 0.3 0.0 0.5 0.0 3.2 0.0 0.2 0.2 0.6 2.5 0.2 2.1 0.0 0.0 4.7 0.4 0.0 0.0 0.0 11.8 0.9 1.2 1.3 0.0 0.4 2.3 0.0 0.1 0.0 2.2 1.8 0.1 1.0 15.5 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.7 0.6 0.0 5.4 0.2 0.2 0.3 0.6 1.0 0.9 0.6 0.3 0.0 0.9 1.6 1.0 2.2 0.4 0.6 0.1 1.4 0.1 2.5 0.8 1.0 0.5 0.4 0.2 0.6 0.1 0.3 0.7 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.2 0.5 0.7 0.8 0.7 0.5 0.7 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 65.2 0.1 0.0 0.0 1.8 1.3 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 128.9 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.5 GLYAT "ACGNAT, GAT" ENSG00000149124 Glycine-N-acyltransferase Q6IB77 11 58640426-58731974 "Enzymes, Predicted intracellular proteins" Detoxification "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 91.2;liver: 115.1" "Group enriched" "Detected in some" 7 "Hepatocytes: 306.5;Proximal tubular cells: 1137.1" "Group enriched" "Detected in some" 158 "liver cancer: 21.7;renal cancer: 25.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 0.7" "HPA040251, HPA044094" Enhanced NA NA "HPA040251: AB_2676902, HPA044094: AB_2678807" "unprognostic (2.15e-2)" "unprognostic (9.38e-4)" "unprognostic (4.60e-2)" "unprognostic (1.65e-3)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.69e-1)" 11.1 0.0 0.1 0.1 0.1 0.0 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.2 0.1 0.0 91.2 115.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.3 1.1 0.7 2.9 0.7 0.2 0.8 0.0 1.5 0.6 1.0 3.3 3.3 2.1 2.1 0.9 0.9 1.5 0.9 0.4 2.0 2.4 1.4 1.4 0.5 1.5 2.3 2.4 2.0 0.1 0.7 3.2 0.6 3.4 2.4 1.8 1.8 2.4 7.6 2.6 2.7 1.3 2.9 1.8 0.9 1.3 3.7 1.2 2.1 3.5 3.0 2.4 1.0 1.4 2.2 0.5 6.8 1.6 0.8 2.5 1.7 1.4 1.4 3.1 2.4 1.5 1.7 1.9 2.0 2.1 1.2 1.5 2.2 1.1 0.6 4.6 2.0 1.0 0.7 0.3 0.4 0.3 0.4 0.1 0.4 0.8 0.2 1.1 0.5 0.5 2.9 0.2 0.3 0.7 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.2 10.2 0.0 0.0 29.6 0.0 0.0 104.5 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 306.5 0.0 0.0 0.0 9.2 8.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1137.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GMNC GEMC1 ENSG00000205835 "Geminin coiled-coil domain containing" A6NCL1 3 190852877-190892429 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 12.7;kidney: 26.9;liver: 8.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 8.1;Early spermatids: 8.8;Hepatocytes: 5.7;Proximal tubular cells: 6.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 4.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043663 Uncertain NA NA "HPA043663: AB_10959313" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (5.45e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.22e-3)" "unprognostic (2.73e-2)" "unprognostic (2.55e-3)" 0.1 0.1 3.5 0.1 2.9 0.1 0.1 0.2 0.7 0.8 0.1 5.0 0.0 0.1 2.0 4.4 0.1 12.7 0.1 0.9 4.6 1.4 26.9 8.5 0.1 0.1 0.6 0.9 0.5 1.1 0.1 0.2 0.3 4.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 2.0 0.1 0.1 2.3 3.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.9 0.2 0.7 4.6 1.4 0.6 0.9 4.2 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.1 0.0 0.0 2.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 9.8 9.7 0.0 0.1 0.5 1.2 0.2 0.7 1.4 0.2 0.2 0.7 51.6 0.0 1.1 1.8 39.2 2.2 4.6 0.9 0.1 0.6 2.2 0.0 3.1 9.5 1.4 2.8 19.0 0.6 0.0 0.3 1.1 3.8 4.8 2.7 7.9 7.8 0.2 1.0 0.7 0.7 0.2 14.5 4.2 0.1 2.2 3.7 9.8 0.6 0.2 0.0 1.9 2.0 5.4 0.5 0.4 0.5 0.2 2.3 4.2 2.3 9.3 0.4 0.6 0.0 22.6 5.6 17.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 6.0 5.0 0.0 41.3 0.0 0.0 0.0 7.6 2.7 9.1 10.4 0.0 0.2 13.3 1.6 68.5 0.6 21.6 0.0 5.9 1.0 0.1 25.8 7.0 11.9 15.3 4.8 1.2 5.5 16.7 17.2 1.1 28.3 0.0 5.4 4.8 0.0 6.6 8.0 0.7 50.3 0.2 6.5 0.0 8.8 1.7 0.0 0.8 0.0 2.1 25.4 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 54.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "CACO-2: 31.4;HeLa: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA040152: AB_2676863, HPA044081: AB_2678801" "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 0.0 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.1 54.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 GPRC6A bA86F4.3 ENSG00000173612 "G protein-coupled receptor class C group 6 member A" Q5T6X5 6 116792085-116829037 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6" "Cell type enhanced" "Detected in single" 35 "Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "U-266/70: 6.0;U-266/84: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.16e-2)" "unprognostic (2.48e-1)" "unprognostic (4.38e-3)" 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPX3 ENSG00000211445 "Glutathione peroxidase 3" P22352 5 151020438-151028993 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 844.2;thyroid gland: 424.1" "Group enriched" "Detected in many" 4 "Muller glia cells: 3198.5;Proximal tubular cells: 9534.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 856.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 16.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.7" "Cell line enriched" "Detected in some" 12 "ASC diff: 427.5" "Region enhanced" "Detected in many" "hypothalamus: 279.6" "Group enriched" "Detected in many" 4 "basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3" CAB069456 Approved "Secreted to blood" NA NA 5090000000 10000000000 "CAB069456: AB_1616682" "unprognostic (4.03e-1)" "unprognostic (7.35e-2)" "unprognostic (5.05e-3)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.13e-2)" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (5.75e-3)" "unprognostic (2.70e-3)" "unprognostic (8.17e-3)" "unprognostic (1.14e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (2.14e-1)" "unprognostic (5.11e-2)" "unprognostic (1.26e-1)" 177.5 21.9 1.2 6.6 5.5 1.6 310.9 3.1 6.3 26.2 33.9 5.1 6.5 7.5 11.8 16.8 44.4 27.0 17.3 108.1 2.7 5.0 844.2 64.1 88.2 43.8 3.9 1.8 28.8 13.0 5.5 32.3 44.8 17.6 41.3 8.3 160.8 14.8 12.4 56.7 18.7 18.5 48.5 3.5 29.6 19.5 23.6 1.2 0.5 424.1 19.0 9.8 58.8 164.2 0.0 3.5 16.7 3.6 0.0 0.2 1.2 0.1 0.5 0.4 0.1 427.5 0.3 0.4 0.1 0.0 0.4 0.1 9.1 0.2 0.0 11.7 0.2 0.1 0.1 2.1 23.0 0.3 0.3 0.1 0.0 0.2 9.9 16.4 0.0 0.2 36.1 2.2 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 4.0 0.2 0.6 0.6 0.0 1.7 0.1 1.9 2.3 0.1 0.1 0.1 1.0 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.0 0.0 3.6 0.1 0.0 1.4 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 1.2 1.2 5.5 3.1 3.6 2.7 5.0 3.9 1.8 17.6 1.2 8.9 50.9 26.2 69.3 16.5 21.7 621.6 15.3 28.1 26.1 615.9 41.2 663.5 1502.1 3.9 2.4 100.8 0.7 0.0 42.8 818.8 102.8 81.4 10.5 137.7 137.1 15.9 43.8 697.9 65.5 7.5 413.6 35.5 21.9 1.0 5.6 3198.5 11.1 7.0 38.5 9534.8 68.9 672.6 191.9 3.8 10.7 18.9 1478.3 13.8 0.6 29.7 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791664-52803910 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4" "Group enriched" "Detected in many" 6 "liver cancer: 555.4;renal cancer: 135.0" "Region enriched" "Detected in single" 6 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Hep G2: 89.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.6 119.4 0.6 0.7 4.2 0.0 0.6 0.6 0.7 0.8 64.3 4.3 0.6 59.9 0.6 1.2 0.7 6.9 16.4 0.6 0.6 0.0 79.7 214.4 7.1 0.6 0.6 0.6 8.5 16.9 0.0 0.7 0.9 0.7 1.8 0.2 1.0 2.6 0.8 0.6 0.1 202.4 0.6 0.6 0.6 10.7 78.2 0.6 0.7 0.6 2.1 4.4 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 89.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 4.2 0.6 0.7 0.6 0.0 0.6 0.6 0.7 0.6 6.0 7.7 0.0 2.8 0.0 0.0 0.0 614.0 837.9 106.9 69.8 0.0 0.1 454.3 72.7 8.0 0.0 11.8 46.7 1419.6 0.0 0.0 51.4 2.3 628.5 0.1 0.0 2.9 23.4 22.6 21.8 60.7 4.4 0.0 22.6 33.3 0.0 1010.1 6.0 4.2 2005.4 0.0 0.0 0.0 5.6 3.4 0.0 0.5 4.3 29.3 42.0 GSTA2 GST2 ENSG00000244067 "Glutathione S-transferase alpha 2" P09210 6 52750089-52763569 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 63.4;liver: 192.2;pancreas: 54.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8" "Group enriched" "Detected in many" 16 "liver cancer: 124.6;renal cancer: 48.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 20.7;Hep G2: 15.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (6.43e-3)" "unprognostic (2.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.34e-2)" "unprognostic (1.91e-1)" "unprognostic (6.54e-2)" 0.2 1.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 6.4 0.2 0.2 13.4 0.2 0.3 0.2 0.0 9.9 0.2 0.2 0.0 63.4 192.2 5.3 0.2 0.2 0.2 0.3 54.1 0.0 0.2 0.3 0.2 0.7 0.0 0.2 0.3 0.2 0.2 0.0 27.6 0.2 0.2 0.2 1.5 14.1 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.3 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 5.9 0.5 0.1 0.0 0.0 0.0 338.8 780.3 46.6 15.7 0.0 0.0 180.8 6.3 4.5 0.0 0.0 0.0 201.6 0.1 0.0 5.3 0.0 50.4 0.1 0.0 0.0 1.3 1.6 6.5 1.1 1.3 0.0 9.0 0.4 0.0 549.6 0.0 0.4 368.8 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 1.0 HAO2 "GIG16, HAOX2" ENSG00000116882 "Hydroxyacid oxidase 2" Q9NYQ3 1 119368779-119394130 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 60 "kidney: 65.1;liver: 90.2" "Group enriched" "Detected in some" 6 "Hepatocytes: 210.7;Proximal tubular cells: 261.6" "Group enriched" "Detected in some" 26 "liver cancer: 25.6;renal cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050355 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA050355: " "unprognostic (1.13e-1)" "unprognostic (1.68e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (6.22e-2)" "unprognostic (5.33e-3)" "unprognostic (2.80e-2)" "unprognostic (3.27e-1)" "unprognostic (3.15e-1)" "unprognostic (3.17e-1)" "unprognostic (1.41e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.92e-4)" "unprognostic (9.66e-2)" "unprognostic (1.79e-1)" "unprognostic (2.89e-2)" "unprognostic (5.14e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 65.1 90.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.3 0.5 0.0 0.6 0.8 2.0 0.4 0.0 0.2 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.8 0.2 1.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 2.5 0.0 0.0 10.4 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 210.7 0.1 0.0 0.0 3.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "A549: 36.6;CACO-2: 44.0;RPTEC TERT1: 17.5" "HPA007173, CAB075697" Uncertain Approved Vesicles NA NA 155000 Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavorable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favorable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 36.6 0.1 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 44.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 1.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112599-43566001 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;kidney: 15.4" "Group enriched" "Detected in some" 4 "Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.5;GAMG: 4.9;U-266/70: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Approved Supported Cytosol NA NA Cytosol "HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.7 0.5 10.3 0.8 12.1 1.4 0.8 13.6 24.0 0.6 0.8 1.1 0.0 0.4 0.8 1.7 2.6 0.5 4.0 0.4 3.9 4.1 15.4 0.6 0.6 1.3 3.8 15.5 1.0 0.4 1.7 0.4 0.6 10.2 3.2 0.5 0.6 1.0 0.8 1.8 2.1 0.6 0.7 1.4 0.6 1.0 3.7 1.6 0.0 1.5 0.0 0.8 1.2 0.6 2.4 1.6 7.0 1.7 1.6 0.7 0.1 0.1 5.5 0.6 0.8 0.0 0.0 0.0 1.6 2.8 0.1 0.7 0.0 0.0 0.2 3.1 2.7 4.9 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.2 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.0 0.0 0.0 0.0 0.0 2.4 0.1 0.9 0.5 0.0 0.0 0.0 0.1 0.2 0.7 0.5 0.1 0.0 0.3 0.4 0.0 0.0 0.8 1.1 1.3 0.4 15.7 0.5 0.0 3.5 0.4 0.0 6.4 1.7 1.1 0.7 1.0 0.5 1.0 0.7 0.3 0.2 2.4 0.6 0.7 7.0 1.6 0.9 1.6 0.2 0.1 10.3 12.1 13.6 24.0 3.9 4.1 3.8 15.5 10.2 1.6 0.0 0.0 0.0 0.3 0.3 13.6 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 118.3 0.3 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 42.9 0.0 0.6 0.0 44.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.4 15.9 1.8 0.0 0.8 2.1 2.5 0.3 0.0 0.5 0.4 0.3 HELT "bHLHb44, HCM1228, HESL, MEGANE, Mgn" ENSG00000187821 "Helt bHLH transcription factor" A6NFD8 4 185018841-185020804 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 2.9;lung: 2.2;skin 1: 2.0" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 5.2;HEK 293: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036188, HPA036189" Uncertain NA NA "HPA036188: AB_10672237, HPA036189: AB_2674997" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148122-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 5.1;kidney: 5.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Group enriched" "Detected in some" 41 "hypothalamus: 5.1;pons and medulla: 3.0" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in some" 13 "REH: 29.0" "Region enhanced" "Detected in single" "hypothalamus: 0.6" "Group enriched" "Detected in some" 4 "basal ganglia: 1.1;hypothalamus: 4.0" "CAB013268, CAB022752" Approved NA NA "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 HNF1A "HNF1, LFB1, MODY3, TCF1" ENSG00000135100 "HNF1 homeobox A" 12 120978543-121002512 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.2;kidney: 17.2;liver: 15.6" "Cell type enhanced" "Detected in some" 8 "Enterocytes: 16.0;Hepatocytes: 13.9;Paneth cells: 14.4;Proximal tubular cells: 13.2;Undifferentiated cells: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 6.2;CACO-2: 20.5;Hep G2: 22.4;OE19: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010430, HPA035231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB010430: AB_2116746, HPA035231: AB_2674528" "unprognostic (5.92e-3)" "unprognostic (8.47e-2)" "unprognostic (4.12e-3)" "unprognostic (6.18e-3)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (9.18e-2)" "unprognostic (9.18e-2)" "unprognostic (2.99e-1)" "unprognostic (2.01e-1)" "unprognostic (9.77e-3)" "unprognostic (5.21e-2)" "unprognostic (6.25e-3)" "unprognostic (5.55e-2)" "unprognostic (2.48e-1)" "unprognostic (6.93e-3)" 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 17.3 0.1 0.1 13.7 0.1 1.5 0.1 0.8 5.1 0.1 0.1 0.0 17.2 15.6 0.1 0.1 0.1 0.1 0.2 6.3 0.0 0.1 0.1 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.0 24.2 0.5 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.5 1.8 0.3 0.3 0.4 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.2 0.2 0.3 0.2 0.3 0.4 0.4 0.1 0.5 0.4 0.4 1.6 0.3 0.3 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.8 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 16.0 0.0 4.6 0.1 0.0 0.4 0.0 13.9 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.5 3.2 14.4 0.0 13.2 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 8.9 0.2 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686432-37745247 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.7;kidney: 66.2;pancreas: 18.6" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 73.9;Collecting duct cells: 54.1;Distal tubular cells: 38.1;Ductal cells: 37.2" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 5 "B-cells: 1.0" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 53.3" "Group enriched" "Detected in some" 5 "basal ganglia: 0.7;hypothalamus: 2.3" "Not detected" "Not detected" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB068192: AB_2665649, HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favorable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favorable (2.51e-6)" 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.1 4.5 0.0 4.8 3.8 0.9 7.8 0.0 2.8 34.7 0.0 0.0 66.2 7.7 3.7 0.0 0.0 0.0 0.8 18.6 1.6 0.0 0.6 0.0 1.6 3.4 0.0 0.0 3.8 0.0 0.0 5.5 0.3 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.8 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 53.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.9 10.2 0.0 2.2 0.0 0.0 0.6 73.9 5.3 3.4 54.1 0.0 0.0 38.1 37.2 26.8 0.0 10.9 0.0 22.1 0.0 0.0 1.8 5.7 4.0 0.1 0.0 13.8 0.0 0.3 7.4 0.6 0.0 0.0 1.8 11.4 0.0 25.3 7.0 0.0 31.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 19.4 2.7 HNF4A "HNF4, MODY, MODY1, NR2A1, TCF14" ENSG00000101076 "Hepatocyte nuclear factor 4 alpha" P41235 20 44355700-44434596 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 65.5;kidney: 30.5;liver: 57.3" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 146.5;Hepatocytes: 160.5;Paneth cells: 94.8;Proximal tubular cells: 115.9;Undifferentiated cells: 91.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 48.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 52.3;Hep G2: 38.5;OE19: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004712, CAB019417" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB019417: AB_2295208, HPA004712: AB_1079075" "unprognostic (2.47e-1)" "unprognostic (3.08e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-2)" "unprognostic (4.79e-3)" "unprognostic (2.59e-2)" "unprognostic (3.77e-2)" "unprognostic (2.45e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-2)" "unprognostic (8.40e-3)" "unprognostic (2.12e-1)" "unprognostic (2.70e-2)" 0.2 0.2 0.2 13.4 0.2 0.0 0.2 0.2 0.3 0.2 54.0 0.2 0.1 33.0 0.2 6.2 0.2 0.4 15.7 0.2 0.2 0.2 30.5 57.3 0.3 0.1 0.2 0.1 0.3 22.7 0.0 0.2 0.1 0.2 0.2 14.4 0.2 0.2 0.1 0.2 0.2 65.5 0.3 0.2 0.2 7.1 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.4 0.4 0.6 1.2 0.8 0.8 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.3 2.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 0.4 0.4 0.7 0.8 0.8 0.6 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 43.3 0.0 0.0 12.2 0.0 0.0 13.3 6.8 3.1 0.0 146.5 0.0 19.4 0.0 0.0 0.3 4.6 160.5 0.0 0.0 34.4 3.7 5.1 16.4 0.3 0.0 0.0 1.8 62.7 0.0 17.5 94.8 0.4 115.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 91.6 0.1 HOGA1 "C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2" ENSG00000241935 "4-hydroxy-2-oxoglutarate aldolase 1" Q86XE5 10 97584323-97612802 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 39.8;liver: 31.0" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 35.7;Distal tubular cells: 24.9;Hepatocytes: 41.0;Proximal tubular cells: 71.6" "Group enriched" "Detected in many" 5 "liver cancer: 4.5;renal cancer: 9.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 6.1;EFO-21: 7.3;Hep G2: 19.0;RPTEC TERT1: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039466 Approved NA NA 15000 "HPA039466: AB_2676522" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (7.50e-2)" "unprognostic (2.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.29e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-3)" "unprognostic (4.72e-1)" "unprognostic (2.37e-1)" "unprognostic (1.28e-1)" "unprognostic (6.80e-2)" "prognostic favorable (9.08e-4)" "unprognostic (2.20e-1)" "unprognostic (1.80e-1)" "unprognostic (2.94e-3)" "unprognostic (7.20e-4)" 3.3 5.4 3.3 0.6 3.8 0.8 2.1 7.0 4.3 0.8 0.6 8.2 1.5 0.7 0.9 4.0 1.3 2.0 3.8 10.1 4.2 2.8 39.8 31.0 0.9 0.7 9.3 5.2 0.6 12.0 2.0 2.4 0.6 7.2 1.3 0.6 3.6 1.8 2.2 2.0 1.2 0.6 0.8 8.2 0.7 0.6 0.7 6.9 0.0 1.8 4.1 0.6 0.8 0.6 2.1 1.7 4.4 1.2 1.2 1.3 0.5 0.3 2.8 0.1 6.1 1.2 0.3 0.1 0.1 0.2 0.1 0.0 2.3 0.3 0.2 7.3 0.1 0.3 2.0 0.1 0.2 0.1 0.2 3.2 0.1 1.1 19.0 0.8 0.2 0.2 0.3 0.6 0.2 0.1 1.5 0.3 0.1 0.1 0.4 0.5 1.2 0.1 0.2 0.2 0.2 0.0 0.2 0.5 0.4 23.3 0.4 0.5 0.9 0.1 1.1 0.7 0.2 2.1 0.1 0.3 0.7 0.2 0.4 0.2 0.4 0.7 0.1 1.5 0.3 0.1 2.4 1.1 1.2 1.2 0.9 1.0 1.1 1.3 0.9 0.5 2.1 1.1 1.2 4.4 1.2 1.2 1.7 0.9 0.5 3.3 3.8 7.0 3.9 4.2 2.8 9.3 5.2 7.2 6.9 0.0 0.0 0.0 0.6 0.1 0.1 5.3 35.7 5.3 0.0 8.7 0.0 0.0 24.9 4.4 2.9 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 41.0 0.1 1.6 0.0 0.0 1.8 12.3 0.0 0.0 1.7 0.0 0.0 2.0 0.5 0.0 0.0 71.6 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162435-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.2 3.4 0.2 8.8 0.1 2.4 8.7 0.1 0.2 15.5 12.8 0.2 4.1 0.0 10.4 16.8 1.4 12.2 0.3 0.1 0.1 0.0 35.1 0.1 0.8 0.7 0.1 0.1 2.0 0.1 0.0 0.1 1.4 0.4 16.6 4.5 0.2 0.5 5.6 21.0 13.3 8.2 13.1 0.7 1.0 0.0 2.4 0.1 2.6 0.3 0.3 0.3 16.2 11.4 0.5 6.0 5.4 1.0 11.7 1.5 0.5 12.7 0.0 0.0 6.4 2.1 1.6 0.0 5.1 4.1 0.4 0.4 0.8 0.5 0.1 0.5 2.7 0.0 11.9 8.2 0.0 0.4 0.0 43.6 0.1 0.3 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 15.2 2.7 0.0 0.0 15.0 0.2 40.5 0.0 5.4 0.0 0.1 0.2 0.0 10.7 0.4 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.0 14.5 0.0 5.4 1.0 0.0 1.5 0.2 0.2 0.2 0.0 0.1 6.0 0.5 0.3 0.1 0.9 11.7 0.4 1.9 0.2 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 10.6 22.2 0.0 0.6 0.0 0.0 0.0 17.4 0.0 0.3 46.4 0.0 0.0 0.2 7.9 0.0 0.0 0.3 10.8 14.2 0.0 0.0 0.3 0.0 37.7 0.0 4.8 0.0 0.0 1.6 5.0 0.0 19.1 0.0 0.0 18.4 0.0 60.8 0.0 0.0 3.6 0.0 0.6 24.1 0.2 4.4 19.4 11.5 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48614939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6" "Group enriched" "Detected in some" 7 "Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enriched" "Detected in single" 82 "pons and medulla: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0" "Region enriched" "Detected in single" 48 "pons and medulla: 6.8" "Low region specificity" "Detected in many" HPA075905 Supported Nucleoplasm NA NA Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.5 4.3 0.0 1.6 0.0 0.0 2.5 0.0 0.0 7.7 2.1 0.0 45.4 0.0 2.1 39.2 0.0 0.9 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.2 8.2 1.9 0.8 0.0 0.1 34.6 0.2 0.4 4.0 1.1 49.3 0.0 4.3 2.8 0.0 0.1 0.1 0.0 0.0 5.0 6.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 3.3 0.0 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 20.9 3.3 0.4 0.0 0.0 0.0 0.0 9.4 21.6 0.5 0.0 0.0 0.2 0.0 3.1 0.6 0.0 0.0 0.0 0.4 1.4 0.1 6.2 0.0 11.0 0.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 0.0 23.0 0.6 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 5.2 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 83.7 0.0 0.0 61.3 0.0 0.1 0.5 1.3 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.2 0.0 42.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.3 0.5 9.6 0.0 0.0 0.0 4.1 0.0 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621159-48626356 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 55.8;Distal tubular cells: 33.2;Intestinal endocrine cells: 169.5;Mucus-secreting cells: 37.2;Undifferentiated cells: 43.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 79.2;HEK 293: 30.5;HMC-1: 31.3;K-562: 33.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA004928 Supported Nucleoplasm NA No Nucleoplasm "HPA004928: " "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavorable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.5 0.8 0.1 1.9 0.2 0.0 0.4 0.1 0.3 5.3 16.6 0.1 27.3 0.0 1.4 42.8 0.1 0.4 0.1 0.1 0.1 0.1 15.3 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.5 0.2 1.1 10.4 0.1 0.1 23.5 0.2 0.2 11.3 1.0 3.5 0.2 0.2 2.0 0.1 0.1 0.1 0.1 0.1 2.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.1 1.4 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 1.7 0.0 8.5 0.2 0.9 0.0 1.3 0.0 0.0 79.2 30.5 13.8 0.5 0.0 0.5 0.2 31.3 0.0 0.0 0.0 0.8 2.4 0.0 0.6 33.6 0.0 1.3 0.0 0.0 0.1 0.0 1.8 1.3 0.0 5.3 0.4 13.8 0.0 0.0 0.0 1.0 0.0 8.7 0.1 0.1 0.0 0.1 0.0 7.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 55.8 0.0 0.0 33.2 0.0 0.1 0.2 12.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 169.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 37.2 0.0 0.1 11.5 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 43.2 0.1 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 16.2;skeletal muscle: 53.2" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 18.8;Distal tubular cells: 53.0;Proximal tubular cells: 81.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 78.1;ASC diff: 23.1;ASC TERT1: 21.3;fHDF/TERT166: 17.9;T-47d: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053919: AB_2682308" "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 8.0 0.7 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.5 0.3 0.0 0.4 0.0 1.6 6.8 0.1 2.5 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 1.3 53.2 6.8 0.8 0.5 0.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 78.1 23.1 21.3 0.1 2.7 6.5 3.7 3.5 0.1 0.2 0.1 0.7 17.9 0.5 8.4 1.1 0.0 1.8 3.9 1.5 0.7 9.7 0.0 0.1 0.0 1.0 10.0 0.1 0.2 0.0 0.0 0.0 2.2 0.6 0.0 2.5 0.4 0.0 1.9 0.0 9.5 0.3 0.0 0.1 0.0 8.2 0.0 0.0 1.0 1.8 2.7 4.0 0.1 26.6 0.5 0.0 2.2 2.8 0.0 3.4 0.3 0.0 0.0 0.0 0.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.3 0.0 0.0 0.0 15.7 0.0 0.0 53.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.7 81.2 0.0 0.0 0.1 3.0 4.5 16.8 0.1 0.0 0.0 0.0 HPN TMPRSS1 ENSG00000105707 Hepsin P05981 19 35040506-35066571 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 55.4;liver: 146.5;pancreas: 80.1" "Group enriched" "Detected in many" 7 "Hepatocytes: 406.8;Proximal tubular cells: 178.8" "Cancer enhanced" "Detected in many" "liver cancer: 127.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Group enriched" "Detected in some" 9 "EFO-21: 19.8;Hep G2: 28.1;T-47d: 13.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006804 Approved NA NA 1000000 "HPA006804: AB_1079046" "unprognostic (6.74e-3)" "unprognostic (6.00e-2)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (9.96e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.13e-3)" "unprognostic (9.54e-2)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" "prognostic favorable (5.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (7.96e-2)" 0.2 0.0 0.3 0.1 0.5 0.0 3.2 0.4 1.1 0.3 0.3 0.2 8.4 0.2 1.1 10.7 0.1 1.9 3.2 0.7 0.6 0.3 55.4 146.5 4.9 0.1 0.9 0.2 0.4 80.1 2.6 3.2 0.2 0.4 5.3 0.0 0.4 4.1 8.5 8.5 0.0 0.2 0.1 0.9 0.3 6.9 0.8 0.3 0.1 4.3 0.4 0.2 0.3 0.1 0.2 0.2 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.1 0.0 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.1 0.3 13.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.6 0.2 0.5 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.4 1.1 0.6 0.3 0.9 0.2 0.4 0.3 8.9 26.7 17.7 4.9 0.1 4.5 2.4 35.7 0.0 2.3 31.4 0.0 0.0 44.7 3.3 7.0 0.3 0.0 0.0 23.6 0.3 0.2 7.9 2.3 406.8 0.8 0.0 2.4 8.0 10.0 20.0 0.0 0.5 0.0 1.0 1.7 1.3 23.4 0.0 0.4 178.8 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.5 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.8;kidney: 119.9;salivary gland: 66.0" "Group enriched" "Detected in many" 5 "Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032443, HPA042186, HPA056385" Enhanced Approved "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favorable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 0.4 1.0 0.6 22.2 2.3 0.0 3.2 2.0 1.7 4.8 42.8 0.3 1.3 9.4 3.8 3.6 2.5 2.4 8.3 0.5 0.5 0.1 119.9 1.2 2.3 0.7 0.3 0.8 4.8 2.1 0.0 0.4 42.3 1.1 3.7 24.5 0.4 66.0 1.4 0.4 13.8 62.8 4.3 0.3 1.5 2.1 1.4 1.3 0.5 3.8 3.3 1.6 1.5 4.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.8 0.3 1.1 0.1 1.3 2.8 0.0 0.0 0.1 0.1 4.5 1.0 0.0 2.1 0.0 0.1 5.8 3.9 0.4 0.0 0.0 1.3 0.0 0.5 4.8 0.4 0.5 0.0 1.3 2.3 0.2 0.0 0.0 0.0 3.5 0.3 0.0 0.0 2.8 0.1 0.1 8.7 21.3 0.7 0.0 0.1 10.2 0.4 10.3 11.4 0.7 0.6 10.2 0.4 1.0 4.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 2.3 2.0 1.7 0.5 0.1 0.3 0.8 1.1 1.3 0.0 0.3 0.0 8.0 1.3 0.0 0.5 33.1 0.0 1.2 181.5 0.0 0.8 38.1 1.7 0.1 0.0 273.5 0.0 2.7 0.7 3.1 15.6 9.2 1.3 1.3 0.0 25.8 1.3 0.0 0.0 23.6 0.0 1.7 0.0 229.5 0.0 0.8 137.2 6.3 14.6 0.0 12.9 0.4 0.2 1.0 3.0 95.8 0.0 114.3 5.7 HSD17B14 "DHRS10, retSDR3, SDR47C1" ENSG00000087076 "Hydroxysteroid 17-beta dehydrogenase 14" Q9BPX1 19 48813017-48836678 "Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 44.3" "Cell type enhanced" "Detected in many" 19 "Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8" "Cell line enhanced" "Detected in many" "GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021467 Approved NA NA "HPA021467: AB_1847652" "unprognostic (2.03e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (4.39e-5)" "unprognostic (4.32e-2)" "unprognostic (8.03e-2)" "unprognostic (1.47e-1)" "unprognostic (7.54e-2)" "unprognostic (7.76e-3)" "unprognostic (2.71e-1)" "unprognostic (4.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (4.56e-1)" "unprognostic (5.50e-3)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (5.51e-2)" "unprognostic (1.81e-2)" 5.9 25.7 15.5 2.9 16.2 1.4 4.2 20.2 14.1 11.5 4.1 9.7 3.7 3.3 13.2 8.1 3.3 8.3 9.2 4.8 10.5 13.5 44.3 24.0 11.6 5.7 11.9 15.8 32.2 6.0 15.3 9.2 6.5 9.8 8.0 2.1 34.4 2.6 8.1 1.3 3.4 3.7 7.3 9.0 6.7 3.2 4.5 7.1 5.0 16.6 3.2 3.5 7.8 8.0 5.9 0.7 0.0 0.0 7.5 4.8 1.3 0.0 6.0 6.0 1.0 7.1 1.1 0.1 1.1 8.3 0.5 0.5 5.5 0.1 3.7 6.2 0.2 23.0 0.0 0.6 0.0 0.6 0.2 0.4 1.6 0.1 0.8 21.7 0.0 9.7 8.4 0.2 0.6 0.2 16.3 7.8 2.1 0.0 24.6 0.0 0.2 0.5 0.2 0.5 3.5 4.1 3.3 0.0 0.7 0.0 17.6 1.6 4.1 0.0 0.8 4.6 2.6 0.2 0.2 0.0 0.1 2.3 0.2 0.0 4.2 7.8 0.2 5.3 0.6 0.0 0.0 0.0 0.0 1.4 0.0 2.1 5.9 2.6 1.1 0.0 4.5 4.8 3.6 0.0 7.5 0.0 0.7 0.7 1.3 15.5 16.2 20.2 12.8 10.5 13.5 11.9 15.8 9.8 7.1 3.0 8.6 1.5 3.1 2.3 5.0 1.4 0.0 0.0 3.4 7.0 0.0 1.0 66.3 1.4 0.3 3.6 0.0 0.0 1.0 2.1 11.5 3.7 6.9 26.6 120.5 11.1 12.7 21.5 7.6 0.9 3.7 13.5 20.3 13.6 0.0 38.4 4.0 0.0 6.7 271.8 1.4 0.0 4.1 0.9 7.0 1.6 1.8 2.2 0.0 2.3 IFNA14 "IFN-alphaH, LEIF2H" ENSG00000228083 "Interferon alpha 14" P01570 9 21239002-21239991 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.1;kidney: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "HMC-1: 1.0" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846580-53865800 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.0;liver: 26.6" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002837, HPA005482" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "Mitotic spindle, Centriolar satellite" "HPA002837: , HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 1.1 2.1 13.4 2.2 12.2 0.9 9.2 15.1 14.7 17.1 5.8 6.8 0.0 5.1 5.0 1.3 1.9 3.2 2.4 2.5 17.1 7.4 63.0 26.6 3.5 2.3 11.9 6.4 1.8 5.3 1.4 3.9 1.2 11.2 2.5 6.1 1.9 4.1 1.0 1.4 2.3 5.1 1.2 11.3 1.4 3.4 2.5 15.2 0.0 2.9 0.0 1.0 1.7 1.0 0.9 1.1 4.1 0.6 0.5 3.1 0.5 0.8 1.7 2.5 1.9 0.0 0.0 4.0 1.7 0.0 0.0 0.0 11.1 0.8 2.5 0.6 0.5 0.9 0.4 6.8 0.0 0.0 0.9 1.9 3.3 3.4 32.2 0.0 3.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.9 2.6 1.2 0.0 2.2 0.5 1.2 6.8 25.2 1.4 0.9 1.0 2.9 0.7 2.9 3.6 2.1 5.6 1.3 1.0 1.9 5.2 1.1 1.3 1.7 1.9 1.5 2.1 2.6 2.9 1.6 1.5 1.8 0.9 4.1 0.6 0.2 1.0 0.6 0.6 0.5 2.1 0.6 0.2 0.9 0.8 0.9 0.3 0.5 0.2 1.1 3.1 0.5 13.4 12.2 15.1 14.7 17.1 7.4 11.9 6.4 11.2 15.2 0.0 2.6 0.0 2.0 0.2 0.0 3.4 10.2 0.0 2.3 0.0 0.0 0.3 8.3 3.7 0.8 0.0 1.3 0.0 1.3 0.9 0.2 6.7 2.3 8.9 0.1 0.0 28.0 0.6 0.0 0.0 1.1 0.8 0.0 0.0 4.3 4.5 2.7 2.0 0.4 57.9 0.0 0.0 0.6 0.4 1.3 0.1 0.3 0.0 6.6 0.5 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Cell type enriched" "Detected in many" 11 "granulocytes: 477.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Group enriched" "Detected in some" 6 "HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 3.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.7 0.1 0.1 55.4 0.4 82.4 1.1 0.3 1.3 8.9 0.1 40.2 0.0 0.2 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 8.9 22.8 0.0 15.1 7.6 0.0 1.8 0.0 12.0 13.6 1.8 0.0 0.0 0.0 0.0 0.2 29.2 0.0 0.0 0.4 0.1 4.2 8.9 477.2 0.0 0.0 0.0 0.0 44.2 0.3 0.9 0.9 11.2 3.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.2 38.8 5.2 0.0 0.0 4.4 0.0 4.3 0.0 11.1 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859018 "Enzymes, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.5;brain: 5.9;kidney: 8.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 1.3;Cardiomyocytes: 1.7;Early spermatids: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 5.5;SH-SY5Y: 19.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA025285 Uncertain NA NA "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.9 5.5 0.0 0.3 5.9 0.1 0.8 1.9 1.4 1.9 0.1 0.0 0.0 0.1 2.7 0.1 0.1 0.6 0.3 1.9 0.5 1.3 8.3 0.1 0.1 0.4 0.8 0.6 0.3 0.9 0.1 1.7 0.4 5.6 2.7 0.1 2.1 0.6 0.5 0.4 0.1 0.2 0.3 0.0 0.2 3.0 4.2 0.4 0.3 0.3 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 19.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.9 1.4 0.5 1.3 0.8 0.6 5.6 0.4 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 KAAG1 "RU2, RU2AS" ENSG00000146049 "Kidney associated antigen 1" Q9UBP8 6 24356903-24358284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.1;pancreas: 4.3" "Cell type enhanced" "Detected in single" 15 "Spermatocytes: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 8.7;EFO-21: 7.0;Hep G2: 8.5" HPA036021 Approved NA NA "HPA036021: AB_10601918" "unprognostic (7.57e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.65e-1)" "unprognostic (3.32e-2)" "unprognostic (3.58e-2)" "unprognostic (3.05e-1)" "unprognostic (3.05e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (2.23e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.4 0.0 0.0 0.0 9.1 1.3 0.0 0.0 0.0 0.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 KCNE1B ENSG00000276289 "Potassium voltage-gated channel subfamily E regulatory subunit 1B" A0A087WTH5 21 7816675-7829926 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8" "Cell type enriched" "Detected in single" 5 "Ciliated cells: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.0;eosinophil: 4.0" "Group enriched" "Detected in many" 17 "granulocytes: 4.0;monocytes: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;SK-MEL-30: 2.4;SuSa: 3.9" NA NA "unprognostic (5.41e-4)" "unprognostic (8.78e-2)" "unprognostic (7.14e-3)" "unprognostic (1.35e-1)" "unprognostic (3.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.08e-1)" "unprognostic (7.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-3)" "unprognostic (6.59e-2)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 8.3 3.8 0.4 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.0 1.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.7 0.5 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 3.0 1.6 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNH6 "erg2, HERG2, Kv11.2" ENSG00000173826 "Potassium voltage-gated channel subfamily H member 6" Q9H252 17 63523334-63548977 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 10.0;Cardiomyocytes: 19.6;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 33.3;Proximal tubular cells: 15.4" "Cancer enhanced" "Detected in some" "prostate cancer: 5.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "SCLC-21H: 8.7;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 4.7;pons and medulla: 1.4" HPA061704 Approved NA NA "HPA061704: " "unprognostic (8.00e-2)" "unprognostic (1.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.68e-2)" "unprognostic (5.98e-5)" "unprognostic (3.39e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-1)" "unprognostic (1.28e-2)" "unprognostic (3.25e-1)" "unprognostic (1.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.19e-1)" "unprognostic (9.80e-2)" "unprognostic (3.66e-1)" "unprognostic (8.05e-2)" "unprognostic (9.15e-2)" 0.0 0.2 0.3 0.7 1.1 0.3 0.0 0.1 1.2 0.0 4.2 0.0 0.0 3.9 0.0 0.5 0.0 0.3 0.1 0.6 0.3 2.8 15.4 0.0 0.9 0.1 1.1 0.5 0.1 2.4 0.1 7.6 0.6 1.0 6.2 0.4 7.6 0.1 0.0 0.2 0.3 8.7 0.0 0.7 0.1 1.7 1.4 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.8 0.4 1.7 0.5 0.7 0.5 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.7 0.0 0.2 0.1 0.1 0.0 0.0 0.3 8.7 3.3 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.3 1.0 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 1.2 0.5 0.4 0.4 0.3 0.1 0.6 0.2 0.2 0.2 0.8 0.5 0.4 1.7 0.7 0.3 0.4 0.2 0.4 0.3 1.1 0.1 1.2 0.3 2.8 1.1 0.5 1.0 0.3 0.0 0.0 0.0 0.2 0.2 10.0 19.6 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 33.3 0.0 0.0 2.0 0.0 0.0 1.7 0.0 1.6 0.5 0.1 0.0 0.0 15.4 2.7 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium voltage-gated channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "kidney: 123.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 165.8" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Region enriched" "Detected in single" 4 "basal ganglia: 2.3" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "RPTEC TERT1: 51.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced NA NA "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.1 0.0 0.5 0.2 2.3 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 123.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 36.6 0.0 0.0 165.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KCNJ10 "Kir1.2, Kir4.1" ENSG00000177807 "Potassium voltage-gated channel subfamily J member 10" P78508 1 159998651-160070483 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Deafness, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.1;kidney: 28.1" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 83.5" "Cancer enriched" "Detected in some" 6 "glioma: 27.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 6 "NK-cells: 1.7;T-cells: 2.5" "Cell line enhanced" "Detected in some" "Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078302 Enhanced NA NA "HPA078302: AB_2732378" "unprognostic (2.64e-2)" "unprognostic (3.54e-3)" "unprognostic (6.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (6.98e-4)" "unprognostic (1.96e-1)" "unprognostic (7.13e-2)" "unprognostic (3.43e-1)" "unprognostic (1.28e-3)" "unprognostic (5.80e-4)" "unprognostic (9.52e-2)" "unprognostic (2.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "unprognostic (6.70e-3)" 1.4 1.5 23.6 3.0 28.1 1.3 1.3 10.5 74.1 1.4 1.7 37.9 0.0 1.5 1.3 1.3 1.4 1.3 1.3 1.3 21.8 13.2 28.1 3.1 1.3 7.1 28.1 15.1 1.3 1.3 1.3 0.3 1.3 25.5 1.3 1.5 0.5 1.5 1.5 1.2 1.6 1.7 1.3 42.9 10.3 2.0 1.8 25.5 0.0 1.5 0.0 2.9 1.5 0.1 0.0 0.0 0.0 0.3 1.7 2.5 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.2 1.7 0.2 0.0 1.1 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.1 11.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 2.2 0.1 0.0 0.0 0.2 0.4 0.0 0.3 3.7 1.0 0.1 0.5 0.1 0.1 0.3 0.9 0.0 3.8 1.7 0.0 0.2 0.2 1.8 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 0.0 1.7 0.3 0.0 2.5 0.2 23.6 28.1 10.5 22.2 21.8 13.2 28.1 15.1 25.5 25.5 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 3.5 3.9 0.0 10.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 1.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favorable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favorable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.1 26.1 0.2 0.3 1.7 0.0 0.0 0.0 0.2 0.1 0.0 2.7 37.4 8.8 0.0 25.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 7.7 2.5 6.5 1.4 0.5 1.2 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 25.0 29.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.6 0.1 0.0 2.1 1.5 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 56.6 153.4 0.8 8.5 2.5 0.0 1.2 63.7 9.4 52.4 29.6 0.0 0.1 14.9 23.3 1.4 1.4 0.0 0.0 7.8 0.4 0.8 0.4 5.8 0.0 0.3 0.0 0.0 1.3 5.1 1.9 0.6 2.6 1.7 0.0 0.0 0.0 26.3 0.0 0.0 211.6 0.0 0.0 1.0 0.9 1.0 1.4 0.1 0.0 0.0 4.1 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium voltage-gated channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4" "Cell type enhanced" "Detected in some" 27 "Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.4 0.3 4.1 0.3 4.4 0.4 1.5 22.6 6.1 0.3 0.4 1.7 12.6 0.4 0.4 6.4 0.3 2.0 6.5 0.4 6.0 7.2 96.5 0.9 0.5 0.4 8.3 3.4 0.4 15.8 59.4 0.8 0.5 25.5 1.0 0.3 0.0 4.1 14.3 0.4 0.5 1.2 0.2 7.5 1.1 7.4 0.8 5.3 0.0 60.4 0.0 0.2 0.3 0.3 1.1 0.5 5.1 0.2 0.9 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 80.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.9 0.1 1.2 1.0 1.0 0.5 0.1 1.1 0.7 0.6 5.1 0.9 0.1 0.5 1.1 0.3 4.1 4.4 22.6 6.1 6.0 7.2 8.3 3.4 25.5 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 43.3 17.4 4.5 232.1 0.0 0.0 34.9 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 89.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059148 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059148: AB_2683929" "unprognostic (1.46e-1)" "prognostic favorable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favorable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favorable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 0.4 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 0.0 4.3 18.0 0.0 0.0 6.1 8.7 4.3 7.9 14.7 0.0 0.0 0.8 7.3 3.0 2.9 1.0 0.8 3.1 4.0 0.0 1.7 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 0.0 19.2 0.0 1.8 3.3 0.0 0.4 43.3 0.0 6.8 1.8 0.0 22.6 5.0 13.0 0.0 0.2 50.9 0.0 10.8 3.9 1.9 1.8 0.0 23.1 1.8 0.0 0.0 0.0 0.3 0.0 0.6 0.7 1.7 1.0 10.8 0.0 7.5 10.5 0.0 29.1 0.0 0.0 0.4 0.0 0.7 2.4 38.1 1.0 6.4 10.7 KCP "CRIM2, FLJ33365, NET67" ENSG00000135253 "Kielin/chordin-like protein" 7 128862451-128910719 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 50.6;Early spermatids: 18.3;Late spermatids: 21.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.7;HMC-1: 7.7;U-87 MG: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (6.12e-2)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (6.33e-3)" "unprognostic (2.14e-1)" "unprognostic (5.24e-3)" "unprognostic (2.01e-3)" "unprognostic (3.25e-3)" "unprognostic (9.59e-2)" "unprognostic (1.52e-1)" "unprognostic (2.20e-3)" "unprognostic (6.46e-2)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.84e-2)" "unprognostic (7.64e-3)" 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 30.0 0.9 0.1 1.7 0.4 0.6 2.1 0.3 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.1 0.1 28.3 0.0 0.0 2.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 13.7 0.2 2.1 0.0 0.3 1.0 0.0 0.0 0.0 1.9 0.1 1.0 0.0 1.2 0.2 0.0 7.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.1 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.9 0.4 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 4.3 0.8 1.1 0.0 2.5 0.8 0.0 0.0 6.8 50.6 2.0 0.2 0.0 0.2 18.3 0.3 5.9 0.0 0.2 1.0 1.1 0.3 2.3 0.2 1.0 3.2 2.4 2.5 2.2 21.8 1.1 2.3 0.0 0.0 3.1 0.2 2.5 1.9 0.4 2.9 1.0 0.0 0.0 5.1 2.4 0.0 1.1 1.9 6.4 3.6 KHK ENSG00000138030 Ketohexokinase P50053 2 27086747-27100772 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 60.2;kidney: 38.4;liver: 67.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 359.6;Proximal tubular cells: 948.1" "Group enriched" "Detected in all" 7 "liver cancer: 62.2;renal cancer: 32.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.6;Hep G2: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007040 Enhanced Approved Cytosol NA NA 320000 Cytosol "HPA007040: AB_1079185" "unprognostic (8.44e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.62e-8)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "unprognostic (3.08e-2)" "unprognostic (3.13e-2)" "unprognostic (1.67e-2)" "unprognostic (2.50e-2)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (1.68e-2)" "unprognostic (2.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.44e-1)" "unprognostic (1.02e-2)" 0.9 1.9 2.1 1.2 2.7 0.7 1.9 5.2 3.9 1.1 22.3 1.9 0.2 40.0 1.5 0.9 1.1 1.6 0.6 0.6 2.2 2.2 38.4 67.0 0.7 0.8 3.5 1.9 1.8 4.2 0.6 0.7 0.4 3.0 0.9 0.6 0.6 1.7 0.7 1.4 1.0 60.2 0.9 1.8 0.8 1.0 1.6 3.6 0.0 0.5 1.2 0.6 0.7 0.9 5.1 7.3 0.6 6.6 5.4 8.8 6.0 14.0 10.7 1.7 6.4 1.2 0.3 1.4 1.0 0.6 1.3 0.8 5.1 3.1 2.1 3.4 0.0 1.5 6.2 5.5 1.8 0.4 5.0 10.1 18.6 2.8 27.1 0.6 2.5 2.2 0.1 0.8 1.6 0.1 0.7 1.2 3.0 3.3 3.6 0.1 9.1 3.0 2.0 2.3 12.7 4.2 10.7 0.8 11.8 1.6 1.7 6.0 9.4 2.1 3.6 4.0 0.6 1.6 1.1 1.1 0.4 2.1 0.9 3.7 4.4 7.9 3.6 1.8 6.1 1.0 0.0 6.6 0.4 5.4 3.8 7.4 5.1 8.8 7.8 6.1 5.1 6.4 7.8 0.6 5.4 1.6 7.3 5.5 6.0 2.1 2.7 5.2 3.9 2.2 2.2 3.5 1.9 3.0 3.6 3.0 5.9 9.6 2.3 3.2 3.6 1.9 15.3 0.0 1.2 38.4 2.0 2.6 109.5 3.1 0.8 5.8 12.3 0.0 2.6 3.6 1.9 0.9 4.6 359.6 7.5 6.4 5.8 6.7 13.2 3.6 1.7 5.8 8.5 1.0 5.9 8.5 2.7 1.7 1.4 948.1 5.2 0.0 4.5 0.9 6.8 5.9 7.9 4.6 14.3 1.0 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.1;kidney: 51.5;pancreas: 42.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 101.9;Collecting duct cells: 85.5;Distal tubular cells: 68.0;Intestinal endocrine cells: 61.7;Proximal tubular cells: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.5;OE19: 11.2;RPTEC TERT1: 30.9;SCLC-21H: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA020192, HPA024127" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.4 0.0 0.8 0.8 1.2 0.0 9.1 0.8 0.6 3.3 5.8 0.4 3.3 11.8 4.7 18.0 0.5 3.8 33.1 0.4 0.4 0.2 51.5 9.8 1.0 0.4 0.4 0.5 1.1 42.1 0.0 0.6 1.3 0.4 2.4 1.7 0.8 1.8 4.2 0.4 0.4 7.3 0.4 0.4 0.4 5.5 1.5 0.4 1.0 11.6 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 3.6 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.1 11.2 0.4 0.0 0.0 0.0 30.9 0.1 4.5 0.1 0.0 0.6 0.0 0.1 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.8 0.6 0.4 0.2 0.4 0.5 0.4 0.4 0.0 4.1 0.8 0.8 0.0 0.0 0.4 101.9 0.0 0.0 85.5 0.0 0.1 68.0 28.9 5.4 0.0 7.1 0.0 10.4 6.4 0.2 2.2 0.0 7.4 0.3 0.0 61.7 0.0 0.0 9.5 0.6 0.0 0.0 1.8 22.5 0.0 8.1 20.9 0.0 57.8 0.0 0.0 0.0 1.5 4.5 0.0 0.5 0.0 23.4 0.1 KL ENSG00000133116 Klotho Q9UEF7 13 33016433-33066145 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 99.7" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Region enhanced" "Detected in some" "pons and medulla: 11.6" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HMC-1: 5.1;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 510000 "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favorable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favorable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 4.8 0.6 0.8 0.9 4.3 0.1 7.4 0.0 0.8 0.7 2.1 3.3 0.2 1.0 1.0 3.2 0.8 0.7 0.9 0.9 2.4 0.8 64.3 0.2 10.4 0.9 0.5 0.3 0.4 1.6 76.9 0.3 25.5 11.6 3.3 0.4 0.3 0.7 1.0 0.9 0.4 3.2 0.7 0.4 3.1 1.9 0.6 0.3 0.0 1.4 1.3 0.3 1.5 1.1 0.0 0.0 0.0 1.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 4.3 0.0 0.8 2.4 0.8 0.5 0.3 11.6 0.3 0.0 0.3 0.0 0.1 0.1 0.0 0.8 0.0 1.4 1.2 12.2 0.0 0.1 5.0 0.0 1.7 1.8 0.9 0.0 0.0 0.1 0.7 4.4 0.0 0.0 2.1 0.0 15.6 0.0 0.8 0.0 0.3 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.4 99.7 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.0 0.6 0.1 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480982-18486126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 36.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056616: AB_2683193" "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favorable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.88e-4)" 0.6 0.0 0.0 0.3 0.2 0.0 5.0 0.5 0.5 2.5 0.6 0.7 2.6 0.3 0.0 2.6 1.8 0.8 7.4 0.3 0.0 0.0 36.4 6.9 1.4 0.0 0.1 0.6 0.2 5.7 0.0 0.3 0.3 2.9 0.5 0.7 2.8 2.2 1.2 0.0 0.1 0.4 1.0 0.1 0.0 4.8 0.2 0.0 0.0 1.6 0.3 0.8 5.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 5.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.1 10.4 0.0 5.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.2 0.0 0.0 11.9 9.4 2.9 0.0 0.0 0.8 0.0 1.1 10.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.5 0.0 0.0 0.1 0.6 2.9 0.0 0.0 2.7 0.0 0.1 0.1 0.0 1.2 7.6 6.7 1.2 8.7 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50548033-50551022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.4;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 5 "monocytes: 30.7" "Cancer enhanced" "Detected in many" "cervical cancer: 42.3;urothelial cancer: 40.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favorable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.4 0.4 0.3 3.9 1.2 1.2 0.7 0.3 1.5 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.2 0.3 0.3 0.3 0.1 8.4 1.1 1.1 4.0 0.3 0.3 0.8 0.3 12.5 2.2 0.3 0.9 0.7 0.0 0.8 3.0 0.3 0.3 0.3 2.0 0.3 0.3 5.4 0.5 0.3 0.3 6.5 2.9 0.3 1.7 3.0 0.3 3.8 2.0 2.4 4.0 1.4 5.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.1 47.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.4 2.2 0.2 4.5 4.0 3.3 3.8 4.7 5.7 2.0 3.1 5.2 4.3 0.4 1.4 2.8 0.7 4.1 2.5 0.3 1.2 0.3 1.5 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.1 3.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 5.7 0.0 1.6 0.0 0.0 0.0 4.7 0.0 0.0 1.7 0.0 30.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.4 0.0 0.1 KRTAP5-8 "KRTAP5-2, KRTAP5.8, UHSKerB" ENSG00000241233 "Keratin associated protein 5-8" O75690 11 71538025-71539207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "epididymis: 3.4;kidney: 7.1;skin 1: 8.7;testis: 2.7" "Cell type enriched" "Detected in single" 8 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;RT4: 4.2" NA NA "unprognostic (9.72e-2)" "unprognostic (8.49e-2)" "unprognostic (9.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-2)" "unprognostic (1.99e-1)" "unprognostic (6.92e-2)" "unprognostic (2.89e-2)" "unprognostic (2.42e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (2.21e-3)" 0.0 0.1 0.2 0.1 0.6 0.0 0.3 0.3 0.4 0.0 0.2 0.3 0.0 3.4 0.0 0.1 0.2 0.0 0.2 0.3 7.1 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.4 8.7 0.4 0.0 0.1 0.1 0.0 2.7 0.1 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.7 0.5 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669174 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.1;liver: 58.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 194.5;Proximal tubular cells: 262.2;Spermatocytes: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 99.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 24000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 9.3 31.4 6.8 6.7 10.0 1.2 8.9 2.0 7.1 5.5 13.5 9.0 5.3 17.8 5.7 8.3 7.6 5.2 14.6 19.3 7.2 7.2 70.1 58.8 9.7 8.9 11.5 7.5 5.5 10.6 6.2 12.6 6.3 10.1 7.5 10.0 6.2 7.8 8.6 12.0 6.1 19.1 7.2 11.6 8.0 7.7 45.7 11.7 6.0 9.8 10.9 5.9 8.2 7.4 14.0 18.2 13.4 17.3 11.0 13.8 6.4 14.3 15.0 4.7 1.9 8.3 12.7 2.9 8.0 4.7 8.7 6.6 7.1 16.2 0.0 3.3 3.9 17.5 10.3 5.7 8.5 6.9 8.6 6.4 6.7 2.0 3.9 17.4 6.5 5.8 15.3 10.4 4.3 6.5 4.1 2.2 5.3 11.6 13.6 11.4 4.3 3.7 1.2 5.1 19.4 14.2 3.3 2.8 3.0 33.2 7.6 6.8 2.4 17.9 99.3 8.9 6.4 16.6 8.8 3.6 0.6 4.8 15.4 6.5 11.1 8.3 0.0 4.9 11.2 6.4 11.1 15.2 13.4 9.9 17.3 12.5 14.0 10.4 9.7 18.2 13.2 10.1 10.6 6.4 11.0 16.4 12.8 13.8 6.4 6.8 10.0 2.0 7.1 7.2 7.2 11.5 7.5 10.1 11.7 53.6 33.1 13.5 17.8 14.5 13.8 31.9 25.5 20.1 30.7 17.4 7.9 19.6 64.6 43.6 194.5 15.3 25.3 0.0 101.8 11.7 10.3 12.0 9.2 70.0 40.7 7.9 11.6 22.1 31.8 14.1 19.0 23.7 15.1 11.8 21.3 33.2 68.2 19.2 14.2 262.2 14.8 6.5 11.3 198.5 24.5 14.6 16.2 23.0 26.4 8.1 LDHB ENSG00000111716 "Lactate dehydrogenase B" P07195 12 21635342-21757857 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 255.8;kidney: 233.1" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 145.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004641, HPA019007" Enhanced Supported Cytosol No No 780000000 Cytosol "CAB004641: AB_425525, HPA019007: AB_2670008" "unprognostic (2.93e-1)" "unprognostic (9.20e-3)" "unprognostic (6.10e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-3)" "unprognostic (1.36e-3)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (5.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.91e-1)" "unprognostic (6.41e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (2.55e-1)" "unprognostic (9.32e-2)" 70.9 60.2 79.5 33.3 79.6 40.8 33.4 52.4 80.1 24.9 31.8 30.6 13.2 11.8 38.7 27.3 25.6 34.4 32.3 255.8 58.8 69.9 233.1 9.8 27.7 52.3 91.6 62.3 68.0 54.8 41.8 19.4 40.1 84.9 34.9 39.4 26.8 21.8 42.2 29.7 8.6 18.0 42.9 52.9 23.8 47.5 16.4 47.6 59.1 48.5 56.3 58.7 49.7 21.8 28.1 32.9 33.0 15.3 33.7 145.1 93.2 32.6 87.5 77.0 50.6 55.2 61.5 89.5 45.6 45.6 63.8 63.2 138.5 0.1 115.5 29.9 30.7 62.2 16.4 105.9 84.5 81.3 29.6 73.7 118.8 83.7 0.1 52.8 110.9 51.4 70.3 30.3 55.9 76.1 75.5 72.7 83.7 64.9 17.4 70.1 0.1 94.2 134.3 222.1 53.5 38.0 85.1 107.5 93.1 316.6 145.6 24.8 57.4 20.9 32.5 78.6 213.4 0.2 87.0 28.3 43.0 56.4 30.5 85.8 15.4 20.8 151.7 47.6 53.2 51.0 33.0 15.3 1.8 28.5 9.4 47.5 28.1 110.7 59.4 28.3 17.7 145.1 92.2 2.5 33.7 6.7 32.9 105.4 93.2 79.5 79.6 52.4 80.1 58.8 69.9 91.6 62.3 84.9 47.6 131.0 259.8 264.1 356.5 64.9 144.4 2212.6 252.3 329.2 235.4 450.1 64.8 1548.4 2801.9 8.8 8.2 201.1 10.6 163.5 278.5 675.2 313.9 183.2 261.1 6.8 514.5 133.5 88.8 124.0 155.9 19.6 254.3 185.3 170.4 154.1 114.8 173.5 149.2 14.4 390.3 2766.7 85.3 232.8 418.6 17.7 95.7 56.1 1371.1 274.1 316.8 307.0 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570246-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5" "Group enriched" "Detected in many" 51 "dendritic cells: 100.5;monocytes: 129.0" "Group enriched" "Detected in some" 4 "CACO-2: 46.8;Hep G2: 26.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.1 0.4 0.6 4.3 0.5 1.8 0.6 0.4 0.5 0.5 12.6 0.5 0.4 6.1 1.0 1.9 0.8 0.6 91.7 0.7 0.4 0.4 35.3 1.0 2.3 7.9 0.5 0.4 0.6 87.3 0.0 0.4 0.9 0.5 0.5 13.0 0.5 1.8 0.4 0.4 0.9 43.0 0.4 0.5 8.3 1.5 0.6 0.4 4.5 0.5 1.0 9.6 0.7 0.6 0.6 100.5 2.2 129.0 0.1 0.2 70.1 1.1 0.6 0.4 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.0 46.8 0.0 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.4 0.2 9.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.7 0.8 1.1 0.2 0.7 0.7 2.7 0.9 0.4 1.9 0.3 0.0 0.1 0.1 1.2 0.0 0.5 0.6 129.0 0.6 0.1 47.0 0.2 0.6 0.1 0.2 100.5 0.2 0.2 0.1 2.2 0.1 2.9 0.8 0.2 70.1 0.6 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.4 6.0 4.6 32.7 0.1 15.1 0.0 0.1 800.0 1.4 2.3 27.9 0.0 0.1 107.8 20.9 0.0 0.1 838.5 0.0 175.0 0.2 3.5 0.1 2.3 0.6 27.7 0.0 70.9 0.6 23.7 0.0 0.6 71.1 23.6 13.6 374.8 0.0 476.7 354.2 0.0 1320.5 0.0 0.0 6.2 0.0 0.2 10.8 0.2 2.5 571.4 0.1 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.2;liver: 9.3" "Cell type enhanced" "Detected in some" 9 "Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "lung cancer: 2.2" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 5.2 9.3 0.7 0.2 0.4 0.2 0.2 0.5 0.0 0.2 2.3 2.9 0.5 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 1.6 0.3 0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.0 3.4 0.7 0.3 0.5 0.1 0.1 10.6 0.1 0.1 0.0 0.0 5.7 0.1 0.1 0.0 0.0 3.4 0.1 0.1 0.0 0.0 0.3 0.1 0.6 0.4 0.0 0.0 0.0 0.1 3.9 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.6 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.1 1.9 0.1 0.4 0.1 0.1 0.4 0.1 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 1.6 0.7 0.3 0.5 0.3 0.2 0.7 0.5 0.3 0.1 0.7 0.4 0.5 3.4 0.3 0.3 1.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.2 2.9 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 4.0 3.4 0.0 0.0 1.7 1.7 0.0 0.8 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.3 2.2 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.5 0.0 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 341.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 1.7 0.0 0.0 0.9 1.2 0.0 0.3 0.0 0.0 0.0 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Cell type enhanced" "Detected in many" 23 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 21.9;CACO-2: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria No NA "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: AB_2685353" "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 6.0 39.5 0.0 0.1 0.2 1.9 1.7 2.5 4.0 4.5 3.5 82.5 52.4 14.9 0.0 1.4 0.0 0.0 0.0 0.0 1.9 0.8 0.0 2.3 0.0 4.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 250.3 18.0 0.0 0.0 0.0 0.5 0.0 19.3 0.0 0.0 0.1 LRRC19 FLJ21302 ENSG00000184434 "Leucine rich repeat containing 19" Q9H756 9 26993136-27005693 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 61.3;kidney: 50.0" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 22.7;Enterocytes: 78.3;Paneth cells: 39.5;Proximal tubular cells: 50.0;Undifferentiated cells: 24.0" "Group enriched" "Detected in some" 5 "colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 2.4;RPTEC TERT1: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 96000 "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (6.30e-2)" "unprognostic (5.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (4.16e-2)" "unprognostic (9.21e-5)" "unprognostic (1.87e-2)" "unprognostic (4.48e-2)" "prognostic favorable (7.08e-8)" "unprognostic (2.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" 0.2 0.2 0.2 5.9 0.2 0.0 0.2 0.2 0.2 0.2 23.4 0.1 0.1 11.9 0.2 1.3 0.2 0.2 2.9 0.1 0.2 0.2 50.0 0.8 0.2 0.1 0.2 0.1 0.2 0.6 0.0 0.2 0.1 0.1 0.2 17.0 0.1 0.2 0.1 0.1 0.2 61.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.2 2.0 0.9 1.1 0.7 0.4 0.8 0.0 2.4 0.6 0.3 0.4 0.0 0.4 0.9 0.7 0.0 0.0 0.0 0.6 0.3 0.3 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.6 1.0 0.5 0.0 0.6 0.8 0.1 0.5 0.0 0.3 1.0 0.0 0.2 0.3 1.0 0.0 0.3 0.5 1.5 1.7 0.3 1.1 0.5 0.5 0.6 4.2 0.4 0.6 0.3 1.7 0.3 0.1 0.6 0.3 0.5 1.2 0.8 0.4 1.6 0.5 0.3 0.3 0.1 0.2 0.6 0.2 1.0 0.7 0.6 0.5 0.6 0.4 0.6 0.8 0.4 0.5 2.0 0.8 0.7 1.1 0.4 0.6 0.9 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.4 20.4 0.0 0.0 22.7 0.0 0.0 8.3 0.1 0.0 0.0 78.3 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.1 0.1 39.5 0.4 50.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LYG1 SALW1939 ENSG00000144214 "Lysozyme g1" Q8N1E2 2 99284238-99304742 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "kidney: 22.5" "Group enriched" "Detected in some" 6 "Distal tubular cells: 18.3;Proximal tubular cells: 70.3" "Cancer enriched" "Detected in many" 15 "renal cancer: 31.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted - unknown location" NA NA "unprognostic (1.53e-2)" "unprognostic (3.13e-2)" "unprognostic (1.53e-2)" "unprognostic (3.73e-1)" "unprognostic (9.74e-2)" "unprognostic (3.76e-4)" "unprognostic (6.94e-4)" "unprognostic (2.58e-2)" "unprognostic (4.72e-2)" "unprognostic (9.74e-3)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.58e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-3)" 1.0 0.4 1.0 1.1 1.0 0.7 2.1 2.3 1.0 1.1 1.0 1.0 1.0 1.2 1.4 1.9 1.0 0.7 1.0 1.0 1.0 0.4 22.5 3.1 1.0 1.5 1.0 1.0 1.1 1.0 0.0 1.0 1.0 1.0 1.6 1.1 1.0 1.0 1.0 2.0 1.5 1.2 1.0 1.0 2.6 0.6 2.9 1.0 1.0 1.2 1.0 1.2 1.0 1.0 1.0 0.4 1.2 0.9 0.0 2.4 0.5 0.5 3.9 3.0 4.9 6.9 4.1 3.4 1.5 1.7 1.6 2.7 0.8 3.5 0.8 2.7 0.7 0.4 1.7 4.0 0.6 1.9 2.7 2.4 2.2 2.9 1.3 1.4 0.8 5.4 3.2 4.3 2.6 1.0 3.6 0.8 5.2 1.2 2.6 1.8 0.8 2.0 6.7 0.7 2.0 3.8 4.9 1.7 1.3 6.9 1.5 1.7 1.0 0.6 1.2 1.1 3.8 0.5 0.7 2.2 2.0 2.5 3.6 1.7 3.0 1.8 0.6 0.6 4.0 1.0 0.0 0.9 1.2 1.5 0.1 1.4 0.2 0.2 0.6 0.4 1.0 1.2 0.7 0.0 0.0 0.0 0.0 2.4 0.5 1.0 1.0 2.3 1.0 1.0 0.4 1.0 1.0 1.0 1.0 0.0 0.0 0.0 0.2 0.0 1.0 0.3 0.0 0.0 2.3 1.8 2.0 0.2 18.3 0.5 7.8 0.3 0.3 0.0 0.2 0.1 0.4 0.5 4.6 0.0 0.3 0.0 0.0 1.3 0.3 3.6 0.3 0.4 0.0 1.0 0.3 0.3 0.6 0.0 0.4 70.3 0.5 0.0 0.4 1.8 0.2 0.0 0.5 0.5 0.2 0.1 MACC1 "7A5, SH3BP4L" ENSG00000183742 "MACC1, MET transcriptional regulator" Q6ZN28 7 20134655-20217404 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.5;kidney: 23.9" "Cell type enhanced" "Detected in many" 11 "Club cells: 103.5;Pancreatic endocrine cells: 96.6;Urothelial cells: 233.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 41.3;CAPAN-2: 9.7;HaCaT: 29.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020081, HPA020103, HPA029476, CAB068194" Supported Approved Mitochondria NA NA Mitochondria "CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136" "unprognostic (1.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.26e-1)" "unprognostic (1.42e-2)" "unprognostic (7.01e-2)" "unprognostic (2.52e-2)" "unprognostic (2.05e-1)" "unprognostic (2.43e-2)" "unprognostic (2.43e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.71e-9)" "unprognostic (4.49e-2)" "unprognostic (2.91e-1)" "unprognostic (1.78e-1)" "unprognostic (6.93e-3)" 4.8 2.6 0.5 5.6 0.4 0.7 4.5 0.4 0.5 8.3 13.7 0.0 4.4 10.1 0.7 6.1 14.1 0.9 9.6 0.5 0.5 0.5 23.9 1.0 13.3 1.1 0.4 0.0 1.3 11.3 0.1 4.0 1.6 0.1 3.9 3.3 0.1 11.4 6.0 0.5 4.5 29.5 0.1 0.8 6.0 5.0 0.8 0.0 1.7 1.5 16.0 13.6 4.0 5.1 2.3 1.0 1.4 1.0 0.8 0.6 0.5 41.3 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 9.2 9.7 5.8 0.4 0.0 0.0 29.1 0.1 0.4 0.0 0.0 0.1 5.5 0.1 0.0 0.0 2.3 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 5.9 2.8 0.0 3.4 0.0 0.5 0.4 8.1 0.0 0.0 0.3 4.4 7.3 2.8 0.1 0.2 0.0 3.3 0.0 0.2 1.7 0.1 0.1 0.1 0.0 0.0 0.1 8.9 0.4 2.2 0.0 0.3 0.0 1.0 0.6 0.3 0.3 0.7 0.6 2.3 0.2 0.5 0.3 2.0 0.3 0.3 1.4 0.8 1.0 1.0 0.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.4 0.0 0.1 0.0 65.5 63.4 1.4 71.9 2.5 2.1 0.6 22.9 58.9 103.5 38.4 2.0 0.5 6.6 49.2 2.2 0.7 25.7 0.0 55.2 0.1 2.3 64.3 11.6 1.0 4.6 1.6 37.1 3.7 2.4 0.8 2.0 4.4 1.7 13.6 15.0 0.5 96.6 14.0 2.5 12.9 1.0 0.0 0.4 0.2 0.4 3.4 0.2 3.9 13.3 233.0 MCCD1 ENSG00000204511 "Mitochondrial coiled-coil domain 1" P59942 6 31528717-31530232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 188 "kidney: 63.6" "Group enriched" "Detected in some" 34 "Distal tubular cells: 339.8;Proximal tubular cells: 251.4" "Cancer enhanced" "Detected in some" "liver cancer: 2.4;renal cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (2.71e-1)" "unprognostic (3.22e-2)" "prognostic favorable (1.73e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 339.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 251.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEI4 ENSG00000269964 "Meiotic double-stranded break formation protein 4" A8MW99 6 77690658-77926974 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 59.5;Late spermatids: 15.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.5;NTERA-2: 1.5;TIME: 2.6;U-266/70: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.47e-1)" "unprognostic (9.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (1.88e-1)" "unprognostic (4.62e-2)" "unprognostic (9.70e-4)" "unprognostic (3.16e-1)" "unprognostic (2.86e-4)" "unprognostic (3.35e-2)" "unprognostic (4.17e-2)" "unprognostic (4.85e-2)" 0.0 1.3 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.0 0.2 0.9 8.5 1.7 0.0 0.0 0.8 0.0 4.1 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 4.7 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.6 0.4 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 3.5 0.0 0.0 0.0 4.3 2.5 0.0 0.0 0.0 0.0 0.0 MFSD4A "DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064" ENSG00000174514 "Major facilitator superfamily domain containing 4A" Q8N468 1 205568885-205602918 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;kidney: 37.6;stomach 1: 60.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.0;Ciliated cells: 5.3;Club cells: 11.4;Collecting duct cells: 8.7;Distal tubular cells: 11.6;Exocrine glandular cells: 5.6;Proximal tubular cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;HAP1: 2.7;HMC-1: 4.6;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0" NA NA "unprognostic (7.15e-4)" "prognostic favorable (7.54e-4)" "unprognostic (5.60e-2)" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic favorable (4.59e-4)" "unprognostic (2.73e-2)" "unprognostic (1.65e-2)" "unprognostic (3.20e-2)" "unprognostic (6.97e-3)" "prognostic favorable (2.27e-13)" "unprognostic (1.58e-1)" "unprognostic (4.44e-2)" "unprognostic (5.75e-3)" "unprognostic (8.78e-2)" 1.7 0.6 17.3 0.8 10.6 0.3 2.1 18.8 24.9 4.9 7.3 1.3 0.0 1.2 0.8 5.2 1.0 1.6 11.1 0.8 11.9 4.3 37.6 0.5 3.8 0.5 3.6 13.3 0.6 1.0 0.4 3.2 3.5 8.4 1.1 9.5 2.4 8.6 0.6 0.6 3.3 1.1 0.7 2.8 0.6 60.0 0.5 0.2 0.0 0.7 0.8 2.8 0.9 0.8 1.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.8 0.0 0.1 2.1 2.7 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.6 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.2 0.5 5.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 17.3 10.6 18.8 24.9 11.9 4.3 3.6 13.3 8.4 0.2 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 11.4 8.7 0.0 0.5 11.6 1.2 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MIOX ALDRL6 ENSG00000100253 "Myo-inositol oxygenase" Q9UGB7 22 50486784-50490648 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "kidney: 136.7" "Cell type enriched" "Detected in some" 5 "Proximal tubular cells: 1814.0" "Cancer enriched" "Detected in many" 16 "renal cancer: 56.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 21.8;Hep G2: 4.9;Karpas-707: 11.6;U-266/70: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039451, HPA039562" Enhanced NA NA "HPA039451: AB_2676513, HPA039562: AB_2676574" "unprognostic (2.11e-1)" "unprognostic (4.32e-2)" "unprognostic (2.22e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (5.25e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-3)" "unprognostic (2.84e-1)" "unprognostic (4.72e-2)" "unprognostic (1.85e-2)" "unprognostic (9.83e-2)" "prognostic favorable (2.60e-6)" "unprognostic (1.77e-1)" "unprognostic (1.50e-1)" "unprognostic (1.36e-2)" "unprognostic (2.23e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 136.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 2.7 0.1 0.1 0.1 0.1 1.3 0.6 3.1 0.7 0.4 1.4 0.4 0.0 0.0 0.1 0.3 0.2 0.1 1.8 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.4 0.0 0.1 0.1 0.0 0.0 21.8 0.0 0.1 0.3 4.9 2.9 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 11.6 0.0 1.1 0.0 0.1 0.2 0.5 0.4 0.1 0.1 0.1 2.3 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.0 1.2 0.0 0.0 0.5 0.1 0.0 7.0 0.6 0.3 0.1 0.0 0.2 3.1 0.4 0.6 0.5 0.3 0.2 1.3 0.5 1.4 0.1 0.9 0.5 0.6 1.8 0.4 0.7 0.6 0.4 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.7 2.4 0.8 0.7 0.5 0.0 0.0 0.0 0.0 94.2 0.0 0.0 359.8 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.1 0.0 1.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1814.0 0.2 0.0 0.2 0.1 0.4 0.1 0.2 0.9 0.0 0.6 MME "CALLA, CD10, NEP" ENSG00000196549 "Membrane metalloendopeptidase" P08473 3 155024124-155183729 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.1;intestine: 136.0;kidney: 64.9" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 62.4;Cytotrophoblasts: 71.6;Proximal tubular cells: 101.6;Syncytiotrophoblasts: 105.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 129 "neutrophil: 61.1" "Lineage enriched" "Detected in single" 129 "granulocytes: 61.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 97.1;BJ hTERT+: 146.1;HSkMC: 94.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 26.8" "CAB000013, HPA052583, HPA056072" Enhanced NA NA 99000 "CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027" "unprognostic (1.36e-1)" "unprognostic (1.02e-3)" "unprognostic (8.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.78e-2)" "unprognostic (6.52e-3)" "unprognostic (1.20e-1)" "unprognostic (1.67e-2)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (7.30e-3)" "unprognostic (1.31e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-1)" "unprognostic (7.29e-2)" "unprognostic (1.06e-2)" "unprognostic (1.37e-2)" 26.5 0.4 0.4 3.4 7.4 1.9 14.7 0.4 0.7 4.8 65.6 0.1 18.4 74.0 2.8 8.1 0.7 0.9 8.5 1.8 0.3 0.4 64.9 11.5 13.7 3.0 2.1 0.2 0.9 0.6 0.0 0.6 35.0 8.6 18.3 0.4 1.3 3.7 11.3 11.7 1.4 136.0 0.6 0.9 2.7 0.7 1.0 1.2 13.2 1.0 5.3 2.3 3.4 4.9 0.1 0.4 61.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 39.4 97.1 0.2 21.7 146.1 11.1 28.7 0.0 0.0 23.9 0.0 19.2 15.1 0.0 0.7 0.8 26.7 0.0 0.1 0.0 0.0 0.0 31.6 0.0 0.0 94.2 0.1 5.9 42.5 12.3 8.4 0.0 0.0 0.0 17.7 0.1 0.0 0.1 0.9 0.0 0.1 39.7 18.7 0.1 0.6 0.2 0.0 0.2 0.0 0.0 4.2 8.9 0.0 0.0 23.8 47.7 0.1 16.3 3.7 0.0 0.0 31.5 5.7 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 61.1 0.0 0.0 0.4 0.0 0.0 0.4 7.4 0.4 0.7 0.3 0.4 2.1 0.2 8.6 1.2 8.9 18.3 0.9 62.4 0.7 0.0 1.1 17.8 2.7 19.4 21.0 0.0 71.6 8.3 0.1 0.3 0.6 0.0 0.0 0.0 48.9 19.2 29.2 2.3 48.9 8.1 0.0 0.0 3.1 1.8 0.2 3.7 2.7 0.0 0.0 0.2 0.0 0.3 0.0 1.1 101.6 0.0 0.0 3.1 0.2 0.4 0.3 105.4 0.0 0.0 29.2 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530753 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3" "Cell type enriched" "Detected in many" 6 "Ductal cells: 5335.6" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 6.8 0.2 0.2 1.2 0.2 0.0 28.8 0.2 0.2 5.2 0.2 0.2 2.1 0.0 17.2 12.3 3.3 16.4 93.0 0.2 0.2 0.2 129.5 1.4 5.0 0.9 0.2 0.2 3.9 23.5 0.0 0.7 2.7 1.3 42.0 0.0 0.2 79.3 6.7 0.2 7.8 0.3 0.5 0.2 0.2 0.9 9.4 0.2 1.2 0.3 1.4 4.5 19.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 129.5 0.0 30.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 80.4 30.5 0.0 310.5 0.9 0.0 0.6 119.8 113.8 646.0 964.8 0.0 0.3 0.0 5335.6 3.9 0.3 0.0 0.0 184.1 0.2 0.4 323.2 2.3 0.0 103.8 0.0 0.0 0.0 0.0 6.5 10.9 7.3 0.0 113.6 0.0 0.0 723.2 0.0 0.0 6.0 0.0 0.0 0.4 0.0 0.1 2.0 0.7 0.0 0.0 640.3 MRO "B29, C18orf3, FLJ30140" ENSG00000134042 Maestro Q9BYG7 18 50795120-50825402 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;kidney: 24.3;testis: 30.9" "Group enriched" "Detected in some" 4 "Ito cells: 55.9;Kupffer cells: 14.2" "Cancer enriched" "Detected in some" 7 "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 4.6;ASC TERT1: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022011 Approved NA NA "HPA022011: AB_2670880" "unprognostic (9.21e-5)" "unprognostic (5.22e-2)" "unprognostic (7.87e-3)" "unprognostic (1.45e-2)" "unprognostic (2.47e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.32e-1)" "unprognostic (4.71e-1)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (3.99e-3)" "unprognostic (6.06e-4)" 2.7 3.2 12.2 0.9 13.9 0.6 1.0 4.5 17.5 0.7 0.7 13.9 1.0 8.3 0.5 4.1 0.9 0.7 1.7 4.4 15.4 5.9 24.3 7.7 0.7 0.7 9.1 10.3 3.8 2.2 3.8 1.3 1.2 11.1 0.7 0.6 1.6 0.7 2.7 2.4 0.5 5.3 0.7 10.7 2.5 1.8 30.9 12.4 0.0 6.6 0.0 0.5 0.8 0.6 0.8 0.9 2.1 1.2 0.5 0.4 0.0 0.0 0.0 0.1 0.3 4.6 14.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.0 0.5 0.2 0.3 0.9 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.1 0.5 1.2 0.9 0.2 0.0 12.2 13.9 4.5 11.2 15.4 5.9 9.1 10.3 11.1 12.4 0.0 0.0 2.2 0.1 0.0 0.0 5.3 2.5 0.0 0.0 0.0 2.0 0.0 5.0 0.0 0.5 0.0 0.0 0.0 0.9 0.6 0.2 0.1 0.0 4.3 8.7 0.0 0.0 55.9 14.2 2.2 1.1 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.7 7.5 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 MT1F MT1 ENSG00000198417 "Metallothionein 1F" P04733 16 56657694-56660698 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 84.1;liver: 98.0;thyroid gland: 152.5" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4487.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 14.7;classical monocyte: 10.2;gdT-cell: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 18.4;NB-4: 29.8;NTERA-2: 19.1;RPTEC TERT1: 82.7;THP-1: 17.9;U-937: 16.0" NA NA "unprognostic (4.15e-2)" "unprognostic (3.60e-2)" "unprognostic (6.78e-2)" "unprognostic (2.78e-2)" "unprognostic (1.95e-3)" "unprognostic (1.88e-3)" "unprognostic (2.70e-1)" "unprognostic (4.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.14e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.02e-7)" "unprognostic (2.78e-1)" "unprognostic (3.50e-2)" "unprognostic (2.65e-2)" "unprognostic (2.85e-1)" 6.4 12.1 14.8 5.8 22.9 2.4 3.1 5.9 18.6 2.2 24.6 9.7 4.9 15.9 2.3 13.5 2.2 3.7 10.6 1.9 16.0 13.7 84.1 98.0 2.5 6.5 27.5 15.7 1.3 55.7 1.4 4.5 1.5 37.0 11.6 17.6 8.3 3.9 4.3 1.1 2.0 37.9 3.3 23.8 3.9 15.1 1.6 9.2 0.0 152.5 0.0 2.8 3.3 1.1 7.4 2.5 14.7 10.2 2.3 25.4 14.4 1.3 0.8 0.0 0.0 0.0 0.0 1.6 0.9 1.9 0.6 1.1 0.3 5.0 0.0 3.2 0.1 1.3 4.6 5.8 0.9 0.7 18.4 0.8 1.3 0.2 0.6 0.4 0.0 15.3 0.1 0.2 0.7 0.2 0.4 0.0 0.4 0.0 0.0 0.0 2.5 0.0 29.8 19.1 0.3 1.8 0.0 0.0 0.7 82.7 0.8 9.6 1.2 1.2 0.4 0.5 2.8 0.6 17.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 13.9 16.0 0.1 14.7 10.2 2.8 14.0 0.9 12.7 7.4 15.3 23.9 2.5 3.0 15.2 25.4 1.5 2.3 0.4 0.8 23.9 14.4 14.8 22.9 5.9 18.6 16.0 13.7 27.5 15.7 37.0 9.2 0.0 9.4 25.5 29.5 7.6 0.0 6.1 137.6 38.8 21.6 310.6 0.0 3.4 948.3 194.8 0.4 5.4 802.3 23.3 105.7 281.1 9.2 83.9 11.5 847.0 26.2 0.0 164.4 28.3 35.5 0.0 29.1 28.8 87.7 79.4 549.3 0.0 152.7 997.7 4.9 4487.9 0.0 6.5 36.6 0.2 1.7 6.9 16.2 34.8 560.8 18.8 MT1G "MT1, MT1K" ENSG00000125144 "Metallothionein 1G" P13640 16 56666731-56668065 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4" "Cell type enhanced" "Detected in many" 22 "Distal tubular cells: 5804.3;Hepatocytes: 13716.6;Paneth cells: 6754.7;Proximal tubular cells: 31723.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-937: 156.0" "Intracellular and membrane" NA NA "unprognostic (1.62e-1)" "unprognostic (4.21e-1)" "unprognostic (2.77e-2)" "unprognostic (3.15e-1)" "unprognostic (1.32e-2)" "unprognostic (1.73e-3)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (5.97e-2)" "unprognostic (2.49e-2)" "unprognostic (4.21e-1)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (7.92e-2)" "unprognostic (2.26e-2)" 10.1 1.0 11.7 10.4 50.7 0.7 2.8 1.1 27.4 1.0 78.1 3.1 1.9 49.6 1.5 15.9 21.7 4.6 23.2 0.9 25.1 7.6 210.7 396.4 2.4 7.0 23.6 11.3 0.6 217.1 0.4 1.0 0.6 46.9 21.6 48.9 22.4 2.4 1.0 0.6 2.9 101.1 7.9 7.7 0.5 47.4 0.6 3.6 0.0 278.4 1.9 1.8 2.4 1.2 0.1 1.1 0.7 1.1 0.3 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.2 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.5 0.6 0.1 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 35.6 0.0 0.0 0.0 0.0 0.1 10.2 6.0 0.0 3.2 0.4 0.0 0.2 0.1 1.6 0.0 15.3 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 156.0 0.0 0.7 1.1 0.3 1.5 1.1 1.4 0.1 1.7 2.6 1.1 0.0 1.6 2.9 0.1 0.3 0.5 0.3 2.8 1.5 11.7 50.7 1.1 27.4 25.1 7.6 23.6 11.3 46.9 3.6 26.8 5.4 164.5 23.0 51.4 0.0 9.4 145.2 6.7 15.9 2184.4 0.0 2.9 5804.3 77.4 0.3 3.5 4202.6 140.2 238.0 320.8 7.8 355.3 17.3 13716.6 22.8 0.0 237.6 129.5 169.9 0.2 21.6 83.6 28.7 18.0 3803.0 0.0 432.8 6754.7 2.1 31723.3 0.0 0.0 18.1 0.3 0.9 68.1 111.0 37.1 2367.7 10.9 MT1H MT1 ENSG00000205358 "Metallothionein 1H" P80294 16 56669814-56671129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3" "Cell type enhanced" "Detected in many" 21 "Distal tubular cells: 1414.2;Hepatocytes: 2756.5;Paneth cells: 1455.4;Proximal tubular cells: 6160.6" "Cancer enhanced" "Detected in many" "testis cancer: 173.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "EFO-21: 5.5;SuSa: 14.2" NA NA "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-1)" "unprognostic (8.65e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (8.48e-3)" "unprognostic (6.26e-2)" "unprognostic (7.44e-2)" "unprognostic (3.31e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.44e-5)" "unprognostic (5.77e-2)" "unprognostic (3.50e-2)" "unprognostic (2.37e-2)" "unprognostic (1.34e-1)" 0.6 0.0 1.4 1.1 20.1 0.0 0.2 0.2 4.7 0.3 21.7 0.6 0.2 9.4 0.8 3.1 4.1 0.2 2.8 0.2 7.4 0.9 88.1 134.0 0.3 1.3 4.4 1.6 0.3 50.2 0.0 0.2 0.3 8.3 2.3 11.0 1.6 0.5 0.2 0.3 0.7 53.9 1.4 1.9 0.2 6.7 0.4 1.5 0.2 60.3 0.9 0.4 1.0 0.2 0.2 0.1 0.0 1.6 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 1.9 0.2 0.0 0.0 0.2 0.0 1.0 0.4 0.0 1.4 0.9 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 1.4 20.1 0.2 4.7 7.4 0.9 4.4 1.6 8.3 1.5 0.0 0.0 30.6 1.2 10.9 0.0 2.0 17.8 0.0 1.2 507.7 0.0 2.4 1414.2 1.6 0.0 0.7 931.8 0.0 39.8 466.6 1.5 11.5 4.6 2756.5 16.3 0.0 42.0 27.6 30.2 0.0 0.3 40.9 0.0 1.0 787.0 0.0 66.2 1455.4 0.0 6160.6 0.0 0.0 2.9 0.0 0.4 16.6 56.0 4.9 264.0 0.4 MTNR1A MEL-1A-R ENSG00000168412 "Melatonin receptor 1A" P48039 4 186533655-186555567 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;EFO-21: 2.0;HEK 293: 2.1;NTERA-2: 1.8;SCLC-21H: 1.6;SH-SY5Y: 3.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (7.99e-2)" "unprognostic (2.27e-1)" "unprognostic (2.16e-1)" "unprognostic (3.67e-1)" "unprognostic (2.14e-1)" "unprognostic (9.88e-2)" "unprognostic (9.20e-2)" "unprognostic (8.81e-2)" 0.0 0.0 0.1 1.2 0.1 0.0 0.0 3.8 0.2 0.0 3.1 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 5.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "Group enriched" "Detected in many" 6 "CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.4 0.7 1.9 0.0 139.4 0.0 10.1 1.1 0.3 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 1.5 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 65.3 0.2 0.2 0.0 3.4 107.0 0.1 0.6 0.2 3.3 5.9 0.1 0.5 47.0 0.6 0.2 0.4 0.8 1.3 0.1 2.1 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 402.0 1308.2 0.9 16.1 0.6 1.0 0.4 384.7 92.3 252.5 465.9 3.9 0.1 29.9 144.7 27.3 3.5 49.2 0.0 994.6 1.2 3.1 11.6 45.2 0.5 0.2 1.6 29.4 1.3 3.4 68.9 2.3 2.6 5.0 42.3 249.7 1.1 807.2 66.2 1.4 0.9 0.2 0.0 1.9 6.2 0.8 1.0 0.2 0.0 132.5 164.3 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 NAPSA "KAP, Kdap, NAP1, NAPA" ENSG00000131400 "Napsin A aspartic peptidase" O96009 19 50358477-50365830 "Enzymes, Plasma proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 47.5;lung: 153.3" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 2552.8" "Cancer enriched" "Detected in many" 18 "lung cancer: 249.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.5" "Group enriched" "Detected in many" 9 "B-cells: 5.1;dendritic cells: 10.5" "Cell line enriched" "Detected in some" 24 "U-698: 29.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB009591, HPA045280, HPA047236, HPA047744" Enhanced "Secreted in other tissues" NA NA 380000 "CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143" "unprognostic (5.36e-2)" "unprognostic (4.77e-2)" "unprognostic (1.64e-3)" "unprognostic (1.78e-1)" "unprognostic (1.93e-1)" "unprognostic (4.65e-2)" "unprognostic (1.02e-1)" "unprognostic (8.30e-3)" "unprognostic (2.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.76e-3)" "unprognostic (7.67e-3)" "prognostic favorable (1.21e-4)" "unprognostic (4.08e-4)" "unprognostic (3.29e-1)" "unprognostic (9.83e-3)" "unprognostic (7.26e-5)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 5.0 0.1 0.1 0.1 0.1 0.1 0.0 47.5 0.1 153.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 5.1 10.5 0.5 0.9 0.5 0.6 1.1 0.2 0.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.3 1.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.6 0.1 0.3 0.2 0.3 0.3 0.6 0.0 0.1 0.9 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.2 0.4 29.8 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.9 0.0 5.1 0.2 0.4 3.0 1.9 0.6 0.5 0.5 0.5 0.9 10.5 0.0 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 485.3 2552.8 8.0 0.4 0.1 1.3 0.4 0.0 29.4 84.2 43.6 3.9 0.4 8.3 0.4 34.9 0.1 0.9 0.0 0.7 0.2 0.2 0.6 64.0 0.0 0.3 0.0 0.0 0.0 0.3 4.5 0.9 4.0 0.0 0.0 0.9 1.3 0.1 2.8 0.4 230.9 0.7 0.0 0.3 0.5 0.7 0.5 0.1 0.0 0.8 0.0 NAT8 "ATase2, GLA, Hcml1, TSC501" ENSG00000144035 "N-acetyltransferase 8 (putative)" Q9UHE5 2 73640832-73642393 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 140.4" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 1951.9" "Cancer enriched" "Detected in some" 5 "renal cancer: 242.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 16.9" "Low region specificity" "Detected in all" "HPA067855, HPA074519" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA067855: AB_2732774, HPA074519: AB_2686699" "unprognostic (4.51e-2)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (4.95e-3)" "unprognostic (2.46e-1)" "unprognostic (1.90e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (8.60e-2)" "unprognostic (1.37e-3)" "unprognostic (2.07e-2)" "unprognostic (4.11e-3)" "unprognostic (2.13e-2)" "unprognostic (8.36e-5)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 140.4 15.8 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 16.9 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 159.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.0 22.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1951.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NECAB2 EFCBP2 ENSG00000103154 "N-terminal EF-hand calcium binding protein 2" Q7Z6G3 16 83968632-84002776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 30.6;brain: 42.5;kidney: 12.4;liver: 15.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 13.3;Hepatocytes: 10.0;Late spermatids: 36.4;Muller glia cells: 10.2;Proximal tubular cells: 19.6" "Cancer enhanced" "Detected in many" "liver cancer: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 68 "neutrophil: 30.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 30.6" "Cell line enhanced" "Detected in some" "AF22: 7.6;SCLC-21H: 29.2;U-87 MG: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA013998, HPA014144, CAB068211" Enhanced Supported NA NA "CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017" "unprognostic (5.27e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (3.48e-5)" "unprognostic (3.45e-2)" "unprognostic (4.20e-2)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" "unprognostic (4.15e-1)" "unprognostic (2.59e-1)" "unprognostic (5.75e-3)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (8.89e-3)" "unprognostic (3.48e-1)" "unprognostic (8.61e-3)" "unprognostic (3.75e-2)" 1.8 1.1 34.1 1.3 42.5 1.3 0.9 0.2 35.2 0.7 1.1 2.2 0.0 1.9 2.2 0.9 0.7 0.7 1.3 1.0 9.5 21.7 12.4 15.1 1.0 0.8 5.0 14.0 0.7 2.1 1.6 3.3 0.9 7.4 0.8 0.9 0.1 0.6 0.8 0.5 0.7 1.7 1.2 1.9 1.1 2.8 5.4 5.9 0.0 0.8 0.0 0.5 1.1 0.0 0.0 0.0 30.6 0.4 0.0 0.0 0.0 0.1 3.8 7.6 0.0 0.0 1.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.3 0.2 0.5 0.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.1 0.0 1.2 0.4 0.1 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.0 4.4 0.0 0.0 4.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 29.2 1.2 0.0 0.1 2.3 1.1 3.9 1.3 0.2 0.1 2.3 0.3 0.0 0.1 0.0 0.0 10.4 0.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 34.1 42.5 0.2 21.2 9.5 21.7 5.0 14.0 7.4 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.5 0.0 6.9 0.0 0.0 36.4 0.3 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.7 19.6 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 NELL1 "FLJ45906, IDH3GL" ENSG00000165973 "Neural EGFL like 1" Q92832 11 20669551-21575681 "Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;kidney: 24.2" "Cell type enhanced" "Detected in some" 20 "Distal tubular cells: 5.0;Early spermatids: 20.1;Late spermatids: 16.1" "Cancer enhanced" "Detected in many" "melanoma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051535 Approved "Secreted in other tissues" NA NA 120000 "HPA051535: AB_2681524" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.29e-2)" "unprognostic (5.35e-4)" "unprognostic (3.78e-4)" "unprognostic (1.67e-2)" "unprognostic (3.91e-1)" "unprognostic (4.38e-2)" "unprognostic (4.65e-2)" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" "unprognostic (4.23e-2)" "unprognostic (1.83e-1)" "unprognostic (2.29e-1)" 0.6 0.6 5.5 0.6 10.3 0.4 0.5 1.8 19.6 0.9 0.8 0.5 0.1 0.5 0.9 2.8 1.3 0.6 1.0 0.4 8.8 6.9 24.2 0.4 1.1 0.4 2.0 13.3 0.6 0.4 0.5 4.5 0.4 4.1 7.9 1.0 0.0 1.1 4.2 0.4 0.9 0.6 0.7 0.9 0.6 1.3 1.8 0.5 0.0 0.4 0.0 1.3 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.6 0.0 0.0 0.6 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 10.3 1.8 18.7 8.8 6.9 2.0 13.3 4.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.6 5.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.5 0.0 0.1 0.0 0.0 0.0 0.0 16.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 119.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm NA NA Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 8.5 15.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.3 0.0 34.8 0.1 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 4.1 1.1 0.0 0.0 0.0 10.4 5.9 1.2 13.3 0.0 0.8 1.1 0.0 0.0 0.0 0.6 1.1 0.1 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 119.8 19.3 0.0 0.3 0.5 0.1 0.3 2.1 0.0 0.0 0.0 NPHS1 "CNF, NPHN" ENSG00000161270 "NPHS1, nephrin" O60500 19 35825964-35869287 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 20.2;pancreas: 21.8" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 3.5;Early spermatids: 9.6;Late spermatids: 4.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "A549: 1.1;HMC-1: 4.8;JURKAT: 3.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB035555 Enhanced NA NA "CAB035555: " "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" "unprognostic (1.65e-1)" "unprognostic (2.39e-2)" "unprognostic (6.47e-3)" "unprognostic (2.25e-2)" "unprognostic (1.58e-1)" "unprognostic (1.69e-1)" "unprognostic (3.32e-2)" "unprognostic (3.17e-1)" "unprognostic (3.83e-5)" "unprognostic (4.30e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 3.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.7 1.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 2.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.5 0.0 0.0 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.3 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 143 "kidney: 66.5" "Group enriched" "Detected in some" 12 "Collecting duct cells: 19.2;Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "NTERA-2: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB037267, HPA049486" Enhanced NA NA "CAB037267: AB_261982, HPA049486: AB_2680788" "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.2" "Group enriched" "Detected in many" 4 "Distal tubular cells: 44.7;Proximal tubular cells: 133.6" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;fHDF/TERT166: 10.5;HeLa: 37.5;HSkMC: 24.4;U-138 MG: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 26.9 3.5 0.4 0.4 1.5 1.9 2.7 0.2 0.8 4.5 5.3 0.3 1.4 0.3 4.2 3.3 6.8 2.5 3.9 16.4 0.4 0.5 54.2 7.6 24.2 0.5 0.2 0.8 1.9 0.7 0.3 0.7 5.3 3.1 8.8 0.5 7.3 1.2 18.1 9.5 3.7 1.4 1.8 0.3 4.5 1.0 1.5 0.0 1.1 11.0 13.4 1.4 5.5 4.5 1.4 0.9 7.3 0.6 1.1 1.1 0.2 0.1 1.9 0.1 0.2 1.1 17.3 0.0 4.6 0.9 0.2 0.2 0.0 0.1 0.0 0.1 10.5 0.3 0.0 2.3 0.0 0.5 0.0 0.0 0.2 37.5 0.0 3.4 0.0 0.1 24.4 0.3 1.2 3.3 1.1 0.1 0.0 0.0 0.3 1.5 0.3 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 6.3 0.0 0.1 0.1 0.0 0.1 10.3 0.1 0.8 0.1 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.6 0.4 0.8 0.3 0.5 0.9 0.7 0.5 0.0 1.4 0.9 1.1 7.3 1.1 0.1 0.9 0.4 0.2 0.4 1.5 0.2 0.8 0.4 0.5 0.2 0.8 3.1 0.0 14.9 8.2 0.9 0.0 4.7 3.3 20.6 0.0 6.7 2.3 8.7 0.0 0.0 44.7 0.0 1.1 3.3 0.0 0.0 0.0 0.1 1.5 2.5 3.5 1.5 0.1 3.2 0.0 4.9 0.0 2.2 10.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 12.0 133.6 1.2 6.5 2.7 0.1 0.9 1.1 0.1 0.0 0.0 0.1 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138670772-138780348 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "brain: 23.0;kidney: 8.0;ovary: 19.3" "Cell type enriched" "Detected in single" 7 "Distal tubular cells: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 4 "pons and medulla: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" NA Yes "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.4 0.5 3.1 0.6 3.7 0.2 0.4 0.8 6.0 0.6 0.3 0.0 0.0 0.2 1.1 0.5 0.2 0.6 0.2 0.2 1.9 1.5 8.0 0.3 0.3 0.2 2.4 2.0 19.3 0.2 0.4 0.4 0.4 23.0 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 0.3 0.7 0.2 0.2 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 1.6 6.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.7 0.8 5.6 1.9 1.5 2.4 2.0 23.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OGDHL FLJ10851 ENSG00000197444 "Oxoglutarate dehydrogenase like" Q9ULD0 10 49734643-49762379 "Citric acid cycle related proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.9;liver: 48.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 28.8;Collecting duct cells: 27.9;Cone photoreceptor cells: 29.5;Distal tubular cells: 77.9;Hepatocytes: 45.6;Horizontal cells: 28.6;Proximal tubular cells: 55.6" "Cancer enhanced" "Detected in many" "renal cancer: 44.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "AN3-CA: 13.7;RPTEC TERT1: 28.2;SH-SY5Y: 10.6;SK-BR-3: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043716, HPA052497" Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043716: , HPA052497: AB_2681853" "unprognostic (9.05e-2)" "unprognostic (3.93e-3)" "unprognostic (5.30e-2)" "unprognostic (2.50e-1)" "unprognostic (3.70e-3)" "unprognostic (2.03e-1)" "unprognostic (1.46e-3)" "unprognostic (4.19e-1)" "unprognostic (2.07e-1)" "unprognostic (1.46e-2)" "unprognostic (1.52e-3)" "unprognostic (4.60e-1)" "prognostic favorable (1.21e-14)" "unprognostic (3.25e-2)" "unprognostic (1.85e-1)" "unprognostic (1.59e-3)" "unprognostic (8.38e-2)" 0.9 8.1 8.3 1.0 15.3 0.8 0.8 16.2 23.6 1.3 1.3 4.9 2.7 1.4 2.2 1.7 0.9 1.5 1.1 4.1 8.7 13.7 74.9 48.8 0.8 0.9 12.1 11.0 1.9 3.4 23.1 11.7 0.9 23.6 1.8 1.0 8.2 10.3 5.0 0.9 0.8 1.4 1.2 2.9 1.0 1.4 1.9 3.2 0.0 13.0 0.0 1.1 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.0 13.7 0.0 0.0 1.7 0.0 0.0 0.7 0.1 6.6 1.5 0.0 7.4 0.0 2.2 0.2 4.7 0.1 0.2 0.0 0.3 0.0 0.1 3.3 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 3.4 0.3 0.0 0.0 2.0 5.0 4.5 1.3 0.5 0.6 0.0 0.0 0.0 28.2 0.4 7.8 10.6 0.1 10.4 0.7 4.2 2.9 1.8 0.0 0.0 7.1 0.0 0.4 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 15.3 16.2 23.6 8.7 13.7 12.1 11.0 23.6 3.2 0.0 0.0 1.9 0.5 0.0 28.8 3.2 2.5 0.0 0.0 27.9 29.5 0.0 77.9 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 45.6 0.1 28.6 4.6 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.0 0.0 55.6 16.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.1 OR2T10 ENSG00000184022 "Olfactory receptor family 2 subfamily T member 10" Q8NGZ9 1 248590487-248597700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "kidney: 11.2" "Cell type enriched" "Detected in single" 59 "Proximal tubular cells: 5.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" "Group enriched" "Detected in some" 7 "BJ hTERT+: 3.1;Karpas-707: 2.4" HPA052019 Uncertain NA NA "HPA052019: AB_2681696" "unprognostic (8.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T2 OR2T2P ENSG00000196240 "Olfactory receptor family 2 subfamily T member 2" Q6IF00 1 248445512-248455725 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 14.1" "Cell type enriched" "Detected in single" 14 "Proximal tubular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enriched" "Detected in single" 22 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T29 ENSG00000182783 "Olfactory receptor family 2 subfamily T member 29" Q8NH02 1 248556912-248562772 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.5;kidney: 2.7;prostate: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "memory B-cell: 1.3;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enriched" "Detected in single" 33 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell type enriched" "Detected in some" 11 "Extravillous trophoblasts: 35.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Cell line enhanced" "Detected in some" "RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.2 0.0 3.6 0.0 0.2 1.7 0.0 0.0 0.0 4.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 35.1 0.1 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.8 0.0 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 20.3" "Lineage enriched" "Detected in single" 104 "dendritic cells: 20.3" "Cell line enhanced" "Detected in many" "GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 2.4 22.6 2.9 4.0 3.9 0.2 3.1 0.7 2.2 14.3 11.8 6.2 11.5 1.2 15.0 13.5 8.9 4.6 8.4 3.8 2.8 2.1 74.5 3.5 22.5 3.6 8.1 1.0 11.2 3.9 1.4 6.1 11.0 5.6 19.9 5.3 10.3 2.7 14.3 0.6 8.6 3.6 16.3 7.6 33.7 12.0 2.8 5.3 2.0 1.7 6.3 2.7 5.7 9.8 0.0 20.3 0.1 0.1 0.0 0.0 0.1 14.0 5.6 11.0 0.0 0.2 0.4 13.3 15.0 5.9 2.4 4.0 4.5 5.5 0.0 8.5 2.6 38.1 34.0 0.0 20.1 5.1 0.1 1.9 0.0 3.8 0.0 11.4 0.0 0.1 5.4 6.8 4.8 1.7 23.3 0.4 0.0 0.0 0.1 3.8 0.3 0.0 0.1 3.4 9.4 1.1 0.0 2.2 0.8 34.7 23.7 0.8 0.1 20.4 1.1 8.9 16.9 0.0 0.2 7.5 14.6 5.5 0.1 2.7 1.0 0.0 0.1 3.3 0.0 18.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.1 2.9 3.9 0.7 2.2 2.8 2.1 8.1 1.0 5.6 5.3 44.7 62.9 1.9 7.4 0.0 2.2 1.0 5.1 0.0 5.7 41.8 3.9 30.9 5.0 3.8 14.3 4.5 0.0 0.0 0.7 11.7 2.0 13.7 1.1 0.6 9.1 9.5 0.0 44.8 4.6 11.4 4.4 4.7 0.0 1.0 0.2 49.8 18.0 0.0 0.0 24.5 0.8 0.0 2.7 0.5 0.4 0.0 32.3 0.0 0.0 2.8 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836885-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 65.1;liver: 220.0" "Group enriched" "Detected in some" 8 "Cholangiocytes: 226.7;Hepatocytes: 723.9;Proximal tubular cells: 215.9" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "Hep G2: 72.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" No NA "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.1 1.3 0.5 0.0 0.5 0.0 0.1 0.2 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 20.3 0.1 0.8 0.3 65.1 220.0 0.0 0.0 0.3 0.7 0.1 1.7 0.0 1.6 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 1.0 0.8 0.3 0.3 0.7 0.8 0.4 0.0 0.0 16.2 0.0 0.0 0.0 0.4 226.7 0.0 0.0 5.2 0.0 0.0 18.3 2.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 723.9 0.0 3.2 1.7 14.1 22.2 13.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 215.9 0.1 0.0 0.0 0.7 0.4 0.0 0.0 5.0 0.0 0.0 PANK1 "MGC24596, PANK, PANK1a, PANK1b" ENSG00000152782 "Pantothenate kinase 1" Q8TE04 10 89579497-89645572 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 20.1;liver: 63.8" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 59.7;Hepatocytes: 103.1;Proximal tubular cells: 48.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.00e-1)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" "unprognostic (1.09e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "prognostic favorable (1.50e-4)" "unprognostic (1.59e-1)" "unprognostic (1.38e-2)" "unprognostic (1.61e-1)" "unprognostic (4.55e-4)" "unprognostic (4.61e-2)" "prognostic favorable (1.55e-10)" "unprognostic (3.49e-2)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" "unprognostic (6.64e-2)" 1.1 2.5 2.3 1.2 1.9 0.0 1.0 13.4 4.1 2.4 6.1 1.3 0.5 9.0 0.9 1.9 2.9 1.2 1.5 3.9 1.9 2.6 20.1 63.8 2.1 0.6 2.1 2.7 1.1 1.2 2.6 2.2 1.0 3.1 1.5 7.8 1.8 1.4 1.0 5.7 5.5 9.2 1.0 1.7 0.9 2.0 1.5 1.0 2.6 4.7 2.4 1.0 1.1 5.5 1.0 2.3 0.9 0.6 0.1 1.6 0.7 5.6 3.7 20.4 14.0 11.1 8.1 10.3 3.3 3.6 3.2 4.2 5.7 5.8 4.1 2.2 2.5 2.3 5.6 9.2 2.1 3.4 1.4 4.1 2.7 4.0 11.3 3.3 8.4 1.5 4.9 9.3 4.8 3.8 6.7 3.6 3.5 4.7 0.5 4.5 4.3 9.3 8.7 16.0 14.7 2.2 8.3 4.0 2.7 9.7 2.7 6.4 7.6 4.1 5.0 3.2 12.7 5.4 6.2 1.5 1.9 1.8 3.8 3.9 4.7 8.7 5.0 2.5 6.8 1.3 0.9 0.3 0.1 0.7 0.1 1.4 1.0 0.8 1.6 1.0 0.1 1.0 0.2 0.7 0.1 0.6 2.3 1.1 0.7 2.3 1.9 13.4 4.1 1.9 2.6 2.1 2.7 3.1 1.0 6.0 3.0 5.6 0.7 2.1 4.1 10.2 10.2 1.4 2.3 10.4 2.0 3.9 59.7 0.8 0.4 1.0 20.9 0.0 0.6 3.8 1.8 0.5 0.0 103.1 2.0 12.7 10.9 4.3 3.7 0.2 1.1 1.6 0.0 0.0 16.2 0.8 0.1 8.6 2.1 48.4 1.0 0.0 2.7 0.5 0.9 2.5 1.5 1.5 22.8 0.4 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298947-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.4" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 39.7;Early spermatids: 33.3;granulocytes: 65.8;Late spermatids: 86.2;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 17.5;CAPAN-2: 21.1;fHDF/TERT166: 14.9;HMC-1: 37.0;U-87 MG: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA076729 Approved Vesicles NA NA Vesicles "HPA076729: AB_2686813" "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 1.8 15.4 1.9 4.1 2.6 0.7 1.2 1.5 3.1 1.6 12.3 3.0 1.7 1.5 1.1 1.6 9.0 1.0 1.7 1.9 1.8 1.5 41.4 1.0 10.4 0.3 2.0 1.0 0.5 4.8 5.8 0.9 1.0 3.5 1.1 10.8 3.6 1.8 4.2 0.4 3.2 5.2 3.2 3.8 0.2 4.5 1.5 2.2 0.0 0.6 5.7 4.9 2.3 2.6 0.2 0.2 3.5 0.3 0.4 0.7 0.0 5.1 17.5 0.3 0.3 0.7 2.0 0.1 1.6 10.1 2.0 4.3 1.0 21.1 0.0 2.7 14.9 1.7 0.3 5.0 0.2 3.5 0.0 0.7 3.0 2.7 0.3 1.3 0.1 37.0 1.0 0.8 9.0 9.7 2.6 0.0 0.1 0.0 0.3 8.4 0.7 0.0 0.1 1.2 2.7 1.5 0.0 0.3 0.9 7.7 0.4 1.5 0.3 2.7 1.0 1.4 1.0 0.4 1.2 0.2 6.1 2.0 0.5 0.2 0.1 0.1 0.0 15.4 0.0 1.7 3.5 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.7 1.3 0.4 0.2 0.2 0.1 0.0 1.9 2.6 1.5 3.1 1.8 1.5 2.0 1.0 3.5 2.2 11.9 21.8 0.0 1.1 0.8 0.5 0.8 22.9 1.4 1.2 19.2 0.0 0.0 39.7 16.0 33.3 0.4 18.4 0.0 0.4 0.0 0.2 0.5 65.8 0.0 3.5 0.0 0.0 0.0 0.3 86.2 0.9 0.9 0.0 0.0 4.8 5.7 1.8 3.5 1.1 33.2 0.0 6.5 0.4 0.3 0.5 1.6 0.1 0.5 11.5 0.7 PARD6B PAR-6B ENSG00000124171 "Par-6 family cell polarity regulator beta" Q9BYG5 20 50731544-50756795 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 40.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 15.8;MCF7: 27.8;T-47d: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013376 Uncertain Supported Cytosol NA NA Cytosol "HPA013376: AB_1854972" "unprognostic (1.13e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-3)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.27e-1)" "prognostic favorable (6.38e-5)" "unprognostic (1.84e-2)" "unprognostic (1.97e-1)" "unprognostic (4.18e-2)" "unprognostic (1.07e-2)" 3.7 2.3 1.6 3.1 2.3 2.6 7.9 3.5 2.0 2.7 13.9 1.4 11.3 4.5 2.2 12.1 5.8 5.7 6.6 2.1 2.0 1.9 40.0 8.0 15.4 1.9 1.5 1.3 3.4 9.9 7.3 3.7 24.1 2.7 4.0 3.0 12.2 3.6 17.2 4.3 3.8 17.5 1.0 1.6 2.4 8.3 6.4 0.5 2.9 14.4 1.0 5.8 3.5 5.5 3.6 3.1 3.4 1.5 3.8 6.1 1.1 2.9 3.4 1.0 2.1 0.6 0.2 4.5 0.2 0.3 0.5 0.4 15.8 7.0 1.3 3.0 0.0 2.2 2.4 1.4 2.1 0.8 0.6 0.8 0.7 1.1 6.2 0.6 0.5 0.7 0.0 1.0 0.3 0.9 1.0 0.0 1.2 1.6 0.9 0.0 27.8 1.3 1.2 1.7 4.9 1.3 0.7 0.9 1.1 7.1 3.2 0.6 0.9 2.2 5.3 1.5 4.2 27.2 0.7 0.1 0.3 1.8 0.3 0.5 1.1 0.7 1.1 0.7 0.5 0.6 2.9 0.7 3.4 3.6 0.9 4.0 2.9 3.7 3.6 0.8 3.6 6.1 3.8 2.8 3.8 1.5 3.1 2.3 1.1 1.6 2.3 3.5 2.0 2.0 1.9 1.5 1.3 2.7 0.5 175.7 50.3 4.5 51.0 55.9 12.3 3.3 28.1 25.4 33.0 85.5 51.1 28.8 34.9 22.0 3.2 1.1 39.4 0.0 21.2 12.5 2.6 39.6 1.1 17.8 3.1 4.8 14.3 2.5 0.3 2.2 1.7 2.5 15.1 1.0 18.0 10.0 40.3 18.2 0.7 63.2 52.4 6.5 2.3 11.2 9.8 59.7 40.5 4.6 12.1 85.3 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735603-100829941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 137.9;Distal tubular cells: 41.4" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Group enriched" "Detected in some" 6 "cerebellum: 1.0;pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AN3-CA: 14.6;EFO-21: 20.2;RPTEC TERT1: 14.5" "Group enriched" "Detected in some" 9 "cerebellum: 1.5;pons and medulla: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 8.1" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 1.0 0.1 3.1 0.1 0.0 30.5 0.0 1.5 93.7 0.1 9.1 0.0 0.1 0.1 0.1 43.1 0.1 0.1 0.0 0.2 0.0 1.5 0.3 0.6 0.7 0.0 1.8 0.8 0.0 0.5 0.1 19.4 0.1 0.1 0.1 0.0 1.7 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 14.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.1 0.1 0.1 0.2 0.0 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 137.9 0.0 0.0 41.4 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 18.8 0.4 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 PAX8 ENSG00000125618 "Paired box 8" Q06710 2 113215997-113278950 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 69.3;thyroid gland: 120.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 233.8;Proximal tubular cells: 100.4" "Group enriched" "Detected in many" 12 "endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8" "Region enriched" "Detected in some" 4 "pons and medulla: 5.8" "HPA030062, CAB055097, CAB061888, HPA064554" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283" "unprognostic (2.63e-3)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.24e-2)" "unprognostic (5.16e-5)" "unprognostic (1.56e-2)" "unprognostic (3.29e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (4.13e-2)" "unprognostic (4.00e-2)" "unprognostic (3.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.37e-1)" "unprognostic (8.93e-3)" "unprognostic (1.02e-1)" 0.9 1.4 1.1 0.5 0.4 0.0 0.6 0.2 0.8 3.8 0.4 0.2 11.7 0.1 2.2 15.2 0.6 9.6 0.8 0.6 0.5 0.5 69.3 0.4 0.5 0.7 0.4 0.3 3.8 0.6 0.1 0.7 0.8 1.5 1.1 0.1 0.5 0.5 10.0 0.3 0.5 0.6 0.4 0.8 0.3 0.4 1.9 0.2 0.4 120.5 0.0 0.2 0.8 1.9 4.4 2.8 1.5 3.4 1.9 2.5 1.1 2.9 0.2 0.1 0.0 0.1 0.0 1.0 0.8 2.7 0.2 0.4 1.8 0.5 0.5 27.1 0.2 16.8 0.0 0.5 0.8 0.2 1.2 0.0 0.4 0.2 1.0 0.3 0.0 0.0 0.7 0.1 0.2 0.6 3.3 0.0 0.0 0.4 2.0 0.8 0.6 0.3 1.2 0.1 0.7 1.8 0.0 0.2 0.6 63.8 4.7 0.5 0.0 3.4 0.0 1.8 0.0 0.0 1.1 0.9 4.6 0.1 0.8 2.3 0.4 1.4 0.1 4.0 0.6 0.0 1.5 3.4 0.0 0.6 1.8 1.5 4.4 1.5 1.1 2.8 1.9 2.5 1.5 0.5 1.9 1.3 1.1 0.8 1.1 1.1 0.4 0.2 0.8 0.5 0.5 0.4 0.3 1.5 0.2 3.0 1.3 0.8 1.7 0.6 0.6 0.8 2.5 0.0 4.5 233.8 0.0 2.1 39.7 9.6 1.5 0.5 5.8 0.0 2.6 2.0 1.9 1.0 0.0 0.0 4.5 0.0 4.6 1.3 1.3 3.1 4.6 2.6 0.0 2.8 2.3 3.3 17.3 7.0 0.4 100.4 0.7 6.5 0.1 4.2 5.8 0.6 0.7 1.0 3.7 1.7 PBLD "FLJ14767, MAWBP, MAWDBP" ENSG00000108187 "Phenazine biosynthesis like protein domain containing" P30039 10 68282660-68333049 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 47.3;kidney: 74.5;liver: 91.4" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 92.9;Enterocytes: 114.6;Hepatocytes: 159.6;Proximal tubular cells: 362.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038035, HPA038036" Enhanced Approved Vesicles NA NA 420000 Vesicles "HPA038035: AB_10672470, HPA038036: AB_10675625" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (6.14e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "prognostic favorable (1.44e-4)" "unprognostic (8.25e-2)" "unprognostic (3.62e-2)" "unprognostic (3.36e-3)" "unprognostic (1.19e-1)" "unprognostic (6.26e-3)" "unprognostic (3.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.07e-2)" "unprognostic (8.28e-2)" "unprognostic (6.68e-2)" 5.0 5.9 3.6 2.4 6.4 2.5 2.9 2.3 8.0 4.1 9.4 11.8 6.8 47.3 4.5 5.1 1.5 2.3 2.9 3.3 3.9 3.1 74.5 91.4 2.3 2.8 6.7 5.6 2.3 17.9 2.4 2.4 7.0 8.4 2.6 8.0 9.4 2.2 6.2 2.3 1.8 39.3 6.5 4.9 1.6 15.0 2.1 6.2 2.5 1.9 4.3 1.6 4.1 1.6 1.7 5.6 6.4 5.8 3.3 2.3 2.5 3.4 6.9 6.7 4.6 6.1 3.5 3.1 13.9 8.8 5.3 5.6 6.3 8.8 3.9 5.4 9.7 2.2 5.3 3.1 3.6 4.6 1.8 5.1 3.1 7.5 5.7 3.0 4.5 3.1 6.2 4.3 3.2 4.0 9.6 3.2 3.7 2.7 8.6 8.3 5.3 4.1 7.9 1.9 2.7 3.0 7.2 8.8 6.4 10.6 5.0 3.9 5.2 9.3 5.4 6.4 1.9 18.7 5.4 10.0 5.3 3.8 2.5 2.2 5.2 3.7 5.7 6.3 2.5 1.3 4.2 5.8 2.9 0.9 2.9 1.8 1.7 1.4 0.9 5.6 1.6 2.3 1.6 6.4 3.3 1.7 2.4 2.3 2.5 3.6 6.4 2.3 8.0 3.9 3.1 6.7 5.6 8.4 6.2 3.0 3.4 6.1 1.7 1.6 4.7 2.8 25.5 17.4 5.7 52.4 9.8 3.1 92.9 5.7 0.8 2.9 114.6 0.0 28.7 2.1 3.3 2.4 1.1 159.6 2.6 9.5 6.9 7.4 7.8 0.0 3.7 4.2 1.7 4.6 34.2 5.0 16.3 35.1 2.8 362.3 16.5 0.0 5.6 1.2 1.4 0.5 2.6 2.2 34.0 3.1 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831094-48835633 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.9;kidney: 72.9;pituitary gland: 127.7" "Group enriched" "Detected in many" 5 "Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1" "Lineage enriched" "Detected in single" 77 "T-cells: 8.2" "Cell line enhanced" "Detected in some" "HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" NA NA 5300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favorable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 4.1 27.5 49.1 2.6 72.7 2.1 2.2 15.6 70.3 3.2 9.8 10.8 1.5 12.4 4.4 10.9 2.1 2.3 2.8 2.7 38.5 74.9 72.9 2.1 2.6 2.2 33.5 29.0 2.2 20.0 12.4 127.7 2.3 32.9 4.6 2.7 6.6 2.8 3.1 2.2 2.8 8.5 2.7 18.3 2.4 26.0 3.8 9.8 0.0 2.2 0.0 2.1 2.1 0.5 0.1 0.0 0.0 0.0 0.0 8.2 0.8 0.0 1.8 0.0 5.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.6 0.0 1.4 0.2 0.0 0.3 0.0 0.0 20.0 0.0 0.0 3.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 2.7 0.0 50.7 0.0 0.0 0.1 0.4 0.0 20.1 18.6 17.6 0.0 1.4 0.2 0.0 0.0 0.0 0.0 7.8 0.0 1.6 4.6 23.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 3.0 0.0 6.5 6.3 0.0 0.1 2.7 8.2 0.0 0.0 0.0 0.0 2.1 0.8 49.1 72.7 15.6 70.3 38.5 74.9 33.5 29.0 32.9 9.8 0.0 0.0 2.2 1.5 14.1 134.7 1.0 5.1 1.4 0.0 369.9 49.1 0.5 235.4 7.5 11.6 0.5 12.9 0.0 0.6 43.5 6.2 36.6 0.0 0.0 1.5 413.2 2932.5 0.0 0.0 41.9 3.1 2.7 54.0 0.0 16.6 54.9 36.6 411.7 6.7 1024.2 101.7 0.0 16.5 18.2 20.6 10.0 1.6 3.2 10.1 2.6 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in many" 6 "Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.0 22.8 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 13.5 0.0 0.0 28.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 0.0 1.6 0.0 2.2 1.1 12.6 3.6 0.0 0.0 2.3 26.2 0.0 0.1 157.5 0.3 314.8 5.8 0.0 0.0 0.3 0.0 1.9 2.0 0.0 0.0 0.1 0.0 0.0 8.0 0.0 455.7 13.8 0.2 0.0 0.0 0.6 0.2 0.2 0.0 7.8 1.4 1.1 51.8 47.4 4.4 3.9 1.1 0.0 0.0 0.0 0.7 PDZD3 "FLJ22756, IKEPP, PDZK2" ENSG00000172367 "PDZ domain containing 3" Q86UT5 11 119185457-119190223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.8;intestine: 44.2;kidney: 12.5" "Group enriched" "Detected in some" 4 "Enterocytes: 67.0;Paneth cells: 26.4;Proximal tubular cells: 25.2;Undifferentiated cells: 17.9" "Cancer enhanced" "Detected in some" "renal cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 3.3;OE19: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077887 Enhanced NA NA "HPA077887: " "unprognostic (2.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.39e-2)" "unprognostic (6.07e-2)" "unprognostic (3.22e-1)" "unprognostic (1.86e-2)" "unprognostic (6.58e-3)" "unprognostic (9.00e-2)" "unprognostic (6.08e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (3.41e-3)" 0.9 0.0 0.1 5.8 0.1 0.0 0.1 0.1 0.1 0.1 24.9 0.0 0.0 15.1 0.0 2.6 0.1 0.8 12.8 0.3 0.0 0.0 12.5 0.5 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 5.5 0.0 0.1 0.0 0.1 0.1 44.2 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 7.6 1.4 0.0 0.0 5.9 0.0 3.3 0.0 0.0 0.0 67.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 26.4 0.0 25.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.9 0.0 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 758.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 43.1;T-47d: 112.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.3 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.9 0.1 0.1 0.2 1.1 0.0 0.6 0.0 0.1 0.1 1.8 0.3 0.1 0.4 7.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.1 0.1 0.2 0.2 0.2 0.5 0.0 1.3 0.2 43.1 0.0 0.1 1.2 0.3 0.3 0.0 1.2 112.0 0.1 0.1 0.2 0.2 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.4 0.4 61.1 0.0 0.0 54.1 0.0 0.0 117.7 1.7 8.9 0.0 18.0 0.0 1.6 0.1 0.2 0.1 0.0 45.6 0.2 0.0 6.3 1.8 1.2 5.2 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.9 0.0 758.4 0.3 0.0 0.3 0.2 0.2 0.0 0.1 0.0 1.0 0.0 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4006.8" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 31.5;RPTEC TERT1: 104.5" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 11.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 31.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 104.5 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 71.5 39.6 6.7 11.1 12.6 0.0 0.0 359.2 6.7 34.2 221.6 0.0 0.0 351.5 818.0 0.0 1.6 60.9 140.2 656.9 0.0 0.9 37.3 10.4 1.0 0.2 0.0 38.1 2.5 0.3 0.0 3.1 1.5 8.5 21.6 123.8 0.5 959.8 81.8 0.0 4006.8 0.0 0.0 2.3 0.0 0.1 47.2 0.7 1.5 119.5 16.8 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521794 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 92.9;kidney: 106.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1020.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm NA NA 1000000000 Nucleoplasm "HPA015599: AB_1855192, HPA072045: AB_2732194" "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 23.5 17.2 9.8 8.9 10.4 4.1 21.8 7.6 14.9 9.8 60.1 18.7 6.9 58.1 14.3 11.5 14.9 9.6 13.6 8.0 10.8 9.1 106.0 48.6 11.1 10.6 16.0 7.7 12.6 9.0 9.6 12.5 10.4 13.0 9.2 6.6 13.3 9.6 9.0 9.7 11.4 92.9 10.4 17.4 13.4 9.3 8.4 11.5 8.4 15.0 9.7 10.6 11.9 11.9 17.1 32.3 27.5 39.1 16.8 25.8 32.6 13.3 36.3 10.7 17.3 45.7 17.6 24.8 11.9 24.4 15.2 17.3 31.6 11.8 5.4 17.8 29.8 11.7 3.5 15.4 9.7 12.5 15.4 15.2 34.7 7.4 32.1 31.3 10.1 42.1 21.7 9.2 13.8 8.6 11.2 20.3 10.7 6.6 15.8 16.5 16.3 7.7 3.4 14.7 26.6 14.8 15.2 14.6 15.0 13.1 35.3 13.2 33.8 22.2 11.0 17.9 9.4 7.6 11.0 16.9 14.7 15.9 19.0 13.7 14.5 21.5 4.8 15.7 14.6 20.9 27.5 36.1 2.5 25.8 39.1 22.6 17.1 25.7 23.8 32.3 16.3 16.9 19.6 1.9 16.8 27.2 9.9 23.6 32.6 9.8 10.4 7.6 14.9 10.8 9.1 16.0 7.7 13.0 11.5 20.8 24.3 20.2 26.1 17.2 33.9 11.7 43.3 26.8 11.4 69.8 3.9 19.3 167.5 63.4 7.6 44.9 37.6 0.0 38.3 59.7 34.6 21.4 55.5 161.7 189.6 58.8 16.6 35.0 46.9 8.9 45.8 63.2 64.1 131.7 14.5 69.3 37.3 28.5 57.0 1020.8 23.8 38.8 38.8 11.4 48.3 17.8 25.4 31.0 16.7 18.0 PIPOX LPIPOX ENSG00000179761 "Pipecolic acid and sarcosine oxidase" Q9P0Z9 17 28950513-29057220 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "kidney: 33.5;liver: 114.3" "Group enriched" "Detected in many" 6 "Hepatocytes: 183.0;Proximal tubular cells: 123.0" "Group enriched" "Detected in many" 13 "glioma: 15.5;liver cancer: 73.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AF22: 12.5;Hep G2: 37.6;NTERA-2: 24.8;RH-30: 35.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 390000 "unprognostic (8.02e-2)" "unprognostic (3.50e-4)" "unprognostic (3.03e-1)" "unprognostic (6.25e-3)" "unprognostic (1.52e-1)" "unprognostic (5.01e-2)" "unprognostic (1.95e-3)" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (3.45e-1)" "prognostic favorable (1.49e-4)" "unprognostic (2.39e-1)" "unprognostic (3.13e-3)" "unprognostic (2.58e-3)" "unprognostic (2.01e-1)" "unprognostic (2.79e-2)" "unprognostic (1.22e-1)" 0.2 0.2 2.4 0.2 3.1 0.1 0.2 2.2 2.9 0.2 1.4 3.8 0.0 3.1 0.4 5.8 0.5 2.1 0.8 0.2 3.5 2.5 33.5 114.3 0.3 0.3 3.6 3.1 0.3 0.2 0.3 0.2 1.0 4.0 0.5 0.3 0.2 0.2 0.9 0.1 0.2 2.6 0.6 1.7 0.3 0.2 0.2 0.7 0.0 0.1 0.0 0.2 0.3 0.1 0.7 4.7 3.7 0.7 0.9 1.9 0.7 0.0 0.0 12.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.1 37.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.2 24.8 0.7 0.0 0.1 35.8 0.7 0.0 0.0 4.0 1.2 0.1 0.0 0.2 2.1 0.0 1.5 0.0 0.0 0.0 0.0 1.6 0.3 4.2 0.1 0.0 0.2 1.2 1.8 0.7 0.7 0.8 0.5 0.9 0.3 0.5 1.2 4.7 0.7 0.3 1.9 3.7 0.9 0.3 0.4 0.8 0.7 2.4 3.1 2.2 2.9 3.5 2.5 3.6 3.1 4.0 0.7 0.0 1.1 2.2 0.2 0.2 1.7 0.4 5.1 0.0 0.0 0.0 3.9 0.1 8.3 0.0 1.3 0.6 0.7 0.0 0.2 4.4 0.4 0.3 5.7 183.0 1.2 0.0 1.2 2.5 3.5 1.5 0.3 1.7 0.0 3.6 0.0 24.0 0.0 0.0 1.1 123.0 1.3 0.0 0.4 0.0 1.0 0.1 0.3 0.5 0.0 0.1 PKHD1 "ARPKD, FCYT, FPC, TIGM1" ENSG00000170927 "PKHD1, fibrocystin/polyductin" P08F94 6 51615300-52087625 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 19.8;kidney: 49.4;pancreas: 32.9" "Group enriched" "Detected in some" 5 "Cholangiocytes: 56.0;Collecting duct cells: 43.6;Early spermatids: 167.1;Late spermatids: 63.8" "Group enriched" "Detected in some" 5 "pancreatic cancer: 1.4;renal cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA031227 Enhanced NA NA "HPA031227: AB_10602068" "unprognostic (6.34e-3)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" "unprognostic (1.35e-1)" "unprognostic (3.80e-2)" "unprognostic (1.29e-2)" "unprognostic (4.03e-2)" "unprognostic (6.42e-2)" "unprognostic (7.08e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (2.62e-2)" "prognostic favorable (9.74e-8)" "unprognostic (2.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 5.6 0.0 0.1 19.8 0.1 0.1 6.3 0.1 0.1 0.1 49.4 2.5 0.1 0.0 0.1 0.0 0.1 32.9 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.1 0.5 1.4 0.0 0.0 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.5 15.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 56.0 0.0 0.0 43.6 0.0 0.1 1.7 11.7 167.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.0 0.0 0.0 63.8 2.0 0.0 5.0 0.0 0.0 1.9 2.9 0.0 0.4 17.7 0.0 0.0 0.0 1.4 1.8 0.0 0.0 0.0 0.0 0.1 PKLR ENSG00000143627 "Pyruvate kinase L/R" P30613 1 155289293-155301434 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.2;kidney: 12.4;liver: 47.8" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2" "Cancer enriched" "Detected in some" 9 "liver cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "K-562: 48.5" "Region enhanced" "Detected in single" "basal ganglia: 1.7" "Not detected" "Not detected" "HPA006653, CAB034376, CAB034378" Enhanced Approved "Golgi apparatus,Cytosol" No NA 2900000 "Golgi apparatus, Cytosol" "CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632" "unprognostic (9.16e-2)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (2.62e-1)" "unprognostic (7.86e-4)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (8.79e-2)" "unprognostic (1.89e-1)" "unprognostic (4.07e-1)" "unprognostic (4.53e-2)" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (6.21e-3)" 0.1 0.0 0.1 0.3 0.1 7.2 0.1 0.9 0.2 0.1 4.9 0.1 0.1 5.8 0.1 1.3 0.1 0.0 0.7 0.1 0.1 0.4 12.4 47.8 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 17.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 8.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 31.5;Proximal tubular cells: 27.8" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.8;SCLC-21H: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.9 10.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 0.0 4.6 0.0 0.0 0.0 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 31.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.1 0.0 1.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 55.8;Distal tubular cells: 23.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.6 26.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.9 0.6 0.0 31.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.0 0.0 0.0 55.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PPARGC1A "PGC-1alpha, PGC1, PGC1A, PPARGC1" ENSG00000109819 "PPARG coactivator 1 alpha" Q9UBK2 4 23755041-23904089 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Activator, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 49.5;liver: 49.7;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 81.8;Cholangiocytes: 66.2;Early spermatids: 52.7;Hepatocytes: 48.9;Late spermatids: 51.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "A-431: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063136 Supported Nucleoplasm NA NA Nucleoplasm "HPA063136: AB_2684948" "unprognostic (1.08e-1)" "unprognostic (7.47e-2)" "unprognostic (6.85e-3)" "unprognostic (2.28e-6)" "unprognostic (5.00e-2)" "unprognostic (1.15e-1)" "prognostic favorable (3.35e-6)" "unprognostic (3.04e-1)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (6.77e-2)" "unprognostic (4.58e-2)" "prognostic favorable (1.49e-14)" "unprognostic (3.62e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.07e-3)" 5.7 2.4 3.1 2.4 4.2 0.3 1.3 4.7 5.5 2.6 9.4 4.2 1.8 5.7 0.9 4.8 3.0 1.2 2.2 24.6 3.3 3.1 49.5 49.7 2.5 0.4 3.1 1.8 1.3 2.8 14.6 7.6 0.3 7.8 2.6 6.6 14.0 30.4 3.0 55.6 5.5 14.2 1.6 3.2 0.8 3.1 3.4 3.4 0.3 17.4 18.2 1.5 1.7 1.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 43.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 2.1 5.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.3 0.0 6.3 0.0 2.1 0.1 1.4 0.0 1.8 2.2 0.2 0.7 0.0 0.4 0.4 0.0 0.8 3.9 0.0 0.0 0.8 0.7 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 4.2 4.7 5.5 3.3 3.1 3.1 1.8 7.8 3.4 17.9 1.6 1.7 5.5 0.8 3.8 81.8 66.2 8.1 6.8 34.9 37.3 0.0 44.7 6.6 52.7 0.3 26.8 0.0 0.0 0.0 0.2 1.4 1.1 48.9 0.0 0.0 25.6 1.8 2.4 51.4 0.9 0.0 6.8 0.0 13.0 5.8 0.9 7.0 2.1 22.6 0.7 0.0 5.1 0.7 0.2 1.0 0.0 1.0 10.8 0.4 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "kidney: 51.2;liver: 49.3" "Group enriched" "Detected in some" 8 "Hepatocytes: 140.6;Proximal tubular cells: 216.9" "Group enriched" "Detected in some" 50 "liver cancer: 28.1;renal cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "Hep G2: 26.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA051287 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051287: AB_2681420" "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.7 0.1 0.0 0.3 0.1 0.1 0.0 51.2 49.3 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.3 0.0 0.0 0.0 12.2 0.0 0.0 23.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.6 0.1 0.0 0.0 1.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 216.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PSAT1 PSA ENSG00000135069 "Phosphoserine aminotransferase 1" Q9Y617 9 78297143-78330093 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 56.0;liver: 112.2" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 129.9;Proximal tubular cells: 244.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.3" "Lineage enriched" "Detected in many" 4 "T-cells: 13.3" "Cell line enhanced" "Detected in many" "hTCEpi: 147.9;SK-MEL-30: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014882, CAB040567, HPA042924" Enhanced Enhanced Cytosol NA NA 1700000 Cytosol "CAB014882: , CAB040567: , HPA042924: AB_2678223" "unprognostic (8.26e-3)" "unprognostic (4.69e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.62e-5)" "unprognostic (4.05e-3)" "unprognostic (1.41e-1)" "unprognostic (2.21e-3)" "unprognostic (1.86e-1)" "unprognostic (9.85e-2)" "unprognostic (2.25e-2)" "unprognostic (4.53e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.87e-3)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (1.71e-1)" 3.1 25.0 44.6 3.8 33.4 1.7 3.0 8.5 50.5 2.4 3.3 44.8 0.9 3.2 2.7 28.4 9.3 16.0 1.6 1.4 33.9 22.3 56.0 112.2 1.6 4.5 42.2 24.6 3.7 54.6 4.8 2.1 2.2 21.9 5.3 3.3 8.1 26.2 2.8 1.1 24.7 2.8 2.3 29.8 2.4 7.0 5.1 35.0 2.2 13.7 4.9 5.9 4.2 2.6 3.0 0.2 0.2 0.1 0.0 13.3 3.1 26.7 18.0 15.2 26.9 4.5 5.3 35.9 22.7 16.2 11.6 21.7 4.6 5.2 17.4 10.1 51.1 10.5 26.6 25.9 25.1 17.4 17.0 9.2 5.9 8.3 35.4 41.6 33.1 10.7 16.9 147.9 15.3 41.1 2.8 10.5 68.0 6.3 44.8 9.6 10.0 11.3 5.3 34.8 50.3 19.7 5.6 9.8 20.4 15.8 6.2 6.9 16.0 6.3 10.9 90.5 10.0 5.2 41.8 2.4 2.9 9.5 10.8 18.4 30.5 28.1 0.1 34.2 26.2 13.9 0.0 0.0 0.0 4.9 0.0 5.7 3.0 4.8 6.5 0.2 1.0 7.9 7.3 0.2 0.0 0.1 0.0 13.3 3.1 44.6 33.4 8.5 24.9 33.9 22.3 42.2 24.6 21.9 35.0 0.0 0.0 16.4 6.8 37.3 0.8 0.5 0.0 2.7 0.0 10.4 0.0 25.8 53.0 14.1 1.3 2.1 0.7 46.7 41.7 10.5 2.4 14.9 0.0 129.9 4.4 4.8 3.5 3.7 3.2 1.7 4.6 1.8 18.6 6.4 2.0 22.2 28.4 0.0 1.8 244.0 1.3 0.0 1.0 1.4 2.8 44.4 7.8 4.4 3.0 11.2 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTGER1 EP1 ENSG00000160951 "Prostaglandin E receptor 1" P34995 19 14472466-14475362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 13.6;lymphoid tissue: 14.2" "Cell type enriched" "Detected in some" 75 "Collecting duct cells: 188.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.5;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 2.9;PC-3: 7.2;SH-SY5Y: 4.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (3.31e-1)" "unprognostic (2.68e-1)" "unprognostic (3.50e-4)" "unprognostic (8.69e-2)" "unprognostic (5.58e-2)" "unprognostic (2.39e-2)" "unprognostic (3.19e-2)" "unprognostic (2.05e-1)" "unprognostic (3.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (7.74e-8)" "unprognostic (1.19e-1)" "unprognostic (4.41e-2)" "unprognostic (4.27e-3)" "unprognostic (4.88e-2)" 0.7 1.4 1.1 2.7 1.3 0.2 1.5 0.6 1.2 1.3 1.5 0.1 0.0 1.2 0.4 0.3 1.7 1.0 0.4 3.1 0.4 0.4 13.6 0.5 4.9 6.7 1.8 0.0 1.6 1.8 0.2 1.4 0.3 1.0 0.5 0.3 0.3 0.3 0.4 0.7 0.2 1.9 1.4 0.1 14.2 3.2 0.4 0.6 0.0 0.7 0.0 0.3 0.6 1.3 0.0 0.4 0.0 1.5 2.6 1.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.3 0.6 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.9 0.3 0.0 7.2 0.8 0.0 0.2 0.0 0.1 0.5 4.2 0.1 0.1 0.2 0.0 0.2 0.4 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.2 1.1 1.3 0.6 1.2 0.4 0.4 1.8 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.8 2.5 0.0 0.0 188.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.2 PTH1R "PTHR, PTHR1" ENSG00000160801 "Parathyroid hormone 1 receptor" Q03431 3 46877746-46903799 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 90.4" "Cell type enhanced" "Detected in many" 20 "Distal tubular cells: 81.2;Proximal tubular cells: 259.5;Sertoli cells: 135.8" "Cancer enhanced" "Detected in many" "renal cancer: 18.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075879 Enhanced NA NA "HPA075879: " "unprognostic (1.26e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-5)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (5.02e-2)" "unprognostic (3.84e-3)" "unprognostic (5.47e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (7.51e-2)" "unprognostic (8.44e-2)" "prognostic favorable (6.79e-6)" "unprognostic (4.22e-3)" "unprognostic (1.50e-1)" "unprognostic (1.35e-4)" "unprognostic (6.62e-3)" 8.5 17.9 4.2 1.4 5.9 0.8 5.0 3.7 5.0 6.2 2.3 5.2 1.1 1.5 4.5 2.5 2.3 3.8 2.8 4.3 5.5 3.9 90.4 13.4 4.1 6.9 6.0 5.0 5.4 1.6 1.0 0.9 10.1 4.7 3.2 1.2 3.4 1.5 3.0 4.0 2.6 1.8 4.6 4.1 9.6 1.5 2.2 5.7 0.0 1.2 0.6 1.0 2.8 5.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 7.2 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.3 0.0 51.7 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 5.9 3.7 5.0 5.5 3.9 6.0 5.0 4.7 5.7 0.0 0.0 0.5 0.0 1.1 0.7 2.2 0.0 0.0 0.0 31.4 0.0 0.5 81.2 0.0 8.7 1.5 0.0 0.0 0.5 48.7 10.8 0.0 0.0 0.4 1.8 1.6 0.0 22.1 1.5 22.5 5.5 0.0 0.0 0.0 0.0 3.0 0.2 0.0 2.1 259.5 0.6 135.8 3.1 0.7 1.3 0.6 0.7 0.0 0.0 0.1 PTPRO "GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2" ENSG00000151490 "Protein tyrosine phosphatase, receptor type O" Q16827 12 15322397-15597399 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;intestine: 28.5;kidney: 21.6" "Cell type enhanced" "Detected in some" 7 "Bipolar cells: 16.3;Collecting duct cells: 15.7;Hofbauer cells: 22.6;Horizontal cells: 23.8;Kupffer cells: 17.2;monocytes: 19.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 8.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "GAMG: 13.0;NTERA-2: 8.2;SCLC-21H: 5.0;SH-SY5Y: 9.9;THP-1: 4.1" "Region enhanced" "Detected in many" "olfactory region: 215.3" "Low region specificity" "Detected in all" HPA034525 Enhanced "Intracellular and membrane" NA NA "HPA034525: AB_10669785" "unprognostic (3.68e-2)" "unprognostic (3.49e-1)" "unprognostic (9.64e-2)" "unprognostic (1.25e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-1)" "unprognostic (5.93e-3)" "unprognostic (5.37e-2)" "unprognostic (2.03e-1)" "unprognostic (3.72e-2)" "unprognostic (2.00e-1)" "unprognostic (5.43e-2)" "unprognostic (4.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 3.3 1.2 16.2 3.1 26.1 0.6 1.1 1.0 15.3 1.7 10.4 1.5 0.0 2.0 4.5 2.1 0.8 1.2 1.6 0.7 11.3 10.6 21.6 1.6 6.7 3.2 4.8 8.8 0.7 0.6 0.6 3.8 4.4 4.0 0.7 28.5 1.1 0.8 1.1 0.5 0.7 1.9 7.1 2.6 3.6 1.0 0.9 3.5 0.0 0.5 0.0 3.5 1.7 0.5 8.3 9.5 0.0 10.5 0.1 2.9 2.7 0.0 0.1 0.5 0.3 0.5 0.1 0.2 0.0 0.0 0.8 2.0 0.0 0.0 0.3 0.1 0.0 13.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 8.2 1.7 0.0 0.0 0.0 0.0 0.1 0.2 5.0 9.9 1.2 0.0 0.1 0.1 0.1 4.1 0.0 0.1 0.3 0.0 0.3 1.2 0.0 0.4 0.1 0.3 1.5 0.0 5.2 0.0 0.0 10.5 0.0 8.3 1.7 0.4 7.4 7.0 2.9 1.3 0.0 0.1 10.5 9.5 1.3 2.7 16.2 26.1 1.0 15.3 11.3 10.6 4.8 8.8 4.0 3.5 0.0 0.3 4.5 0.8 0.2 16.3 0.6 0.0 0.0 3.4 15.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 22.6 23.8 3.5 1.8 17.2 0.0 0.6 9.2 0.0 19.0 2.6 0.3 0.1 3.5 0.4 0.0 4.6 0.0 0.4 0.3 1.0 0.4 0.2 0.0 11.2 0.7 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425619-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.5" "Cell type enriched" "Detected in many" 14 "Proximal tubular cells: 333.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Enhanced Enhanced "Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria" Yes No "Vesicles, Centriolar satellite" "Nucleoplasm, Cytokinetic bridge, Mitochondria" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favorable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favorable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favorable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 10.2 13.4 19.3 7.5 16.9 8.7 7.3 29.7 27.4 11.5 10.6 12.2 9.0 13.4 11.9 11.0 8.2 9.5 11.3 14.0 18.7 12.1 70.5 12.2 10.5 8.1 12.0 18.0 13.4 22.2 22.4 14.6 10.0 10.6 11.5 5.4 9.9 13.2 12.6 23.5 12.2 14.6 10.8 8.9 10.2 7.6 13.5 11.9 5.7 8.6 7.4 5.3 9.7 16.6 1.1 0.8 0.1 0.1 0.1 1.5 0.6 4.4 10.2 9.8 8.6 14.5 9.5 8.5 8.5 8.0 7.8 5.6 7.5 2.1 12.3 10.0 12.4 6.9 4.6 6.1 9.0 2.7 9.1 8.7 5.5 9.5 21.7 15.5 5.5 6.9 9.1 6.2 8.0 7.0 9.1 11.9 8.5 2.8 4.9 9.8 13.7 8.9 10.9 8.2 3.2 4.2 18.5 7.8 3.2 7.8 2.7 10.2 9.5 8.7 10.7 5.4 3.5 5.9 10.2 19.2 11.4 7.6 10.6 5.6 6.8 5.3 14.5 4.3 3.9 8.4 0.0 0.1 0.0 1.5 0.0 1.3 0.8 0.9 0.7 0.5 1.1 0.6 0.3 0.1 0.1 0.0 0.8 0.0 0.6 19.3 16.9 29.7 27.4 18.7 12.1 12.0 18.0 10.6 11.9 3.0 1.7 3.4 0.4 3.3 8.2 11.7 7.6 4.0 6.8 5.2 5.9 0.8 23.2 1.4 1.0 2.5 6.4 0.0 1.0 0.1 2.3 1.1 1.1 14.1 0.7 20.6 2.9 19.6 5.1 1.6 0.6 1.2 0.0 0.0 2.7 6.1 1.6 1.7 1.8 333.9 7.1 6.5 2.1 2.7 3.0 1.9 0.7 2.6 4.1 0.3 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 38.5;Distal tubular cells: 150.9;Horizontal cells: 31.8;Muller glia cells: 33.3" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 26.8" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055868: AB_2682950, HPA059112: AB_2683908" "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 26.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 0.0 0.0 0.0 0.0 0.0 38.5 4.4 22.9 0.0 0.0 7.0 2.0 0.0 150.9 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 31.8 1.7 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 14.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 8.7;Distal tubular cells: 39.7;Muller glia cells: 12.8;Sertoli cells: 12.9" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 8.7 0.0 0.0 39.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.2 0.0 1.3 1.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 1.7 0.0 0.0 12.8 0.0 0.0 2.1 0.1 0.5 12.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RARRES3 "HRASLS4, TIG3" ENSG00000133321 "Retinoic acid receptor responder 3" Q9UL19 11 63536809-63546462 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 86.6" "Cell type enhanced" "Detected in many" 9 "Proximal tubular cells: 687.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 60.2;HHSteC: 22.0;HSkMC: 22.0;RPTEC TERT1: 30.5;SK-BR-3: 46.1;U-266/70: 23.0" NA NA "prognostic favorable (1.35e-5)" "prognostic favorable (4.00e-4)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "unprognostic (6.91e-2)" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (6.26e-6)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (3.42e-1)" "unprognostic (2.11e-1)" "unprognostic (9.36e-3)" "unprognostic (2.64e-1)" 13.3 5.9 15.0 16.4 14.6 4.6 30.9 3.1 10.6 13.7 32.7 12.9 12.5 25.1 16.0 18.6 12.1 29.7 21.0 7.3 11.7 10.2 86.6 31.8 36.5 23.5 12.1 10.8 23.1 8.2 0.2 7.9 5.8 8.7 25.0 16.8 9.8 25.4 23.5 7.1 2.6 50.0 12.6 15.0 21.6 18.0 5.4 11.4 24.0 66.4 8.5 17.0 14.3 7.5 10.9 6.6 30.8 15.4 33.3 66.1 63.1 5.8 3.6 0.0 0.1 5.5 19.1 1.3 0.5 10.1 7.7 7.0 0.1 60.2 0.9 5.1 1.0 6.1 1.6 1.3 1.0 1.6 9.9 0.0 0.3 0.4 0.0 22.0 0.1 0.2 22.0 0.1 2.9 0.0 16.2 0.9 2.0 0.0 7.7 1.1 0.0 14.1 1.1 0.0 0.9 0.5 6.4 0.0 0.4 30.5 1.2 0.0 0.0 1.2 46.1 2.4 0.3 5.4 0.4 1.7 0.5 0.0 1.1 0.2 23.0 0.3 0.2 2.3 3.6 0.4 30.8 11.3 7.1 63.6 15.4 47.3 10.9 47.6 66.1 6.6 7.2 41.5 53.7 8.4 33.3 12.5 0.8 35.7 63.1 15.0 14.6 3.1 10.6 11.7 10.2 12.1 10.8 8.7 11.4 291.8 62.1 57.5 128.0 17.3 0.2 5.0 76.5 232.9 87.6 82.0 0.0 11.3 252.0 40.6 0.1 30.9 264.6 0.0 98.0 19.1 35.1 48.0 63.4 78.1 25.0 0.0 20.1 56.4 44.3 1.1 68.7 43.5 13.5 14.4 46.4 43.6 91.5 259.6 19.1 687.8 1.1 6.5 15.5 0.4 0.0 11.2 25.2 276.7 11.5 252.0 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7123684-7128942 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 2221.9" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 12 "granulocytes: 1.3;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HEL: 7.0;Hep G2: 15.6;K-562: 32.0" "Low region specificity" "Detected in all" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA038723: AB_2676175" "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favorable (3.68e-4)" 1.5 2.6 0.3 18.2 0.3 0.7 1.3 0.6 0.3 2.8 1.7 0.1 2.3 1.4 5.3 13.3 2.3 1.5 3.6 2.3 0.3 0.3 99.9 74.2 3.6 54.3 0.2 0.0 3.5 1.3 0.2 1.6 0.1 0.1 2.6 1.6 0.7 5.9 3.3 0.4 0.7 4.4 1.8 0.2 44.3 1.2 1.2 0.0 6.2 2.0 0.7 10.1 2.3 1.4 0.1 0.0 1.3 0.0 0.0 2.4 0.1 1.8 3.2 0.0 1.0 0.0 0.0 0.7 1.2 0.0 0.0 0.2 1.7 2.0 1.1 0.5 0.0 0.2 2.3 0.1 0.0 0.0 2.8 0.0 7.0 5.0 15.6 0.0 0.4 2.0 0.3 0.1 0.0 0.0 3.2 0.0 1.1 32.0 1.5 0.0 0.0 0.1 0.4 0.4 0.0 0.1 0.4 0.0 0.1 0.1 2.7 0.1 0.3 2.8 1.1 0.0 0.9 0.6 1.1 1.1 1.3 1.3 3.7 0.5 0.6 0.2 0.2 0.9 1.5 0.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.4 0.1 0.3 0.3 0.6 0.3 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.1 1.4 0.4 1.3 1.2 0.0 2.5 1.4 0.0 76.8 0.0 0.0 298.4 0.2 3.2 9.0 0.0 0.0 0.4 0.0 0.9 0.4 0.0 302.4 0.1 4.8 0.0 10.4 6.4 5.4 2.3 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.4 2221.9 1.6 0.0 1.0 0.2 0.4 1.9 0.0 2.1 0.0 0.3 REN ENSG00000143839 Renin P00797 1 204154819-204190324 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 63.6" "Group enriched" "Detected in some" 5 "Early spermatids: 6.1;Late spermatids: 19.3" "Cancer enriched" "Detected in many" 8 "renal cancer: 39.4" "Region enriched" "Detected in single" 12 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.4;BJ: 4.9;HMC-1: 6.5;RT4: 1.8;SK-BR-3: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005131 Approved "Secreted to blood" NA NA 692000 "HPA005131: AB_1079174" "unprognostic (4.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.62e-1)" "unprognostic (8.58e-2)" "unprognostic (2.89e-1)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.37e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (6.49e-2)" 0.4 0.3 0.0 0.0 1.2 0.0 0.5 0.0 0.0 3.1 0.2 0.0 0.8 0.1 4.4 13.5 0.1 0.3 0.0 0.6 0.0 0.0 63.6 0.4 0.3 0.0 0.0 0.0 11.6 0.0 0.0 0.4 14.4 0.0 0.3 0.1 0.4 0.3 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.0 0.2 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 4.9 1.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 4.6 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 1.2 6.1 0.0 0.0 0.0 1.0 0.2 0.1 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.0 2.7 RENBP "RBP, RNBP" ENSG00000102032 "Renin binding protein" P51606 X 153935263-153944691 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 32.7;lymphoid tissue: 36.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 128.8;Hofbauer cells: 156.0;Ito cells: 72.4;Proximal tubular cells: 157.3" "Cancer enhanced" "Detected in all" "melanoma: 57.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;HMC-1: 44.8;SK-MEL-30: 29.7;U-266/84: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000428, HPA000522" Enhanced NA NA 42000 "HPA000428: AB_1079799, HPA000522: AB_1079798" "unprognostic (3.08e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.12e-2)" "unprognostic (3.29e-1)" "unprognostic (8.83e-3)" "unprognostic (1.85e-1)" "unprognostic (5.22e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.47e-3)" "unprognostic (1.99e-1)" "prognostic favorable (3.08e-5)" "unprognostic (2.39e-2)" "unprognostic (6.57e-2)" "unprognostic (4.25e-2)" "unprognostic (8.51e-2)" 12.7 11.1 7.8 11.2 16.8 8.6 8.4 2.3 11.5 4.2 6.2 11.3 1.1 7.4 2.1 6.0 3.0 2.5 5.7 8.7 9.4 9.1 32.7 4.6 12.8 12.1 16.9 7.4 1.2 1.6 1.8 3.4 8.1 11.6 3.6 3.0 9.6 3.4 2.0 1.4 5.2 7.5 4.5 12.7 36.5 4.4 1.4 13.5 3.0 2.9 1.1 4.4 5.7 2.9 1.1 0.6 5.3 3.1 0.3 0.9 0.7 0.0 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 10.0 0.0 0.9 7.7 0.0 44.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.8 3.5 0.0 0.2 2.0 0.1 0.1 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 29.7 1.1 0.0 3.5 0.4 0.0 0.3 0.0 0.0 4.5 25.7 1.8 0.9 4.7 3.5 2.9 2.0 5.3 0.3 1.4 0.3 1.1 0.1 0.1 0.2 0.6 0.9 0.4 4.5 0.3 3.1 0.6 0.0 0.7 7.8 16.8 2.3 11.5 9.4 9.1 16.9 7.4 11.6 13.5 0.0 2.1 9.7 1.1 4.1 1.6 0.8 5.1 0.0 0.0 8.7 0.0 1.0 31.5 1.0 0.0 4.3 1.3 0.0 0.3 4.4 2.3 1.3 128.8 0.8 156.0 14.3 1.7 72.4 62.0 0.0 0.3 37.4 27.0 35.1 0.5 12.6 0.5 0.9 0.4 157.3 0.7 12.9 3.9 0.0 1.2 1.8 2.4 7.9 0.5 0.4 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 21.0 0.0 0.0 16.6 0.3 10.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 4.3 0.1 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 1.0 0.0 1.1 0.1 0.0 0.4 0.9 0.0 0.0 0.0 2.2 0.4 0.4 0.0 0.0 0.0 0.0 RIDA "HRSP12, P14.5, PSP, UK114" ENSG00000132541 "Reactive intermediate imine deaminase A homolog" P52758 8 98102344-98117241 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "kidney: 81.4;liver: 248.6" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1135.9" "Cancer enhanced" "Detected in all" "liver cancer: 162.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022856, HPA023489" Enhanced NA NA 5700000 "HPA022856: AB_1858253, HPA023489: AB_1858252" "unprognostic (1.67e-2)" "unprognostic (3.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (4.16e-1)" "unprognostic (2.20e-2)" "prognostic favorable (9.61e-6)" "unprognostic (6.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.81e-1)" "unprognostic (4.46e-1)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-2)" "unprognostic (1.51e-2)" 8.3 9.4 16.8 2.5 18.8 1.6 4.2 5.6 11.6 2.6 4.7 4.5 2.7 5.8 2.1 4.8 2.8 2.2 4.3 5.2 11.7 12.5 81.4 248.6 2.2 2.1 19.1 9.5 4.6 5.2 3.5 1.8 2.4 11.8 4.0 4.8 2.3 3.2 2.7 6.8 2.3 4.2 2.5 7.9 1.8 4.6 3.3 9.5 0.6 3.2 3.5 2.6 3.2 1.8 12.1 10.0 5.0 8.3 8.4 12.8 7.1 13.9 12.1 9.8 11.9 22.2 17.3 10.7 12.9 9.1 8.6 10.4 16.4 9.4 19.8 16.6 9.4 11.5 9.9 21.4 18.3 17.5 6.9 9.2 14.4 8.2 17.5 10.1 5.3 2.3 14.9 6.3 12.1 13.3 10.9 11.1 21.4 25.6 4.3 11.5 18.1 11.2 14.4 15.5 61.2 22.1 13.0 7.1 5.7 20.8 10.0 10.6 5.3 8.2 5.7 8.9 13.0 14.5 7.0 6.7 6.7 4.2 11.3 5.1 10.3 14.1 9.7 11.7 11.2 4.3 0.1 8.3 5.0 6.5 7.0 8.3 12.1 9.4 9.5 10.0 9.5 12.2 12.8 1.5 8.4 7.0 7.6 12.3 7.1 16.8 18.8 5.6 11.6 11.7 12.5 19.1 9.5 11.8 9.5 23.8 15.3 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.4 45.4 0.0 25.5 242.1 13.4 0.0 0.0 0.0 0.0 7.5 23.7 0.0 0.0 2.3 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 10.0 0.0 0.0 14.6 0.0 0.0 1135.9 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 RIPPLY1 ENSG00000147223 "Ripply transcriptional repressor 1" Q0D2K3 X 106900063-106903335 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.4;liver: 11.5" "Cell type enriched" "Detected in single" 4 "Hepatocytes: 2.9" "Group enriched" "Detected in some" 6 "liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RH-30: 12.3" "Low region specificity" "Detected in many" HPA052284 Uncertain "Intracellular and membrane" NA NA "HPA052284: AB_2681785" "unprognostic (1.48e-1)" "unprognostic (4.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.52e-3)" "unprognostic (7.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.42e-1)" "unprognostic (5.37e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-3)" "unprognostic (1.97e-1)" "unprognostic (1.97e-1)" "unprognostic (1.97e-3)" "unprognostic (1.31e-1)" 0.2 0.9 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.0 6.4 11.5 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.0 2.4 0.2 1.8 0.4 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 12.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RNF152 FLJ39176 ENSG00000176641 "Ring finger protein 152" Q8N8N0 18 61808063-61894247 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 53.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 71.0;Proximal tubular cells: 104.4;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 16.3;HBEC3-KT: 8.7;SH-SY5Y: 10.1;TIME: 10.1;U-138 MG: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.64e-1)" "unprognostic (8.55e-3)" "unprognostic (2.05e-1)" "unprognostic (2.09e-1)" "unprognostic (2.96e-3)" "unprognostic (3.62e-1)" "unprognostic (1.51e-2)" "unprognostic (8.13e-2)" "unprognostic (5.14e-2)" "unprognostic (6.73e-2)" "prognostic favorable (1.13e-8)" "prognostic unfavorable (2.85e-5)" "unprognostic (3.26e-2)" "unprognostic (2.82e-2)" "unprognostic (4.83e-2)" 8.3 3.9 2.4 2.3 6.8 1.5 8.8 19.1 3.8 8.5 7.4 4.0 6.2 2.2 8.6 10.4 4.5 3.9 8.0 6.5 2.5 3.1 53.7 28.3 7.8 1.2 4.1 1.4 3.8 3.1 4.7 2.6 6.6 7.7 4.7 6.7 3.4 11.8 6.8 4.6 9.6 9.8 4.6 4.2 1.3 5.7 3.9 4.5 0.0 5.1 4.9 2.0 5.0 11.6 0.5 0.4 1.7 0.4 0.6 0.4 0.2 0.0 0.0 3.5 0.8 3.4 0.5 0.0 2.3 7.1 0.5 0.4 0.0 0.1 0.1 0.7 3.6 0.1 16.3 4.4 8.7 1.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 0.5 6.0 2.8 1.7 1.6 6.5 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.2 0.5 0.0 0.2 2.3 0.0 0.3 2.6 3.0 10.1 0.0 6.4 1.1 3.2 3.9 0.0 10.1 16.5 1.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.3 0.3 0.3 0.3 0.2 0.5 0.4 0.4 1.5 0.6 0.4 0.4 0.3 0.2 2.4 6.8 19.1 3.8 2.5 3.1 4.1 1.4 7.7 4.5 0.0 0.0 0.0 21.4 37.5 13.4 2.5 12.7 0.0 2.3 19.2 0.0 0.4 39.7 2.0 0.2 16.3 37.1 0.0 2.4 0.1 8.3 7.3 0.0 71.0 0.1 20.6 15.5 5.5 2.2 0.0 8.1 2.2 27.0 0.0 4.9 3.7 1.1 31.6 17.3 104.4 3.6 64.7 48.4 0.1 0.1 28.4 0.2 0.0 11.8 18.8 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 19.0;kidney: 9.5" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 7.6;Collecting duct cells: 5.2;Intestinal endocrine cells: 8.1;Proximal tubular cells: 18.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 20.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057675 Uncertain NA NA "HPA057675: AB_2683499" "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.9 0.2 0.2 1.2 19.0 5.1 1.2 6.2 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.8 0.3 6.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 3.7 4.3 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 7.6 0.0 0.0 5.2 0.0 0.0 1.7 0.3 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.2 2.1 0.0 0.4 18.3 2.7 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.5 0.8 RNF186 FLJ20225 ENSG00000178828 "Ring finger protein 186" Q9NXI6 1 19814029-19815278 "Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 83.2;Mucus-secreting cells: 32.9;Paneth cells: 108.7;Proximal tubular cells: 98.1;Undifferentiated cells: 113.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034547, HPA035558" Enhanced NA NA "HPA034547: AB_10670975, HPA035558: AB_2674678" "unprognostic (1.66e-2)" "unprognostic (2.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.93e-3)" "unprognostic (1.77e-3)" "unprognostic (3.23e-1)" "unprognostic (3.05e-1)" "unprognostic (3.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (1.40e-1)" "unprognostic (8.60e-3)" 0.2 0.1 0.1 7.8 0.1 0.0 0.8 0.1 0.1 0.2 38.2 0.0 0.5 47.1 0.2 25.8 0.2 0.2 0.1 0.1 0.1 0.1 44.0 0.7 0.1 0.0 0.1 0.0 0.3 30.5 0.0 0.2 0.0 0.0 0.6 5.4 0.0 0.2 0.0 0.1 0.2 59.0 0.0 0.1 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.5 6.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.9 0.0 0.0 17.2 0.0 16.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 7.1 108.7 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.9 0.1 RNF212B C14orf164 ENSG00000215277 "Ring finger protein 212B" A8MTL3 14 23185316-23273477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "kidney: 24.3;testis: 7.5" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 25.0;Late spermatids: 7.6;Proximal tubular cells: 14.6;Spermatocytes: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CAPAN-2: 2.6;Daudi: 3.8;hTERT-RPE1: 1.8;Karpas-707: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" HPA053574 Uncertain NA NA "HPA053574: AB_2682195" "unprognostic (2.88e-1)" "unprognostic (2.17e-1)" "unprognostic (4.65e-1)" "unprognostic (8.54e-2)" "unprognostic (1.30e-1)" "unprognostic (4.79e-1)" "unprognostic (4.48e-2)" "unprognostic (2.98e-2)" "unprognostic (3.82e-1)" "unprognostic (1.83e-2)" "unprognostic (4.96e-3)" "unprognostic (4.45e-1)" "unprognostic (7.33e-5)" "unprognostic (9.60e-2)" "unprognostic (3.40e-1)" "unprognostic (7.56e-2)" "unprognostic (5.39e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 7.5 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 2.6 3.8 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 0.2 2.6 0.0 0.8 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.2 0.0 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.6 0.9 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.4 14.6 0.2 0.0 0.1 14.2 4.2 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Group enriched" "Detected in some" 14 "Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 15.2 0.1 0.4 0.3 0.0 5.0 12.9 0.3 0.7 0.0 0.0 0.0 5.8 7.1 4.5 0.0 9.4 0.0 0.4 0.0 5.7 0.0 0.0 9.1 0.3 0.0 4.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 1.8 0.9 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 24.1 0.0 5.0 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 0.0 0.0 0.0 0.0 0.2 0.0 1.1 7.6 0.0 0.0 8.7 23.6 0.0 10.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.2 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 317.6;Early spermatids: 90.6;Enterocytes: 121.7;Paneth cells: 111.2" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 38.6;SK-BR-3: 41.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" No No "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favorable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.1 8.5 0.2 0.2 0.1 0.6 0.1 2.2 1.3 0.1 0.2 0.0 38.6 1.4 1.7 0.0 0.4 41.8 0.0 0.3 4.4 0.3 0.0 0.1 0.3 0.8 0.1 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 0.0 20.5 0.0 1.3 2.5 0.4 0.8 7.6 22.7 6.8 317.6 0.0 14.0 69.6 0.7 90.6 0.7 121.7 0.0 0.2 3.7 1.3 4.5 38.2 0.0 76.4 0.0 8.7 0.0 0.6 64.0 0.3 3.1 10.1 2.8 36.1 0.5 5.2 111.2 1.1 1.8 2.5 0.0 0.0 3.9 5.4 5.6 55.0 0.0 13.5 7.1 SCNN1A "ENaCalpha, SCNN1" ENSG00000111319 "Sodium channel epithelial 1 alpha subunit" P37088 12 6346843-6377730 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.4" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 108.2;Mucus-secreting cells: 167.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "pons and medulla: 9.4" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012743 Enhanced NA NA "HPA012743: AB_1856627" "unprognostic (1.68e-1)" "unprognostic (4.16e-2)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (5.16e-2)" "unprognostic (6.77e-3)" "unprognostic (3.09e-2)" "unprognostic (2.62e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.86e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (5.56e-2)" "prognostic favorable (9.21e-8)" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" 0.9 3.7 0.4 7.5 0.4 0.0 10.1 0.4 0.9 22.0 20.6 2.2 60.9 5.6 8.1 15.7 47.3 19.3 7.0 0.4 1.1 0.1 100.4 2.2 53.6 0.4 0.5 0.4 5.9 14.2 0.0 10.2 1.6 9.4 15.0 21.5 6.2 53.1 55.5 0.6 14.4 11.8 1.0 0.4 0.4 20.3 2.8 0.4 0.9 74.7 21.1 41.3 10.3 13.8 0.0 3.0 4.4 0.5 0.0 1.7 0.3 5.0 0.9 0.0 0.4 0.0 0.1 4.3 0.0 0.0 0.0 0.0 1.4 71.8 0.0 0.1 0.0 0.0 3.3 0.0 48.2 0.0 0.0 0.0 0.0 4.0 0.7 5.2 0.0 0.0 1.2 20.7 0.0 15.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 4.2 9.1 0.1 0.0 0.0 0.1 25.2 27.0 0.3 0.0 0.5 23.3 0.0 4.3 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.0 0.0 0.2 0.6 0.5 0.0 1.7 0.3 4.4 0.0 0.1 3.0 1.3 0.3 0.4 0.4 0.4 0.9 1.1 0.1 0.5 0.4 9.4 0.4 68.5 63.0 0.0 21.9 1.6 0.8 0.8 68.8 26.8 47.8 108.2 3.9 1.2 5.0 41.1 0.4 1.4 57.4 0.0 30.8 0.2 2.4 31.3 2.3 2.4 0.3 1.6 26.0 0.6 1.9 0.2 1.7 2.1 0.0 1.8 167.5 0.3 24.0 47.5 1.4 4.2 1.6 0.0 1.0 1.4 2.1 7.8 1.4 1.9 31.6 33.3 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "hTCEpi: 31.4;RT4: 14.2" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071194: AB_2686359" "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 17.9 3.4 0.0 4.0 0.3 0.0 0.8 0.0 2.7 21.6 85.5 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 SGK2 ENSG00000101049 "SGK2, serine/threonine kinase 2" Q9HBY8 20 43558968-43588237 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.1;kidney: 39.1;liver: 32.9" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 64.6;Enterocytes: 26.9;Hepatocytes: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.3;CAPAN-2: 8.0;Hep G2: 10.4;OE19: 34.0;RPTEC TERT1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008859, HPA011387" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008859: AB_2668159, HPA011387: AB_1856744" "unprognostic (1.82e-1)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.98e-4)" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.72e-4)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (2.56e-1)" "unprognostic (3.11e-2)" "prognostic favorable (5.65e-4)" 11.4 0.7 2.8 4.3 9.9 0.2 3.1 1.0 10.2 1.4 21.3 33.1 0.9 17.8 1.0 19.7 0.7 1.6 7.9 0.7 4.3 2.5 39.1 32.9 0.6 0.5 6.9 5.1 3.2 14.1 0.5 1.7 0.5 13.7 1.4 23.4 0.0 0.9 1.8 0.4 3.2 20.7 1.0 14.2 0.7 11.9 1.0 6.0 0.0 1.0 0.2 0.2 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 8.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 34.0 0.0 0.0 0.0 0.0 14.7 1.7 0.1 0.4 0.0 0.7 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 9.9 1.0 10.2 4.3 2.5 6.9 5.1 13.7 6.0 0.0 0.0 0.0 0.1 0.1 0.8 2.2 12.7 0.0 0.0 10.4 0.0 3.4 64.6 3.9 0.1 0.1 26.9 0.0 5.4 1.0 0.2 0.1 0.0 26.9 0.6 6.4 1.7 1.3 1.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 2.6 8.4 0.4 15.7 0.8 0.0 0.0 0.0 0.2 0.1 14.3 0.0 5.9 0.1 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397839-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 30.0" "Group enriched" "Detected in some" 9 "Distal tubular cells: 36.5;Ito cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "memory B-cell: 2.1;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Group enriched" "Detected in some" 7 "AN3-CA: 70.7;PC-3: 41.0" "Region enriched" "Detected in single" 24 "olfactory region: 63.3" "Low region specificity" "Detected in some" HPA054754 Approved "Lipid droplets,Cytosol" NA NA Cytosol "Lipid droplets" "HPA054754: AB_2682593" "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.5 2.1 1.0 2.3 3.5 0.1 1.8 0.7 1.3 0.9 5.0 0.1 2.9 2.9 0.3 6.2 8.6 0.4 4.2 12.9 0.9 1.5 30.0 1.0 4.7 15.4 8.3 0.7 1.4 0.3 0.1 0.5 0.2 3.3 2.6 4.1 0.3 1.2 1.5 3.4 0.4 8.4 10.7 1.0 0.6 3.5 2.0 2.2 0.0 4.6 2.6 1.1 6.8 4.7 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 41.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.5 0.7 1.3 0.9 1.5 8.3 0.7 3.3 2.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 36.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 23.9 0.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 57.8;liver: 108.3" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 213.8;Proximal tubular cells: 332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023314, HPA078682" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA023314: AB_1856830, HPA078682: " "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favorable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favorable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 10.9 3.2 2.2 4.9 4.1 2.1 10.4 6.5 3.0 4.6 15.2 5.3 7.3 12.3 2.8 7.4 16.3 3.9 4.0 2.0 2.6 1.8 57.8 108.3 4.3 3.8 3.5 1.9 4.1 3.5 30.1 1.6 2.8 3.6 3.4 3.5 7.2 9.8 8.0 5.7 6.2 15.1 2.3 2.9 8.6 3.9 6.3 3.8 11.1 10.9 10.8 8.7 4.3 6.3 8.6 6.7 6.2 10.6 13.0 18.7 7.9 22.6 23.0 7.3 11.4 18.6 11.6 27.0 4.8 5.9 16.1 17.8 22.8 10.1 17.6 14.3 4.1 11.7 22.4 15.2 19.3 9.2 10.5 22.2 7.9 18.0 17.2 4.7 5.2 8.6 9.7 7.6 12.5 5.6 6.5 11.0 22.7 6.6 4.0 5.7 16.7 26.1 7.3 9.1 34.5 7.5 21.4 28.9 14.9 25.6 15.4 10.0 5.3 32.6 6.2 8.2 38.7 25.4 7.5 2.6 3.1 9.3 28.4 15.1 8.2 7.8 7.1 6.1 12.4 7.4 6.0 8.2 6.2 10.1 10.6 17.1 8.6 12.3 12.8 6.7 6.9 12.3 13.0 0.1 13.0 7.5 3.1 18.7 7.9 2.2 4.1 6.5 3.0 2.6 1.8 3.5 1.9 3.6 3.8 11.9 26.5 19.1 16.8 9.2 2.8 2.2 25.5 2.7 9.1 34.9 3.9 17.7 69.6 11.6 4.9 4.3 8.4 0.0 7.0 62.1 4.8 6.6 8.1 213.8 31.1 0.0 1.2 10.4 27.9 4.1 5.5 5.0 11.8 5.4 10.3 31.2 5.1 7.0 2.8 332.8 3.9 19.4 3.8 15.6 21.8 9.3 7.1 10.0 29.5 4.8 SIM1 bHLHe14 ENSG00000112246 "Single-minded family bHLH transcription factor 1" P81133 6 100385015-100464929 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5" "Group enriched" "Detected in some" 4 "Collecting duct cells: 19.2;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in single" "renal cancer: 1.8" "Region enriched" "Detected in single" 21 "hypothalamus: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7" "Region enriched" "Detected in single" 7 "hypothalamus: 6.1" "Group enriched" "Detected in some" 5 "basal ganglia: 2.6;hypothalamus: 5.2" HPA024385 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024385: AB_1856879" "unprognostic (1.04e-1)" "unprognostic (4.34e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-1)" "unprognostic (4.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (4.64e-2)" "unprognostic (3.76e-2)" "prognostic favorable (5.32e-7)" "unprognostic (1.00e-1)" "unprognostic (1.19e-1)" 5.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 13.2 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 2.2 21.6 0.5 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 17.5 4.7 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 8.0 0.0 12.8 18.7 5.8 5.4 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 4.9 5.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 19.2 0.0 0.0 6.6 3.0 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 1.6 0.0 0.4 0.0 0.0 0.0 0.0 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "Single-minded family bHLH transcription factor 2" Q14190 21 36699133-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 8.9;Collecting duct cells: 8.7;Distal tubular cells: 8.3;Glandular cells: 6.5" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.3;PC-3: 23.0;RPTEC TERT1: 28.9;RT4: 17.4" "Region enhanced" "Detected in single" "hypothalamus: 0.5" "Not detected" "Not detected" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favorable (2.88e-4)" 0.5 0.3 0.8 0.1 2.3 0.0 0.1 2.4 2.3 2.8 0.2 0.2 0.0 0.1 0.3 1.5 31.3 0.3 0.2 0.1 2.5 1.1 16.1 0.1 0.1 0.1 1.4 0.7 0.1 0.1 1.2 1.7 0.1 0.3 6.8 0.0 0.2 0.4 0.0 15.7 0.3 0.1 0.0 0.4 0.1 5.5 0.2 1.3 0.0 0.2 11.0 28.7 1.5 0.4 0.3 0.7 0.0 0.0 0.0 0.8 0.0 3.2 5.0 0.2 0.2 0.0 0.0 5.0 0.1 0.0 0.4 0.0 2.6 7.6 0.1 4.6 0.1 9.0 1.7 2.5 0.0 0.2 3.9 7.9 0.1 7.2 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.4 13.3 0.0 0.1 0.1 0.0 8.4 1.9 0.0 0.0 0.2 3.2 23.0 0.0 0.1 0.1 28.9 17.4 0.2 0.3 8.2 0.0 0.7 0.8 2.1 0.2 0.3 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 2.3 2.4 2.3 2.5 1.1 1.4 0.7 0.3 1.3 0.0 0.0 0.0 8.9 0.2 0.2 2.0 0.0 0.0 0.0 8.7 0.0 0.0 8.3 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.2 0.2 0.4 0.0 0.0 0.0 1.8 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 177.4" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 36.6 0.0 0.0 177.4 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A3 NCCT ENSG00000070915 "Solute carrier family 12 member 3" P55017 16 56865207-56915850 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 88.6" "Group enriched" "Detected in some" 9 "Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 7.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 14.6" "Group enriched" "Detected in some" 10 "BEWO: 10.2;HAP1: 5.6;HeLa: 11.4;SuSa: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA028748 Enhanced NA NA "HPA028748: AB_10603886" "unprognostic (1.54e-3)" "unprognostic (7.09e-5)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.38e-4)" "unprognostic (1.81e-1)" "unprognostic (9.70e-2)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.84e-2)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 88.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 14.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.7 5.6 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A1 "NAS1, NaSi-1" ENSG00000081800 "Solute carrier family 13 member 1" Q9BZW2 7 123113531-123199986 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sulfate transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 67.5" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 400.4" "Cancer enriched" "Detected in single" 219 "renal cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.0" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" "HPA053615, HPA062714" Enhanced NA NA "HPA053615: AB_2682207, HPA062714: AB_2684846" "unprognostic (1.86e-1)" "prognostic favorable (8.95e-5)" "unprognostic (1.71e-1)" "unprognostic (3.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 23.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 400.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 128.6" "Cell type enhanced" "Detected in many" 25 "Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 0.7 0.9 2.6 0.5 6.2 0.4 0.9 2.5 3.6 0.9 0.5 15.1 0.0 0.4 0.9 0.7 0.6 1.1 0.9 0.6 3.4 3.1 128.6 7.0 0.8 0.5 9.3 2.1 1.8 3.0 0.4 0.6 12.9 6.5 2.3 0.5 8.1 1.7 0.6 0.6 1.0 0.4 0.9 7.8 0.5 1.7 2.7 5.6 0.0 0.8 0.0 0.6 1.0 0.4 0.6 2.4 2.7 0.4 0.7 0.9 0.0 0.0 0.0 0.9 3.3 5.1 4.8 10.0 2.1 1.2 1.1 0.9 0.0 0.0 0.1 11.4 0.1 0.0 1.2 0.0 1.5 2.7 0.0 0.3 3.9 0.2 32.6 11.4 0.0 2.9 6.5 4.5 6.6 3.3 3.2 0.0 0.0 8.7 0.2 0.0 0.3 0.0 0.4 6.1 0.2 0.0 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.0 2.4 0.5 0.6 1.7 0.1 0.1 0.1 2.4 5.2 0.0 0.3 0.6 0.0 0.4 0.0 0.2 2.7 0.4 0.3 0.9 0.2 0.2 0.4 0.3 0.3 0.1 0.6 0.6 0.6 1.3 0.7 0.3 2.4 0.3 0.0 2.6 6.2 2.5 3.6 3.4 3.1 9.3 2.1 6.5 5.6 0.0 2.1 0.0 1.1 1.1 0.7 0.5 0.0 5.3 0.0 7.0 0.0 97.7 13.3 0.1 17.2 0.2 0.0 0.0 0.8 4.5 1.1 3.2 0.0 11.6 8.1 0.0 0.0 0.0 0.8 22.8 2.8 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 272.5 0.2 0.0 0.3 1.1 0.9 0.5 66.4 0.0 0.0 0.5 SLC14A2 "HUT2, UT2" ENSG00000132874 "Solute carrier family 14 member 2" Q15849 18 45212995-45683686 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.3;kidney: 5.7" "Cell type enriched" "Detected in some" 5 "Collecting duct cells: 73.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Cell type enhanced" "Detected in some" "eosinophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "U-266/70: 7.2" "Region enriched" "Detected in some" 4 "basal ganglia: 17.9" "Not detected" "Not detected" NA NA "unprognostic (2.33e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.54e-2)" "unprognostic (7.80e-2)" "unprognostic (1.11e-2)" "unprognostic (7.89e-3)" "unprognostic (3.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-3)" "unprognostic (8.96e-2)" "unprognostic (3.50e-3)" "unprognostic (1.20e-1)" "unprognostic (7.64e-2)" "unprognostic (7.52e-2)" "unprognostic (6.62e-2)" 1.8 1.0 0.0 0.1 0.4 0.6 0.9 0.0 0.7 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.3 0.1 0.1 5.7 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.4 1.2 0.0 0.0 0.2 0.1 1.3 1.0 0.0 0.1 0.1 0.4 0.4 3.3 0.3 0.4 0.8 0.1 0.2 0.4 0.4 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.4 0.4 0.8 0.2 0.1 0.4 0.3 0.0 0.0 0.1 0.4 0.2 0.4 0.7 0.0 0.1 1.1 0.4 0.1 0.1 0.1 0.1 0.4 0.2 0.4 0.3 0.6 0.0 0.3 0.4 0.5 0.3 0.2 0.4 0.3 0.1 0.7 0.1 0.4 0.6 0.1 0.2 0.1 0.1 0.2 0.1 0.3 0.3 0.4 0.3 1.0 0.4 7.2 0.4 0.3 0.4 1.1 0.3 1.4 0.3 3.3 0.3 0.2 0.2 0.4 0.2 0.3 0.1 0.4 0.2 0.3 0.8 0.4 0.2 0.4 0.8 0.1 6.0 14.8 0.0 0.5 0.6 1.2 0.5 0.0 2.7 3.4 73.3 2.0 0.3 0.0 0.0 0.9 0.7 1.1 0.0 0.0 0.2 1.1 0.3 3.5 0.0 0.3 1.6 0.0 1.8 0.3 1.0 0.6 0.8 1.7 0.0 0.3 0.8 0.1 0.0 0.7 0.0 1.7 0.0 0.0 0.5 0.4 0.1 0.7 0.0 0.0 0.4 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" 10 89430299-89556641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 28.0;kidney: 55.6" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Region enriched" "Detected in many" 6 "pons and medulla: 11.7" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC TERT1: 22.8;HSkMC: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria NA NA Mitochondria "HPA037587: AB_2732475" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favorable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 2.3 1.3 1.0 0.1 0.7 0.0 2.4 1.3 0.6 4.9 1.6 2.6 6.2 0.1 2.0 28.0 0.5 2.2 0.1 4.0 1.8 0.8 55.6 1.0 3.3 0.1 0.8 0.3 1.8 13.3 0.0 5.0 5.9 11.7 1.4 0.1 16.3 0.9 7.9 4.4 1.1 0.8 0.5 0.6 0.1 1.7 2.4 0.3 0.0 3.8 0.7 0.0 1.8 1.5 0.7 0.5 1.8 0.3 0.9 0.3 0.0 0.2 0.0 0.1 0.1 3.0 22.8 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.1 3.7 0.0 0.0 8.1 0.2 1.1 1.4 1.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.8 0.0 2.7 0.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.7 0.2 0.3 0.8 0.9 0.1 0.5 0.0 0.0 1.0 0.7 1.3 0.6 1.8 0.8 0.8 0.3 11.7 0.3 3.0 3.8 0.0 1.5 0.0 0.0 2.0 2.5 8.1 4.5 14.0 0.0 14.3 13.3 0.0 3.0 1.1 0.0 0.0 3.7 0.6 1.1 0.8 1.1 1.7 1.1 3.2 17.4 0.6 0.0 3.0 25.0 1.0 0.0 0.0 0.0 0.0 3.5 0.0 25.1 55.2 0.3 12.9 1.4 0.1 0.2 0.3 7.6 0.0 0.0 1.4 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 68.0;Proximal tubular cells: 176.8" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 5.5 1.2 1.8 4.0 7.8 11.6 3.0 11.7 1.0 2.9 1.7 17.3 0.3 3.3 9.4 0.1 0.3 0.0 1.1 1.1 0.3 1.4 0.3 1.1 1.7 11.6 0.3 0.3 5.7 0.1 1.7 0.1 25.2 2.4 0.4 0.2 0.6 1.9 0.5 0.2 0.3 0.3 0.0 0.2 0.1 0.8 0.1 2.0 0.2 0.7 0.4 0.3 5.6 17.8 5.6 0.3 0.0 0.2 0.7 0.4 0.2 0.8 0.3 0.0 0.9 0.6 0.2 3.2 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 11.9 17.3 3.2 5.2 2.7 11.1 1.1 15.3 0.0 5.7 68.0 5.9 28.5 3.3 2.9 0.4 4.4 1.3 23.3 0.8 29.3 13.9 2.7 4.7 4.5 3.7 3.2 3.4 3.1 1.0 1.1 16.7 0.8 10.1 1.0 0.9 2.3 1.3 0.2 11.0 176.8 17.7 0.0 5.2 3.0 2.0 3.1 29.4 4.6 0.5 5.0 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 218.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049286: AB_2680699" "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favorable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.1 0.3 4.4 6.1 0.1 0.4 3.3 2.3 0.0 16.4 1.6 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.9 0.1 0.3 0.0 8.8 2.8 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 0.0 0.0 0.0 1.1 0.1 4.7 2.8 0.0 4.0 9.1 7.0 0.0 0.0 21.6 0.7 0.1 0.0 17.7 0.0 0.0 0.8 1.2 12.7 0.0 0.0 0.1 3.2 19.3 0.0 10.5 0.4 12.7 0.0 3.3 1.0 15.5 11.2 0.2 30.3 11.3 218.2 0.8 0.0 2.8 0.3 0.1 0.1 0.0 0.0 12.8 5.7 SLC17A1 "NAPI-1, NPT1" ENSG00000124568 "Solute carrier family 17 member 1" Q14916 6 25782897-25832059 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "kidney: 67.6;liver: 17.9" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 44.6" "Group enriched" "Detected in some" 150 "liver cancer: 7.6;renal cancer: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 389 "RPTEC TERT1: 38.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050513 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050513: AB_2681152" "unprognostic (6.98e-2)" "unprognostic (2.99e-1)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.32e-1)" "unprognostic (2.37e-1)" "unprognostic (4.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 67.6 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A3 NPT4 ENSG00000124564 "Solute carrier family 17 member 3" O00476 6 25833066-25882286 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 62.3" "Cell type enriched" "Detected in some" 10 "Proximal tubular cells: 127.1" "Cancer enriched" "Detected in some" 17 "renal cancer: 57.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Cell line enriched" "Detected in single" 217 "RPTEC TERT1: 51.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.31e-3)" "unprognostic (1.56e-2)" "unprognostic (2.51e-1)" "unprognostic (4.65e-2)" "unprognostic (5.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.34e-1)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 62.3 13.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC1A1 "EAAC1, EAAT3" ENSG00000106688 "Solute carrier family 1 member 1" P43005 9 4490444-4587469 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.4;kidney: 31.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.9" "Lineage enriched" "Detected in single" 30 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062356 Enhanced NA NA "HPA062356: " "unprognostic (1.28e-2)" "unprognostic (2.37e-2)" "unprognostic (6.83e-3)" "unprognostic (3.07e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (4.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-1)" "unprognostic (1.35e-2)" "unprognostic (1.25e-2)" "prognostic favorable (2.86e-8)" "unprognostic (2.68e-1)" "unprognostic (9.49e-2)" "unprognostic (7.78e-2)" "unprognostic (2.64e-1)" 3.3 1.4 8.6 3.4 10.2 0.3 2.9 4.7 12.4 4.0 17.9 2.7 0.5 21.0 4.0 28.8 1.7 1.9 16.3 2.0 10.0 10.2 31.2 29.1 12.8 1.8 8.6 5.8 0.7 1.8 0.4 5.2 5.1 6.7 4.3 6.6 1.9 3.1 2.4 2.2 1.2 40.4 5.6 5.3 0.5 3.4 0.8 4.4 0.0 25.0 1.8 5.0 3.5 1.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.9 0.7 4.4 11.5 13.9 3.9 4.7 9.8 1.5 1.4 7.8 0.2 6.1 0.3 2.4 1.8 0.0 1.6 2.6 1.3 31.6 2.1 0.0 6.6 0.0 0.4 0.4 0.0 0.9 0.1 5.6 0.0 0.7 14.9 0.1 0.0 0.0 1.0 0.1 0.0 0.1 1.9 4.7 0.8 0.0 0.0 0.0 31.0 2.7 1.0 0.9 0.3 1.7 0.0 3.7 0.6 0.2 8.0 2.3 0.1 4.4 1.3 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 8.6 10.2 4.7 11.7 10.0 10.2 8.6 5.8 6.7 4.4 151.8 2.7 0.8 1.0 0.0 0.7 0.8 35.7 4.0 9.1 0.0 0.0 0.0 3.3 5.5 3.5 7.0 37.3 0.0 0.7 0.0 0.9 1.7 0.0 62.7 0.1 0.0 0.0 3.1 2.1 6.1 0.3 0.1 0.0 0.0 6.5 0.8 5.8 8.6 0.0 37.2 0.9 0.0 1.1 0.0 0.2 0.5 0.1 0.8 4.8 0.2 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555626-64572875 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "epididymis: 22.2;kidney: 47.6;placenta: 64.7" "Group enriched" "Detected in some" 17 "Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5" "Group enriched" "Detected in some" 14 "liver cancer: 3.7;renal cancer: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9" "Not detected" "Not detected" HPA026076 Enhanced NA NA "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 4.4 0.0 0.1 22.2 0.1 0.1 0.0 0.1 0.1 0.1 47.6 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.1 64.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 554.5 5.0 0.0 1.0 0.0 0.0 0.0 0.3 13.6 0.6 0.0 0.0 0.0 44.6 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 54.2 0.0 0.0 0.0 0.0 0.1 0.0 1271.5 0.0 0.0 0.0 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 349 "kidney: 70.1" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 149.1" "Group enriched" "Detected in some" 207 "liver cancer: 4.0;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA024575 Enhanced NA NA "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favorable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278315 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 16.4" "Cell type enriched" "Detected in single" 23 "Proximal tubular cells: 6.5" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.3" "Lineage enriched" "Detected in single" 5 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "HeLa: 2.2" "Low region specificity" "Detected in all" "HPA035603, HPA035962" Enhanced NA NA "HPA035603: AB_10672869, HPA035962: AB_2674890" "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.3 0.0 2.3 0.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.3 0.0 0.2 0.3 0.0 0.5 0.9 0.2 0.1 0.6 0.8 0.5 0.7 0.1 0.4 0.1 0.0 2.2 0.0 0.1 0.0 0.8 0.0 0.5 0.1 1.5 0.8 0.0 0.9 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.0 0.5 0.0 0.4 0.1 0.1 0.0 0.3 0.7 1.2 0.3 0.3 0.4 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887780-2903740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 20.1;kidney: 13.4;liver: 13.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 9.1" "Group enriched" "Detected in many" 10 "dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0" HPA068288 Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 1.4 0.3 0.2 6.0 0.7 0.0 0.6 0.2 2.2 0.5 13.7 0.6 0.2 12.8 0.8 1.2 1.1 0.4 4.9 0.3 0.2 0.3 13.4 13.6 0.6 0.2 1.3 1.5 0.4 0.2 0.0 0.3 2.0 1.6 0.7 9.8 0.2 4.2 0.2 0.4 1.0 20.1 0.6 1.6 0.8 1.4 0.6 0.4 0.2 0.3 1.6 0.3 0.5 0.9 0.0 4.9 5.2 9.1 0.5 0.6 2.7 0.8 7.1 0.1 0.3 0.0 0.0 0.7 0.4 0.3 0.0 0.2 1.6 7.0 0.0 0.6 0.0 0.4 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.6 4.1 0.5 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.4 0.0 0.7 0.0 13.2 0.0 0.3 0.1 6.7 0.3 0.2 0.0 0.6 0.6 0.0 0.1 0.2 0.3 0.3 24.5 0.1 0.0 0.7 1.4 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.2 1.9 11.0 5.2 9.1 1.6 0.3 5.1 0.1 0.0 0.1 0.3 4.9 0.0 0.0 0.1 2.2 0.5 3.5 0.0 0.6 2.7 0.2 0.7 0.2 2.2 0.2 0.3 1.3 1.5 1.6 0.4 0.0 0.3 1.3 1.1 0.5 0.0 0.1 2.5 0.0 0.0 7.0 0.0 16.4 8.3 0.8 0.0 0.0 89.5 0.0 0.7 8.2 0.8 1.4 1.1 18.4 15.6 0.0 8.7 1.8 4.1 0.0 0.3 5.4 3.3 3.6 25.4 0.0 1.5 107.4 0.0 73.1 0.0 0.0 0.6 0.0 0.2 1.0 67.5 0.0 23.7 2.3 SLC22A2 OCT2 ENSG00000112499 "Solute carrier family 22 member 2" O15244 6 160171061-160277638 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 61.8" "Group enriched" "Detected in some" 13 "Distal tubular cells: 77.9;Proximal tubular cells: 187.0" "Cancer enriched" "Detected in single" 493 "renal cancer: 30.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA008549, CAB068236, CAB068237" Enhanced NA NA "CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: " "unprognostic (1.01e-1)" "unprognostic (3.67e-1)" "unprognostic (2.26e-1)" "unprognostic (3.67e-2)" "unprognostic (4.24e-1)" "unprognostic (3.33e-1)" "unprognostic (2.51e-2)" "unprognostic (3.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.15e-4)" "unprognostic (1.41e-1)" "unprognostic (3.68e-1)" "prognostic favorable (1.85e-7)" "unprognostic (1.65e-2)" "unprognostic (8.20e-2)" "unprognostic (4.11e-1)" "unprognostic (2.45e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.1 61.8 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.3 0.2 1.9 0.1 0.0 2.7 0.0 0.6 0.3 0.0 0.1 0.1 6.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.2 0.1 0.0 0.2 0.0 3.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.6 0.3 0.2 0.1 0.8 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.4 0.0 0.0 77.9 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 187.0 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins, Transporters" "Ion transport, Lipid metabolism, Steroid metabolism, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 10.5" "Cell type enriched" "Detected in single" 30 "Proximal tubular cells: 8.4" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain NA NA "HPA045015: AB_2679183" "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A5 "CDSP, OCTN2, SCD" ENSG00000197375 "Solute carrier family 22 member 5" O76082 5 132369752-132395614 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.3;skeletal muscle: 93.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 22.3;SiHa: 23.0" HPA063062 Approved Mitochondria NA NA Mitochondria "HPA063062: AB_2684934" "unprognostic (3.88e-1)" "unprognostic (1.69e-1)" "unprognostic (2.19e-2)" "prognostic favorable (2.87e-5)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.50e-2)" "unprognostic (9.24e-2)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.53e-2)" "prognostic favorable (8.36e-4)" "unprognostic (1.12e-2)" "unprognostic (2.98e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-2)" 3.0 4.7 4.0 1.9 4.9 0.6 4.4 9.0 4.2 4.4 10.6 3.6 15.0 11.8 3.6 12.6 2.5 7.4 5.2 7.2 3.8 3.8 42.3 4.5 2.3 1.5 3.5 3.2 3.9 5.2 17.9 8.5 8.1 3.9 8.2 8.3 5.9 4.2 21.8 93.6 3.5 19.6 2.9 3.8 1.7 4.4 2.5 2.7 1.0 5.0 3.2 2.4 3.9 3.2 1.4 6.4 0.4 4.1 1.5 4.0 2.1 3.6 8.7 0.5 7.0 2.8 1.3 12.1 1.6 1.8 2.8 3.9 6.4 7.5 1.7 3.8 1.6 8.1 8.7 5.8 4.3 3.3 2.2 7.1 0.9 22.3 2.9 4.7 1.4 1.5 1.3 8.1 1.9 9.9 4.8 0.7 3.2 4.0 1.1 2.6 6.2 2.1 1.4 0.6 6.3 3.8 0.8 0.0 9.4 8.4 9.1 3.0 2.1 23.0 18.0 4.4 1.9 8.3 1.8 0.4 0.5 2.5 5.9 2.0 3.8 7.4 0.1 1.8 3.6 1.6 0.0 4.1 0.0 2.6 2.2 2.8 1.4 2.4 3.1 6.4 1.4 2.6 3.0 0.4 1.5 0.7 0.6 4.0 2.1 4.0 4.9 9.0 4.2 3.8 3.8 3.5 3.2 3.9 2.7 8.9 5.1 2.7 5.9 6.8 6.5 5.2 20.4 6.7 3.4 15.7 11.8 16.6 1.7 8.8 1.4 3.0 46.4 0.0 4.5 4.8 4.0 12.8 0.0 5.9 4.0 9.5 6.9 1.3 8.7 2.3 6.1 2.6 5.0 0.0 12.6 8.7 5.4 25.9 3.9 23.2 7.4 0.0 1.9 7.2 2.5 5.5 6.9 2.9 16.1 7.8 SLC22A6 "OAT1, PAHT, ROAT1" ENSG00000197901 "Solute carrier family 22 member 6" Q4U2R8 11 62936385-62984983 "FDA approved drug targets, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 94.2" "Cell type enriched" "Detected in some" 14 "Proximal tubular cells: 213.4" "Cancer enriched" "Detected in single" 102 "renal cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA074559, CAB075704" Enhanced NA NA "CAB075704: , HPA074559: AB_2732260" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (4.43e-1)" 0.2 0.2 0.8 0.2 1.3 0.2 0.2 0.4 1.4 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 1.8 94.2 0.2 0.2 0.2 2.4 0.6 0.2 0.2 0.2 0.1 0.2 4.1 0.2 0.2 9.4 0.2 0.2 0.2 0.2 0.2 0.2 2.4 0.2 0.2 0.2 0.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.4 1.4 0.8 1.8 2.4 0.6 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 213.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A8 OAT3 ENSG00000149452 "Solute carrier family 22 member 8" Q8TCC7 11 62989154-63015839 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Detoxification, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 341 "brain: 33.7;kidney: 127.3;retina: 93.5" "Cell type enriched" "Detected in some" 30 "Proximal tubular cells: 197.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enriched" "Detected in some" 25 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "EFO-21: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044174 Enhanced NA NA "HPA044174: AB_10963058" "unprognostic (5.35e-4)" "unprognostic (4.66e-1)" "unprognostic (6.88e-3)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.0 0.1 0.1 3.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 127.3 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.2 0.1 33.7 0.1 0.1 93.5 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.7 0.1 0.1 1.3 33.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.0 0.0 5.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 6.7;Proximal tubular cells: 8.9" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 9.0;U-266/70: 6.6" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Not detected" "Not detected" HPA019059 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 4.0 2.2 0.8 2.2 0.6 0.4 1.3 2.4 1.6 0.5 0.8 1.5 0.1 3.2 0.7 0.3 0.6 1.9 1.8 2.1 1.9 0.2 0.7 0.2 0.9 0.7 9.0 0.9 2.9 3.6 1.2 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.8 0.2 0.5 0.6 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.4 1.1 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.6 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 2.0 1.1 1.3 0.8 0.3 2.5 0.0 0.0 1.8 0.0 0.2 1.7 0.2 0.0 0.7 6.7 0.0 0.0 0.1 0.6 1.4 0.0 0.5 0.2 0.0 1.7 0.6 0.3 0.0 1.4 0.4 1.7 1.0 2.8 1.9 0.2 3.1 1.1 8.9 0.1 0.0 0.8 0.0 0.1 1.4 0.3 0.0 1.6 0.7 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4;kidney: 11.7;skeletal muscle: 12.8" "Cell type enhanced" "Detected in some" 26 "Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" NA NA "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 1.0 0.8 10.8 1.0 13.0 0.9 1.6 1.3 18.8 0.9 2.0 10.3 0.0 2.0 1.0 0.7 1.3 0.7 0.9 0.9 11.9 8.1 11.7 1.3 0.7 1.0 22.4 4.1 0.7 3.3 0.8 0.4 1.1 5.6 1.3 1.8 0.0 3.5 0.6 12.8 3.2 4.1 0.7 5.4 0.9 0.8 1.2 15.2 0.0 1.0 0.5 0.7 0.8 0.3 0.6 1.0 2.1 1.0 0.8 0.7 0.2 0.4 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.4 0.7 0.1 0.4 0.0 0.1 0.5 5.0 0.0 0.0 0.7 4.2 4.1 0.6 0.8 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.1 0.0 0.0 1.7 0.8 0.0 0.1 0.1 0.0 3.7 0.3 0.6 3.9 0.4 0.7 0.5 1.0 1.3 1.8 0.6 0.5 0.4 5.1 0.3 0.2 1.7 0.5 0.2 0.4 0.4 0.3 2.1 0.3 0.7 0.5 0.5 0.6 0.5 0.5 0.4 0.3 0.6 0.6 0.7 1.5 0.8 1.0 1.0 0.5 0.2 10.8 13.0 1.3 9.9 11.9 8.1 22.4 4.1 5.6 15.2 0.0 0.0 0.0 0.0 2.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.8 0.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.2 0.1 2.9 0.0 27.1 0.1 0.0 0.0 0.1 0.5 0.6 0.1 0.0 1.6 0.1 SLC26A1 "EDM4, SAT-1" ENSG00000145217 "Solute carrier family 26 member 1" Q9H2B4 4 979073-993440 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 17.1;liver: 45.4" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA041654 Uncertain Approved Microtubules NA NA Microtubules "HPA041654: AB_10796350" "unprognostic (1.96e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-1)" "unprognostic (4.91e-2)" "unprognostic (1.74e-1)" "unprognostic (2.67e-4)" "unprognostic (5.13e-2)" "unprognostic (5.82e-2)" "unprognostic (2.16e-1)" "unprognostic (3.88e-2)" "unprognostic (1.53e-3)" "unprognostic (2.92e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.65e-3)" 1.1 6.5 1.4 1.7 1.7 1.5 1.6 4.6 2.7 1.3 7.4 1.1 1.1 6.5 1.4 1.9 1.1 1.1 2.6 1.1 1.4 1.5 17.1 45.4 1.1 1.7 1.1 1.1 1.6 4.0 0.0 2.1 1.1 1.1 1.8 0.0 1.1 4.2 1.1 1.5 3.1 10.5 1.1 1.1 2.4 4.0 1.1 1.1 1.1 2.0 1.1 1.1 1.1 1.1 0.4 0.3 7.0 0.6 1.1 1.8 0.7 1.3 2.3 0.0 1.8 0.2 0.4 4.2 1.9 0.1 0.0 0.0 4.5 2.6 0.7 2.3 0.0 1.8 1.3 0.1 0.0 0.0 2.6 0.9 3.4 3.1 13.3 0.2 2.1 9.1 0.6 0.2 0.1 0.0 1.0 0.3 2.9 3.5 0.0 0.4 2.9 1.3 3.6 1.0 1.7 7.2 7.3 0.0 0.3 0.7 5.1 0.2 1.4 0.5 0.2 1.2 0.4 9.2 1.4 2.1 4.8 1.0 4.8 1.3 7.0 3.2 1.2 1.7 4.4 2.1 7.0 0.6 0.4 0.4 0.3 0.8 0.4 1.2 0.9 0.2 0.1 0.8 1.8 0.0 1.1 0.3 0.3 1.6 0.7 1.4 1.7 4.6 1.6 1.4 1.5 1.1 1.1 1.1 1.1 0.0 0.6 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 1.3 0.0 0.3 3.3 0.2 0.1 1.1 9.0 0.6 0.0 0.0 1.3 0.3 0.0 0.9 0.0 1.7 0.0 0.6 0.2 0.6 0.2 0.4 8.5 0.1 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.6 0.1 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945796 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "intestine: 32.7;kidney: 35.6;liver: 43.8" "Group enriched" "Detected in some" 5 "Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.1 0.1 17.3 0.1 1.5 0.1 0.1 0.1 0.5 0.1 0.1 35.6 43.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 32.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.1 0.4 0.1 1.8 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 7.6 1.4 0.0 7.0 0.0 0.4 10.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 34.1 40.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 88.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 SLC2A9 "Glut9, GLUTX, URATv1" ENSG00000109667 "Solute carrier family 2 member 9" Q9NRM0 4 9771153-10054936 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 43.4" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 20.6;myeloid DC: 16.7" "Group enriched" "Detected in many" 31 "dendritic cells: 16.7;monocytes: 20.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA066229, HPA075669" Enhanced NA NA "HPA066229: AB_2685639, HPA075669: " "unprognostic (3.21e-1)" "unprognostic (8.99e-3)" "unprognostic (1.25e-2)" "unprognostic (2.01e-1)" "unprognostic (2.14e-2)" "unprognostic (2.56e-2)" "unprognostic (8.94e-2)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (1.28e-2)" "unprognostic (3.16e-1)" "unprognostic (2.23e-1)" "prognostic favorable (1.32e-11)" "unprognostic (1.01e-1)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.20e-1)" 5.6 2.8 1.0 1.3 2.0 1.2 3.2 0.6 1.2 2.6 10.4 2.3 5.7 7.8 1.7 12.0 5.8 2.6 1.7 2.7 1.0 0.9 43.4 17.7 4.7 2.8 1.9 0.7 1.5 1.3 1.5 1.8 8.8 2.1 4.6 1.1 4.1 10.8 15.6 1.1 2.4 12.0 1.4 4.1 3.0 1.2 1.3 2.3 3.0 2.9 3.4 3.9 7.1 3.9 0.2 16.7 0.6 20.6 0.1 0.2 4.9 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.2 1.5 0.0 2.2 0.4 0.0 4.5 0.0 29.6 0.0 4.8 0.1 0.0 0.0 14.2 1.0 0.1 4.0 2.2 12.5 0.0 3.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.2 1.4 0.0 0.2 0.1 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 20.6 0.4 0.1 4.1 0.2 0.2 0.2 0.0 16.7 0.1 0.1 0.0 0.6 0.1 0.4 6.6 0.1 4.9 1.0 2.0 0.6 1.2 1.0 0.9 1.9 0.7 2.1 2.3 0.0 0.0 1.4 11.1 0.8 0.0 2.1 0.0 4.0 3.4 3.5 2.0 16.4 3.3 0.4 3.9 1.4 2.9 0.0 0.9 1.3 1.1 1.0 1.1 4.9 9.3 0.0 0.0 2.5 6.5 2.8 0.0 10.2 0.0 1.0 0.8 0.8 0.4 0.0 0.4 47.2 0.4 0.0 1.0 0.7 1.2 0.5 7.1 0.5 1.0 8.8 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLC34A3 "FLJ38680, NPTIIc" ENSG00000198569 "Solute carrier family 34 member 3" Q8N130 9 137230757-137236554 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.4;kidney: 14.8" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 20.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA023776 Enhanced NA NA "HPA023776: AB_1857102" "unprognostic (2.69e-1)" "unprognostic (4.16e-1)" "unprognostic (9.08e-3)" "unprognostic (1.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-3)" "unprognostic (1.75e-2)" "unprognostic (1.05e-2)" "unprognostic (9.84e-3)" "unprognostic (2.05e-2)" "unprognostic (2.20e-2)" "unprognostic (5.94e-2)" "unprognostic (1.94e-2)" "unprognostic (9.12e-2)" "unprognostic (5.80e-2)" "unprognostic (2.20e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 3.6 0.5 0.2 0.2 0.2 0.0 14.8 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 1.6 0.2 0.2 0.2 0.0 0.2 1.2 0.2 0.2 0.3 10.4 0.2 0.2 0.2 0.4 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.7 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 6.0 0.4 0.2 0.0 0.1 3.0 0.0 0.0 0.0 3.7 0.2 0.0 4.0 2.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.7 0.0 9.7 0.1 0.1 0.6 1.1 1.2 1.3 0.5 0.0 0.0 0.5 0.0 1.5 0.6 1.4 0.3 0.7 3.4 0.1 0.4 0.5 0.4 1.9 0.1 1.1 0.5 0.4 0.8 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC36A2 "PAT2, TRAMD1, tramdorin" ENSG00000186335 "Solute carrier family 36 member 2" Q495M3 5 151314978-151347590 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 44.0" "Cancer enriched" "Detected in single" 9 "renal cancer: 0.5" "Region enhanced" "Detected in single" "midbrain: 1.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.9;NB-4: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA044002, HPA062229" Enhanced NA NA "HPA044002: AB_10964214, HPA062229: AB_2684717" "unprognostic (3.47e-1)" "unprognostic (3.40e-1)" "unprognostic (2.26e-2)" "unprognostic (6.23e-2)" "unprognostic (8.38e-3)" "unprognostic (4.66e-3)" "unprognostic (3.03e-1)" "unprognostic (7.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (3.89e-2)" 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 2.6 0.5 0.1 0.0 0.2 0.1 0.1 60.3 0.1 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 1.1 2.0 0.0 36.8 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.0 0.0 0.1 16.1 1.4 0.1 0.1 2.1 1.5 4.3 0.8 1.5 0.9 0.3 0.1 0.3 0.4 0.7 0.3 0.1 1.0 0.4 0.0 0.1 0.0 0.6 0.3 0.8 0.3 0.2 0.3 0.4 0.0 0.7 0.0 1.5 1.5 0.3 0.8 0.3 0.0 1.9 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.1 1.4 0.2 0.3 0.4 2.0 1.2 0.0 0.2 0.5 0.4 0.2 0.2 0.1 0.4 0.4 0.1 1.2 0.0 0.2 0.3 0.3 0.5 0.2 0.2 1.2 0.2 0.5 0.2 0.4 0.3 0.3 0.1 3.2 0.8 0.9 0.7 0.6 0.6 1.1 0.6 0.6 0.2 2.1 0.7 0.9 4.3 1.5 0.6 1.5 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 256.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 49.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.2 49.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 3.0 1.0 1.5 0.2 0.0 12.5 0.3 63.7 0.0 0.0 40.1 9.8 0.0 53.0 18.3 10.9 0.0 32.7 0.0 12.6 0.0 0.2 1.4 0.0 2.8 0.1 20.6 0.0 0.6 0.0 3.3 1.1 0.0 0.0 2.8 3.8 1.6 3.4 7.2 0.4 256.0 11.9 0.0 0.1 0.7 0.3 0.1 0.1 0.0 8.0 0.5 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.6;kidney: 51.1;liver: 44.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 40.8;Proximal tubular cells: 54.2" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Region enhanced" "Detected in many" "pons and medulla: 11.4" "Group enriched" "Detected in some" 7 "eosinophil: 12.2;plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.9;granulocytes: 12.2" "Cell line enhanced" "Detected in many" "A549: 13.2;AN3-CA: 10.6;Hep G2: 25.4;U-266/70: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced NA NA "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 2.2 45.6 0.8 0.4 2.2 1.1 0.6 1.0 3.1 13.2 1.2 3.7 1.3 0.7 7.6 12.2 0.9 2.4 1.7 3.5 4.7 0.5 51.1 44.9 3.0 3.5 0.9 2.5 5.0 0.2 0.2 7.2 0.3 11.4 2.6 0.5 4.3 1.1 5.5 12.1 10.4 0.6 3.5 2.3 1.9 0.5 15.5 0.6 0.9 4.7 5.7 1.2 0.6 4.5 0.1 6.9 12.2 1.3 0.0 0.7 0.4 0.0 13.2 0.4 10.6 0.3 0.0 0.0 0.4 0.3 1.6 1.5 0.0 0.4 0.1 2.5 1.9 5.3 0.0 4.7 0.3 0.4 0.0 6.2 0.1 7.0 25.4 0.1 0.1 0.3 0.2 2.4 1.2 0.2 1.8 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.2 1.4 0.1 0.5 0.1 0.1 0.1 0.0 0.8 2.5 2.2 4.3 0.0 1.1 3.7 4.5 1.2 0.0 0.1 0.5 0.2 1.2 19.8 7.8 0.0 0.5 0.1 2.3 0.2 1.3 12.2 0.3 1.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.7 0.3 0.0 0.2 6.9 0.0 0.4 0.8 2.2 1.0 3.1 4.7 0.5 0.9 2.5 11.4 0.6 6.0 3.0 0.0 2.2 4.1 0.3 3.8 5.1 1.4 0.0 1.8 0.0 0.0 3.3 0.1 11.3 0.7 0.0 0.0 0.0 0.0 2.3 1.3 5.7 40.8 1.5 0.0 0.0 0.0 1.6 2.7 3.4 0.6 1.7 0.0 0.0 1.2 0.0 0.0 1.4 54.2 0.7 6.5 1.0 0.2 0.7 5.8 0.0 0.0 0.0 1.3 SLC47A2 "FLJ31196, MATE2, MATE2-K" ENSG00000180638 "Solute carrier family 47 member 2" Q86VL8 17 19678288-19718979 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 55.5" "Cell type enriched" "Detected in some" 13 "Proximal tubular cells: 69.0" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7" "Not detected" "Not detected" NA NA "unprognostic (4.52e-3)" "unprognostic (8.28e-3)" "unprognostic (1.54e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (5.22e-2)" "unprognostic (2.72e-1)" "unprognostic (1.99e-2)" "unprognostic (3.29e-2)" "unprognostic (1.51e-1)" "unprognostic (1.36e-3)" "unprognostic (7.77e-2)" "unprognostic (1.04e-3)" "unprognostic (4.33e-2)" "unprognostic (1.61e-1)" "unprognostic (6.44e-2)" "unprognostic (5.71e-2)" 0.2 0.3 3.0 0.1 4.4 0.1 0.3 0.2 0.4 0.1 0.2 10.3 0.6 0.2 0.2 6.5 0.2 8.6 0.1 0.3 6.2 5.5 55.5 0.1 0.1 0.1 1.1 0.1 0.6 0.1 0.1 0.0 0.1 12.8 0.1 0.1 0.7 0.1 0.3 0.7 1.8 0.4 0.2 2.0 0.1 0.1 0.2 2.8 0.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 1.2 0.0 0.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.8 0.0 0.3 0.0 0.1 0.3 0.5 0.2 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 3.0 4.4 0.2 0.4 6.2 5.5 1.1 0.1 12.8 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 5.2 0.0 0.1 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 69.0 0.2 0.0 0.3 0.5 0.2 0.3 0.0 0.0 0.0 0.1 SLC4A4 "hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5" ENSG00000080493 "Solute carrier family 4 member 4" Q9Y6R1 4 71186757-71572087 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.4;pancreas: 113.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5" "Group enriched" "Detected in many" 5 "glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.8;memory CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 5 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022493, HPA035628, HPA035629, HPA079220" Enhanced NA NA "CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: " "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "prognostic favorable (7.69e-4)" "unprognostic (5.32e-2)" "unprognostic (1.01e-1)" "unprognostic (5.09e-2)" "unprognostic (4.24e-2)" "unprognostic (7.49e-2)" "unprognostic (1.46e-1)" "unprognostic (9.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.18e-4)" "unprognostic (7.00e-2)" "unprognostic (2.92e-1)" "unprognostic (2.05e-3)" "unprognostic (2.04e-1)" 2.4 0.9 14.3 4.3 19.9 0.7 1.1 18.1 15.2 5.8 17.2 4.5 0.1 22.4 0.8 0.7 1.1 1.0 24.9 2.9 13.1 8.1 47.4 9.4 5.8 0.6 9.7 11.2 1.0 113.8 10.0 4.1 1.6 18.1 14.6 17.1 11.1 1.5 1.1 1.3 0.7 10.4 1.3 21.6 0.9 8.3 0.7 8.0 0.0 9.5 0.0 0.6 2.6 0.9 0.0 0.1 0.0 0.0 0.5 2.8 0.3 0.0 3.6 1.0 0.0 0.0 0.0 0.1 13.9 1.9 2.3 1.8 0.0 0.1 0.0 0.1 6.3 0.6 0.0 0.2 0.0 5.7 0.0 1.8 0.9 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 6.0 0.0 0.9 0.0 0.6 1.2 0.0 4.7 0.2 0.1 0.2 0.0 0.0 0.0 0.9 14.9 4.2 1.0 0.1 0.0 0.0 0.2 1.2 0.0 0.0 0.0 7.9 0.7 5.7 0.6 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 1.4 0.0 0.8 2.4 0.1 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.3 14.3 19.9 18.1 12.4 13.1 8.1 9.7 11.2 18.1 8.0 3.0 32.5 1.3 4.2 0.0 0.0 20.1 107.0 14.7 31.8 24.4 0.0 0.2 13.3 81.5 6.6 1.9 173.4 0.0 21.6 0.1 1.1 63.3 1.1 31.7 0.2 0.0 8.2 1.8 0.6 1.0 0.0 1.0 1.7 1.8 66.7 3.3 19.9 56.6 0.0 149.5 1.1 6.5 2.5 0.1 0.4 0.0 0.2 6.9 42.6 7.0 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360202-140375143 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 26.7" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.8;U-698: 2.0" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Low region specificity" "Detected in all" HPA051307 Uncertain NA NA "HPA051307: AB_2681434" "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 26.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.2 0.0 0.7 0.6 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.8 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 1.0 0.5 2.0 0.0 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.0 0.1 SLC5A10 SGLT5 ENSG00000154025 "Solute carrier family 5 member 10" A0PJK1 17 18950345-19022595 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 70.6" "Group enriched" "Detected in some" 4 "Late spermatids: 20.1;Proximal tubular cells: 51.2" "Cancer enriched" "Detected in some" 11 "renal cancer: 6.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 3.0;non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 7 "monocytes: 7.9" "Cell line enriched" "Detected in some" 5 "U-937: 11.0" "Not detected" "Not detected" HPA052014 Uncertain NA NA "HPA052014: AB_2681694" "unprognostic (3.74e-1)" "unprognostic (2.92e-1)" "unprognostic (3.04e-2)" "unprognostic (6.11e-2)" "unprognostic (6.56e-2)" "unprognostic (3.36e-4)" "unprognostic (7.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.52e-1)" "unprognostic (8.94e-2)" "unprognostic (3.24e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-2)" "unprognostic (2.61e-2)" "unprognostic (2.75e-2)" "unprognostic (2.11e-1)" 0.1 0.1 0.1 0.5 0.1 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.1 0.0 70.6 0.4 0.3 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 15.1 0.1 0.1 0.1 0.7 1.1 0.1 0.2 3.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.4 1.2 0.1 7.9 0.0 0.6 0.5 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.1 1.8 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.1 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 11.0 0.0 0.1 0.0 0.0 0.1 3.0 0.0 0.4 0.3 0.0 1.2 0.3 0.6 0.2 0.0 0.0 7.9 0.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.3 8.7 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.0 20.1 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 51.2 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC5A2 SGLT2 ENSG00000140675 "Solute carrier family 5 member 2" P31639 16 31483002-31490860 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "kidney: 33.7" "Group enriched" "Detected in some" 11 "Early spermatids: 46.9;Late spermatids: 103.8;Proximal tubular cells: 139.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.6" "Group enriched" "Detected in many" 16 "NK-cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 1.2;EFO-21: 2.0;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041603 Enhanced NA NA "HPA041603: AB_10960540" "unprognostic (1.61e-1)" "unprognostic (2.95e-1)" "unprognostic (2.84e-1)" "unprognostic (3.00e-2)" "unprognostic (8.04e-2)" "unprognostic (8.23e-3)" "unprognostic (1.49e-1)" "unprognostic (2.25e-3)" "unprognostic (2.57e-1)" "unprognostic (1.12e-2)" "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (1.42e-3)" "unprognostic (5.88e-2)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.6 0.1 0.4 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 1.2 0.1 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.5 0.0 0.0 0.5 0.1 0.0 1.4 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.3 0.0 1.4 0.0 8.7 0.0 0.2 6.6 0.7 46.9 0.0 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 103.8 2.0 0.4 0.0 0.0 0.2 0.0 0.7 0.0 1.4 139.8 0.0 0.0 0.0 3.2 0.9 0.3 0.1 0.0 0.6 0.0 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073570-34106262 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 10.1 9.5 10.5 7.3 11.0 3.6 26.6 8.0 10.1 6.5 7.6 4.6 9.4 5.0 11.3 9.1 7.5 8.5 4.9 6.8 11.6 6.8 46.0 9.5 8.5 7.6 11.7 4.7 9.0 5.8 6.3 6.6 15.8 13.6 7.0 8.8 11.3 6.4 6.9 7.8 10.1 7.4 5.9 14.7 4.9 7.8 10.6 9.0 5.9 42.7 4.4 8.0 6.5 22.1 0.8 2.3 0.7 1.0 1.0 2.6 0.7 6.3 5.7 11.9 8.4 10.0 8.2 5.7 7.2 22.1 4.5 6.9 9.4 13.9 10.2 5.9 14.6 8.5 3.3 14.4 4.1 7.7 10.6 3.7 10.6 5.3 3.1 2.6 4.5 4.5 3.9 10.7 12.3 4.9 13.9 2.7 8.5 10.4 2.4 11.6 4.3 4.8 3.7 6.0 2.4 5.6 4.9 2.1 4.6 17.8 8.9 6.2 2.9 15.0 4.0 3.4 7.4 2.4 4.8 2.6 8.9 6.9 16.9 2.9 12.7 10.9 7.7 17.9 6.6 5.9 0.0 1.0 0.2 2.6 0.9 2.1 0.8 1.4 1.7 0.9 0.8 1.9 2.6 0.7 1.0 0.4 2.3 0.4 0.7 10.5 11.0 8.0 10.1 11.6 6.8 11.7 4.7 13.6 9.0 14.9 12.2 8.0 40.9 0.0 28.5 7.6 12.7 16.0 23.9 130.9 19.6 21.2 18.3 3.4 8.6 4.5 28.0 0.0 4.5 15.7 10.7 71.1 41.4 15.3 12.8 35.0 47.1 6.7 12.1 5.2 6.1 9.8 0.0 24.4 48.3 6.0 5.8 46.0 19.4 6.5 20.8 12.9 2.2 12.1 18.9 0.0 23.6 17.3 26.6 32.3 SLC5A8 AIT ENSG00000256870 "Solute carrier family 5 member 8" Q8N695 12 101155493-101210407 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Symport, Transport" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 7.7;Horizontal cells: 9.5;Intestinal endocrine cells: 30.3;Proximal tubular cells: 10.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SK-BR-3: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic favorable (9.04e-6)" "unprognostic (1.84e-1)" "unprognostic (1.17e-2)" "unprognostic (1.27e-3)" "unprognostic (1.24e-1)" "unprognostic (5.20e-1)" "unprognostic (1.16e-2)" "prognostic favorable (1.97e-4)" "unprognostic (6.16e-2)" "unprognostic (2.30e-2)" "unprognostic (2.87e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.8 0.0 1.9 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 1.4 3.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 21.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.6 0.0 0.0 7.7 0.0 0.0 0.0 4.0 0.6 0.0 1.4 1.2 1.8 0.0 0.0 1.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 9.5 30.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 SLC6A12 BGT-1 ENSG00000111181 "Solute carrier family 6 member 12" P48065 12 190077-214570 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.1;liver: 59.3" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2" "Cancer enhanced" "Detected in many" "renal cancer: 11.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 57 "classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 51 "dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034973 Approved Approved Vesicles NA NA Vesicles "HPA034973: AB_10610427" "unprognostic (3.48e-1)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.70e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (8.30e-2)" "unprognostic (6.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.85e-2)" "unprognostic (3.68e-1)" "prognostic favorable (2.70e-6)" "unprognostic (2.30e-1)" "unprognostic (4.92e-4)" "unprognostic (3.35e-1)" "unprognostic (4.31e-4)" 0.6 0.8 6.3 1.3 12.9 0.6 0.8 6.6 14.7 0.9 1.0 4.3 0.0 3.7 1.3 5.6 0.5 3.0 1.2 0.7 7.2 4.6 22.1 59.3 2.2 0.8 8.1 4.9 0.7 1.3 0.6 0.3 0.9 9.4 0.6 1.8 0.2 0.6 0.5 0.5 0.7 1.1 1.2 3.1 0.8 2.3 1.6 8.8 0.0 4.5 0.0 0.7 0.9 0.2 0.0 2.9 3.7 8.6 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 17.0 0.1 0.0 0.5 0.0 0.0 0.1 3.7 0.3 0.5 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 6.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.7 0.0 8.6 0.0 0.0 1.9 6.3 12.9 6.6 14.7 7.2 4.6 8.1 4.9 9.4 8.8 0.0 0.3 0.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 43.6 0.0 0.0 1.7 0.0 3.6 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 17.4 2.4 0.0 0.0 1.3 0.3 3.4 0.6 1.8 0.0 17.2 1.2 6.3 0.0 0.0 0.0 6.8 0.2 6.5 0.0 0.5 1.7 0.4 0.7 0.0 0.8 0.0 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC6A18 "FLJ31236, Xtrp2" ENSG00000164363 "Solute carrier family 6 member 18" Q96N87 5 1225355-1246189 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "kidney: 14.1" "Group enriched" "Detected in some" 71 "Distal tubular cells: 6.6;Proximal tubular cells: 21.3" "Cancer enriched" "Detected in single" 44 "renal cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011885 Enhanced NA NA "HPA011885: AB_1857198" "unprognostic (2.02e-1)" "unprognostic (5.69e-3)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A13 "AGT-1, XAT2" ENSG00000164893 "Solute carrier family 7 member 13" Q8TCU3 8 86214052-86321146 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "kidney: 31.7" "Cell type enhanced" "Detected in some" 31 "Collecting duct cells: 1.8;Distal tubular cells: 3.3;Proximal tubular cells: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.96e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A7 "LPI, y+LAT-1" ENSG00000155465 "Solute carrier family 7 member 7" Q9UM01 14 22773222-22829820 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 63.8;intestine: 93.5;kidney: 67.3" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 59.5;non-classical monocyte: 63.8" "Lineage enriched" "Detected in many" 4 "monocytes: 63.8" "Cell line enhanced" "Detected in some" "BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036227 Enhanced NA NA "HPA036227: AB_10696653" "unprognostic (1.34e-1)" "unprognostic (7.65e-2)" "unprognostic (4.25e-2)" "unprognostic (2.52e-1)" "unprognostic (6.12e-2)" "unprognostic (3.69e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.60e-3)" "unprognostic (7.15e-2)" "prognostic unfavorable (6.28e-6)" "unprognostic (2.68e-3)" "unprognostic (1.86e-2)" "unprognostic (2.61e-1)" "unprognostic (1.12e-1)" 10.4 2.8 1.9 8.3 3.1 3.6 3.2 0.7 2.7 2.6 48.0 4.1 0.2 24.1 2.7 2.3 2.1 4.6 7.6 3.0 2.2 1.6 67.3 6.5 15.3 20.5 3.7 1.0 2.6 2.7 26.3 1.0 6.5 3.2 2.7 3.4 2.1 3.3 0.9 1.6 1.8 93.5 3.5 4.5 32.4 3.0 13.4 2.7 2.1 2.8 0.8 5.7 4.1 3.6 3.0 14.6 5.4 63.8 0.0 0.1 17.8 0.0 2.4 0.2 0.1 0.4 0.8 44.5 0.5 3.6 0.1 0.3 72.0 7.3 3.5 15.6 0.3 0.2 2.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.7 2.1 0.3 0.3 1.6 0.2 0.2 0.1 0.3 5.5 0.2 0.0 2.8 0.5 0.1 0.0 0.3 0.7 63.3 0.0 0.6 7.8 2.1 0.1 0.2 0.0 0.1 0.1 0.1 0.5 2.1 0.1 1.7 0.3 0.1 0.3 0.1 0.1 0.6 0.1 1.8 0.2 0.1 0.0 0.0 41.2 0.1 0.0 59.5 0.0 3.0 0.0 0.0 14.6 2.3 0.1 0.0 5.4 0.0 63.8 0.5 0.1 17.8 1.9 3.1 0.7 2.7 2.2 1.6 3.7 1.0 3.2 2.7 11.9 10.3 23.7 0.1 0.9 0.0 0.8 58.6 9.4 4.5 3.5 0.0 1.0 10.0 6.7 40.8 4.5 8.6 0.0 5.8 4.5 4.8 0.2 1.1 1.3 200.4 0.0 1.2 22.1 312.3 7.5 3.4 142.1 5.0 34.3 0.4 0.5 7.3 0.0 0.0 254.4 1.2 6.5 2.8 12.2 1.7 0.4 1.5 5.0 0.3 0.0 SLC7A9 CSNU3 ENSG00000021488 "Solute carrier family 7 member 9" P82251 19 32830509-32869766 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 63.3;kidney: 26.4" "Cell type enriched" "Detected in some" 5 "Proximal tubular cells: 55.5" "Group enriched" "Detected in some" 7 "liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042591 Enhanced NA NA "HPA042591: AB_10962500" "unprognostic (4.12e-2)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" "unprognostic (3.37e-3)" "unprognostic (1.69e-1)" "unprognostic (1.54e-1)" "unprognostic (4.17e-2)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (9.69e-2)" "unprognostic (5.97e-2)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (5.10e-5)" 0.1 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.2 0.2 20.1 0.1 0.1 30.5 0.1 1.1 0.1 0.2 0.1 0.1 0.1 0.1 26.4 11.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 63.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 4.9 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 2.7 0.0 5.2 3.9 0.1 1.7 0.0 0.7 0.0 0.0 0.0 6.6 6.5 0.0 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 55.5 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SLC9A3 NHE3 ENSG00000066230 "Solute carrier family 9 member A3" P48764 5 470458-524332 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 65.8;intestine: 85.1;kidney: 43.6" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 28.2" "Region enriched" "Detected in single" 14 "cerebellum: 4.6" "Not detected" "Not detected" "HPA036493, HPA036669" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA036493: AB_10673353, HPA036669: AB_10670843" "unprognostic (1.27e-1)" "unprognostic (4.88e-1)" "unprognostic (9.35e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (3.35e-1)" "unprognostic (2.51e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (8.49e-4)" "unprognostic (5.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.69e-2)" "unprognostic (3.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-1)" 0.6 0.6 0.5 16.2 1.0 0.0 0.6 4.2 0.9 0.9 27.5 0.7 1.1 12.7 0.9 3.4 2.4 0.8 65.8 0.6 0.6 0.6 43.6 0.5 0.5 0.9 0.9 0.7 0.8 1.1 0.6 0.9 0.5 1.2 1.4 2.3 1.2 2.1 0.8 0.7 4.2 85.1 1.1 0.6 0.5 22.7 1.1 0.5 0.6 0.7 2.4 2.7 0.8 2.0 1.9 2.0 0.2 1.2 3.5 6.8 2.9 4.2 3.8 7.0 7.4 1.7 2.0 5.5 4.2 2.5 5.2 3.3 9.3 4.9 10.2 5.5 1.9 3.8 7.0 3.9 2.5 2.5 28.2 7.3 4.6 16.5 3.4 2.6 3.4 5.9 2.7 5.2 2.3 3.5 2.6 1.5 4.2 6.1 5.4 1.8 6.6 3.7 16.7 2.6 12.2 6.3 5.6 6.6 5.3 1.8 3.6 7.9 3.3 12.6 3.5 2.6 3.2 8.0 2.7 1.9 6.0 5.3 4.1 2.7 9.1 3.6 5.8 3.8 15.3 3.8 0.0 1.2 0.1 4.3 0.5 3.8 1.6 5.6 4.1 1.4 1.9 6.8 5.2 0.2 3.5 0.4 2.0 4.2 2.9 0.5 1.0 4.2 0.9 0.6 0.6 0.9 0.7 1.2 0.5 14.9 4.3 0.0 0.0 0.0 0.0 0.6 0.0 5.3 10.3 15.7 0.0 0.0 5.0 7.5 0.0 0.0 1.0 0.0 7.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 8.2 0.0 0.0 6.5 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SMIM32 ENSG00000271824 "Small integral membrane protein 32" 5 136191468-136193134 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 233.2" "Cancer enhanced" "Detected in many" "renal cancer: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HaCaT: 2.3;SCLC-21H: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.35e-5)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (7.79e-2)" "unprognostic (2.11e-2)" "unprognostic (9.13e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.86e-2)" "unprognostic (1.75e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-3)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 1.2 2.2 0.0 0.0 0.0 7.8 0.0 5.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 9.8 0.0 0.6 26.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.1 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 1.5 0.0 1.4 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 6.1 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 233.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMIM34A ENSG00000243627 "Small integral membrane protein 34A" A8MWV9 21 34418715-34423966 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.5;SK-MEL-30: 1.2;U-87 MG: 1.0" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.3 0.1 0.3 0.3 0.5 0.2 2.9 1.6 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.1 0.3 0.6 0.3 0.2 9.6 0.5 0.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.3 0.7 1.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 1.6 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34B ENSG00000278961 "Small integral membrane protein 34B" A8MWV9 21 7784482-7793954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.5;kidney: 16.1" "Group enriched" "Detected in some" 7 "Ciliated cells: 12.0;Distal tubular cells: 5.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.1;myeloid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 6.5;SK-MEL-30: 2.7;U-87 MG: 2.5" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.4 16.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 3.1 0.6 0.0 0.0 0.4 1.1 0.2 0.2 0.0 0.0 0.0 0.3 0.2 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.7 0.0 1.2 0.3 0.0 0.0 0.5 0.4 0.0 1.2 0.1 0.0 2.5 0.3 0.1 0.0 0.5 3.1 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM35 TMPRSS4-AS1 ENSG00000255274 "Small integral membrane protein 35" 11 118003634-118088299 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Karpas-707: 14.6;RPMI-8226: 9.1" "Group enriched" "Detected in some" 5 "basal ganglia: 1.1;olfactory region: 4.3" NA NA "unprognostic (8.83e-2)" "unprognostic (3.42e-2)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-4)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" 0.0 0.0 1.2 3.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.4 0.1 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.5 0.0 1.7 0.8 0.1 0.5 1.2 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 9.1 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.7 0.7 1.1 0.7 0.4 0.0 0.6 0.1 1.2 0.5 0.8 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOST "DAND6, VBCH" ENSG00000167941 Sclerostin Q9BQB4 17 43753731-43758788 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 17.1;retina: 7.2" "Cell type enriched" "Detected in single" 6 "Collecting duct cells: 1.8" "Group enriched" "Detected in some" 8 "head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5" "Group enriched" "Detected in some" 6 "basal ganglia: 1.0;cerebral cortex: 3.1" "Cell type enhanced" "Detected in single" "eosinophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Group enriched" "Detected in some" 34 "HaCaT: 10.2;SuSa: 6.3" "Group enriched" "Detected in some" 11 "basal ganglia: 1.7;cerebellum: 1.1" "Region enhanced" "Detected in some" "basal ganglia: 1.1" "Secreted to extracellular matrix" NA NA "unprognostic (1.26e-1)" "unprognostic (4.06e-2)" "unprognostic (6.57e-2)" "unprognostic (2.55e-3)" "unprognostic (3.37e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-1)" "unprognostic (8.35e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-1)" "unprognostic (8.92e-2)" "unprognostic (1.56e-1)" "unprognostic (7.90e-2)" 0.3 0.1 0.1 1.4 1.0 0.1 0.1 0.1 3.1 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 0.1 0.1 2.9 0.1 0.1 17.1 0.1 2.4 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 7.2 1.1 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.5 0.1 0.1 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 3.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SOX6 ENSG00000110693 "SRY-box 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.1;kidney: 28.4" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 221.4;Erythroid cells: 116.8;Muller glia cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 30 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "AF22: 4.4;CACO-2: 5.9;HAP1: 4.9;hTCEpi: 5.6;SK-MEL-30: 5.0;WM-115: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.4 0.9 3.9 0.8 3.5 17.7 0.8 0.8 5.7 1.4 30.5 0.8 2.3 5.0 0.8 4.9 1.6 3.3 6.3 2.5 2.6 2.5 28.4 3.8 2.0 0.8 3.0 0.8 1.7 14.5 0.0 2.9 1.9 0.9 0.8 0.8 1.1 0.8 0.8 8.1 4.5 70.1 0.8 1.4 1.1 0.6 10.3 1.0 0.8 2.8 1.4 0.8 0.8 0.8 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.6 4.4 4.2 0.0 0.0 0.0 0.3 1.4 0.1 0.1 5.9 0.0 0.0 3.8 0.0 0.0 0.1 4.9 1.3 0.0 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.1 0.4 0.0 5.0 0.5 0.0 0.0 0.0 2.9 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 3.9 3.5 0.8 2.5 2.6 2.5 3.0 0.8 0.9 1.0 3.0 4.6 0.0 4.2 35.6 2.1 18.7 25.5 12.0 5.7 34.9 9.8 1.0 8.3 12.3 221.4 3.5 3.2 116.8 3.3 0.5 16.2 2.6 0.0 2.8 1.0 0.0 7.5 3.7 0.3 43.5 3.1 2.2 33.7 0.0 1.5 66.8 6.2 8.6 2.1 17.2 3.3 0.0 13.3 20.1 3.5 14.1 0.5 0.0 0.9 2.8 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 303.9;kidney: 700.7;placenta: 331.0" "Cell type enriched" "Detected in many" 9 "Hofbauer cells: 50179.8" "Cancer enhanced" "Detected in all" "glioma: 1690.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 19.2" "Lineage enriched" "Detected in single" 192 "granulocytes: 19.2" "Cell line enhanced" "Detected in some" "EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9" "Region enhanced" "Detected in all" "pons and medulla: 331.4" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 54000000 "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 20.7 4.1 25.5 8.3 42.7 1.1 8.7 4.3 61.0 4.7 2.7 27.3 0.0 2.1 17.3 2.3 1.5 4.2 303.9 2.6 37.2 26.4 700.7 3.9 3.2 2.0 97.0 9.1 3.1 23.6 1.3 1.5 331.0 52.3 2.4 1.9 3.9 7.3 3.9 2.5 1.1 2.1 5.6 147.9 2.1 2.0 2.4 58.9 0.0 1.7 0.0 1.6 5.3 0.3 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 218.9 0.1 17.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 107.8 0.0 0.3 0.2 0.0 0.0 1.5 0.0 5.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.1 0.0 51.4 477.9 0.0 0.0 0.0 0.0 0.0 14.4 21.2 0.0 0.2 0.0 0.5 1.1 0.0 1.1 0.0 0.3 0.4 20.0 0.0 20.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 25.5 42.7 4.3 28.8 37.2 26.4 97.0 9.1 52.3 58.9 3.0 6.6 20.0 2.2 1.3 34.3 4.3 1834.4 2.7 0.0 2071.0 25.5 256.7 850.5 3124.6 0.0 17.5 0.0 0.0 59.8 221.1 15.4 0.3 0.0 2.9 50179.8 742.1 0.0 6.7 63.8 0.4 0.9 93.6 1.7 120.8 0.0 3889.3 343.9 0.0 0.0 5328.4 135.9 0.0 4.4 0.3 0.2 0.9 558.5 1.5 0.0 12.7 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558728-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4" "Cell type enhanced" "Detected in some" 23 "B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Region enriched" "Detected in single" 7 "hippocampal formation: 3.2" "Cell type enhanced" "Detected in many" "memory B-cell: 28.1;naive B-cell: 36.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 63.5;U-698: 28.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Low region specificity" "Detected in many" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.7 0.3 0.4 27.8 0.3 2.9 0.6 0.3 0.4 0.7 2.1 0.0 12.3 0.8 0.6 1.2 2.4 0.4 0.7 0.4 3.2 0.3 20.0 0.5 2.7 23.9 0.4 0.0 0.3 0.6 0.0 0.4 0.1 0.2 1.0 1.3 0.3 2.6 5.1 0.4 0.5 9.3 0.1 0.4 26.5 1.1 2.1 0.0 5.9 0.7 0.7 30.4 4.6 0.6 36.8 1.7 7.7 0.0 12.6 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 8.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 9.2 0.0 1.2 0.0 7.7 0.3 0.0 0.7 28.1 0.7 0.3 0.4 36.8 2.9 0.1 0.3 12.6 0.0 1.7 0.1 1.7 0.4 0.3 0.3 0.4 3.2 0.3 0.4 0.0 0.2 0.0 0.0 10.1 31.9 0.0 0.2 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.0 8.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.6 0.0 0.0 0.0 0.0 5.2 0.3 0.6 15.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.9 0.0 0.0 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell type enhanced" "Detected in some" 25 "Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.8 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.9 8.2 11.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 11.7 0.6 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 0.0 10.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.3 0.0 0.0 3.0 0.0 1.2 18.7 0.0 0.4 0.0 0.0 0.0 0.0 47.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 0.0 0.6 0.0 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.8 83.1 1.6 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.4 1.4 0.9 5.0 0.0 0.0 0.0 0.3 0.0 1.1 13.3 0.0 0.0 0.3 0.9 3.0 0.9 0.0 0.0 0.0 0.0 STRA8 ENSG00000146857 "Stimulated by retinoic acid 8" Q7Z7C7 7 135231979-135258492 "Predicted intracellular proteins" "Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.0;skin 1: 2.5;testis: 4.0" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 1.4;Early spermatids: 1.1;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;K-562: 1.2;SK-BR-3: 2.3;THP-1: 6.9;U-266/84: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.84e-1)" "unprognostic (4.86e-2)" "unprognostic (3.89e-2)" "unprognostic (9.67e-4)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (1.26e-3)" "unprognostic (1.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.45e-1)" "unprognostic (2.69e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 3.0 0.0 0.7 0.0 0.0 0.0 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 792.5;Proximal tubular cells: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA 330000 Mitochondria "Plasma membrane, Cytosol" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavorable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 20.8 23.0 18.2 22.1 34.2 23.1 31.5 23.8 20.4 30.7 22.5 52.6 17.3 28.8 16.5 28.5 24.7 30.5 37.4 28.1 36.5 27.7 34.0 25.0 19.8 29.9 29.0 25.4 20.4 27.4 23.0 25.9 35.3 18.8 27.3 23.6 25.3 23.7 27.9 31.9 36.0 23.2 9.5 78.5 41.2 22.9 42.2 31.5 41.2 25.4 22.1 12.3 19.0 39.5 37.9 17.8 24.1 20.0 22.1 24.1 23.4 29.5 29.2 20.8 29.5 24.8 28.2 35.3 21.2 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 59.6 67.8 89.4 89.8 31.5 32.1 379.6 132.5 91.0 108.1 134.3 21.6 202.1 792.5 102.4 24.5 56.3 282.3 23.3 99.5 100.2 83.9 68.7 90.0 177.6 116.1 42.9 102.0 59.5 64.6 28.6 50.6 82.9 113.1 78.5 140.8 56.0 65.8 217.5 69.6 1327.5 31.0 51.8 72.6 79.7 46.4 36.1 157.6 70.5 304.8 88.9 SUCNR1 GPR91 ENSG00000198829 "Succinate receptor 1" Q9BXA5 3 151873643-151884619 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.1;lymphoid tissue: 23.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 16.6;Hofbauer cells: 18.9;Kupffer cells: 22.2;Macrophages: 11.8;Proximal tubular cells: 31.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 20 "dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7" "Group enriched" "Detected in some" 5 "HEL: 28.0;NB-4: 16.2;U-937: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB022745 Uncertain NA NA "CAB022745: " "unprognostic (1.54e-1)" "unprognostic (2.65e-2)" "unprognostic (3.45e-2)" "unprognostic (6.94e-2)" "unprognostic (1.58e-1)" "unprognostic (6.01e-2)" "unprognostic (3.17e-1)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (8.92e-2)" "unprognostic (2.59e-1)" "unprognostic (1.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.14e-2)" "unprognostic (7.49e-2)" "unprognostic (1.58e-1)" 13.7 1.6 0.6 0.7 0.9 4.7 1.6 0.2 1.2 0.3 0.5 0.7 0.0 0.7 0.4 0.6 0.5 0.3 0.2 2.8 0.4 0.4 63.1 3.6 2.2 3.3 0.6 0.1 0.7 0.4 4.2 0.3 0.2 0.8 0.5 0.5 0.1 1.3 0.0 0.3 0.7 0.5 0.3 0.5 23.3 6.7 0.4 0.0 1.3 14.6 0.8 0.3 0.7 0.3 0.0 2.2 2.0 1.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.1 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.7 2.2 0.0 0.2 0.6 0.9 0.2 1.2 0.4 0.4 0.6 0.1 0.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 2.7 0.0 3.5 0.0 0.0 16.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.2 18.9 0.0 0.0 0.0 22.2 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 SUGCT "C7orf10, DERP13, FLJ11808, ORF19" ENSG00000175600 "Succinyl-CoA:glutarate-CoA transferase" Q9HAC7 7 40134977-40860763 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.1;liver: 27.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 24.1;Proximal tubular cells: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.0;LHCN-M2: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026698, HPA026704, HPA026705" Enhanced NA NA "HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003" "unprognostic (4.66e-3)" "unprognostic (3.45e-2)" "unprognostic (2.06e-2)" "unprognostic (3.32e-3)" "unprognostic (5.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.14e-3)" "unprognostic (1.75e-2)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (5.27e-3)" "unprognostic (7.65e-2)" "prognostic favorable (3.93e-7)" "unprognostic (2.62e-2)" "unprognostic (3.38e-1)" "unprognostic (3.41e-3)" "prognostic unfavorable (2.53e-4)" 2.7 13.5 3.2 5.1 4.6 0.7 4.0 1.1 3.1 4.4 5.0 1.1 0.7 1.4 9.6 2.9 3.2 2.7 4.5 6.9 4.3 2.4 42.1 27.6 1.2 3.9 2.8 2.4 5.7 3.8 3.8 3.5 1.2 4.8 3.4 2.9 5.4 2.4 4.3 11.3 1.6 5.6 13.9 5.0 1.3 1.8 4.1 4.1 0.0 2.4 6.3 1.5 2.9 3.5 1.4 0.2 1.1 0.2 0.0 4.6 0.7 0.5 0.0 3.1 2.3 3.3 7.7 1.2 1.6 2.9 2.2 2.5 1.3 0.6 2.1 0.8 2.2 2.3 0.1 1.0 28.0 3.5 0.0 1.4 1.8 0.2 4.5 4.2 0.2 0.2 9.8 6.4 2.4 1.4 4.5 0.6 0.9 2.4 0.3 16.9 0.0 0.1 0.3 5.3 0.0 2.4 1.9 0.3 0.0 4.8 0.0 0.2 1.8 2.5 1.1 3.5 5.5 0.1 0.4 2.3 9.6 2.7 0.1 0.6 0.2 0.0 0.1 1.8 0.8 2.2 0.0 0.1 0.3 0.7 0.0 1.2 1.4 2.0 1.0 0.1 1.2 4.6 2.7 1.1 0.0 0.2 0.2 0.0 0.7 3.2 4.6 1.1 3.1 4.3 2.4 2.8 2.4 4.8 4.1 3.0 0.3 2.2 1.8 1.8 0.8 4.3 0.0 0.0 5.7 1.8 7.9 1.4 14.9 1.5 24.1 0.6 7.9 0.0 0.7 2.1 2.0 0.7 0.0 15.3 0.3 0.0 3.5 0.0 1.5 12.2 5.8 0.4 3.3 0.0 1.3 5.2 0.6 3.2 2.8 61.7 4.3 6.5 5.6 2.1 2.5 0.5 0.7 0.0 5.2 0.6 SULT1C2 "ST1C1, SULT1C1" ENSG00000198203 "Sulfotransferase family 1C member 2" O00338 2 108288639-108309915 "Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 69.2;kidney: 58.4;stomach 1: 59.2" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 19.2;Distal tubular cells: 49.7;Proximal tubular cells: 60.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "RPTEC TERT1: 24.1;RT4: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007190 Approved NA NA "HPA007190: AB_1857647" "unprognostic (3.31e-2)" "unprognostic (1.63e-2)" "unprognostic (3.41e-1)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (3.61e-2)" "unprognostic (3.78e-1)" "unprognostic (3.62e-2)" "unprognostic (8.74e-2)" "unprognostic (2.76e-1)" "unprognostic (3.19e-2)" "unprognostic (9.27e-2)" "unprognostic (6.28e-2)" "unprognostic (4.63e-2)" "unprognostic (9.96e-5)" 0.5 0.1 0.2 2.2 0.2 0.0 0.4 0.1 0.2 0.8 1.5 1.0 0.5 10.6 0.8 13.3 0.4 1.0 69.2 0.5 0.2 0.2 58.4 1.5 2.5 0.6 0.4 0.3 0.3 3.2 0.2 4.6 0.6 2.2 0.3 1.9 18.6 3.5 4.9 0.1 0.2 1.8 0.6 0.6 0.4 59.2 0.4 0.0 0.4 10.3 0.4 0.3 0.6 0.4 0.1 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.2 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.2 0.0 24.1 6.9 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.4 0.3 2.2 0.0 3.0 13.1 0.0 1.2 1.3 1.2 1.9 17.8 1.4 4.5 19.2 2.0 0.2 49.7 2.5 0.0 2.7 4.9 0.0 0.2 0.2 3.9 2.3 1.1 0.5 14.2 1.6 0.0 3.1 0.0 0.0 0.0 2.2 0.0 0.0 6.3 0.0 3.8 7.0 0.0 60.0 0.6 0.0 0.3 0.3 0.2 1.6 0.1 0.0 4.7 0.8 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 5.6;Late spermatids: 9.2;Melanocytes: 3.3;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 21.1;WM-115: 14.9" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles NA NA Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.2 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 TAAR6 "TA4, TRAR4" ENSG00000146383 "Trace amine associated receptor 6" Q96RI8 6 132570322-132571359 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "kidney: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "REH: 1.0" "Not detected" "Not detected" NA NA "unprognostic (1.70e-1)" 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAL2 bHLHa19 ENSG00000186051 "TAL bHLH transcription factor 2" Q16559 9 105662457-105663112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 8.8;kidney: 4.6;skeletal muscle: 17.3" "Cell type enhanced" "Detected in some" 16 "Cone photoreceptor cells: 3.9;Distal tubular cells: 6.6;Intestinal endocrine cells: 3.4;Muller glia cells: 1.8" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Group enriched" "Detected in some" 21 "memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 18 "B-cells: 8.8;dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;HAP1: 4.9;K-562: 12.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA030886 Uncertain Approved Cytosol NA NA Cytosol "HPA030886: AB_10601596" "unprognostic (3.89e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "unprognostic (5.54e-2)" "unprognostic (2.24e-1)" "unprognostic (9.06e-2)" "unprognostic (4.98e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-3)" "unprognostic (2.63e-1)" "unprognostic (7.00e-4)" "unprognostic (2.84e-2)" "prognostic favorable (2.69e-4)" "unprognostic (2.70e-2)" "unprognostic (1.24e-1)" "unprognostic (1.29e-1)" "unprognostic (7.39e-2)" 0.1 0.3 0.5 0.1 0.7 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 0.9 0.1 0.2 0.0 0.3 0.4 0.5 4.6 0.3 0.0 0.2 0.7 0.3 0.1 0.0 0.8 0.1 0.1 0.1 0.0 0.2 17.3 0.1 0.1 0.0 0.8 0.3 0.0 0.6 0.1 0.4 0.1 0.0 8.8 2.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 2.5 0.7 0.3 0.0 0.3 0.1 0.3 0.1 0.4 3.4 0.2 0.1 0.3 0.0 0.7 0.1 4.9 0.0 0.2 0.6 0.5 1.1 0.0 0.0 0.2 0.6 1.9 0.3 0.6 0.1 0.2 0.2 0.0 0.8 12.9 0.3 0.4 0.3 0.8 0.7 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 2.9 1.2 0.2 0.3 0.2 0.1 0.2 2.1 0.5 0.3 0.8 0.7 1.1 1.0 2.0 0.1 0.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.4 1.1 0.9 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 TCF24 bHLHa25 ENSG00000261787 "Transcription factor 24" Q7RTU0 8 66946501-66962590 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "heart muscle: 8.0;kidney: 4.1;testis: 7.0" "Group enriched" "Detected in some" 25 "Cardiomyocytes: 4.4;Spermatocytes: 1.4;Spermatogonia: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.8;HEK 293: 9.5;HMC-1: 8.3;K-562: 2.5" "Low region specificity" "Detected in some" NA NA "unprognostic (1.07e-1)" "unprognostic (9.14e-3)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.30e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (2.25e-1)" "unprognostic (9.38e-3)" "unprognostic (9.36e-2)" "unprognostic (1.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" 0.1 0.0 0.5 0.1 0.9 0.3 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.0 0.2 0.3 0.1 1.6 0.1 8.0 0.6 0.8 4.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.5 0.1 0.6 7.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 3.8 0.0 0.1 0.0 9.5 0.4 0.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.7 0.0 0.4 1.6 0.7 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.9 0.1 0.9 0.6 0.8 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.0 0.0 0.0 0.0 0.0 TCN2 "D22S676, D22S750, TC2" ENSG00000185339 "Transcobalamin 2" P20062 22 30606838-30627278 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 104.9;Ito cells: 111.1;Kupffer cells: 140.0;Proximal tubular cells: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8" "Lineage enriched" "Detected in many" 8 "monocytes: 29.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.3;HUVEC TERT2: 41.4;Karpas-707: 53.8;RPTEC TERT1: 20.9;TIME: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000837 Approved Cytosol "Secreted to blood" NA NA 13000000 Cytosol "HPA000837: AB_1080235" "unprognostic (6.43e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.53e-3)" "unprognostic (3.17e-1)" "unprognostic (1.49e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.64e-4)" "unprognostic (1.52e-2)" "unprognostic (2.90e-1)" "unprognostic (1.07e-1)" "unprognostic (4.03e-2)" "unprognostic (1.59e-1)" "unprognostic (6.95e-3)" "unprognostic (4.94e-3)" "unprognostic (2.09e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" 39.8 15.2 6.5 7.2 8.1 2.2 30.0 3.4 10.9 13.1 14.8 9.2 9.6 10.9 15.0 23.9 7.0 11.2 31.7 15.8 6.6 7.3 73.2 8.7 21.7 43.3 8.6 8.5 7.8 6.3 5.7 7.9 8.7 10.7 9.6 13.5 13.5 6.8 23.0 5.4 4.5 30.4 17.6 9.0 24.8 8.4 9.7 5.1 1.9 12.8 4.8 4.6 11.6 10.9 0.0 3.4 0.6 29.0 0.0 0.3 6.5 0.0 2.6 12.1 0.0 7.2 35.3 0.4 0.8 8.8 2.2 3.7 1.2 6.1 0.1 13.4 1.7 0.2 0.4 1.0 0.6 0.7 0.0 0.6 0.0 0.3 0.5 17.3 0.1 9.9 5.8 0.7 1.7 1.5 2.5 41.4 0.0 0.2 53.8 3.6 0.0 0.0 0.9 4.7 3.3 0.3 1.3 1.7 18.1 20.9 0.3 4.2 0.5 0.0 0.1 3.5 0.8 0.1 0.5 24.2 7.8 1.0 0.9 0.3 1.4 0.3 0.0 2.7 0.4 0.1 0.0 19.2 0.0 0.0 29.0 0.3 0.0 0.3 0.2 3.4 0.0 0.1 0.2 0.6 0.0 9.8 0.6 0.1 6.5 6.5 8.1 3.4 10.9 6.6 7.3 8.6 8.5 10.7 5.1 3.0 3.8 6.0 0.8 4.6 7.3 5.0 35.7 2.7 4.5 12.2 19.6 0.4 6.6 5.9 0.8 59.1 104.9 0.0 5.2 0.7 11.2 2.0 4.6 5.0 40.3 1.6 6.4 111.1 140.0 1.0 9.8 32.3 21.9 7.2 23.3 6.0 5.6 49.1 9.2 115.0 28.1 12.9 4.7 0.7 7.8 4.5 0.3 2.1 10.0 2.4 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 102.8" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 9.5 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.2 1.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 102.8 0.1 4.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 2.4 0.0 0.0 0.7 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285207 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 7.0" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 7 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" Yes NA "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favorable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.0 0.2 0.6 4.0 1.1 0.0 12.9 0.6 0.9 8.7 8.5 1.2 6.3 0.2 0.8 8.2 6.0 1.5 8.7 0.1 0.6 0.1 52.2 0.1 12.3 1.5 0.4 0.0 0.6 2.8 0.4 1.5 4.7 7.0 6.1 10.5 0.8 93.5 2.9 2.4 13.1 1.3 0.4 0.4 0.9 6.2 0.8 0.3 0.4 37.3 7.2 6.3 1.4 4.1 0.0 0.1 0.1 0.1 0.4 2.9 0.0 0.0 1.0 0.0 0.1 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.4 0.0 0.4 0.2 2.7 2.7 0.0 0.0 1.9 9.4 0.0 0.0 0.0 0.0 0.3 0.0 10.8 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.3 1.2 26.7 19.3 8.3 0.0 1.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.9 0.6 0.1 0.4 0.0 7.0 0.3 6.0 20.8 0.0 45.7 1.4 0.0 2.2 25.5 0.0 12.5 75.0 0.0 23.2 26.6 2.2 0.1 0.1 75.7 0.0 1.3 1.2 0.6 33.2 0.0 0.2 4.3 0.0 9.8 0.0 5.4 0.0 0.3 2.1 6.8 0.0 37.4 0.4 4.7 34.0 0.0 23.2 0.0 0.0 0.1 0.0 0.2 2.9 16.9 0.0 34.7 33.5 TFEC "bHLHe34, TCFEC, TFECL" ENSG00000105967 "Transcription factor EC" O14948 7 115935148-116159896 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.6" "Group enriched" "Detected in some" 6 "Hofbauer cells: 40.9;Kupffer cells: 42.8;Macrophages: 48.6;Proximal tubular cells: 52.2" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 8.7;myeloid DC: 7.7" "Group enriched" "Detected in many" 32 "B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7" "Cell line enhanced" "Detected in some" "HEL: 12.3;HUVEC TERT2: 8.6;THP-1: 16.3;TIME: 9.6;U-937: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032260, HPA063577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB032260: AB_2202845, HPA063577: AB_2685047" "unprognostic (1.36e-1)" "unprognostic (1.08e-2)" "unprognostic (8.70e-2)" "unprognostic (1.91e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (8.26e-2)" "unprognostic (2.15e-1)" "unprognostic (6.54e-2)" "unprognostic (2.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.05e-3)" "unprognostic (2.92e-1)" "unprognostic (4.14e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-2)" 11.2 3.5 5.8 15.4 9.2 12.3 7.6 0.8 4.6 1.8 3.7 1.4 0.6 3.4 1.6 6.1 2.4 2.6 4.2 2.5 6.0 2.1 22.6 2.8 15.7 17.0 13.0 2.2 1.6 1.8 0.4 1.8 3.9 8.8 1.9 3.6 0.8 3.1 0.7 1.2 1.3 11.6 2.6 15.2 16.4 2.3 1.7 9.4 1.6 2.1 1.1 10.0 3.8 1.7 4.9 7.7 0.2 8.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.3 9.6 1.7 0.1 1.0 0.0 4.3 0.0 0.0 0.0 18.5 0.9 0.0 8.7 0.0 0.0 3.7 0.0 4.9 0.0 0.0 7.7 2.1 0.0 0.0 0.2 0.0 0.5 3.9 0.0 1.7 5.8 9.2 0.8 4.6 6.0 2.1 13.0 2.2 8.8 9.4 0.0 2.1 5.0 0.0 0.5 0.0 0.7 2.5 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 2.3 0.0 40.9 0.0 0.0 0.0 42.8 2.7 0.0 48.6 0.0 8.2 0.0 0.0 0.1 0.0 0.0 52.2 0.0 0.0 0.0 0.2 0.4 0.4 0.7 0.0 0.0 0.0 TINAG ENSG00000137251 "Tubulointerstitial nephritis antigen" Q9UJW2 6 54307859-54390152 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 27.2;kidney: 53.0" "Group enriched" "Detected in some" 6 "Enterocytes: 52.3;Proximal tubular cells: 176.4" "Cancer enhanced" "Detected in some" "renal cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "RPTEC TERT1: 46.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035427, HPA073753" Approved "Secreted to extracellular matrix" NA NA 26000 "HPA035427: AB_10601822, HPA073753: " "unprognostic (7.62e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (7.27e-2)" "unprognostic (5.99e-3)" "prognostic favorable (8.75e-5)" "unprognostic (7.10e-2)" 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 53.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.2 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 0.0 0.0 19.9 0.0 0.7 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 1.3 10.5 0.0 176.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 TLN2 "ILWEQ, KIAA0320" ENSG00000171914 "Talin 2" Q9Y4G6 15 62390526-62844631 "Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.9" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 46.1;Rod photoreceptor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 29.8;hTERT-HME1: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017194, HPA051828, HPA054787" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 81000000 "Focal adhesion sites, Cytosol" "CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587" "prognostic favorable (6.53e-4)" "unprognostic (2.61e-1)" "unprognostic (9.47e-2)" "unprognostic (8.95e-2)" "unprognostic (3.74e-1)" "unprognostic (1.43e-1)" "unprognostic (8.24e-2)" "unprognostic (9.94e-2)" "unprognostic (1.68e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (1.91e-1)" "prognostic favorable (1.81e-6)" "prognostic favorable (7.74e-4)" "unprognostic (1.34e-1)" "unprognostic (5.79e-2)" "unprognostic (2.30e-1)" 12.5 3.1 7.0 12.1 7.0 2.3 5.3 5.4 18.9 5.6 24.3 4.0 1.7 3.3 6.5 4.2 3.4 3.2 6.3 8.5 6.8 6.0 36.9 1.8 1.9 1.3 6.2 4.2 7.0 3.3 2.3 3.0 2.4 4.5 3.1 5.4 5.5 5.4 1.6 16.9 1.6 16.6 6.9 9.6 0.8 4.1 3.5 1.3 0.9 29.0 4.5 1.3 4.3 7.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.8 2.7 3.9 4.6 29.8 2.8 4.4 6.6 5.2 6.1 6.0 7.2 0.9 2.2 3.0 11.4 10.1 1.1 5.0 1.0 5.3 7.1 0.5 0.2 10.8 4.7 1.0 0.7 0.2 5.2 2.7 8.1 24.2 3.5 0.2 2.8 0.2 0.1 10.1 3.5 0.3 0.3 6.9 12.4 2.0 2.7 9.9 2.7 3.2 5.5 0.9 4.5 5.0 0.5 1.7 8.8 1.4 1.7 1.9 11.0 15.0 17.7 16.8 0.1 0.4 1.4 5.0 1.6 13.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 7.0 7.0 5.4 12.9 6.8 6.0 6.2 4.2 4.5 1.3 0.0 2.7 1.3 1.5 2.2 11.7 35.9 2.5 0.0 1.2 26.2 35.3 1.0 10.0 3.4 3.4 4.9 16.5 0.0 3.3 22.8 11.6 1.5 0.0 10.6 4.5 46.1 2.4 4.3 5.6 4.0 10.9 5.1 0.0 1.0 16.7 10.1 2.9 17.3 14.9 25.8 47.3 0.0 7.6 2.6 19.4 1.4 1.1 0.0 27.9 1.4 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 9.0" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.4 0.7 1.3 0.0 0.0 0.0 0.0 0.0 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.7 0.7 0.1 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 2.3 18.3 0.1 12.9 0.0 0.8 8.3 0.0 4.2 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.6 0.7 0.4 0.0 0.2 0.7 0.1 0.1 0.0 32.2 2.5 0.1 0.0 0.5 11.3 0.0 0.2 31.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 14.9 5.1 0.0 2.4 0.1 0.0 2.0 35.7 2.7 5.7 48.8 0.0 26.6 29.9 42.9 12.0 0.3 54.0 0.0 4.0 4.7 0.3 0.3 0.0 13.4 1.7 0.0 3.5 1.3 0.6 8.8 0.0 0.1 5.0 1.8 4.3 8.3 23.3 23.0 0.0 67.4 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 7.4 1.2 TMEM171 PRP2 ENSG00000157111 "Transmembrane protein 171" Q8WVE6 5 73120292-73131817 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 20.4;Enterocytes: 49.5;Paneth cells: 44.1;Undifferentiated cells: 49.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MAIT T-cell: 18.2;memory CD8 T-cell: 6.3" "Lineage enriched" "Detected in single" 86 "T-cells: 18.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.9;RPTEC TERT1: 16.0;WM-115: 58.5" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.9" "Region enhanced" "Detected in single" "pons and medulla: 3.6" HPA042308 Approved NA NA "HPA042308: AB_10796901" "unprognostic (7.34e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (7.74e-3)" "unprognostic (2.81e-5)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.44e-3)" "unprognostic (1.77e-1)" "unprognostic (1.85e-1)" "unprognostic (4.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (3.93e-10)" "unprognostic (6.13e-3)" "unprognostic (2.43e-1)" "unprognostic (9.10e-3)" "unprognostic (1.57e-1)" 0.2 0.2 0.8 5.6 2.1 0.0 0.7 0.7 3.3 0.4 20.1 3.2 2.2 16.2 0.2 1.4 3.9 0.2 1.5 0.2 1.2 0.7 25.4 3.9 0.4 0.1 0.9 1.6 0.2 0.6 0.0 0.3 0.1 1.1 0.5 18.9 0.6 1.4 2.8 0.6 0.7 18.8 0.6 1.4 14.6 16.7 0.6 0.6 0.0 25.9 3.2 6.3 0.4 0.3 0.0 0.0 0.2 0.0 0.0 18.2 0.5 7.5 0.3 0.0 0.0 2.4 3.3 0.0 2.4 11.2 4.5 7.7 0.2 3.5 0.0 5.2 3.0 0.9 5.7 0.1 0.3 3.5 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.3 0.7 0.2 6.1 0.5 1.8 2.8 0.0 0.0 0.1 20.9 0.7 0.0 0.0 0.6 0.1 0.5 0.0 0.0 3.8 16.0 0.1 0.0 0.0 1.8 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.4 6.6 0.1 0.0 0.0 0.0 6.1 0.0 58.5 0.0 0.0 0.0 1.3 0.0 18.2 0.0 0.7 6.3 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.5 0.8 2.1 0.7 3.3 1.2 0.7 0.9 1.6 1.1 0.6 0.0 0.0 0.0 0.3 1.5 0.0 0.3 20.4 0.0 0.0 7.0 0.0 0.1 13.3 5.9 0.0 0.0 49.5 0.0 9.0 0.3 0.8 0.0 0.0 1.1 1.0 0.0 2.4 0.6 0.0 0.0 0.0 0.0 1.7 0.0 16.0 0.0 7.2 44.1 0.0 9.1 0.0 0.0 0.1 0.2 0.7 1.5 0.5 0.0 49.5 0.9 TMEM174 "FLJ31268, MGC13034" ENSG00000164325 "Transmembrane protein 174" Q8WUU8 5 73173195-73175143 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 282 "kidney: 61.5" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 143.8" "Cancer enriched" "Detected in single" 126 "renal cancer: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.7;RPTEC TERT1: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA037975 Enhanced NA NA "HPA037975: AB_10672732" "unprognostic (8.11e-2)" "prognostic favorable (3.30e-6)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 76.8;liver: 234.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 38.4;intermediate monocyte: 27.1" "Lineage enriched" "Detected in many" 4 "monocytes: 38.4" "Cell line enriched" "Detected in some" 30 "HSkMC: 127.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria NA NA Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 10.5 4.9 5.8 17.1 6.0 0.7 7.8 1.2 4.3 6.2 32.2 4.8 2.0 16.1 3.6 12.8 7.5 6.3 34.2 15.0 5.2 4.5 76.8 234.5 8.8 23.5 6.9 3.4 19.0 5.0 0.4 2.2 8.9 6.6 6.3 22.3 22.8 3.9 2.0 3.1 3.3 51.2 6.5 6.9 17.3 7.1 3.7 5.4 2.1 4.8 4.8 9.2 13.5 9.1 0.4 9.3 3.3 38.4 0.0 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 3.3 0.1 27.1 0.1 0.4 0.0 0.1 9.3 0.0 0.0 0.0 0.5 0.0 12.9 0.6 0.1 10.7 5.8 6.0 1.2 4.3 5.2 4.5 6.9 3.4 6.6 5.4 0.0 6.9 29.6 0.4 6.5 48.5 19.4 150.3 14.7 15.9 190.1 3.9 0.5 129.3 42.7 0.1 9.6 542.2 0.0 23.6 0.8 57.1 2.4 26.7 864.2 53.0 0.0 71.1 29.4 40.2 0.5 55.8 35.8 5.0 525.8 156.3 73.3 68.7 691.0 7.1 954.7 4.4 0.0 20.0 0.7 1.5 7.3 1.1 7.2 159.5 0.9 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 75 "kidney: 21.1" "Cell type enriched" "Detected in some" 17 "Distal tubular cells: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain NA NA "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 58.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 TMEM213 ENSG00000214128 "Transmembrane protein 213" A2RRL7 7 138797952-138838101 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "kidney: 48.1;salivary gland: 35.6" "Cell type enhanced" "Detected in some" 28 "Collecting duct cells: 50.6;Distal tubular cells: 122.7;Melanocytes: 25.3" "Cancer enriched" "Detected in some" 22 "renal cancer: 21.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.5" "Not detected" "Not detected" HPA054059 Enhanced NA NA "HPA054059: AB_2682361" "unprognostic (2.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (6.84e-2)" "unprognostic (1.17e-2)" "unprognostic (2.10e-1)" "unprognostic (6.14e-2)" "unprognostic (6.08e-2)" "unprognostic (1.91e-2)" "prognostic favorable (5.54e-7)" "unprognostic (4.33e-1)" "unprognostic (9.99e-2)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" 0.1 0.0 0.1 0.0 0.1 0.4 2.1 0.0 0.1 1.2 0.0 0.0 4.3 0.3 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 48.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 35.6 2.9 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 1.1 0.8 4.1 0.7 4.6 1.2 0.2 0.4 0.4 0.7 1.6 0.3 0.3 1.4 0.6 0.2 0.1 0.3 1.1 1.7 0.9 0.6 0.1 0.6 0.9 0.0 0.0 0.3 0.6 1.2 1.4 1.0 0.7 0.1 1.0 0.9 0.5 0.2 0.1 0.4 0.5 0.5 0.8 1.2 1.9 0.3 0.2 0.4 0.9 0.3 0.2 0.3 0.6 0.9 0.7 4.5 1.7 1.3 1.1 0.5 1.1 0.2 1.0 1.2 0.3 0.1 1.8 0.9 1.4 0.8 1.7 0.5 1.2 0.8 0.4 0.9 4.1 0.7 0.7 0.9 0.6 1.2 0.7 0.5 0.6 0.3 1.1 0.6 0.6 3.4 4.6 0.6 0.8 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.0 6.9 0.0 0.7 0.0 0.3 0.4 0.0 5.3 3.4 50.6 0.0 0.0 122.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 TMEM252 "C9orf71, MGC34760" ENSG00000181778 "Transmembrane protein 252" Q8N6L7 9 68536580-68540867 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 16.0;kidney: 64.2" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 15.1" "Cancer enriched" "Detected in many" 17 "renal cancer: 35.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 7.6" "Group enriched" "Detected in some" 6 "EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA079457 Enhanced NA NA "HPA079457: " "unprognostic (2.64e-1)" "unprognostic (3.28e-3)" "unprognostic (3.72e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.64e-2)" "unprognostic (6.42e-2)" "prognostic favorable (1.75e-7)" "unprognostic (7.63e-2)" "unprognostic (6.15e-2)" "unprognostic (7.66e-2)" "unprognostic (2.50e-1)" 0.5 2.0 0.4 0.6 0.4 0.0 0.4 0.9 0.4 0.6 5.6 0.4 0.4 1.0 4.3 0.8 4.3 2.7 0.7 3.0 0.4 0.0 64.2 0.9 0.4 0.4 0.4 0.4 0.6 0.4 0.0 0.4 2.6 0.4 1.8 0.0 0.4 0.4 0.4 0.7 0.2 16.0 0.9 0.4 0.4 1.7 0.6 0.4 0.4 0.4 0.4 0.5 6.0 0.6 0.0 0.1 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.9 0.0 6.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.9 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM52B "C12orf59, FLJ31166" ENSG00000165685 "Transmembrane protein 52B" Q4KMG9 12 10170542-10191801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "kidney: 85.1" "Cell type enriched" "Detected in some" 16 "Distal tubular cells: 603.5" "Cancer enriched" "Detected in some" 5 "renal cancer: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "CACO-2: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058096 Enhanced Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058096: AB_2683603" "unprognostic (1.10e-2)" "unprognostic (7.61e-2)" "unprognostic (1.37e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (5.33e-3)" "unprognostic (1.37e-1)" "unprognostic (8.65e-2)" "unprognostic (7.14e-4)" "unprognostic (2.23e-1)" "unprognostic (6.36e-2)" "unprognostic (7.33e-2)" "unprognostic (3.24e-2)" "unprognostic (5.80e-2)" "unprognostic (5.51e-2)" "unprognostic (1.66e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.6 0.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 85.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 2.0 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 3.7 1.4 1.3 0.6 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.3 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 6.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.4 4.4 0.0 1.6 2.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 1.4 1.3 1.0 0.4 0.2 0.4 0.4 0.4 0.5 3.7 0.9 0.5 0.5 1.0 0.6 0.2 0.6 0.4 0.4 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 12.2 0.0 38.1 603.5 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.6 0.0 0.3 4.2 1.7 2.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.2 0.0 16.2 0.0 0.0 0.0 TMEM61 ENSG00000143001 "Transmembrane protein 61" Q8N0U2 1 54980792-54992293 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1" "Group enriched" "Detected in many" 4 "Distal tubular cells: 41.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 52.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 5.2;pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 22.6" "Low region specificity" "Detected in many" HPA030614 Uncertain NA NA "HPA030614: AB_10603216" "unprognostic (7.62e-2)" "unprognostic (1.67e-3)" "prognostic favorable (1.07e-4)" "unprognostic (1.00e-1)" "unprognostic (6.63e-4)" "unprognostic (6.15e-2)" "unprognostic (2.67e-3)" "unprognostic (1.49e-1)" "unprognostic (3.05e-1)" "unprognostic (4.46e-2)" "unprognostic (1.91e-2)" "unprognostic (7.24e-2)" "prognostic favorable (1.78e-7)" "unprognostic (8.47e-2)" "unprognostic (2.20e-2)" "unprognostic (4.01e-2)" "unprognostic (4.62e-3)" 0.2 3.9 0.4 0.7 1.0 0.0 2.7 5.2 0.5 0.9 3.7 0.2 4.9 2.4 0.2 3.8 2.9 2.0 1.7 0.0 0.5 0.6 22.1 0.0 2.4 0.0 1.1 0.7 1.1 4.2 7.8 29.1 0.5 5.2 2.4 2.3 0.5 34.1 6.7 0.4 1.8 3.5 5.3 0.8 0.4 2.2 0.2 0.1 0.1 0.6 0.8 1.8 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 22.6 2.4 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 5.2 0.5 0.5 0.6 1.1 0.7 5.2 0.1 0.0 1.9 0.0 6.7 0.8 0.7 0.0 0.0 10.7 2.3 7.0 2.0 0.1 41.4 4.0 0.1 0.0 1.7 0.0 3.0 0.1 0.2 3.1 0.0 0.0 0.1 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 52.9 0.1 4.2 5.8 0.7 0.0 0.8 0.0 0.1 0.1 0.7 2.0 0.2 0.0 2.0 2.6 TMEM72 "bA285G1.3, C10orf127, KSP37" ENSG00000187783 "Transmembrane protein 72" A0PK05 10 44911200-44937002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.5;retina: 17.1" "Group enriched" "Detected in some" 4 "Collecting duct cells: 26.2;Distal tubular cells: 28.2;Late spermatids: 11.4;Paneth cells: 8.6" "Cancer enriched" "Detected in some" 8 "renal cancer: 8.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.2;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 118 "RPMI-8226: 26.1;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA039894, HPA062907" Enhanced NA NA "HPA039894: AB_10795261, HPA062907: AB_2684900" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (8.58e-2)" "unprognostic (5.45e-2)" "prognostic favorable (1.01e-4)" "unprognostic (4.99e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" 0.1 0.0 0.1 0.9 0.2 0.1 0.0 0.3 0.2 0.0 4.2 1.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.3 46.5 0.1 0.0 0.0 0.4 0.0 0.0 5.7 0.1 0.3 0.0 4.9 0.0 4.9 17.1 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 1.9 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 1.2 0.3 0.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 26.2 0.0 0.0 28.2 0.0 4.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 8.6 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.7 0.0 TNFRSF11B "OCIF, OPG, TR1" ENSG00000164761 "TNF receptor superfamily member 11b" O00300 8 118923557-118952200 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 18.6;thyroid gland: 52.8" "Group enriched" "Detected in many" 4 "Collecting duct cells: 69.8;Ductal cells: 23.2;Proximal tubular cells: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 66 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 66 "dendritic cells: 6.5" "Group enriched" "Detected in some" 4 "BJ: 50.9;BJ hTERT+: 189.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034939 Approved "Secreted in other tissues" NA NA "CAB034939: " "unprognostic (1.39e-2)" "prognostic unfavorable (6.22e-4)" "unprognostic (5.27e-2)" "unprognostic (2.33e-2)" "unprognostic (4.27e-3)" "unprognostic (1.10e-3)" "unprognostic (1.21e-3)" "unprognostic (5.50e-2)" "unprognostic (9.94e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (2.43e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.32e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-3)" "prognostic unfavorable (3.88e-4)" 3.0 3.0 2.2 2.8 2.8 0.2 4.4 2.9 5.2 1.2 1.5 0.7 0.5 0.9 5.5 4.1 1.0 1.7 3.2 7.3 2.8 1.4 18.6 7.6 8.1 5.3 1.7 0.8 0.5 2.8 0.3 1.9 4.0 12.0 1.1 2.0 1.8 1.4 0.8 0.6 0.7 1.4 1.5 7.9 1.5 0.8 0.3 2.7 0.9 52.8 0.8 1.7 1.7 1.1 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.6 0.5 0.0 50.9 189.3 2.4 0.7 0.5 0.1 0.0 13.7 28.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 1.0 0.0 0.0 0.0 0.0 7.1 1.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.8 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.2 2.8 2.9 5.2 2.8 1.4 1.7 0.8 12.0 2.7 3.0 0.0 0.5 0.5 1.9 0.0 3.1 5.1 0.0 1.2 69.8 0.0 0.0 8.3 23.2 0.1 4.5 1.4 0.0 1.2 0.1 6.9 7.9 0.0 1.0 0.4 0.0 9.1 6.2 0.0 0.0 0.3 0.0 0.0 14.4 8.8 0.7 6.9 0.0 0.0 89.5 0.0 0.0 2.2 0.0 0.3 1.0 0.0 0.0 2.1 0.3 TNFSF10 "Apo-2L, CD253, TL2, TRAIL" ENSG00000121858 "TNF superfamily member 10" P50591 3 172505508-172523507 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 115.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3" "Group enriched" "Detected in all" 5 "granulocytes: 50.3;monocytes: 39.5" "Cell line enhanced" "Detected in many" "BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054938 Uncertain "Secreted to blood" NA NA 67400 "HPA054938: AB_2682643" "unprognostic (9.16e-2)" "unprognostic (2.79e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-3)" "unprognostic (2.52e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-1)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (1.32e-1)" "unprognostic (6.27e-2)" 30.9 22.1 3.4 14.6 4.7 2.0 23.3 3.0 5.4 31.4 25.8 4.4 17.1 20.6 13.0 10.3 33.3 9.6 10.7 9.9 3.8 3.2 115.1 44.4 91.5 23.5 5.5 3.4 13.5 11.6 10.9 6.7 100.8 6.7 37.6 19.5 12.0 50.6 12.9 13.9 13.0 54.0 7.9 5.6 35.8 9.5 6.0 4.6 8.3 28.2 17.7 16.1 22.4 24.0 3.4 9.5 50.3 39.5 9.3 7.0 11.9 3.4 0.1 0.0 0.0 2.4 1.8 21.0 0.0 0.1 1.0 1.6 0.0 14.9 2.1 10.1 0.0 0.9 14.7 0.0 1.8 0.2 5.3 0.0 0.0 0.4 0.3 0.1 3.9 69.1 2.4 2.4 0.4 0.0 0.0 7.6 0.4 0.0 2.5 0.0 0.0 0.5 5.2 0.0 0.1 0.1 0.8 0.0 0.9 34.8 1.3 0.1 0.1 7.7 0.3 0.1 0.1 4.2 2.2 0.3 0.0 0.0 0.0 0.2 2.6 0.3 2.6 0.2 2.2 0.0 42.4 25.6 2.7 2.3 39.5 3.1 3.2 6.4 3.5 9.5 3.4 4.7 1.8 50.3 9.3 38.3 0.6 7.0 11.9 3.4 4.7 3.0 5.4 3.8 3.2 5.5 3.4 6.7 4.6 65.5 119.9 15.2 153.0 19.6 0.1 4.5 63.7 99.0 113.7 62.8 0.0 1.1 38.1 542.5 3.9 163.8 223.5 23.3 368.6 166.3 27.9 96.6 248.5 58.7 22.3 1.6 46.3 140.0 77.7 2.8 17.0 51.4 6.8 16.2 96.5 21.7 249.5 190.0 4.6 449.0 0.8 0.0 10.3 0.0 0.2 22.3 9.2 43.6 68.5 109.1 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TRABD2B TIKI2 ENSG00000269113 "TraB domain containing 2B" A6NFA1 1 47760528-47996895 "Predicted intracellular proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 34.3" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 7.4;Cholangiocytes: 10.2;Hepatocytes: 10.4;Proximal tubular cells: 20.3;Smooth muscle cells: 7.6" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.8" "Region enhanced" "Detected in single" "cerebellum: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 8.0;U-2197: 17.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045817 Approved "Intracellular and membrane" NA NA 22000 "HPA045817: AB_2679460" "unprognostic (2.38e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-2)" "unprognostic (2.26e-2)" "unprognostic (5.65e-2)" "unprognostic (4.49e-2)" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (2.74e-1)" "unprognostic (3.29e-3)" "unprognostic (1.84e-1)" "unprognostic (2.95e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-2)" "unprognostic (4.77e-1)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" 3.6 1.5 0.5 2.2 0.3 0.1 3.3 2.7 0.5 4.8 3.0 0.5 1.5 0.9 1.8 9.3 4.7 2.2 9.5 8.2 0.1 0.1 34.3 7.1 1.8 1.9 0.4 0.5 2.5 7.0 0.3 2.3 0.9 0.8 4.9 1.6 2.7 2.3 8.5 1.7 1.7 1.8 7.1 0.7 1.5 1.9 1.8 0.0 0.6 1.1 1.0 0.8 6.9 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.5 0.0 8.0 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.8 17.1 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.7 0.5 0.1 0.1 0.4 0.5 0.8 0.0 0.0 0.3 0.0 1.4 0.7 0.0 7.4 10.2 0.0 0.0 1.8 0.0 0.0 5.0 3.3 0.1 0.8 0.0 0.0 1.8 0.0 2.1 0.2 0.0 10.4 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 2.1 20.3 0.0 0.0 7.6 0.0 2.2 0.3 0.0 0.0 0.0 0.1 TRIM10 "HERF1, RFB30, RNF9" ENSG00000204613 "Tripartite motif containing 10" Q9UDY6 6 30151945-30160934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8" "Cell type enriched" "Detected in some" 12 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "EFO-21: 1.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "hippocampal formation: 4.0" HPA043325 Uncertain NA NA "HPA043325: AB_2678428" "unprognostic (2.98e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (2.13e-1)" "unprognostic (2.98e-1)" "unprognostic (9.53e-3)" "unprognostic (6.32e-2)" "unprognostic (2.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.74e-3)" "unprognostic (1.46e-2)" "unprognostic (4.37e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.0 3.0 0.0 0.0 1.4 0.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 70.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 TRIM6 RNF89 ENSG00000121236 "Tripartite motif containing 6" Q9C030 11 5596109-5612958 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 42.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 11.1;Extravillous trophoblasts: 12.7;Proximal tubular cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 14.4;SuSa: 25.2;U-2 OS: 14.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA060514 Uncertain NA NA "HPA060514: AB_2684300" "unprognostic (9.00e-2)" "unprognostic (2.10e-3)" "unprognostic (9.16e-3)" "unprognostic (1.82e-1)" "unprognostic (3.25e-3)" "unprognostic (3.25e-3)" "unprognostic (2.35e-2)" "unprognostic (3.26e-3)" "unprognostic (8.59e-2)" "unprognostic (3.40e-2)" "unprognostic (8.61e-2)" "unprognostic (3.90e-1)" "unprognostic (5.68e-2)" "unprognostic (4.65e-4)" "unprognostic (4.77e-1)" "unprognostic (3.33e-2)" "unprognostic (4.36e-1)" 3.7 5.8 0.6 1.5 1.3 1.3 3.0 0.2 1.4 4.2 2.6 1.4 3.2 0.1 4.2 4.3 6.0 3.1 1.8 2.6 0.8 0.7 42.7 1.1 2.2 0.2 0.7 0.6 3.9 1.8 1.9 1.9 10.9 2.1 3.9 1.2 6.6 14.7 3.9 1.3 1.1 2.2 4.7 1.4 2.8 1.6 15.5 1.0 1.6 3.8 1.1 3.2 4.9 3.7 0.3 2.2 3.9 0.7 1.0 0.3 0.4 0.4 10.4 0.7 0.0 1.2 2.0 12.2 2.8 2.1 2.8 2.7 0.3 2.3 0.0 1.6 2.8 7.8 1.8 4.7 4.3 4.0 0.3 3.2 1.2 1.0 0.0 0.4 4.1 5.7 3.4 4.1 3.9 2.8 4.2 2.4 0.0 4.9 0.1 1.2 0.1 0.0 0.5 14.4 1.6 3.6 4.8 0.0 0.1 0.6 4.2 0.0 0.1 0.0 5.4 0.5 25.2 2.0 0.7 12.2 2.7 14.2 0.0 2.9 0.1 0.1 0.0 2.4 0.0 2.2 0.7 0.7 1.4 0.3 0.0 0.1 0.3 0.1 0.0 2.2 0.2 0.1 0.1 3.9 1.0 0.0 0.9 0.1 0.4 0.6 1.3 0.2 1.4 0.8 0.7 0.7 0.6 2.1 1.0 0.0 4.5 0.0 0.4 0.5 0.0 0.4 0.0 1.4 0.0 1.8 0.0 11.1 3.3 0.9 1.0 0.6 0.0 0.0 0.2 12.7 1.9 0.4 0.0 0.6 2.8 0.0 0.0 0.0 2.9 0.0 0.9 1.1 1.7 3.6 0.1 0.0 0.5 0.0 1.8 42.8 0.0 0.0 0.4 7.7 2.1 0.4 4.8 0.0 0.1 0.2 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "kidney: 30.3;salivary gland: 9.5;testis: 8.0" "Cell type enriched" "Detected in single" 9 "Ciliated cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "A549: 10.1" HPA077996 Uncertain Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" 0.9 0.7 0.4 0.6 0.4 0.1 0.9 0.4 0.4 1.4 0.4 0.0 0.7 0.8 1.5 1.6 1.9 0.7 0.2 1.4 0.4 0.3 30.3 0.4 0.7 0.1 0.3 0.0 1.7 2.7 1.1 0.4 1.4 0.3 1.5 0.2 2.2 9.5 1.9 0.4 0.4 0.6 1.9 0.4 1.1 0.4 8.0 0.0 0.0 1.7 0.0 1.5 1.1 0.5 0.5 1.5 1.3 0.8 0.9 0.2 0.2 0.0 10.1 0.0 0.0 0.2 0.8 1.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 1.1 0.0 0.0 0.7 0.6 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.2 0.2 0.1 0.4 0.0 0.1 1.5 0.5 0.1 0.1 1.3 0.9 0.4 0.3 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 278.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Cell line enriched" "Detected in some" 4 "HAP1: 19.4" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles NA NA Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.1 0.1 1.3 3.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.4 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.2 0.0 0.0 1.2 4.5 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 1.0 0.0 1.3 0.0 0.2 0.0 0.4 0.2 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 3.0 4.0 0.0 0.9 0.3 9.5 4.8 2.5 1.4 4.5 15.7 62.8 0.0 5.0 0.0 3.9 1.3 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.0 0.2 1.6 14.8 0.6 0.0 1.7 5.2 1.1 0.0 0.0 0.0 278.6 0.1 0.0 8.5 25.8 4.7 0.0 1.0 1.5 0.4 0.6 0.2 0.8 0.0 0.3 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933808 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 26.0" "Cell type enriched" "Detected in single" 8 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA063175 Uncertain NA NA "HPA063175: AB_2684954" "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.1 0.0 0.8 0.4 0.7 0.5 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 1.1 0.7 26.0 0.1 0.1 0.2 1.6 0.4 0.1 0.3 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.1 0.2 0.1 0.1 0.1 3.5 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.5 1.1 0.7 1.6 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144892-129169697 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 56.8" "Cell type enhanced" "Detected in many" 11 "Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.3;naive B-cell: 6.4" "Group enriched" "Detected in many" 5 "B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules NA NA Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favorable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 2.8 3.5 7.4 13.4 7.7 3.8 3.5 7.5 10.0 1.9 4.3 9.9 8.7 3.8 1.5 15.9 3.4 2.6 3.8 5.4 7.2 12.4 56.8 17.2 3.2 15.9 12.1 6.5 1.8 13.0 9.4 13.0 4.6 7.9 8.0 4.8 5.5 20.5 9.5 7.1 4.5 7.1 2.8 8.0 13.7 4.3 6.8 6.0 10.4 8.5 2.9 19.6 6.2 2.4 6.4 2.8 0.2 3.2 0.4 0.9 2.1 1.2 2.7 0.8 20.9 0.0 0.0 1.0 0.0 0.2 0.5 0.2 0.4 1.9 15.8 1.6 0.5 12.2 1.4 10.8 3.3 0.8 13.4 8.3 32.6 0.8 5.9 0.8 4.5 0.6 0.6 3.3 0.1 1.1 0.0 0.5 9.4 0.3 2.0 0.0 3.6 9.5 0.1 6.0 0.9 2.9 2.9 0.4 0.4 1.7 3.9 4.9 5.9 2.0 0.6 11.0 6.2 4.5 1.9 0.0 0.0 1.5 1.7 0.5 38.6 4.5 6.8 0.3 14.5 2.0 0.0 1.1 0.0 0.1 3.2 0.0 5.3 0.1 0.0 2.8 6.4 0.9 0.1 0.2 0.4 0.2 1.1 0.0 2.1 7.4 7.7 7.5 10.0 7.2 12.4 12.1 6.5 7.9 6.0 0.0 1.1 24.2 0.8 2.3 3.8 5.6 0.0 2.7 0.0 5.2 3.9 0.1 11.6 2.0 2.0 0.4 0.8 0.0 7.4 0.2 1.1 2.5 0.0 12.5 7.1 0.0 3.4 0.6 17.8 3.3 2.6 25.0 1.7 64.9 0.3 4.8 3.0 0.0 30.8 50.8 1.4 0.0 0.0 0.5 0.7 2.6 0.1 1.5 0.2 1.0 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 111.7;liver: 50.1;urinary bladder: 32.7" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 19.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 40.4;OE19: 160.5" "CAB009819, HPA054065" Enhanced NA NA "CAB009819: AB_2241481, HPA054065: AB_2682367" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 0.5 0.2 0.5 2.0 0.3 0.9 13.0 0.0 1.1 0.1 0.1 0.0 111.7 50.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.3 0.1 3.3 0.4 0.1 1.3 1.2 0.1 3.8 1.2 2.3 0.1 0.1 8.1 0.2 0.1 0.5 0.2 5.6 8.7 32.7 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.0 11.3 0.0 0.1 40.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 160.5 0.0 0.0 0.0 0.0 0.4 20.4 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.3 0.0 0.0 4.5 1.8 0.0 0.0 0.0 0.0 37.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.6 0.0 19.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 2.1 UGT1A9 "HLUGP4, LUGP4, UGT1AI" ENSG00000241119 "UDP glucuronosyltransferase family 1 member A9" O60656 2 233671853-233773300 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 169.8" "Cell type enhanced" "Detected in some" 29 "Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3" "Group enriched" "Detected in some" 157 "liver cancer: 16.1;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "A549: 4.9;RT4: 4.0" NA NA "unprognostic (2.46e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (5.04e-5)" "unprognostic (4.26e-2)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A1 ENSG00000173610 "UDP glucuronosyltransferase family 2 member A1 complex locus" Q9Y4X1 4 69588417-69653249 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 10.6;liver: 14.5;pituitary gland: 21.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 32.3" "Cancer enhanced" "Detected in some" "liver cancer: 0.7" "Region enriched" "Detected in single" 17 "pons and medulla: 1.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6" "HPA017261, HPA045108" Uncertain NA NA "HPA017261: AB_10963582, HPA045108: AB_2679218" "unprognostic (3.93e-3)" "unprognostic (5.62e-1)" "unprognostic (1.28e-4)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 14.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 2.0 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 1.7 0.5 0.4 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.3 0.2 0.1 2.0 0.9 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A2 ENSG00000271271 "UDP glucuronosyltransferase family 2 member A2" Q9Y4X1 4 69589309-69639642 "Enzymes, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 2.6" "Not detected" "Not detected" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951791 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 150.5;kidney: 43.2" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 9 "Hep G2: 21.0" HPA045108 Supported NA NA "HPA045108: AB_2679218" "prognostic favorable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favorable (6.07e-7)" "unprognostic (2.10e-2)" 0.1 0.1 0.1 4.3 0.1 0.0 0.7 0.1 0.1 0.1 63.8 0.1 0.1 31.9 0.1 1.7 0.1 0.1 14.6 0.3 0.1 0.1 43.2 9.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.1 0.1 0.1 0.1 8.6 0.1 0.1 0.1 0.1 0.1 150.5 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 94.3 0.0 0.0 3.5 0.0 0.0 10.0 21.3 0.0 0.0 115.5 0.0 2.3 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 28.2 0.0 6.0 52.6 0.0 125.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 UGT2B7 UGT2B9 ENSG00000171234 "UDP glucuronosyltransferase family 2 member B7" P16662 4 69051363-69112987 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 125.4;liver: 156.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 539.4;Proximal tubular cells: 775.7" "Group enriched" "Detected in many" 7 "liver cancer: 116.4;renal cancer: 101.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 21.0;RPTEC TERT1: 83.6" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic favorable (7.65e-5)" "unprognostic (1.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-2)" "unprognostic (5.41e-3)" "unprognostic (1.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" "prognostic favorable (3.79e-4)" "unprognostic (1.08e-2)" "unprognostic (2.55e-1)" "unprognostic (6.23e-3)" "prognostic favorable (5.38e-4)" 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 3.1 7.9 0.1 2.5 6.4 0.6 4.7 0.1 4.7 1.5 0.1 0.1 0.1 125.4 156.0 0.2 0.1 0.1 0.1 0.6 14.7 0.0 0.1 0.2 0.1 0.3 0.4 0.2 1.0 2.7 0.3 0.2 27.7 0.1 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 83.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 3.9 0.6 0.1 0.0 0.0 58.6 0.0 0.0 118.7 0.0 0.0 82.9 5.6 0.2 0.0 6.7 0.0 9.1 0.0 0.0 0.4 0.0 539.4 0.1 0.0 3.4 6.2 10.7 0.0 1.7 0.0 3.3 0.0 20.1 0.0 11.8 11.9 0.0 775.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 2.0 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 25.3" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 47.1 0.0 0.0 3.3 0.0 91.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.1 0.0 0.0 2.5 2.2 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 58.6 0.3 6.5 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 UMOD ENSG00000169344 Uromodulin P07911 16 20333052-20356301 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 417 "kidney: 237.4" "Group enriched" "Detected in some" 383 "Collecting duct cells: 235.5;Distal tubular cells: 805.7" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "EFO-21: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" NA NA 55000000 83000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 235.5 0.0 0.0 805.7 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026911-41039217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 52.2;kidney: 60.9;liver: 29.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 40.8;Collecting duct cells: 21.0;Exocrine glandular cells: 59.0;Hepatocytes: 25.2;Pancreatic endocrine cells: 25.3;Proximal tubular cells: 29.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 31.1;RPTEC TERT1: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015725 Enhanced Approved Centrosome NA NA Centrosome "HPA015725: AB_2669283" "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 0.4 0.2 0.4 0.6 0.4 0.3 0.5 0.4 0.4 0.4 9.9 0.5 0.4 23.7 0.8 0.8 0.5 0.7 10.2 0.4 0.4 0.1 60.9 29.9 0.9 0.4 0.4 0.4 0.5 17.7 0.1 0.6 0.8 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.6 52.2 0.4 0.4 1.2 15.9 0.6 0.4 0.4 0.7 0.4 0.4 0.4 0.4 0.3 1.0 0.7 0.3 0.0 2.4 0.2 0.3 0.1 0.4 0.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.9 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.2 0.0 0.7 0.9 0.4 0.0 2.6 0.1 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.0 2.0 0.3 0.3 0.0 0.1 0.6 1.5 0.2 31.1 0.1 0.6 0.0 0.3 9.5 0.0 0.4 0.4 0.0 0.0 0.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.0 3.1 1.5 0.4 0.0 1.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.2 0.7 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.3 1.0 2.4 0.2 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 3.0 1.4 0.9 0.6 0.7 0.2 0.6 40.8 0.0 0.0 21.0 3.9 0.4 3.3 14.5 1.7 0.2 5.9 0.0 59.0 0.7 0.4 0.5 0.0 25.2 0.3 1.6 1.2 1.3 0.6 0.0 0.3 1.0 1.7 1.0 2.7 0.3 25.3 1.5 0.7 29.6 0.3 0.0 0.3 0.4 0.7 0.1 0.7 0.5 4.1 0.3 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 11.6;Proximal tubular cells: 23.3" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.9 0.0 0.7 0.8 0.9 0.0 0.0 0.0 0.1 1.1 0.6 1.2 1.4 0.3 0.0 0.3 0.6 0.6 0.4 0.4 0.5 0.0 0.4 0.8 0.1 0.0 0.2 0.2 0.0 0.0 1.2 0.1 0.4 0.3 1.2 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 USH1C "AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C" ENSG00000006611 "USH1 protein network component harmonin" Q9Y6N9 11 17493895-17544416 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Hearing" "Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 26.0;intestine: 57.0;kidney: 22.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 240.3;Muller glia cells: 140.5;Paneth cells: 192.9;Proximal tubular cells: 119.4;Undifferentiated cells: 94.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 31.4;HeLa: 11.2;OE19: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013690, HPA027398, HPA027492, HPA028033" Enhanced Enhanced Cytosol No NA Cytosol "CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782" "unprognostic (3.60e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-1)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.51e-2)" "unprognostic (9.65e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" 0.1 0.1 1.6 4.3 7.1 0.0 0.0 0.8 3.3 0.1 23.8 6.2 0.0 40.5 0.0 6.3 0.0 1.3 26.0 0.3 5.0 2.3 22.1 0.4 0.0 0.0 4.8 1.9 0.3 2.1 0.0 5.2 0.0 3.5 0.1 20.7 1.8 0.0 0.1 0.0 0.0 57.0 0.9 10.2 0.0 11.5 0.2 3.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.4 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 7.1 0.8 2.3 5.0 2.3 4.8 1.9 3.5 3.6 0.0 0.0 0.8 0.0 0.0 0.7 0.6 48.4 0.0 1.2 5.2 2.0 0.0 18.3 18.8 1.0 0.0 240.3 0.0 25.0 0.0 0.0 0.0 4.6 0.0 0.0 1.6 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 140.5 34.3 192.9 0.0 119.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 94.1 0.0 VAV3 ENSG00000134215 "Vav guanine nucleotide exchange factor 3" Q9UKW4 1 107571160-107965144 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.5;placenta: 54.4" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 99.5;Syncytiotrophoblasts: 205.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 19.1;RH-30: 23.5;RPTEC TERT1: 33.0;T-47d: 40.3" "Low region specificity" "Detected in all" CAB002012 Uncertain NA NA "CAB002012: " "unprognostic (4.80e-3)" "unprognostic (7.99e-3)" "unprognostic (5.31e-3)" "unprognostic (3.78e-3)" "unprognostic (1.15e-1)" "unprognostic (1.67e-3)" "unprognostic (6.84e-2)" "unprognostic (2.34e-2)" "unprognostic (3.39e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.60e-8)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-2)" "unprognostic (1.23e-2)" 2.3 1.2 1.8 12.2 2.4 7.1 15.2 2.7 3.0 11.4 17.5 0.8 6.4 3.8 3.3 4.8 32.6 1.6 1.7 2.0 1.2 1.9 47.5 1.1 7.1 8.6 3.8 0.8 1.0 7.3 0.5 2.0 54.4 3.1 6.2 22.2 6.9 6.3 5.3 0.8 27.1 7.6 2.1 1.0 13.1 3.7 2.5 0.4 8.9 4.2 17.6 17.6 7.3 11.5 4.4 4.8 6.8 1.1 3.8 4.6 1.1 0.0 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.3 0.2 0.0 0.0 0.0 1.7 6.4 2.3 3.7 0.0 5.9 2.5 0.0 13.9 0.0 0.4 0.0 0.0 3.2 0.0 5.0 0.0 2.0 12.2 1.5 1.9 0.0 0.4 19.1 23.5 0.1 33.0 10.9 1.1 1.0 6.1 2.7 0.1 0.6 40.3 10.9 0.4 0.2 0.0 0.0 0.2 3.0 1.1 0.2 5.0 9.6 0.4 6.8 1.1 1.4 4.1 1.0 2.3 2.9 1.2 2.0 4.8 4.4 0.3 2.9 3.3 3.8 0.4 3.1 4.6 1.1 1.8 2.4 2.7 3.0 1.2 1.9 3.8 0.8 3.1 0.4 0.0 1.7 22.9 10.8 10.4 14.6 1.7 2.5 13.4 19.4 48.8 2.0 73.5 99.5 3.9 44.5 6.3 29.0 0.0 0.0 24.7 2.6 1.9 7.0 0.0 20.4 0.0 20.3 12.9 16.3 31.8 0.3 12.8 3.3 0.0 25.9 1.8 0.1 43.2 0.4 39.3 28.4 6.5 1.0 0.6 0.5 18.3 205.7 14.1 47.7 1.3 VCAM1 CD106 ENSG00000162692 "Vascular cell adhesion molecule 1" P19320 1 100719742-100739045 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "kidney: 69.6;lymphoid tissue: 129.2" "Cell type enhanced" "Detected in many" 21 "Ductal cells: 130.8;Ito cells: 82.3;Kupffer cells: 410.3;Proximal tubular cells: 200.7" "Cancer enriched" "Detected in all" 8 "renal cancer: 89.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.9" "Group enriched" "Detected in some" 5 "HHSteC: 58.3;HSkMC: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000154, HPA034796, HPA069867" Enhanced Supported "Cell Junctions" NA NA 624000000 960000000 "Cell Junctions" "CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215" "unprognostic (2.96e-1)" "prognostic favorable (3.82e-4)" "unprognostic (1.31e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.19e-5)" "unprognostic (1.60e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (3.95e-2)" "unprognostic (8.23e-2)" "unprognostic (1.80e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.55e-2)" 10.9 18.1 1.5 20.2 3.2 1.3 5.2 0.9 1.1 3.7 5.0 3.3 1.4 3.3 4.9 4.5 5.3 4.9 6.8 7.2 1.7 2.3 69.6 11.8 9.8 26.8 2.8 1.7 11.1 6.6 10.6 3.5 10.9 4.2 8.3 5.5 15.3 4.9 1.1 4.7 1.8 6.3 4.2 3.7 129.2 3.0 2.5 1.6 13.3 3.5 2.8 20.9 8.2 2.8 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.3 0.1 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 58.3 0.0 0.0 38.9 0.0 10.2 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 3.2 0.9 1.1 1.7 2.3 2.8 1.7 4.2 1.6 0.0 6.4 2.4 0.1 8.9 0.0 2.0 0.0 2.7 0.0 3.5 0.0 0.9 8.3 130.8 0.1 16.1 0.0 0.0 2.7 0.8 67.5 0.6 1.1 2.5 3.0 0.0 0.0 82.3 410.3 0.0 15.8 1.9 1.7 0.0 0.0 3.0 2.6 0.0 7.1 200.7 0.0 0.0 14.0 0.0 0.0 6.5 2.3 1.5 0.0 0.0 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 74.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 74.4 0.0 9.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.2 0.0 4.0 10.3 52.4 0.0 1.7 0.0 73.6 1.6 0.0 0.0 0.0 31.1 1.1 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.9 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 64.1;thyroid gland: 36.3" "Group enriched" "Detected in some" 5 "Collecting duct cells: 21.0;Hepatocytes: 38.9;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.1;OE19: 14.9;RPMI-8226: 13.9;RPTEC TERT1: 9.1;SuSa: 13.6;U-266/70: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles NA NA Vesicles "HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133" "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favorable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.7 0.2 0.1 3.0 0.8 0.6 4.9 0.3 0.8 4.6 0.2 0.1 0.1 64.1 13.1 0.8 0.1 0.1 0.1 0.5 1.3 1.5 0.9 0.8 0.1 0.2 0.1 0.3 11.2 0.4 0.1 1.1 0.6 0.1 0.1 0.1 0.2 1.1 0.1 0.1 36.3 0.4 0.5 0.6 0.1 0.2 0.0 0.1 0.0 0.2 0.8 0.1 0.0 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.6 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 14.9 0.1 0.0 0.1 13.9 9.1 2.9 1.6 0.0 0.0 0.1 0.0 13.6 2.0 0.0 0.1 0.3 0.4 0.0 0.1 6.4 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.0 5.1 0.0 0.8 0.1 0.4 0.4 7.6 0.0 0.0 21.0 0.0 0.3 8.3 1.0 0.9 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.0 38.9 0.1 3.2 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 75.4 0.0 0.0 0.0 1.1 0.9 0.4 0.1 0.0 0.3 4.9 WFDC2 "dJ461P17.6, EDDM4, HE4, WAP5" ENSG00000101443 "WAP four-disulfide core domain 2" Q14508 20 45469706-45481532 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1206.7;Ciliated cells: 1080.1;Club cells: 1101.0;Collecting duct cells: 1886.1;Mucus-secreting cells: 1147.4;Urothelial cells: 3035.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 1815.6" "Region enriched" "Detected in single" 5 "basal ganglia: 3.0" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Group enriched" "Detected in some" 9 "A-431: 26.9;CAPAN-2: 50.2;EFO-21: 42.0;HaCaT: 36.6;RPTEC TERT1: 38.9" "Low region specificity" "Detected in some" HPA042302 Enhanced "Secreted in other tissues" NA NA 1300000 "HPA042302: AB_2677939" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (4.37e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (7.19e-3)" "unprognostic (1.94e-1)" "unprognostic (5.49e-3)" "unprognostic (3.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.42e-1)" "unprognostic (1.40e-1)" "prognostic favorable (4.44e-5)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" "unprognostic (3.20e-2)" 1.2 0.1 0.3 1.5 3.0 0.0 10.6 0.2 0.6 352.3 11.0 0.4 143.4 0.7 19.4 385.4 4.5 44.6 10.4 0.4 0.3 0.3 135.1 9.9 31.6 0.2 0.3 0.3 20.4 5.0 5.0 14.9 1.3 0.5 27.2 14.7 2.2 343.7 60.9 0.2 2.8 5.0 10.9 0.2 0.1 3.8 15.6 0.5 0.7 45.5 15.3 29.1 21.9 6.9 0.0 1.2 0.0 0.0 0.0 0.0 0.1 26.9 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 50.2 0.0 42.0 0.0 0.1 36.6 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.6 4.4 0.1 0.0 0.0 0.0 0.0 38.9 0.3 1.2 0.2 2.5 0.0 0.2 0.5 0.7 0.1 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 3.0 0.2 0.6 0.3 0.3 0.3 0.3 0.5 0.5 157.8 201.9 2.7 1206.7 7.9 23.5 1.2 107.0 1080.1 1101.0 1886.1 21.6 0.7 187.3 214.0 0.9 0.6 87.9 0.0 117.6 0.6 4.1 847.7 9.3 1.1 1.6 0.0 406.4 3.1 1.2 2.7 33.4 5.6 10.1 10.0 1147.4 14.8 130.4 454.8 0.0 77.8 4.2 6.5 11.9 11.6 11.0 12.3 0.6 1.3 278.2 3035.7 WNK4 PRKWNK4 ENSG00000126562 "WNK lysine deficient protein kinase 4" Q96J92 17 42780678-42796936 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.1;ovary: 14.6" "Group enriched" "Detected in some" 7 "Distal tubular cells: 135.9;Mucus-secreting cells: 39.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 19.9;K-562: 22.2;TIME: 21.4;WM-115: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016500 Approved NA NA "HPA016500: AB_10962984" "unprognostic (6.34e-3)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (2.48e-1)" "unprognostic (1.69e-1)" "unprognostic (5.84e-2)" "unprognostic (3.94e-1)" "unprognostic (2.08e-3)" "unprognostic (4.33e-3)" "unprognostic (7.70e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (1.43e-1)" "unprognostic (7.99e-2)" 1.1 0.0 0.8 5.8 0.2 0.0 2.6 0.6 0.3 0.7 12.9 0.4 0.4 2.1 0.2 2.8 8.7 0.5 1.0 0.2 2.6 0.0 28.1 0.2 0.4 0.1 0.1 0.3 14.6 1.0 0.0 2.4 0.0 1.7 11.1 11.7 12.2 1.4 1.2 0.0 0.5 3.3 0.4 0.8 0.1 2.6 0.4 0.2 0.0 0.0 0.2 2.0 0.3 0.4 0.4 0.0 0.0 0.3 0.0 1.0 0.0 1.2 0.6 0.2 0.0 0.2 0.1 2.9 7.4 2.9 2.8 0.9 0.4 0.5 0.2 4.4 19.9 0.7 0.0 0.1 0.2 4.8 0.4 1.0 0.0 0.0 2.9 4.7 0.0 0.4 2.5 0.4 4.0 1.2 1.4 0.2 0.2 22.2 0.7 0.0 0.6 0.0 0.5 0.2 1.2 5.1 0.3 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.1 1.0 2.7 1.4 1.6 21.4 0.2 1.9 0.2 0.1 3.6 3.1 0.7 0.0 1.2 14.5 0.0 0.3 0.0 0.0 0.0 0.7 0.4 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.3 2.6 0.0 0.1 0.3 1.7 0.2 0.0 1.1 0.0 0.1 0.0 0.2 0.7 2.5 5.3 1.2 7.0 0.0 0.0 135.9 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 6.5 4.6 0.0 0.0 0.0 12.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.1 2.9 0.4 0.5 0.3 0.0 0.3 0.7 0.8 0.4 0.0 0.0 13.3 0.1 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738974-129769538 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 145.6;kidney: 49.7" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2" "Group enriched" "Detected in many" 7 "monocytes: 4.4;T-cells: 7.3" "Cell line enhanced" "Detected in some" "ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 8900000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 4.7 0.5 0.0 1.1 0.1 0.0 3.2 0.0 0.1 1.7 57.4 0.1 0.8 37.0 1.2 1.7 4.2 3.4 1.3 2.6 0.0 0.0 49.7 8.0 1.0 1.2 0.0 0.0 3.5 0.9 0.0 0.0 0.6 0.1 3.6 2.0 0.7 0.7 0.3 1.6 2.1 145.6 2.5 0.1 0.2 1.7 1.2 0.0 0.1 0.9 1.4 0.3 4.0 10.7 0.4 0.8 0.2 4.4 0.0 7.3 1.3 0.0 0.0 0.5 0.0 6.3 33.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.3 2.1 2.2 0.0 2.4 4.8 0.3 0.4 0.7 3.6 0.2 0.0 4.4 0.8 2.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 5.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 4.4 0.0 0.0 11.6 0.7 0.0 1.2 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 5.8 0.0 49.7 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.0 0.2 0.0 ZNF99 "C19orf9, MGC24986" ENSG00000213973 "Zinc finger protein 99" A8MXY4 19 22752183-22784107 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 5.5;testis: 11.2" "Group enriched" "Detected in some" 6 "Sertoli cells: 19.4;Spermatocytes: 11.2" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.7;NTERA-2: 3.5;SuSa: 2.5" NA NA "unprognostic (8.31e-2)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-2)" "unprognostic (2.28e-1)" "unprognostic (9.83e-2)" "unprognostic (4.22e-2)" "unprognostic (2.65e-1)" "unprognostic (1.92e-3)" "unprognostic (2.61e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (3.49e-1)" "unprognostic (4.05e-3)" "unprognostic (8.55e-2)" 0.7 0.5 1.6 0.4 2.9 1.0 1.1 1.1 2.8 0.8 0.5 0.3 0.0 0.4 1.5 1.3 0.5 0.7 0.4 0.8 1.6 0.6 5.5 0.5 0.5 1.5 0.6 1.4 0.8 0.5 0.3 0.5 0.5 2.4 0.5 0.3 0.3 0.5 0.4 0.7 0.9 0.5 0.7 0.6 0.7 0.5 11.2 0.7 0.4 0.8 0.0 0.3 0.6 0.7 1.1 1.2 2.9 0.6 0.8 0.8 0.2 0.1 0.4 0.2 0.3 0.1 0.0 2.7 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.2 0.1 0.4 3.5 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.4 0.6 0.0 0.3 0.1 2.5 0.8 0.1 0.3 0.2 0.1 1.2 0.2 0.3 0.3 0.2 0.1 0.2 0.0 1.7 0.5 0.5 0.5 0.5 0.4 0.7 0.5 0.3 0.2 1.1 0.8 0.7 2.9 0.8 0.6 1.2 0.4 0.2 1.6 2.9 1.1 2.8 1.6 0.6 0.6 1.4 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.7 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.4 0.0 11.2 2.5 0.0 0.2 0.0 0.0 0.1 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.4" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 1.3 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.4 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0